data_1eiw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eiw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 6' ' ' ARG . 57.2 mt -114.63 162.58 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -93.57 105.09 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.395 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.492 HD11 ' N ' ' A' ' 7' ' ' LEU . 8.9 mp -112.35 168.24 9.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.699 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -153.09 142.19 21.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 mt -130.76 151.45 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 109.643 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 157.44 25.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -85.84 135.07 33.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.89 177.09 20.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -123.99 -12.57 7.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -1.095 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 16' ' ' ASP . 27.9 m -67.81 165.97 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.02 -20.29 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG21 ' A' ' 14' ' ' VAL . 42.8 m-20 -62.1 -32.78 73.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.46 18.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.08 -35.31 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.526 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 18.6 t80 -65.88 -47.99 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -45.92 71.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.633 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -58.36 -49.94 75.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -59.74 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.96 . . . . 0.0 109.439 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -45.5 -38.28 6.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.64 -44.65 93.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -23.07 67.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -51.74 38.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.25 -33.09 6.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -57.76 148.63 24.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -82.16 131.76 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -138.56 145.37 40.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' NH2' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -130.53 147.8 67.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.188 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD2' ' NH2' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.7 101.88 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.459 2.106 . . . . 0.0 110.529 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 6' ' ' ARG . . . -101.81 154.92 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -59.89 164.87 5.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.341 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -77.37 -7.6 17.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.497 2.131 . . . . 0.0 110.114 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -28.6 15.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.3 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.05 46.53 2.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.17 148.35 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -95.43 -26.68 15.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.437 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.9 119.21 10.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.6 t -110.11 100.28 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.659 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG21 HG21 ' A' ' 73' ' ' VAL . 1.4 mt -84.19 106.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 136.68 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 45' ' ' LEU . 4.2 mm? -88.67 128.6 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 109.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.71 4.63 15.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.97 . . . . 0.0 109.486 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.33 -24.02 61.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.61 27.3 3.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 6.6 t-105 -76.83 -42.45 40.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' ' 51' ' ' THR . . . -89.65 28.41 7.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 50' ' ' GLY . 40.0 p -141.08 -58.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.497 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -117.28 50.55 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.331 -0.856 . . . . 0.0 109.601 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -30.09 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -38.14 82.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.44 -55.7 8.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -48.84 -43.29 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mt -45.78 -49.36 15.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' ALA . . . -56.17 -58.79 12.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . . . -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -1.129 . . . . 0.0 109.649 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.91 -53.84 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.24 -53.05 23.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.34 -33.14 73.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.554 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LYS . . . -71.23 -21.67 62.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -71.73 -3.05 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.762 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 64' ' ' ARG . 0.5 OUTLIER -124.99 18.23 8.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.4 m -143.94 45.54 1.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.707 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' SER . 2.8 t 78.21 -3.59 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 109.723 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 50.34 60.01 15.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.301 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.4 Cg_endo -82.1 53.14 4.43 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.57 2.18 . . . . 0.0 109.764 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 63' ' ' ALA . 1.4 mt -99.98 117.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.265 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.9 mt -110.91 131.44 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 m -96.93 129.82 44.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.25 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.465 HG21 HG21 ' A' ' 43' ' ' ILE . 86.9 t -107.72 116.84 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -46.51 154.57 0.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.69 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.11 161.64 29.31 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.751 2.3 . . . . 0.0 110.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.98 -23.75 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.17 37.08 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.02 -32.52 12.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.44 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.57 -143.24 0.14 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.295 -0.878 . . . . 0.0 109.076 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -148.28 140.48 24.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.905 . . . . 0.0 109.424 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.529 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 1.5 t -69.97 142.15 90.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.276 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.547 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.7 Cg_endo -79.33 173.0 13.81 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.524 2.149 . . . . 0.0 110.486 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.23 19.35 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.76 -8.66 23.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.867 -1.146 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.4 -49.41 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.01 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -20.98 5.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.98 26.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 0.0 109.385 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -102.59 144.94 30.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -99.19 -29.45 12.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.235 -0.915 . . . . 0.0 109.231 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.21 155.32 36.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.24 130.55 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.37 -171.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.76 -146.9 5.35 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.463 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 83.7 m95 -89.64 69.87 7.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -1.127 . . . . 0.0 109.495 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 95' ' ' TRP . 6.6 m-20 -141.62 149.21 53.04 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 -38.65 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.681 2.254 . . . . 0.0 110.357 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -74.11 -41.4 61.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.863 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.88 -59.55 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.8 mt -51.81 -30.85 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 0.0 109.611 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -69.46 -37.95 77.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.13 -43.4 92.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.23 62.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.26 -62.01 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.82 -16.96 7.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -68.73 -38.72 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.13 -27.2 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.295 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 1.8 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' HB ' HD11 ' A' ' 7' ' ' LEU . 13.2 mt -138.47 140.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 2.8 mpp_? -94.08 97.6 10.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 5' ' ' ILE . 1.5 mp -107.29 157.23 18.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.43 119.85 31.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.367 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.571 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 20.5 mt -111.54 132.6 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.35 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.99 156.8 44.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.11 -175.41 42.54 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.25 39.25 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -1.085 . . . . 0.0 109.182 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -115.43 -171.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -10.25 57.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -76.51 -74.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.665 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 6.2 t80 -50.82 -26.15 5.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 109.635 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -72.28 -68.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.571 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' ARG . 98.8 t -43.34 -44.94 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.813 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CD2' HD23 ' A' ' 45' ' ' LEU . 66.1 t80 -60.52 -44.62 95.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.689 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.95 -41.16 82.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.72 -45.62 93.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -17.84 63.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.569 HD23 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -72.55 -56.34 5.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 109.506 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.34 -42.24 88.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.61 -20.57 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.6 m -69.73 -61.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.583 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.97 -153.23 19.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.62 159.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.464 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 2.6 mp0 -113.1 95.73 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.722 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' HD13 ' A' ' 9' ' ' ILE . 31.0 p-90 -112.18 169.3 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -144.3 162.79 38.2 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.859 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.9 Cg_endo -78.48 119.48 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.642 2.228 . . . . 0.0 110.273 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' CG ' ' A' ' 6' ' ' ARG . . . -106.37 -177.55 3.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.47 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -93.41 173.26 5.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.3 Cg_endo -78.18 -6.47 15.73 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.607 2.204 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.18 -0.94 16.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.509 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.45 56.04 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.85 119.06 36.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 4.9 t70 -49.94 -41.74 47.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -145.7 154.55 42.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 109.19 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.1 mt -92.74 94.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.413 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.33 130.68 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.864 . . . . 0.0 109.51 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.518 HD23 ' CD2' ' A' ' 20' ' ' PHE . 2.0 mm? -88.49 116.39 26.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB2' ' CH2' ' A' ' 49' ' ' TRP . . . -57.45 -22.19 41.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.28 34.8 3.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.2 mm? -121.08 -27.4 4.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -1.131 . . . . 0.0 109.765 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' A' ' 46' ' ' ALA . 1.9 p90 -65.31 -21.51 66.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.3 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.562 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -58.61 -18.44 37.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 p -110.08 -39.08 5.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.61 57.24 1.51 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 49' ' ' TRP . 4.0 ttt180 -53.73 -22.07 8.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.385 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.94 -42.34 60.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -66.75 -47.9 70.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 49' ' ' TRP . 1.8 mp -60.69 -37.29 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.95 -54.61 44.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.13 64.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.64 74.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.244 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.55 -33.99 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -59.92 -52.4 65.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.31 -30.67 71.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.393 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' CB ' ' CD1' ' A' ' 70' ' ' ILE . . . -72.18 -20.23 61.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -10.13 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.358 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 66' ' ' SER . 11.4 tttp -68.05 -9.23 44.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 14.9 t 68.27 45.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.627 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -110.77 -37.41 5.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -127.25 155.62 76.02 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.092 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' CG ' ' HB1' ' A' ' 107' ' ' ALA . 35.0 Cg_endo -77.3 122.86 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.509 2.139 . . . . 0.0 110.547 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 63' ' ' ALA . 69.0 mt -91.92 127.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.09 113.9 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.336 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 85' ' ' LEU . 19.0 p -96.01 121.53 37.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.478 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 92.3 t -98.91 121.48 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' CZ2' ' A' ' 95' ' ' TRP . 12.0 mmt180 -43.14 151.98 0.4 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.27 151.88 26.8 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.654 2.236 . . . . 0.0 110.525 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -49.22 -49.87 40.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.59 111.59 0.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -167.3 -46.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.362 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.86 -143.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.033 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.27 115.82 15.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 82' ' ' PRO . 78.9 t -50.24 134.27 23.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.26 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 81' ' ' VAL . 35.7 Cg_endo -77.95 148.25 24.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.453 2.102 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.62 -4.09 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.642 2.228 . . . . 0.0 110.47 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.63 -42.91 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 72' ' ' THR . 0.4 OUTLIER -67.71 -31.15 70.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.466 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.38 -0.59 42.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.28 28.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.125 -0.984 . . . . 0.0 109.646 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.85 -0.25 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 m -72.71 128.84 36.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 109.302 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.6 m -89.07 -18.85 26.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.57 142.94 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.863 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.41 115.26 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.014 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.465 ' CG2' ' HB1' ' A' ' 103' ' ' ALA . 86.6 t -88.95 149.94 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.834 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.29 -145.66 15.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.463 ' CZ2' ' O ' ' A' ' 74' ' ' ARG . 67.7 m95 -114.09 57.95 0.69 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 109.584 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -130.93 168.94 15.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.32 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.641 2.227 . . . . 0.0 110.636 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -10.27 56.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -62.68 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mt -51.07 -22.92 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -46.32 41.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.49 -12.86 35.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 93' ' ' VAL . . . -69.31 -60.89 2.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -68.22 -25.48 65.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.2 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.66 -47.35 67.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -22.63 61.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.293 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HB1' ' CG ' ' A' ' 69' ' ' PRO . . . -72.67 -19.62 61.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.503 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.461 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -143.49 149.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.1 126.91 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 mp -134.96 159.41 41.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -112.75 97.52 6.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.475 HG22 ' CE1' ' A' ' 17' ' ' TYR . 44.9 mt -94.94 124.05 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.512 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.59 128.55 29.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 142.46 58.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -0.997 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA3' HD22 ' A' ' 48' ' ' LEU . . . -153.69 170.38 32.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.75 57.73 1.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' O ' ' HD3' ' A' ' 18' ' ' ARG . 1.6 m -142.85 -176.45 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.63 -11.8 60.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -76.84 -55.24 5.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.485 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 3.2 t80 -67.7 -22.38 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.478 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 1.5 mpt_? -73.82 -55.41 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.39 -36.24 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 73' ' ' VAL . 34.6 t80 -64.17 -52.78 57.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.75 -22.61 64.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -76.54 -39.12 53.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.9 65.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -49.32 65.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.95 -20.69 61.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 109.978 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.91 -39.83 95.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 109.658 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 p -49.92 -49.52 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.56 60.23 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.83 154.91 49.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 9.1 tp10 -91.73 59.6 3.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -86.4 160.79 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -151.97 154.49 32.73 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.65 153.95 26.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.683 2.255 . . . . 0.0 110.376 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.23 171.24 17.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.9 168.34 4.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB2' HD23 ' A' ' 62' ' ' LEU . 35.6 Cg_endo -77.82 -9.25 16.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.634 2.223 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 -21.92 25.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 50.87 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.13 103.94 13.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -50.67 -46.73 58.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.315 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -122.25 137.72 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.71 140.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.443 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -137.6 121.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 119.38 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 73' ' ' VAL . 5.7 mt -85.14 125.13 32.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.52 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.04 35.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.51 90.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' HA3' ' A' ' 12' ' ' GLY . 2.4 mt -120.21 24.02 10.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -1.148 . . . . 0.0 109.438 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.517 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 1.5 t90 -81.18 4.72 19.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.97 -4.11 29.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -124.9 -38.8 2.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.126 -1.22 . . . . 0.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.49 ' HG2' ' CB ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -114.11 72.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -74.43 -65.19 0.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.22 -19.1 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.49 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -77.24 -41.71 40.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.692 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 49' ' ' TRP . 45.4 mt -73.18 -35.46 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 8.4 mt -67.19 -32.69 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -46.22 46.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.8 -54.35 47.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -1.124 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.71 -28.37 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 109.438 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -63.83 -46.94 82.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 36' ' ' PRO . 8.7 tp -69.04 -32.87 72.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.44 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.481 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . . . -74.62 -19.05 60.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.299 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -10.3 32.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' SER . 10.1 tptm -61.0 -14.08 20.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 5.6 t 73.7 68.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 p -154.06 -39.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -106.86 153.41 40.83 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -78.28 119.18 4.51 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.715 2.277 . . . . 0.0 110.356 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 23.5 mt -94.13 122.64 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.501 ' CG2' HG11 ' A' ' 93' ' ' VAL . 14.5 mt -115.64 117.58 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 93' ' ' VAL . 86.2 m -83.34 146.08 28.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 45' ' ' LEU . 43.3 t -120.2 114.96 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.72 146.63 45.41 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.361 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 165.92 24.65 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.662 2.241 . . . . 0.0 110.49 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.425 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -79.33 -26.02 42.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 78' ' ' LEU . . . -89.2 -13.83 61.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 29.4 tp 61.29 90.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 17.18 21.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 81' ' ' VAL . 10.8 m-80 56.34 82.91 0.1 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -44.52 147.21 1.07 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 170.51 19.16 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.517 2.145 . . . . 0.0 110.435 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 2.71 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.619 2.213 . . . . 0.0 110.518 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -83.06 -44.6 14.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -5.65 59.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.08 -12.78 49.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.42 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.14 13.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 98.81 12.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -30.2 67.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -155.26 127.61 7.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.84 128.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.501 HG11 ' CG2' ' A' ' 71' ' ' ILE . 7.3 p -128.29 145.29 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.649 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.09 -145.77 10.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -91.2 17.47 8.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -1.165 . . . . 0.0 109.394 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' CB ' ' HB2' ' A' ' 99' ' ' CYS . 2.5 m-20 -65.27 153.21 90.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.71 -57.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -77.06 -20.37 55.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.315 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -71.3 -13.0 61.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.07 -1.019 . . . . 0.0 109.901 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 96' ' ' ASN . 17.6 mm -75.74 -38.21 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -77.17 -31.45 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.3 -26.97 63.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.5 -67.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.417 ' O ' ' HB1' ' A' ' 107' ' ' ALA . 76.9 mt -53.1 -35.09 59.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.927 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.01 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.614 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -20.85 3.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 104' ' ' LEU . . . -77.3 -39.96 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 109.599 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.706 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.525 ' CG2' ' OD2' ' A' ' 40' ' ' ASP . 10.9 mt -145.42 143.06 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 40' ' ' ASP . 21.1 mtt85 -85.1 105.64 15.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.226 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 43' ' ' ILE . 8.0 mp -105.11 168.49 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.674 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 40.3 t80 -152.73 106.95 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 20.8 mt -102.67 135.79 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -51.68 136.4 27.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.161 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.453 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -58.78 131.75 51.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.504 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.91 146.6 17.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.85 17.1 17.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.12 -173.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.37 -11.2 38.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 2.5 m-20 -73.01 -32.36 65.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 23.3 t80 -71.31 -29.73 65.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -75.29 -47.96 25.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.29 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 93.4 t -61.54 -40.61 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.382 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -64.53 -58.01 7.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' CD1' HD13 ' A' ' 9' ' ' ILE . 3.9 tp -55.95 -22.58 27.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 19' ' ' VAL . 73.8 mt-10 -70.47 -55.13 9.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -57.88 -32.7 67.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.06 -58.68 6.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.887 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -70.53 -19.09 62.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -60.54 -41.65 94.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.351 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 16.0 t 174.39 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.59 58.38 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.63 161.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.299 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 148.41 22.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -149.68 174.24 12.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.13 147.74 42.11 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 103.55 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.655 2.236 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . -100.89 -169.61 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.93 168.2 24.52 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.5 Cg_endo -77.75 -8.37 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.615 2.21 . . . . 0.0 110.345 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.18 -6.97 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.21 53.98 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' CB ' ' HB2' ' A' ' 8' ' ' TYR . . . -105.19 124.46 49.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.396 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.525 ' OD2' ' CG2' ' A' ' 5' ' ' ILE . 12.6 t70 -52.02 -30.04 23.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.91 124.2 10.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.693 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -97.28 96.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.027 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CG2' ' A' ' 73' ' ' VAL . 76.7 mt -92.52 107.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.07 133.41 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.37 120.56 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.446 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 81' ' ' VAL . . . -70.16 -15.54 62.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -22.57 71.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 11' ' ' GLU . 11.1 mp -89.28 13.69 12.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -1.18 . . . . 0.0 109.529 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.522 ' CH2' ' CG ' ' A' ' 82' ' ' PRO . 4.8 t-105 -72.72 -30.33 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.64 27.28 21.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 p -135.4 -39.02 0.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -1.179 . . . . 0.0 109.45 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' CB ' ' HB2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -141.47 71.69 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.298 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -52.9 -56.24 17.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -56.27 -38.47 71.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 109.614 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -56.65 -47.99 78.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.424 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.06 -33.36 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 108.872 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.75 -21.43 60.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.113 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.15 -54.95 4.98 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.51 89.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.173 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 70.2 t -58.44 -44.18 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.253 -0.904 . . . . 0.0 109.046 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -58.03 -40.57 81.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.37 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.91 -28.25 66.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -76.83 -28.18 55.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.407 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 40.3 mtp85 -75.92 0.1 19.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -84.02 -30.04 26.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.402 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.44 20.64 3.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.01 23.1 1.02 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.706 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -47.44 163.59 0.26 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 113.98 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.634 2.223 . . . . 0.0 110.603 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 63' ' ' ALA . 2.1 mt -113.7 108.03 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.368 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 25.1 mt -96.36 124.83 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 73' ' ' VAL . 21.9 m -89.77 156.13 18.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.553 ' CG2' ' CG2' ' A' ' 43' ' ' ILE . 3.4 t -123.89 121.76 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -50.71 150.41 5.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.51 178.13 8.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.499 2.133 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.3 -25.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.95 86.26 0.23 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.0 -82.89 0.48 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -136.82 17.61 3.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 -177.92 0.13 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.522 -0.736 . . . . 0.0 109.472 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 34.0 m -85.98 159.89 53.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.522 ' CG ' ' CH2' ' A' ' 49' ' ' TRP . 34.3 Cg_endo -77.72 174.36 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.658 2.238 . . . . 0.0 110.39 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 35.2 Cg_endo -77.43 -33.01 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.606 2.204 . . . . 0.0 110.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.31 -34.4 70.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.181 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.31 -20.03 20.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.98 -35.23 79.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.112 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.98 -11.82 61.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.227 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.56 7.8 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.1 t -105.59 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -44.09 74.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.467 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -146.95 154.56 41.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 92' ' ' VAL . 4.3 p -117.68 119.15 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.95 163.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.53 -157.94 9.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 30.1 m95 -88.74 38.82 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 109.246 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.419 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -103.01 151.22 38.39 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 -46.73 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.67 2.247 . . . . 0.0 110.327 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.14 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.62 -54.2 31.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.539 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 96' ' ' ASN . 31.5 mm -47.38 -24.51 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.46 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -52.65 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.614 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.48 -14.8 59.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.38 -48.16 24.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.786 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.3 -25.87 51.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -74.88 -21.81 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -37.69 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.603 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.32 -55.72 19.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.339 0.59 . . . . 0.0 109.655 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.448 HD13 ' CD1' ' A' ' 108' ' ' LEU . 3.3 tt -131.67 156.67 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.454 ' HG2' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -111.47 127.5 55.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.831 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -128.34 169.7 13.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.87 . . . . 0.0 109.212 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -128.78 102.47 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.626 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 HG23 ' CE1' ' A' ' 17' ' ' TYR . 15.6 mt -100.09 143.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -73.62 -170.34 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.589 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 1.3 pt-20 -135.15 109.04 8.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.0 173.14 15.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.6 tm-20 -115.63 28.3 8.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 109.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.12 158.22 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 109.679 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.3 -9.97 38.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 2.6 m-20 -72.39 -48.63 40.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.555 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CE1' HG23 ' A' ' 9' ' ' ILE . 11.6 t80 -65.12 -26.1 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -70.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.598 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.5 t -49.87 -31.96 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.479 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CE1' ' CD1' ' A' ' 24' ' ' LEU . 31.6 t80 -68.02 -48.23 66.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -41.05 74.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.21 -33.74 76.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -15.69 59.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.518 ' CD1' ' CE1' ' A' ' 20' ' ' PHE . 1.7 tp -74.65 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 26' ' ' GLN . 2.4 pt-20 -59.9 -20.68 58.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -52.35 -41.03 62.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.287 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -26.9 60.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 102.21 -132.47 11.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER 62.75 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.124 . . . . 0.0 109.395 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 85.3 mt-10 -88.74 111.26 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -120.04 156.64 30.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -137.69 159.95 66.92 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.4 Cg_endo -77.79 130.8 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.653 2.235 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -116.63 -165.92 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.518 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -101.99 175.16 2.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.548 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.7 Cg_endo -77.62 -19.36 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.566 2.177 . . . . 0.0 110.405 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -112.39 -6.55 14.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -138.54 49.1 1.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . . . -104.95 133.13 50.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -34.01 76.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 109.322 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -149.68 123.84 9.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 21.7 t -79.9 156.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 109.849 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG12 ' HB ' ' A' ' 71' ' ' ILE . 13.3 mt -147.05 102.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 108.98 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.97 137.34 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.748 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' N ' HD21 ' A' ' 45' ' ' LEU . 3.9 mm? -84.12 131.47 34.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -76.59 -36.7 57.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.95 34.56 3.89 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -125.41 -26.65 3.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.811 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 46' ' ' ALA . 1.7 p90 -57.67 -18.56 21.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.018 -1.051 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.538 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -42.27 -29.9 0.72 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -47.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.63 47.95 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -45.06 85.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -67.33 -31.47 71.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.899 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.94 -59.42 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' HG21 ' A' ' 60' ' ' VAL . 3.0 mp -54.96 -57.79 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.24 -26.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.855 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.06 -68.16 1.73 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -48.53 -37.0 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -1.12 . . . . 0.0 109.988 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 56' ' ' ILE . 58.8 t -59.62 -60.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.58 -58.65 6.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.433 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -50.53 -27.15 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 59' ' ' ALA . . . -70.93 -45.11 64.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -68.29 -7.59 32.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -57.37 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -79.69 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 p 179.01 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -87.04 154.72 55.19 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.434 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.455 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -77.9 116.87 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.701 2.268 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 95.6 mt -95.04 111.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.324 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.465 ' HB ' HG12 ' A' ' 43' ' ' ILE . 35.5 mm -94.33 91.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.722 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -88.06 128.86 35.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 45' ' ' LEU . 58.2 t -98.65 132.35 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -64.05 171.53 2.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 34.8 Cg_endo -77.31 163.49 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.62 2.213 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.2 -15.64 63.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.9 46.54 0.77 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 7.21 3.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -1.092 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -151.68 -143.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.237 -0.914 . . . . 0.0 108.995 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -145.6 153.79 41.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.6 134.87 19.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.84 150.33 23.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.502 2.135 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.12 -20.49 11.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.193 . . . . 0.0 110.467 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.27 -34.69 74.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.624 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.79 55.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.655 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -69.21 -18.75 63.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.01 -7.97 59.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.38 33.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 134.07 55.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -99.84 -31.59 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' OE2' ' HB2' ' A' ' 106' ' ' ASP . 4.0 mt-10 -136.14 118.54 15.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.595 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.99 128.57 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.248 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.526 ' CG1' ' HB1' ' A' ' 103' ' ' ALA . 2.8 m -123.93 165.28 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.71 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.72 -146.57 21.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.98 66.83 0.66 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -1.158 . . . . 0.0 109.586 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -138.44 152.57 71.47 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.31 -41.89 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.619 2.213 . . . . 0.0 110.554 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -76.93 -31.57 56.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.659 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -42.15 67.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.497 HD13 ' CE2' ' A' ' 20' ' ' PHE . 35.6 mt -59.22 -41.94 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.661 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -64.16 -42.09 96.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.725 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -31.09 63.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -0.86 . . . . 0.0 109.783 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 93' ' ' VAL . . . -74.21 -43.18 58.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.732 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.01 -33.55 73.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.675 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -51.94 -28.17 15.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.432 ' HB2' ' OE2' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -67.81 -49.83 60.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.877 . . . . 0.0 109.728 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.28 -43.24 67.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.651 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.448 ' CD1' HD13 ' A' ' 5' ' ' ILE . 1.2 tp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.276 0.56 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.412 ' CG2' HD13 ' A' ' 7' ' ' LEU . 31.6 mt -119.08 139.25 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -92.56 112.29 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 109.319 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.416 ' CD2' HD13 ' A' ' 43' ' ' ILE . 3.7 mp -120.76 153.45 36.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 15.5 t80 -123.94 108.95 12.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 45' ' ' LEU . 1.7 mt -107.74 142.12 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -47.91 145.92 2.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.445 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.04 125.83 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.0 179.57 37.27 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -117.57 -3.74 11.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 109.736 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.9 170.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 109.55 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -77.75 -19.12 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.515 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.01 -50.76 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CE2' HD22 ' A' ' 21' ' ' LEU . 64.6 t80 -63.91 -28.17 69.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -58.32 5.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.27 -48.57 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -53.37 -37.52 62.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD22 ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.62 -61.53 1.84 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.662 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -51.19 -23.81 3.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -51.09 19.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -73.35 -6.17 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.19 -64.12 1.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.66 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.62 -8.28 26.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.952 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -57.07 9.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.87 -27.54 6.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.87 152.08 32.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.149 . . . . 0.0 109.519 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -99.98 50.97 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.852 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 35.5 p-90 -80.11 158.47 26.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.905 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -144.06 157.43 57.34 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.98 131.74 11.24 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.15 172.25 10.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.923 . . . . 0.0 109.588 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.19 162.04 4.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.499 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.527 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.7 Cg_endo -78.67 2.15 8.43 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.787 2.325 . . . . 0.0 110.668 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.43 15.99 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 109.638 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.18 38.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.527 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 131.78 52.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.84 -37.31 60.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.317 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.48 128.89 22.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.99 110.49 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 97.0 mt -97.23 104.7 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 56' ' ' ILE . 9.2 t -84.95 137.97 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.7 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 9' ' ' ILE . 2.8 mm? -102.88 117.59 34.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.343 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -17.31 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.3 -16.99 37.12 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.84 40.64 3.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -1.221 . . . . 0.0 109.622 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 43.1 t-105 -81.49 -29.91 33.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.73 39.04 2.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -139.12 -50.52 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 56' ' ' ILE . 11.2 mtt180 -130.48 64.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -48.57 -22.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.05 -41.94 40.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 11.8 tt0 -69.31 -30.15 68.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 52' ' ' ARG . 4.3 mm -77.12 -63.74 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.885 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -55.48 -47.91 75.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.957 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -31.59 81.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 55' ' ' GLU . . . -63.03 -62.02 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -1.187 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.78 -46.48 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.418 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.89 -39.26 65.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 1.0 OUTLIER -61.42 -47.18 86.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.211 -0.93 . . . . 0.0 109.265 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.57 ' CB ' ' CG1' ' A' ' 70' ' ' ILE . . . -52.88 -49.19 66.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -26.23 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 15.3 21.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.991 . . . . 0.0 109.632 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' LEU . 43.8 m -143.69 -63.37 0.39 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.355 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 75.5 m -109.55 -91.71 0.45 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.208 -0.933 . . . . 0.0 109.022 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tttp 155.21 -47.19 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.831 -0.543 . . . . 0.0 110.237 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 68' ' ' LYS . 36.2 Cg_endo -78.2 119.16 4.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.092 1.861 . . . . 0.0 110.605 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.57 ' CG1' ' CB ' ' A' ' 63' ' ' ALA . 2.7 mp -125.61 104.86 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 mp -91.02 119.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.42 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.526 ' CG2' HG21 ' A' ' 92' ' ' VAL . 13.3 t -104.45 140.29 38.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 109.757 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.7 125.68 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.128 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.3 164.98 15.44 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 162.44 28.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.608 2.206 . . . . 0.0 110.144 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.93 -57.44 6.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.636 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.3 85.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.0 -67.12 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -1.175 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -115.54 -143.89 0.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.294 -0.879 . . . . 0.0 109.087 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.81 122.49 9.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' A' ' 82' ' ' PRO . 53.7 t -52.2 137.26 38.8 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.4 Cg_endo -78.07 165.41 26.12 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.476 2.118 . . . . 0.0 110.557 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.96 5.27 5.45 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.697 2.265 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.29 -35.07 23.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.96 -7.82 44.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.52 -9.46 41.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.579 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.59 -5.35 35.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.63 -41.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -46.6 156.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 m -123.06 -6.61 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.883 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' HG13 ' A' ' 71' ' ' ILE . 22.3 mt-10 -150.89 98.78 2.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.526 HG21 ' CG2' ' A' ' 72' ' ' THR . 59.4 t -102.36 128.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.89 168.53 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.16 -146.84 15.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -95.1 34.48 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.603 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.4 m-80 -106.11 146.0 32.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 -32.63 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.67 2.247 . . . . 0.0 110.594 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.35 -41.28 76.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -28.06 61.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 96' ' ' ASN . 67.7 mt -74.87 -31.55 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.012 . . . . 0.0 109.646 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -44.36 69.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.63 -17.83 64.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.554 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -59.16 2.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -21.17 66.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.98 -45.47 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 -1.52 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 109.786 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.11 -32.98 56.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.639 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 5' ' ' ILE . 4.0 tt -151.17 155.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.048 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -91.57 104.86 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.941 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -130.19 164.85 23.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.959 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -131.29 147.44 52.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.823 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.522 HG23 ' CE1' ' A' ' 17' ' ' TYR . 3.3 mt -131.64 147.06 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.66 145.59 33.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.57 149.82 24.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.64 -155.93 14.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.23 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.82 167.99 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.945 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -25.62 66.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.548 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.63 -66.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' CE1' HG23 ' A' ' 9' ' ' ILE . 6.4 t80 -54.1 -26.77 28.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -69.86 -71.66 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.792 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t -42.11 -39.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -59.82 -54.51 45.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.638 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.75 -28.72 50.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.784 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 63.2 mm-40 -72.75 -45.02 60.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.878 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -23.28 64.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 109.91 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -56.15 24.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -59.44 -21.39 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -49.75 -33.45 16.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER -45.63 -50.6 13.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 109.533 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.25 64.41 0.28 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 tp 61.65 82.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.44 27.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.12 -0.988 . . . . 0.0 109.567 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.436 ' HB2' HD21 ' A' ' 7' ' ' LEU . 44.9 p-90 -158.06 155.99 30.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.95 . . . . 0.0 109.657 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -151.68 148.2 21.49 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.406 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HD2' ' HG2' ' A' ' 32' ' ' ARG . 35.1 Cg_endo -77.72 119.55 4.84 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.596 2.198 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.35 -168.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.676 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -97.61 165.25 15.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 109.404 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.7 Cg_endo -76.91 -23.39 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.478 2.119 . . . . 0.0 110.169 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -2.96 53.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.294 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.34 61.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.82 127.28 54.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -77.21 -39.85 47.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -124.02 134.06 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.37 144.21 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.44 100.46 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.67 135.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.2 136.01 33.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.568 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.35 9.47 28.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.36 -24.15 29.66 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mp -85.3 12.71 7.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -1.126 . . . . 0.0 109.307 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.567 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 1.8 t-105 -68.43 -26.53 65.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.79 28.25 16.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -142.73 -64.84 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -1.094 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -120.41 57.37 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HG3' ' NE1' ' A' ' 49' ' ' TRP . 5.5 ttt180 -55.98 -35.24 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.39 -0.819 . . . . 0.0 109.727 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -52.18 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.696 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -50.25 -38.26 39.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 mt -71.85 -52.52 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.5 tp -47.11 -31.1 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.18 -48.77 57.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.02 -53.25 60.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -1.084 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.94 -40.24 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -36.39 82.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.679 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.13 -47.12 81.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . . . -67.88 -25.8 65.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 0.7 19.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 65' ' ' LYS . 1.6 tppt? -62.47 -48.76 78.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -73.4 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.1 p -178.67 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.059 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 4.8 mtmt -79.67 154.13 75.94 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.93 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 36.3 Cg_endo -78.95 100.94 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.31 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -103.26 115.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CG2' HG23 ' A' ' 93' ' ' VAL . 1.6 mp -105.2 129.77 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.462 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 13.4 t -94.64 132.34 39.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.761 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.51 120.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.38 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -50.11 158.38 0.96 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.19 -164.25 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.72 2.28 . . . . 0.0 110.387 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -88.38 -62.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 109.222 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.8 61.57 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 -51.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.514 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.77 -143.82 0.34 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.299 -0.875 . . . . 0.0 109.104 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -140.76 148.7 41.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.652 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.534 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 15.2 t -74.45 140.68 75.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.339 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.0 Cg_endo -77.37 161.47 31.7 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.474 2.116 . . . . 0.0 110.539 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.03 7.37 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.782 2.321 . . . . 0.0 110.778 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -92.14 -44.66 8.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.37 -19.73 63.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.686 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 39.2 tt0 -84.99 -9.51 57.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 -1.47 25.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.694 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.06 -25.76 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.661 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 2.4 m -81.02 135.82 35.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.502 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -76.69 -23.82 53.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -150.6 167.11 28.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.47 112.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 HG22 ' CB ' ' A' ' 103' ' ' ALA . 2.6 t -96.31 151.38 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.07 -151.3 27.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -100.63 29.21 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -1.172 . . . . 0.0 109.38 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.61 159.95 27.67 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.4 -0.813 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.57 -53.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.65 2.234 . . . . 0.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -56.01 -30.94 62.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.443 ' HB3' HG11 ' A' ' 93' ' ' VAL . 2.7 t -68.27 -44.02 76.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.824 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.81 -32.62 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.881 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -60.25 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.623 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -45.61 82.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.691 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' CB ' HG22 ' A' ' 93' ' ' VAL . . . -60.82 -27.3 67.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.47 -45.6 58.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.295 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -17.77 61.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.264 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.51 -36.83 79.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.34 -42.99 42.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.261 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.9 mt -134.24 137.88 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -99.01 105.1 17.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.465 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -121.82 171.04 9.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.403 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.7 t80 -143.2 106.08 4.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.548 HG23 ' CE1' ' A' ' 17' ' ' TYR . 2.9 mt -104.61 135.83 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.41 167.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 109.141 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.38 102.4 5.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.16 -145.87 6.97 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -138.89 54.1 1.75 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.207 -1.173 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 48' ' ' LEU . 3.5 t -118.22 157.45 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.394 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 19' ' ' VAL . 37.1 tt0 -77.93 -11.9 59.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' OD1' HD12 ' A' ' 45' ' ' LEU . 1.5 t70 -69.62 -59.39 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CE1' HG23 ' A' ' 9' ' ' ILE . 12.3 t80 -60.52 -33.28 72.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -64.42 -41.96 96.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 109.832 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' GLU . 79.3 t -66.66 -50.55 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -51.03 -52.06 46.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.41 -26.1 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.52 -49.19 72.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.703 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.53 -26.13 59.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.528 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.515 ' CD1' HG23 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -76.69 -15.0 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.638 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.16 -57.19 4.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -72.34 -10.25 59.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.1 t -47.02 -46.1 21.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.386 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 121.67 -179.82 16.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER 61.6 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -1.126 . . . . 0.0 109.519 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.83 158.49 15.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.234 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -158.19 155.06 28.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.56 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -145.97 155.0 51.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.534 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 36.1 Cg_endo -78.29 133.71 12.22 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.639 2.226 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -125.29 154.01 42.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -44.1 162.27 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.528 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.96 -31.06 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.634 2.222 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -31.85 69.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -120.17 27.93 8.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 107.48 5.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 47.4 t0 -53.89 -37.34 63.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -131.73 129.95 41.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.19 110.78 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.524 ' CD1' HG12 ' A' ' 9' ' ' ILE . 8.0 mt -104.48 100.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.293 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 ' CG1' HG22 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -96.3 130.7 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.663 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -84.89 135.94 33.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB3' ' CG2' ' A' ' 72' ' ' THR . . . -100.95 25.63 7.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.965 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -110.76 -35.78 1.98 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 14' ' ' VAL . 3.8 pp -119.43 15.43 12.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -1.207 . . . . 0.0 109.625 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.607 ' CZ3' ' CD1' ' A' ' 85' ' ' LEU . 2.8 p-90 -76.65 -21.58 55.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.53 -13.38 55.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -98.86 -41.53 7.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -1.101 . . . . 0.0 109.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 56' ' ' ILE . 7.1 mtt180 -108.45 50.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.269 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NE ' ' CZ3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -71.22 -33.43 69.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.03 -51.17 70.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 56' ' ' ILE . 20.7 mt-10 -68.42 -58.33 4.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.505 HG22 ' CG1' ' A' ' 44' ' ' VAL . 34.0 mm -43.52 -26.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.747 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -59.77 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.665 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.37 -30.17 24.97 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -57.71 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 56' ' ' ILE . 66.6 t -49.98 -45.25 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.57 -48.62 74.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.02 -32.45 61.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' HD13 ' A' ' 70' ' ' ILE . . . -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -66.93 -21.44 65.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.99 -27.34 16.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 68' ' ' LYS . 47.6 t -109.33 15.98 22.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.9 p 45.26 40.23 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -83.26 152.52 64.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 35.5 Cg_endo -78.19 117.86 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.681 2.254 . . . . 0.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 63' ' ' ALA . 2.6 mt -107.81 90.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.514 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.552 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 3.0 mt -93.06 128.2 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.261 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 46' ' ' ALA . 52.0 m -102.07 131.32 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.75 124.4 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -49.33 153.24 1.84 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 34.8 Cg_endo -77.43 -158.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.609 2.206 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' ' CZ2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -117.68 14.99 14.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.679 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.47 6.23 5.74 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -95.37 68.51 3.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -1.179 . . . . 0.0 109.416 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 5.5 tp10 67.27 137.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.886 0.851 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -78.53 -164.16 0.54 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.309 0.575 . . . . 0.0 109.568 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -91.22 150.8 42.18 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.05 173.12 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.644 2.229 . . . . 0.0 110.404 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.9 Cg_endo -77.8 -5.46 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 110.31 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -83.36 -49.37 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.607 ' CD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -69.11 -27.38 65.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.54 -12.13 56.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.358 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.7 -12.28 20.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 85' ' ' LEU . 7.3 m -123.84 8.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.385 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 p -94.66 131.17 40.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -76.31 -38.58 55.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.11 173.44 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.799 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.54 155.74 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.401 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 3.1 t -123.57 146.25 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.28 -162.44 17.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' CD2' ' A' ' 76' ' ' TYR . 74.2 m95 -98.45 19.38 14.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.18 156.36 54.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.238 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.47 -34.62 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.586 2.19 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -20.67 55.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.593 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -10.14 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.943 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 HG23 ' CD1' ' A' ' 24' ' ' LEU . 28.2 mm -76.39 -64.27 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -32.26 69.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.47 -35.77 72.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.89 60.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.977 . . . . 0.0 109.853 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.73 -23.42 58.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 109.734 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.84 -22.61 63.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.17 -44.68 79.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.89 -18.91 64.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.389 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 5.2 mt-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.305 0.574 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.65 164.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.39 119.82 36.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.639 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 1.3 pp -135.52 169.66 17.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.85 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -142.28 114.11 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.817 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.448 HG12 HD11 ' A' ' 43' ' ' ILE . 11.8 mt -94.44 148.84 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.205 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.91 155.14 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.43 156.96 16.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.6 -164.52 34.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -155.38 65.58 0.62 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -1.149 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.99 -170.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.53 -22.74 22.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -70.65 -52.64 19.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' OH ' HD21 ' A' ' 21' ' ' LEU . 14.1 t80 -65.75 -19.66 65.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -54.52 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -36.35 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -65.82 -61.14 2.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD21 ' OH ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -54.15 -27.16 31.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.91 -36.39 64.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -22.05 54.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -43.88 74.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.63 -14.7 62.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -51.5 51.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.331 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 p -63.33 -47.65 81.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 114.52 -109.94 2.26 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 55.58 169.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.419 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 4.7 mt-10 -120.3 130.11 54.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' ' CE3' ' A' ' 31' ' ' TRP . 25.9 p-90 -160.04 148.46 17.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.512 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -133.07 156.99 79.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.448 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.63 129.92 10.38 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.65 2.233 . . . . 0.0 110.323 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.65 149.81 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.631 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.508 ' CG2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -46.6 160.05 0.33 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.354 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD2' ' CG2' ' A' ' 35' ' ' THR . 35.3 Cg_endo -77.99 0.29 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.656 2.238 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.93 -27.42 12.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -130.44 36.1 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.92 116.4 22.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -36.53 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.937 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -136.3 139.23 42.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.695 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -113.84 149.03 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.324 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 9' ' ' ILE . 4.1 mt -136.98 129.84 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 t -118.83 129.79 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -92.62 128.33 38.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 81' ' ' VAL . . . -87.46 -0.76 57.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 109.585 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.01 -13.25 61.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.52 46.28 2.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.221 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.525 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 44.9 t-105 -77.67 -16.89 58.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.797 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.23 19.47 29.52 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -132.75 -62.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -1.205 . . . . 0.0 109.701 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -99.1 36.09 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -59.33 -40.09 85.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.32 -39.34 66.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.658 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -73.1 -45.33 57.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.904 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.445 ' O ' HG21 ' A' ' 60' ' ' VAL . 5.9 mt -59.93 -24.68 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.684 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.5 -55.77 8.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 109.507 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.06 65.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.71 24.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -1.173 . . . . 0.0 109.431 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 56' ' ' ILE . 51.4 t -56.01 -37.76 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 12.9 mt -63.97 -31.54 72.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.246 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.11 57.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -69.27 -9.04 51.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.1 tttm -61.38 -15.61 38.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' SER . 22.2 m -152.88 -75.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 169.56 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.86 . . . . 0.0 109.342 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.34 155.91 57.02 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.9 Cg_endo -78.36 114.11 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.631 2.221 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mt -103.01 117.35 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.438 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 mt -110.94 114.78 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -85.61 154.86 21.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.37 129.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.17 -0.956 . . . . 0.0 109.796 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.21 155.2 18.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.567 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 176.58 9.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.709 2.273 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 77' ' ' GLY . 6.4 t80 -70.75 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 76' ' ' TYR . . . -132.97 96.36 0.3 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' GLU . 2.4 tt 179.27 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -1.176 . . . . 0.0 109.289 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 78' ' ' LEU . 9.9 mt-10 61.02 126.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -179.53 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 46' ' ' ALA . 80.2 t -104.82 130.75 22.63 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.525 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 34.9 Cg_endo -77.88 168.92 21.46 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.403 2.069 . . . . 0.0 110.38 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 -10.3 15.53 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.656 2.237 . . . . 0.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.7 tt0 -81.88 -2.86 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.48 ' HB2' ' CH2' ' A' ' 49' ' ' TRP . 40.7 tp -112.86 -15.99 12.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.17 -0.956 . . . . 0.0 109.204 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -82.63 -12.07 57.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.18 -36.42 9.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.772 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -79.91 -24.61 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 109.715 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 2.0 p -68.17 94.18 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.427 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' SER . 50.6 m -43.69 -33.64 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.65 157.83 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.375 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.31 145.57 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 103' ' ' ALA . 85.4 t -129.22 147.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 109.568 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.29 -151.15 18.8 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -97.99 43.88 1.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -1.21 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.466 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -106.06 150.76 39.7 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.89 . . . . 0.0 109.703 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.11 -48.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.727 2.285 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.61 -31.98 63.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.464 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 5.3 m -60.68 -18.89 56.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.563 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 96' ' ' ASN . 21.3 mm -70.91 -36.47 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.5 -51.52 12.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.58 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -53.0 -27.08 17.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.657 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB2' HG23 ' A' ' 93' ' ' VAL . . . -77.1 -55.82 5.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.774 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.422 HD11 ' N ' ' A' ' 104' ' ' LEU . 5.0 mp -54.46 -24.32 19.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.67 -42.22 61.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 102' ' ' ASP . 8.7 m-20 -50.13 -23.44 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 104' ' ' LEU . . . -58.61 -48.55 80.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.7 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.09 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -112.96 109.95 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.258 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.4 mp -118.4 171.5 8.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.761 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.3 95.41 2.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.0 109.192 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.9 mp -79.79 132.68 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.65 140.04 19.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 109.547 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -56.41 131.24 47.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.29 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.512 ' CA ' HD23 ' A' ' 48' ' ' LEU . . . -142.46 153.65 24.62 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.5 22.81 5.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -1.12 . . . . 0.0 109.275 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.68 156.2 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -59.35 -19.29 45.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.375 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.81 -66.13 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CE1' ' CG2' ' A' ' 9' ' ' ILE . 10.7 t80 -46.33 -31.28 2.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.269 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -52.08 51.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 77.6 t -57.69 -32.37 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.18 -35.76 76.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -52.95 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.617 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.51 -24.72 65.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -74.16 -31.22 62.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.704 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -35.38 65.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.716 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.03 -46.73 73.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -19.76 63.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.498 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -68.31 -28.96 67.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 97.94 -173.5 28.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 75.39 136.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 109.517 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.38 93.15 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -97.15 169.34 9.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -151.95 152.77 30.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.54 139.19 15.98 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.687 2.258 . . . . 0.0 110.525 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.91 145.09 50.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.462 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -51.44 172.42 0.15 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.99 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.724 2.283 . . . . 0.0 110.671 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -103.9 -52.86 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.109 -0.995 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -100.29 37.09 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.74 124.81 26.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -70.68 -36.27 73.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.517 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -149.2 121.6 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.03 136.48 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 21.8 mt -116.33 88.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.78 126.8 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 73' ' ' VAL . 0.6 OUTLIER -96.67 125.27 41.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.09 54.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.391 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.95 -19.53 69.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD23 ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -95.64 20.39 9.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.286 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 14.9 t-105 -69.91 -15.42 63.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.86 34.94 5.24 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -148.78 -52.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -1.165 . . . . 0.0 109.584 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 55' ' ' GLU . 10.7 mtt-85 -130.67 63.58 1.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -42.07 74.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.242 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -73.13 -35.69 66.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.35 -0.844 . . . . 0.0 109.319 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -65.39 -32.78 74.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.328 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 52' ' ' ARG . 31.5 mt -76.11 -51.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -47.51 -35.85 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -50.16 54.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 -34.55 58.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 109.297 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.81 -52.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.843 . . . . 0.0 109.276 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.74 -39.14 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.29 -34.01 72.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.473 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.09 -54.85 42.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -70.88 -14.03 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -29.33 3.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.89 -79.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -178.5 65.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.0 149.14 37.23 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 34.7 Cg_endo -77.6 127.09 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.569 2.179 . . . . 0.0 110.162 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' SER . 53.5 mt -103.68 118.73 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.5 mm -108.53 119.42 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 93' ' ' VAL . 10.8 m -92.88 143.37 26.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.893 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 45' ' ' LEU . 41.0 t -121.74 115.26 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -43.12 155.3 0.28 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 158.57 32.17 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.671 2.247 . . . . 0.0 110.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -109.16 18.06 20.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.45 13.52 62.79 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 52.09 48.47 22.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.407 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 -143.38 0.35 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.313 -0.867 . . . . 0.0 109.125 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -142.19 108.64 5.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.532 ' CG2' ' HD2' ' A' ' 82' ' ' PRO . 14.1 p -50.49 140.85 17.71 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.91 . . . . 0.0 109.241 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 81' ' ' VAL . 35.3 Cg_endo -77.73 156.46 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.468 2.112 . . . . 0.0 110.316 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.25 71.06 6.91 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.639 2.226 . . . . 0.0 110.716 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.21 -42.66 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.073 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.61 -29.74 22.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.482 ' OE2' ' CG1' ' A' ' 81' ' ' VAL . 6.3 mp0 -72.2 -20.39 61.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.24 83.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.37 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -122.41 48.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -106.78 129.22 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.388 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 5.4 m -71.33 -34.24 70.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -157.13 142.9 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.36 100.34 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 72' ' ' THR . 4.4 m -95.08 144.54 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.85 -146.73 17.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -92.11 13.53 18.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -1.095 . . . . 0.0 109.535 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -87.81 150.26 47.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -35.27 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.654 2.236 . . . . 0.0 110.17 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.93 -26.89 69.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 92.1 m -77.42 -25.04 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.77 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.3 mm -66.97 -58.48 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.73 -33.36 75.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.95 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.741 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.24 76.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.523 ' CD2' HD23 ' A' ' 7' ' ' LEU . 14.4 mt -77.24 -22.41 52.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.718 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.08 91.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.3 98.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.15 60.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.296 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 6' ' ' ARG . 62.4 mt -122.08 165.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.686 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.502 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 66.8 mtt180 -127.86 120.0 26.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.5 pp -145.42 170.79 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.751 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -137.38 139.14 40.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.204 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 10' ' ' THR . 3.8 mt -121.63 147.89 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.459 ' N ' HG21 ' A' ' 9' ' ' ILE . 4.2 p -65.01 121.37 14.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.329 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.29 169.36 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.572 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.22 -166.27 36.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -146.03 36.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.88 163.21 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.148 -0.97 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.77 -31.94 71.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.04 -38.41 79.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -64.11 -46.66 83.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.47 -26.03 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -69.85 -55.23 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 24' ' ' LEU . 9.6 t80 -55.99 -47.27 78.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.356 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.49 -37.79 70.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.03 82.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.25 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -72.69 -28.51 62.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -72.4 -29.63 63.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -41.26 61.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -17.93 9.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.4 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.12 -13.9 11.19 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.37 172.3 13.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -126.02 114.09 17.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -0.844 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -127.1 154.66 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -115.76 149.35 42.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.302 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.9 Cg_endo -78.13 142.56 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.563 2.175 . . . . 0.0 110.683 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 -166.53 1.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -80.14 165.28 47.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.48 -4.54 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.58 2.187 . . . . 0.0 110.38 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.89 -37.35 3.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.253 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.3 33.39 3.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.229 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 35' ' ' THR . . . -102.14 142.96 32.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -66.06 -34.76 78.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.09 115.16 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 109.315 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.5 100.35 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.7 mt -92.26 99.83 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.249 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 70' ' ' ILE . 20.2 t -90.19 135.14 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' A' ' 73' ' ' VAL . 0.9 OUTLIER -89.62 124.62 34.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.426 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.06 -0.07 55.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.96 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.74 79.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 -81.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 109.493 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 48.75 22.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.846 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.86 -79.41 0.69 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' N ' ' A' ' 52' ' ' ARG . 9.5 t -87.97 -26.93 22.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.0 109.345 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.496 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -93.11 34.05 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -59.88 -43.84 94.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.271 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.41 -21.09 62.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.262 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -43.81 62.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 52' ' ' ARG . 1.8 mp -73.68 -58.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -20.76 66.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.435 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -73.93 -56.4 5.36 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.55 75.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -1.103 . . . . 0.0 109.335 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -45.17 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -57.68 -37.2 73.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -68.3 -39.59 82.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -76.3 -11.31 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -73.08 -19.27 61.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -74.24 -25.86 59.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 0.0 109.884 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.62 9.81 4.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.955 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 t 54.17 59.78 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.416 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 9.9 mttm -81.66 169.63 18.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 35.7 Cg_endo -78.27 106.52 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.767 2.311 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.516 ' CG2' HG21 ' A' ' 44' ' ' VAL . 4.0 mt -108.04 98.0 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 93' ' ' VAL . 3.6 mp -81.58 114.33 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -91.88 140.58 29.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 45' ' ' LEU . 57.8 t -107.22 121.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.77 160.89 0.31 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 -175.93 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -42.58 90.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.63 44.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 -23.78 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.104 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.36 126.92 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 109.455 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.72 147.8 41.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.62 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.46 155.64 9.76 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 161.89 29.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.623 2.215 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 35.3 Cg_endo -77.58 -15.47 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.67 2.247 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -70.31 -27.54 64.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.34 -24.8 25.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 83' ' ' PRO . 4.0 mt-10 -58.21 -35.2 71.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.2 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.714 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.9 m -89.46 4.0 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.747 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -101.64 143.57 31.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 t -107.37 -17.48 14.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.77 135.0 14.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.517 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.61 110.09 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.458 HG12 ' CG2' ' A' ' 71' ' ' ILE . 34.5 m -107.14 137.47 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.3 -144.11 12.45 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.96 63.65 1.19 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.243 -1.151 . . . . 0.0 109.477 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -138.55 143.15 37.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.95 -27.64 4.49 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.658 2.239 . . . . 0.0 110.628 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.13 -32.25 64.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.5 m -74.99 -47.35 29.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 100' ' ' ILE . 12.7 mt -67.26 -13.1 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -76.27 -55.96 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.986 . . . . 0.0 109.617 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -72.94 -24.88 60.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.49 73.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.596 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.74 -41.63 62.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -34.39 64.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.606 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.05 -16.83 34.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' C ' HG13 ' A' ' 5' ' ' ILE . 3.4 mt-10 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.433 HG13 ' C ' ' A' ' 4' ' ' GLU . 1.2 mp -131.66 153.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 20.7 mtt-85 -114.96 105.81 13.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -138.46 171.7 13.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -143.86 138.96 28.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.834 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' HD22 ' A' ' 45' ' ' LEU . 3.7 mt -120.85 133.82 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.353 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.466 ' O ' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -58.35 111.89 1.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -52.44 135.37 33.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.84 148.78 19.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -77.9 -31.94 51.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 25.1 m -43.36 137.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.506 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 19' ' ' VAL . 19.3 pt-20 -64.51 -24.28 67.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.173 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.502 ' OD2' ' CG ' ' A' ' 76' ' ' TYR . 11.4 t70 -61.95 -31.06 71.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.102 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 11' ' ' GLU . 69.7 t80 -64.48 -42.75 95.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.42 91.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.258 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' GLU . 4.9 t -57.96 -56.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.185 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -51.14 -40.19 57.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.129 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.88 -58.14 8.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.548 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.69 -17.23 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -71.89 -55.82 6.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.568 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -21.7 30.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.558 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -74.29 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.609 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.37 -1.92 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -43.53 73.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.08 -71.53 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 101' ' ' ARG . 0.7 OUTLIER -66.55 157.5 32.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -1.137 . . . . 0.0 109.513 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -88.96 121.05 30.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -93.37 158.77 15.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.641 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.65 146.2 52.11 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.383 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.71 129.21 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.525 2.15 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.69 164.96 12.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.715 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.423 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -73.95 171.86 9.93 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 36.4 Cg_endo -80.28 42.23 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.805 2.337 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -159.32 -62.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 109.635 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.33 27.98 1.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' ' CE ' ' A' ' 68' ' ' LYS . . . -64.22 132.47 50.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.87 . . . . 0.0 109.286 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -71.2 -33.84 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.26 23.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.34 110.32 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 7' ' ' LEU . 65.6 mt -93.63 94.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.13 122.31 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 4.1 mm? -81.81 121.52 26.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.287 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' CB ' ' CZ3' ' A' ' 49' ' ' TRP . . . -71.22 -12.23 61.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.601 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.33 29.93 11.25 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.86 -19.1 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.925 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.618 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 1.8 p90 -66.82 -21.79 66.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.032 -1.042 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -64.17 -15.52 58.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.72 -48.28 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -1.115 . . . . 0.0 109.274 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -129.37 63.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -23.33 6.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.2 -46.74 40.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -46.6 89.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.3 mm -58.31 -54.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.462 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 tp -50.6 -30.4 13.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -49.2 42.6 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.01 -46.53 64.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -1.132 . . . . 0.0 108.846 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.54 -29.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.25 -0.906 . . . . 0.0 109.037 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 16.8 t70 -59.16 -44.78 92.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.43 -38.23 65.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.339 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.7 -14.44 63.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' ASP . 4.6 mmm180 -65.5 -14.69 61.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -64.2 -11.95 35.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.945 . . . . 0.0 109.499 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 71.44 39.16 0.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.64 -67.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 39' ' ' ALA . 2.3 mmtt -92.95 153.17 41.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 142.65 19.52 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.661 2.241 . . . . 0.0 110.443 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.05 91.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 93' ' ' VAL . 3.0 mt -80.12 115.77 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -98.73 139.84 33.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' ARG . 19.0 t -111.22 130.71 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 73' ' ' VAL . 9.0 mtt180 -43.75 157.57 0.27 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.557 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.48 145.56 23.7 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.675 2.25 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 16.1 t80 -66.98 -10.89 54.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 78' ' ' LEU . . . -68.45 -95.05 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 6.0 mp -135.87 -92.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 3.4 pt-20 -159.31 -142.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.13 -0.982 . . . . 0.0 108.925 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 2.0 m120 69.59 54.57 0.38 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -71.22 144.81 90.14 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.09 146.78 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.548 2.166 . . . . 0.0 110.398 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 86' ' ' GLU . 35.1 Cg_endo -77.75 -9.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.533 2.155 . . . . 0.0 110.229 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.26 -58.39 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.933 . . . . 0.0 109.394 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -72.63 -9.58 58.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.362 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -78.59 -11.25 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.484 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.66 -20.86 56.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.789 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -113.99 6.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t -81.77 105.25 12.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -30.55 57.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.99 152.19 34.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 109.499 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.59 154.95 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.445 HG22 HG21 ' A' ' 71' ' ' ILE . 51.8 t -138.72 144.26 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -161.85 29.31 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -91.56 36.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -1.182 . . . . 0.0 109.503 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -113.27 155.84 43.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.92 -60.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -51.13 -23.88 3.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.77 -51.83 24.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 101' ' ' ARG . 5.2 mt -57.31 -62.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -43.71 -32.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.566 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.21 -60.16 4.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.541 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 101' ' ' ARG . 17.0 mt -58.2 -56.36 23.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 0.0 109.636 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -73.17 -7.97 53.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.79 -24.66 52.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -16.88 64.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.631 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.728 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG12 ' CD2' ' A' ' 7' ' ' LEU . 11.7 tt -150.01 124.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.0 109.329 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -91.76 129.12 37.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.628 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.515 ' CD2' HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -147.96 169.61 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.4 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -124.88 143.08 51.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.16 125.0 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.13 145.06 2.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.46 105.85 10.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.02 -146.06 7.22 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.23 47.16 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.21 150.17 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.41 -45.32 94.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.46 -24.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -75.99 -45.88 32.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 109.829 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -63.8 -35.38 80.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG12 ' CZ3' ' A' ' 95' ' ' TRP . 71.2 t -71.78 -39.06 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.289 -0.882 . . . . 0.0 109.718 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 24' ' ' LEU . 76.5 t80 -67.07 -62.72 1.29 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.23 -49.39 69.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 18' ' ' ARG . 91.9 mt-10 -53.67 -33.96 57.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -35.27 65.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -48.26 -32.3 7.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.816 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.68 -42.69 86.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 0.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -72.15 -4.28 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.515 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -80.8 -12.91 59.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 70.33 -155.15 52.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 1.6 mt 61.68 171.41 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.408 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.19 108.12 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -117.88 153.23 33.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.175 -0.953 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -138.4 146.28 50.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.287 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.67 146.69 21.43 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.553 2.169 . . . . 0.0 110.405 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 -151.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.159 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 169.13 12.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 35.7 Cg_endo -77.85 71.12 6.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.596 2.198 . . . . 0.0 110.278 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 36' ' ' PRO . 2.0 mt-10 -173.66 -35.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.243 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.42 27.99 3.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.406 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.77 110.12 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -51.64 -47.51 63.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.685 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.77 149.83 41.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.79 109.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.83 118.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG13 HG21 ' A' ' 56' ' ' ILE . 6.5 t -102.97 126.35 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 3.5 mm? -92.04 131.82 37.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.81 5.14 51.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.37 -20.7 71.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 HD21 ' CB ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -110.6 38.15 2.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -1.097 . . . . 0.0 109.2 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.488 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 26.3 t-105 -80.96 -17.56 50.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.56 11.11 53.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -122.99 -59.47 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.181 . . . . 0.0 109.585 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.3 mpt_? -116.69 53.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -47.85 82.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.294 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.04 -41.23 59.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -0.867 . . . . 0.0 109.409 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -42.19 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.584 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 52' ' ' ARG . 25.2 mm -59.65 -62.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.65 -31.49 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.822 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.1 -61.92 4.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.49 -35.97 6.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -1.149 . . . . 0.0 109.768 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 80.9 t -67.96 -63.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 60' ' ' VAL . 21.0 t70 -43.14 -30.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.824 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.7 tp -76.92 -42.72 38.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.915 . . . . 0.0 109.595 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.02 -57.0 12.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -62.89 -13.58 35.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -46.82 -27.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -140.36 -71.1 0.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.88 33.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.509 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -71.24 147.02 92.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 35.6 Cg_endo -78.1 125.01 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.657 2.238 . . . . 0.0 110.589 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.94 124.27 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.419 ' HA ' HD12 ' A' ' 71' ' ' ILE . 2.8 mm -92.71 107.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.318 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 93' ' ' VAL . 52.2 m -81.6 109.1 15.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.704 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.2 106.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 18.6 ptt85 -48.86 161.98 0.39 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.496 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -78.02 -162.1 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.626 2.218 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' TYR . 9.0 t80 -108.14 15.33 24.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 17.86 47.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.2 mm? -93.06 -67.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -1.196 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -109.48 14.16 23.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' GLU . 1.3 m120 46.41 -173.62 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.463 HG21 ' HD2' ' A' ' 82' ' ' PRO . 14.9 p -126.28 138.32 32.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.346 -0.847 . . . . 0.0 109.057 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.9 Cg_endo -78.24 165.68 25.43 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.464 2.109 . . . . 0.0 110.437 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.19 4.72 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.57 2.18 . . . . 0.0 110.352 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.87 -10.45 59.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 -29.26 14.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -32.49 74.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.882 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 88' ' ' VAL . . . -70.99 -16.61 62.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 87' ' ' ALA . 17.0 m -144.75 52.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.374 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.37 130.26 52.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.537 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t -103.13 -38.68 7.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.35 140.68 49.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 93' ' ' VAL . 97.2 t -123.1 130.38 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.238 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 72' ' ' THR . 12.8 m -153.34 138.57 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.801 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.41 -145.74 16.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.417 ' CZ3' HG12 ' A' ' 19' ' ' VAL . 20.1 m95 -86.81 -4.69 59.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -1.154 . . . . 0.0 109.588 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -57.64 151.15 42.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.12 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.579 2.186 . . . . 0.0 110.551 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.478 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 11.3 m170 -56.2 -17.56 7.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -43.76 83.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.13 -24.13 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -74.32 -51.39 15.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 109.28 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.14 -35.99 76.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HB3' HG12 ' A' ' 93' ' ' VAL . . . -67.96 -61.99 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -45.75 -32.28 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.724 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.03 -43.18 68.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.94 -44.37 96.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.734 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.12 83.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.617 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -135.64 135.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 7.7 mpt_? -99.2 115.98 30.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.248 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.21 171.08 14.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.683 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -138.29 124.57 20.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.524 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 17' ' ' TYR . 24.8 mt -114.29 139.19 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 m -63.06 134.78 56.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.77 164.84 13.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 169.62 40.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.29 47.6 1.69 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.221 -1.164 . . . . 0.0 109.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.79 172.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.39 -24.32 64.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.536 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.93 -55.28 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 9' ' ' ILE . 13.5 t80 -51.57 -39.17 57.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -63.17 -42.26 99.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.594 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.47 -43.78 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.0 -47.72 83.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.558 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -65.68 -20.31 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' OE2' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -73.15 -55.6 6.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -58.04 -51.08 71.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.43 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -45.26 -44.04 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.92 -53.56 52.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.74 -19.2 5.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.424 ' CB ' HD23 ' A' ' 29' ' ' LEU . 6.0 m -65.6 -68.29 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.374 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.16 8.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 27' ' ' SER . 1.6 pp -59.7 151.53 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -1.117 . . . . 0.0 109.521 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -99.59 106.15 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -105.42 167.47 9.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -147.45 145.4 21.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.21 105.69 2.03 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.613 2.209 . . . . 0.0 110.444 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.85 -154.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.2 p -100.63 158.12 32.48 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.443 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 -3.3 13.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.588 2.192 . . . . 0.0 110.573 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 4.1 mt-10 -102.27 -17.59 15.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 109.314 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -144.16 36.53 1.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.376 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.86 125.11 30.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.647 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.7 t70 -50.87 -31.9 18.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.417 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.41 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.379 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.94 107.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 73' ' ' VAL . 3.2 mt -90.28 102.28 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.31 132.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 73' ' ' VAL . 1.1 mm? -103.13 135.85 44.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.282 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.51 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.44 61.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 1.2 mp -90.94 32.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 109.54 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.472 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 32.0 t-105 -62.56 -16.97 58.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.594 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.38 35.45 3.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -144.31 -67.42 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -107.35 52.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 109.619 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.27 -47.74 81.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.309 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.61 -22.93 48.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -77.16 -50.61 12.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 56' ' ' ILE . 3.9 mt -62.41 -27.13 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.649 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.89 -32.68 67.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.28 -41.12 26.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' O ' ' HB1' ' A' ' 63' ' ' ALA . . . -68.51 -37.72 80.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -1.137 . . . . 0.0 109.854 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 56' ' ' ILE . 39.9 t -74.09 -34.89 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.9 -46.31 82.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 37' ' ' GLU . 62.2 mt -70.88 -41.88 70.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.003 . . . . 0.0 109.806 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 70' ' ' ILE . . . -64.5 -25.62 68.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.704 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -77.25 -20.2 55.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.76 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -79.71 -9.55 59.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 67' ' ' SER . 0.3 OUTLIER -125.67 3.52 7.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 66' ' ' SER . 17.9 m 60.62 38.38 18.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.9 mmpt? -71.28 161.36 78.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 0.0 109.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 34.2 Cg_endo -76.99 108.45 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.429 2.086 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 63' ' ' ALA . 15.2 mt -108.78 109.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.715 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 mt -97.83 117.2 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.258 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -80.54 147.65 30.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' HB ' HD23 ' A' ' 45' ' ' LEU . 74.4 t -122.16 113.17 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.423 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.89 159.35 1.86 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.452 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 36.2 Cg_endo -77.82 166.64 25.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.733 2.289 . . . . 0.0 110.246 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -74.49 -59.1 2.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -149.64 15.83 1.08 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.075 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 32.3 tp -71.83 -78.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -1.228 . . . . 0.0 109.354 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 tt0 -147.51 -143.05 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.041 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' OD1' ' OE1' ' A' ' 79' ' ' GLU . 2.9 p30 -124.59 176.65 6.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.91 134.95 20.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.17 173.04 14.48 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.435 2.09 . . . . 0.0 110.519 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.8 Cg_endo -77.37 -1.53 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.576 2.184 . . . . 0.0 110.596 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -73.91 -70.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.306 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -16.22 54.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.51 -42.96 61.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.16 68.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.94 38.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -128.7 105.63 8.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.539 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' A' ' 91' ' ' GLU . 1.5 m -56.52 -39.68 73.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 106' ' ' ASP . 13.1 mp0 -138.29 157.95 45.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.4 m -141.59 133.57 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.131 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 15.0 m -139.99 169.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.101 -0.999 . . . . 0.0 109.873 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.45 -144.37 11.94 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -93.06 47.63 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -1.143 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -100.73 146.47 32.14 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -38.73 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.551 2.168 . . . . 0.0 110.317 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -23.26 56.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -73.58 -15.44 61.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.63 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.9 mm -73.37 -40.23 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -76.81 -34.66 57.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -31.87 70.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.674 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.19 -44.96 28.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -28.7 69.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.874 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 2.4 tp10 -66.06 -21.31 66.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.884 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD2' ' OE2' ' A' ' 91' ' ' GLU . 1.1 t70 -63.17 -30.31 71.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.59 41.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.573 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.347 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.292 0.568 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.7 141.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -97.64 104.38 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.6 mt -113.35 157.73 21.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -134.88 92.12 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' CG2' ' CE1' ' A' ' 17' ' ' TYR . 2.7 mp -89.28 162.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.46 ' O ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -88.2 159.01 18.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.426 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.14 128.89 56.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.983 . . . . 0.0 109.61 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.21 -162.98 11.66 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -125.42 -4.67 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -1.147 . . . . 0.0 109.578 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.1 m -83.74 -178.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -92.2 -2.46 56.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.95 -69.54 0.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 5.0 t80 -48.64 -29.15 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.664 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -51.5 65.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.096 -1.002 . . . . 0.0 109.427 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 t -62.67 -33.08 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.743 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -63.22 -57.95 8.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.65 -34.23 64.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.57 -40.03 95.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -40.52 74.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.929 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.83 71.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -34.69 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.672 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -68.96 -22.22 64.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -45.41 -45.99 13.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.475 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.04 -32.54 6.27 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.01 150.24 31.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -1.174 . . . . 0.0 109.533 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 151.5 22.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 109.453 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.425 ' C ' ' HG3' ' A' ' 32' ' ' ARG . 46.8 p-90 -153.43 160.84 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.434 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 24.2 mtt-85 -141.86 158.6 61.97 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.2 Cg_endo -78.18 95.47 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.677 2.251 . . . . 0.0 110.129 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -176.77 2.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.681 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.461 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -87.2 173.55 6.45 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.257 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.7 Cg_endo -78.23 -9.81 16.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.557 2.171 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -114.51 -6.48 12.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -139.38 48.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.255 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.83 127.61 48.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.658 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -67.41 -40.71 85.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.07 134.8 28.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.43 126.24 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 45' ' ' LEU . 2.5 mt -109.48 93.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.202 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.77 115.07 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.575 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.478 ' CD2' HG23 ' A' ' 73' ' ' VAL . 13.6 mt -85.59 127.15 34.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.94 -0.47 35.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.35 -15.52 70.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -105.87 29.41 6.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.331 -1.1 . . . . 0.0 109.21 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -72.5 -26.94 61.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.68 40.45 2.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 -55.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -1.182 . . . . 0.0 109.529 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.2 mpt_? -116.29 56.97 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -47.98 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.1 -36.77 75.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.56 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -69.61 -62.04 1.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLU . 16.1 mt -43.14 -36.08 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.04 -56.05 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.42 -47.67 62.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.45 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 0.0 109.585 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 2.7 t -71.89 -29.19 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -66.86 -38.7 86.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -75.83 -43.14 47.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 109.968 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.29 -27.64 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.952 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -77.24 -30.75 54.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 109.82 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 6.5 16.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 7.05 4.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.694 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 m 51.26 38.64 21.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 159.49 53.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.68 108.75 2.62 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.2 mt -108.66 114.71 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 mt -107.0 141.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.329 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 m -109.78 135.03 51.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.478 HG23 ' CD2' ' A' ' 45' ' ' LEU . 22.6 t -101.09 133.49 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -58.13 155.09 26.94 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 159.21 31.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.676 2.251 . . . . 0.0 110.403 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -81.57 -53.59 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.37 83.3 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.14 -35.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -1.155 . . . . 0.0 109.535 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 66.45 128.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' C ' ' HD3' ' A' ' 82' ' ' PRO . 1.8 m-20 171.96 39.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.15 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.5 t -118.04 79.06 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 36.1 Cg_endo -78.29 174.67 12.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.595 2.197 . . . . 0.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.2 Cg_endo -79.05 9.43 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.77 2.313 . . . . 0.0 110.613 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -56.47 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -11.23 60.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.51 -28.82 64.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.556 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.92 42.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.63 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.06 -59.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.97 150.47 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -106.38 -21.04 13.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.372 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -151.39 163.92 37.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.73 159.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 94' ' ' GLY . 54.1 t -128.3 160.25 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.11 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 93' ' ' VAL . . . -112.42 -152.71 11.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -107.14 50.24 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -125.49 162.19 45.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.07 -43.31 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.751 2.301 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -26.34 58.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.827 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.6 m -62.23 -64.57 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 93' ' ' VAL . 67.9 mt -44.68 -25.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -46.93 39.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -0.995 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.86 -17.5 64.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.626 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . . . -71.13 -59.14 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.63 -37.56 86.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.562 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -51.4 -48.21 62.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -31.32 72.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.8 -62.22 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.8 160.68 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.69 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 6.5 mpt_? -106.98 128.83 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.507 ' HG ' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -137.61 166.98 22.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.695 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -151.13 115.42 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG21 ' CE1' ' A' ' 17' ' ' TYR . 36.0 mt -108.56 141.26 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.58 125.67 10.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.78 126.64 28.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.99 30.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.0 53.12 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 17' ' ' TYR . 15.4 m -112.62 143.23 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 19' ' ' VAL . 29.0 tt0 -54.31 -25.12 22.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.58 -65.37 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CE1' HD21 ' A' ' 21' ' ' LEU . 5.5 t80 -50.08 -28.36 7.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -48.4 55.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 15' ' ' GLU . 71.7 t -61.37 -29.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.852 . . . . 0.0 109.657 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -71.19 -45.93 62.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.358 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 HD21 ' CE1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -56.98 -46.17 82.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -36.79 84.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.51 71.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.566 ' CD2' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -75.69 -49.06 19.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -68.22 -17.97 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -70.67 -52.5 20.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.493 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -47.76 -35.85 10.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 125.58 -154.79 18.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 71.04 165.92 0.29 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.454 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.69 100.86 4.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' CD2' ' A' ' 24' ' ' LEU . 60.8 p-90 -115.36 157.93 23.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 109.28 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -125.17 152.46 70.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.46 125.64 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.699 2.266 . . . . 0.0 110.512 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.96 153.43 35.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.47 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -53.92 173.21 0.21 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.331 -0.856 . . . . 0.0 109.392 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -76.9 -0.34 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.541 2.161 . . . . 0.0 110.372 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -104.25 -6.09 21.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.303 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.34 30.07 1.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.82 98.96 12.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 6' ' ' ARG . 12.4 m-20 -50.76 -45.32 58.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.196 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' CB ' ' HG ' ' A' ' 7' ' ' LEU . . . -116.02 121.92 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.01 110.56 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.442 HD13 HD23 ' A' ' 7' ' ' LEU . 6.6 mt -103.23 123.25 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 HG22 ' CG2' ' A' ' 70' ' ' ILE . 2.4 t -113.77 120.89 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -80.21 148.25 30.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.355 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.38 17.06 24.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -87.74 -29.85 19.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 24.14 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -1.152 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 41.8 t-105 -60.71 -14.21 19.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.55 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.91 37.96 2.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -150.31 -58.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -1.137 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HG3' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -116.24 46.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 109.725 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -57.84 -34.26 69.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -39.74 94.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.605 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 3.7 tt0 -65.59 -41.69 92.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG21 HG11 ' A' ' 44' ' ' VAL . 5.2 mt -70.82 -23.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.11 -52.65 13.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.71 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.98 73.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.91 -62.15 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -1.157 . . . . 0.0 109.599 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.8 t -55.62 -31.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -63.0 -55.3 26.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -60.47 -25.08 65.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.281 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.53 62.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -7.56 38.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.644 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HD3' HD22 ' A' ' 62' ' ' LEU . 12.4 tttm -49.21 -32.61 10.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' SER . 22.7 t -135.58 -69.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 66' ' ' SER . 0.1 OUTLIER 172.43 43.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.686 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.25 151.15 75.11 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.08 116.53 4.21 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.807 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 44' ' ' VAL . 4.4 mt -107.43 98.53 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 108.881 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 10.4 mt -90.22 112.75 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 15.0 p -89.41 141.51 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.13 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -115.68 132.36 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HG2' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -51.7 158.47 1.58 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 36.2 Cg_endo -78.96 169.7 19.0 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 0.0 110.507 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 76' ' ' TYR . 74.8 t80 -82.9 8.85 11.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 71.49 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -151.98 81.9 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.562 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' LEU . 3.1 mt-10 70.91 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.476 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.8 137.06 58.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 86.9 t -68.44 141.04 92.92 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HD2' ' CG1' ' A' ' 81' ' ' VAL . 35.5 Cg_endo -78.45 155.81 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.563 2.176 . . . . 0.0 110.412 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.16 -10.09 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.555 2.17 . . . . 0.0 110.312 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.87 -15.93 63.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.295 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.447 HD21 ' CG2' ' A' ' 72' ' ' THR . 42.2 tp -93.84 -18.79 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -24.47 43.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.13 61.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.7 -0.18 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t -96.23 135.84 37.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 -33.01 54.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.82 168.99 24.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.71 156.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.897 . . . . 0.0 109.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 2.1 t -135.97 155.56 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA2' ' HG2' ' A' ' 74' ' ' ARG . . . -116.98 -155.69 10.33 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -88.89 37.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -1.199 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.1 149.05 39.53 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 -66.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.609 2.206 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.24 -32.28 1.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -53.11 59.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.6 mt -55.05 -23.56 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.988 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -69.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -28.08 50.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.993 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.33 -51.73 48.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.452 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.441 HD13 HD22 ' A' ' 7' ' ' LEU . 5.6 tt -72.46 -15.06 61.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.257 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -28.97 63.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.296 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -68.2 -12.53 61.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.429 -0.794 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -58.8 4.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.73 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 2' ' ' THR . 42.1 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.318 0.58 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.494 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.88 75.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.22 10.22 41.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -46.89 152.02 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 109.436 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 6' ' ' ARG . 57.2 mt -114.63 162.58 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -93.57 105.09 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.395 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.492 HD11 ' N ' ' A' ' 7' ' ' LEU . 8.9 mp -112.35 168.24 9.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.699 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -153.09 142.19 21.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 mt -130.76 151.45 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 109.643 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 157.44 25.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -85.84 135.07 33.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.89 177.09 20.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -123.99 -12.57 7.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -1.095 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 16' ' ' ASP . 27.9 m -67.81 165.97 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.02 -20.29 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.406 ' HB2' HG21 ' A' ' 14' ' ' VAL . 42.8 m-20 -62.1 -32.78 73.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.46 18.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.08 -35.31 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.526 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 18.6 t80 -65.88 -47.99 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.85 -45.92 71.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.633 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -58.36 -49.94 75.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -59.74 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.96 . . . . 0.0 109.439 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -45.5 -38.28 6.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.64 -44.65 93.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -23.07 67.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -51.74 38.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.25 -33.09 6.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -57.76 148.63 24.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -82.16 131.76 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -138.56 145.37 40.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' NH2' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -130.53 147.8 67.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.188 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD2' ' NH2' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.7 101.88 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.459 2.106 . . . . 0.0 110.529 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 6' ' ' ARG . . . -101.81 154.92 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -59.89 164.87 5.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.341 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -77.37 -7.6 17.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.497 2.131 . . . . 0.0 110.114 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -28.6 15.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.3 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.05 46.53 2.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.17 148.35 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -95.43 -26.68 15.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.437 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.9 119.21 10.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.502 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.6 t -110.11 100.28 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.659 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG21 HG21 ' A' ' 73' ' ' VAL . 1.4 mt -84.19 106.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 136.68 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 45' ' ' LEU . 4.2 mm? -88.67 128.6 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 109.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.71 4.63 15.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.97 . . . . 0.0 109.486 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.33 -24.02 61.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.61 27.3 3.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.547 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 6.6 t-105 -76.83 -42.45 40.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' ' 51' ' ' THR . . . -89.65 28.41 7.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 50' ' ' GLY . 40.0 p -141.08 -58.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.497 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -117.28 50.55 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.331 -0.856 . . . . 0.0 109.601 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -30.09 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -38.14 82.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.44 -55.7 8.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -48.84 -43.29 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mt -45.78 -49.36 15.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' ALA . . . -56.17 -58.79 12.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . . . -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -1.129 . . . . 0.0 109.649 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.91 -53.84 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.24 -53.05 23.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.34 -33.14 73.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.554 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LYS . . . -71.23 -21.67 62.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -71.73 -3.05 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.762 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 64' ' ' ARG . 0.5 OUTLIER -124.99 18.23 8.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.4 m -143.94 45.54 1.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.707 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' SER . 2.8 t 78.21 -3.59 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 109.723 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 50.34 60.01 15.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.301 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.4 Cg_endo -82.1 53.14 4.43 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.57 2.18 . . . . 0.0 109.764 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 63' ' ' ALA . 1.4 mt -99.98 117.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.265 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.9 mt -110.91 131.44 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.1 m -96.93 129.82 44.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.25 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.465 HG21 HG21 ' A' ' 43' ' ' ILE . 86.9 t -107.72 116.84 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -46.51 154.57 0.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.69 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.11 161.64 29.31 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.751 2.3 . . . . 0.0 110.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.98 -23.75 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.17 37.08 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.02 -32.52 12.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.44 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.57 -143.24 0.14 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.295 -0.878 . . . . 0.0 109.076 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -148.28 140.48 24.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.905 . . . . 0.0 109.424 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.529 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 1.5 t -69.97 142.15 90.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.276 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.547 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.7 Cg_endo -79.33 173.0 13.81 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.524 2.149 . . . . 0.0 110.486 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.23 19.35 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 111.065 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.76 -8.66 23.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.867 -1.146 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.4 -49.41 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.01 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -20.98 5.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.98 26.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 0.0 109.385 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -102.59 144.94 30.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -99.19 -29.45 12.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.235 -0.915 . . . . 0.0 109.231 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.21 155.32 36.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.24 130.55 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.37 -171.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.76 -146.9 5.35 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.463 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 83.7 m95 -89.64 69.87 7.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -1.127 . . . . 0.0 109.495 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 95' ' ' TRP . 6.6 m-20 -141.62 149.21 53.04 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 -38.65 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.681 2.254 . . . . 0.0 110.357 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -74.11 -41.4 61.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.863 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.88 -59.55 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.8 mt -51.81 -30.85 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 0.0 109.611 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -69.46 -37.95 77.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.13 -43.4 92.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.23 62.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.26 -62.01 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.82 -16.96 7.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -68.73 -38.72 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.13 -27.2 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -66.36 -71.2 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.295 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -57.83 97.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 110' ' ' VAL . 12.5 p -99.7 11.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.601 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.413 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 2' ' ' THR . 29.4 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.307 0.575 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 44.33 71.67 0.24 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.73 27.02 4.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 1.8 mt-10 63.33 171.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' HB ' HD11 ' A' ' 7' ' ' LEU . 13.2 mt -138.47 140.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 2.8 mpp_? -94.08 97.6 10.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 5' ' ' ILE . 1.5 mp -107.29 157.23 18.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.43 119.85 31.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.367 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.571 HD13 ' CZ3' ' A' ' 31' ' ' TRP . 20.5 mt -111.54 132.6 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.35 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.99 156.8 44.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.11 -175.41 42.54 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.25 39.25 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -1.085 . . . . 0.0 109.182 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -115.43 -171.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -10.25 57.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -76.51 -74.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.665 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.476 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 6.2 t80 -50.82 -26.15 5.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 109.635 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -72.28 -68.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.571 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' ARG . 98.8 t -43.34 -44.94 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.813 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CD2' HD23 ' A' ' 45' ' ' LEU . 66.1 t80 -60.52 -44.62 95.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.689 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.95 -41.16 82.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.72 -45.62 93.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -17.84 63.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.569 HD23 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -72.55 -56.34 5.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 109.506 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.34 -42.24 88.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.61 -20.57 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.6 m -69.73 -61.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.583 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.97 -153.23 19.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.62 159.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 2.6 mp0 -113.1 95.73 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.722 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.571 ' CZ3' HD13 ' A' ' 9' ' ' ILE . 31.0 p-90 -112.18 169.3 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -144.3 162.79 38.2 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.859 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.9 Cg_endo -78.48 119.48 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.642 2.228 . . . . 0.0 110.273 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' CG ' ' A' ' 6' ' ' ARG . . . -106.37 -177.55 3.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.47 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -93.41 173.26 5.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.3 Cg_endo -78.18 -6.47 15.73 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.607 2.204 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.18 -0.94 16.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.509 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.45 56.04 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -112.85 119.06 36.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.345 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 4.9 t70 -49.94 -41.74 47.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -145.7 154.55 42.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 109.19 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.1 mt -92.74 94.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.413 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.33 130.68 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.864 . . . . 0.0 109.51 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.518 HD23 ' CD2' ' A' ' 20' ' ' PHE . 2.0 mm? -88.49 116.39 26.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB2' ' CH2' ' A' ' 49' ' ' TRP . . . -57.45 -22.19 41.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.28 34.8 3.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 2.2 mm? -121.08 -27.4 4.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -1.131 . . . . 0.0 109.765 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.583 ' CH2' ' HB2' ' A' ' 46' ' ' ALA . 1.9 p90 -65.31 -21.51 66.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.3 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.562 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -58.61 -18.44 37.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 p -110.08 -39.08 5.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.61 57.24 1.51 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 49' ' ' TRP . 4.0 ttt180 -53.73 -22.07 8.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.385 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.94 -42.34 60.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -66.75 -47.9 70.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 49' ' ' TRP . 1.8 mp -60.69 -37.29 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.95 -54.61 44.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.13 64.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.64 74.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.244 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.55 -33.99 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -59.92 -52.4 65.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.31 -30.67 71.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.393 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' CB ' ' CD1' ' A' ' 70' ' ' ILE . . . -72.18 -20.23 61.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -10.13 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.358 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 66' ' ' SER . 11.4 tttp -68.05 -9.23 44.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 14.9 t 68.27 45.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.627 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -110.77 -37.41 5.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -127.25 155.62 76.02 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.092 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' CG ' ' HB1' ' A' ' 107' ' ' ALA . 35.0 Cg_endo -77.3 122.86 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.509 2.139 . . . . 0.0 110.547 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 63' ' ' ALA . 69.0 mt -91.92 127.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.09 113.9 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.336 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 85' ' ' LEU . 19.0 p -96.01 121.53 37.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.478 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 92.3 t -98.91 121.48 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' CZ2' ' A' ' 95' ' ' TRP . 12.0 mmt180 -43.14 151.98 0.4 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.27 151.88 26.8 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.654 2.236 . . . . 0.0 110.525 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -49.22 -49.87 40.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.59 111.59 0.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -167.3 -46.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.362 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.86 -143.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.033 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.27 115.82 15.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 82' ' ' PRO . 78.9 t -50.24 134.27 23.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.26 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 81' ' ' VAL . 35.7 Cg_endo -77.95 148.25 24.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.453 2.102 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.62 -4.09 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.642 2.228 . . . . 0.0 110.47 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.63 -42.91 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 72' ' ' THR . 0.4 OUTLIER -67.71 -31.15 70.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.466 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.38 -0.59 42.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.28 28.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.125 -0.984 . . . . 0.0 109.646 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.85 -0.25 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 m -72.71 128.84 36.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 109.302 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.6 m -89.07 -18.85 26.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.57 142.94 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.863 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.41 115.26 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.014 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.465 ' CG2' ' HB1' ' A' ' 103' ' ' ALA . 86.6 t -88.95 149.94 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.834 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.29 -145.66 15.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.463 ' CZ2' ' O ' ' A' ' 74' ' ' ARG . 67.7 m95 -114.09 57.95 0.69 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 109.584 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -130.93 168.94 15.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.32 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.641 2.227 . . . . 0.0 110.636 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -10.27 56.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -62.68 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mt -51.07 -22.92 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -46.32 41.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -63.49 -12.86 35.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HB1' ' CG2' ' A' ' 93' ' ' VAL . . . -69.31 -60.89 2.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -68.22 -25.48 65.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.2 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.66 -47.35 67.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -22.63 61.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.293 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HB1' ' CG ' ' A' ' 69' ' ' PRO . . . -72.67 -19.62 61.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.503 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -23.32 27.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.3 p30 -118.33 141.17 48.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.42 -14.85 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.474 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.499 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.517 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 98.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.292 0.568 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 -4.02 53.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -134.75 128.02 32.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER 75.65 119.59 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.402 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -143.49 149.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.1 126.91 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 mp -134.96 159.41 41.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -112.75 97.52 6.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.475 HG22 ' CE1' ' A' ' 17' ' ' TYR . 44.9 mt -94.94 124.05 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.512 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.59 128.55 29.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 142.46 58.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -0.997 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA3' HD22 ' A' ' 48' ' ' LEU . . . -153.69 170.38 32.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.75 57.73 1.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' O ' ' HD3' ' A' ' 18' ' ' ARG . 1.6 m -142.85 -176.45 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.63 -11.8 60.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -76.84 -55.24 5.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 3.2 t80 -67.7 -22.38 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.478 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 1.5 mpt_? -73.82 -55.41 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.39 -36.24 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CZ ' HG22 ' A' ' 73' ' ' VAL . 34.6 t80 -64.17 -52.78 57.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.75 -22.61 64.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -76.54 -39.12 53.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.9 65.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -49.32 65.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.95 -20.69 61.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 109.978 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.91 -39.83 95.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 109.658 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 p -49.92 -49.52 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.56 60.23 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.83 154.91 49.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 9.1 tp10 -91.73 59.6 3.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -86.4 160.79 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -151.97 154.49 32.73 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.65 153.95 26.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.683 2.255 . . . . 0.0 110.376 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.23 171.24 17.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.9 168.34 4.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HB2' HD23 ' A' ' 62' ' ' LEU . 35.6 Cg_endo -77.82 -9.25 16.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.634 2.223 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 -21.92 25.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 50.87 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.13 103.94 13.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -50.67 -46.73 58.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.315 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -122.25 137.72 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -104.71 140.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.443 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -137.6 121.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 119.38 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 73' ' ' VAL . 5.7 mt -85.14 125.13 32.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.52 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.04 35.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.51 90.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' HA3' ' A' ' 12' ' ' GLY . 2.4 mt -120.21 24.02 10.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -1.148 . . . . 0.0 109.438 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.517 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 1.5 t90 -81.18 4.72 19.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.97 -4.11 29.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -124.9 -38.8 2.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.126 -1.22 . . . . 0.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' HG2' ' CB ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -114.11 72.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -74.43 -65.19 0.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.22 -19.1 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.49 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -77.24 -41.71 40.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.692 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 49' ' ' TRP . 45.4 mt -73.18 -35.46 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 8.4 mt -67.19 -32.69 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -46.22 46.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.8 -54.35 47.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -1.124 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.71 -28.37 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 109.438 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -63.83 -46.94 82.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 36' ' ' PRO . 8.7 tp -69.04 -32.87 72.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.44 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.481 ' HB3' ' CD1' ' A' ' 70' ' ' ILE . . . -74.62 -19.05 60.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.299 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -10.3 32.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' SER . 10.1 tptm -61.0 -14.08 20.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 5.6 t 73.7 68.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 p -154.06 -39.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -106.86 153.41 40.83 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -78.28 119.18 4.51 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.715 2.277 . . . . 0.0 110.356 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 23.5 mt -94.13 122.64 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.501 ' CG2' HG11 ' A' ' 93' ' ' VAL . 14.5 mt -115.64 117.58 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 93' ' ' VAL . 86.2 m -83.34 146.08 28.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 45' ' ' LEU . 43.3 t -120.2 114.96 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -55.72 146.63 45.41 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.361 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.49 165.92 24.65 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.662 2.241 . . . . 0.0 110.49 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.425 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -79.33 -26.02 42.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 78' ' ' LEU . . . -89.2 -13.83 61.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 29.4 tp 61.29 90.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 17.18 21.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 81' ' ' VAL . 10.8 m-80 56.34 82.91 0.1 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -44.52 147.21 1.07 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 170.51 19.16 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.517 2.145 . . . . 0.0 110.435 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 2.71 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.619 2.213 . . . . 0.0 110.518 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -83.06 -44.6 14.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -5.65 59.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.08 -12.78 49.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.42 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.14 13.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 98.81 12.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -30.2 67.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -155.26 127.61 7.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.84 128.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.501 HG11 ' CG2' ' A' ' 71' ' ' ILE . 7.3 p -128.29 145.29 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.649 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.09 -145.77 10.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -91.2 17.47 8.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -1.165 . . . . 0.0 109.394 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' CB ' ' HB2' ' A' ' 99' ' ' CYS . 2.5 m-20 -65.27 153.21 90.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.71 -57.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -77.06 -20.37 55.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.315 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -71.3 -13.0 61.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.07 -1.019 . . . . 0.0 109.901 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 96' ' ' ASN . 17.6 mm -75.74 -38.21 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -77.17 -31.45 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.3 -26.97 63.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.5 -67.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.417 ' O ' ' HB1' ' A' ' 107' ' ' ALA . 76.9 mt -53.1 -35.09 59.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.927 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.01 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.614 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -20.85 3.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 104' ' ' LEU . . . -77.3 -39.96 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 109.599 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mt -54.52 -49.25 70.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.706 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.32 69.19 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.603 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.96 120.91 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.359 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.446 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.48 168.03 10.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.3 61.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.955 . . . . 0.0 109.64 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -160.89 -172.36 3.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.525 ' CG2' ' OD2' ' A' ' 40' ' ' ASP . 10.9 mt -145.42 143.06 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 40' ' ' ASP . 21.1 mtt85 -85.1 105.64 15.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.226 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.512 HD21 ' CD1' ' A' ' 43' ' ' ILE . 8.0 mp -105.11 168.49 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.674 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.472 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 40.3 t80 -152.73 106.95 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 43' ' ' ILE . 20.8 mt -102.67 135.79 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -51.68 136.4 27.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.161 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.453 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -58.78 131.75 51.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.504 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.91 146.6 17.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.85 17.1 17.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.12 -173.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.37 -11.2 38.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 2.5 m-20 -73.01 -32.36 65.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' C ' ' CD1' ' A' ' 17' ' ' TYR . 23.3 t80 -71.31 -29.73 65.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -75.29 -47.96 25.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.29 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 93.4 t -61.54 -40.61 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.382 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -64.53 -58.01 7.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' CD1' HD13 ' A' ' 9' ' ' ILE . 3.9 tp -55.95 -22.58 27.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 19' ' ' VAL . 73.8 mt-10 -70.47 -55.13 9.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -57.88 -32.7 67.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.06 -58.68 6.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.887 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -70.53 -19.09 62.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -60.54 -41.65 94.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.351 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 16.0 t 174.39 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.59 58.38 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.63 161.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.299 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 148.41 22.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -149.68 174.24 12.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.13 147.74 42.11 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 103.55 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.655 2.236 . . . . 0.0 110.348 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . -100.89 -169.61 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.93 168.2 24.52 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.5 Cg_endo -77.75 -8.37 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.615 2.21 . . . . 0.0 110.345 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.18 -6.97 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.21 53.98 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' CB ' ' HB2' ' A' ' 8' ' ' TYR . . . -105.19 124.46 49.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.396 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.525 ' OD2' ' CG2' ' A' ' 5' ' ' ILE . 12.6 t70 -52.02 -30.04 23.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.91 124.2 10.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.693 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -97.28 96.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.027 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CG2' ' A' ' 73' ' ' VAL . 76.7 mt -92.52 107.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.07 133.41 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.37 120.56 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.446 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 81' ' ' VAL . . . -70.16 -15.54 62.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -22.57 71.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 11' ' ' GLU . 11.1 mp -89.28 13.69 12.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -1.18 . . . . 0.0 109.529 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.522 ' CH2' ' CG ' ' A' ' 82' ' ' PRO . 4.8 t-105 -72.72 -30.33 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.64 27.28 21.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 p -135.4 -39.02 0.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -1.179 . . . . 0.0 109.45 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' CB ' ' HB2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -141.47 71.69 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.298 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -52.9 -56.24 17.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -56.27 -38.47 71.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 109.614 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -56.65 -47.99 78.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.424 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.8 mm -62.06 -33.36 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 108.872 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.75 -21.43 60.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.113 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.15 -54.95 4.98 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.51 89.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.173 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 70.2 t -58.44 -44.18 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.253 -0.904 . . . . 0.0 109.046 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -58.03 -40.57 81.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.37 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -68.91 -28.25 66.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 70' ' ' ILE . . . -76.83 -28.18 55.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.407 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 40.3 mtp85 -75.92 0.1 19.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -84.02 -30.04 26.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.402 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.44 20.64 3.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.01 23.1 1.02 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.706 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -47.44 163.59 0.26 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 113.98 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.634 2.223 . . . . 0.0 110.603 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.451 HD12 ' HB2' ' A' ' 63' ' ' ALA . 2.1 mt -113.7 108.03 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.368 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 25.1 mt -96.36 124.83 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 73' ' ' VAL . 21.9 m -89.77 156.13 18.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.553 ' CG2' ' CG2' ' A' ' 43' ' ' ILE . 3.4 t -123.89 121.76 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -50.71 150.41 5.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.51 178.13 8.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.499 2.133 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.3 -25.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.95 86.26 0.23 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.0 -82.89 0.48 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -136.82 17.61 3.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 -177.92 0.13 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.522 -0.736 . . . . 0.0 109.472 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 34.0 m -85.98 159.89 53.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' CG ' ' CH2' ' A' ' 49' ' ' TRP . 34.3 Cg_endo -77.72 174.36 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.658 2.238 . . . . 0.0 110.39 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 35.2 Cg_endo -77.43 -33.01 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.606 2.204 . . . . 0.0 110.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.31 -34.4 70.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.181 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.31 -20.03 20.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.98 -35.23 79.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.112 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.98 -11.82 61.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.227 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.56 7.8 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.1 t -105.59 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -44.09 74.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.467 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -146.95 154.56 41.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 92' ' ' VAL . 4.3 p -117.68 119.15 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.9 p -108.95 163.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -125.53 -157.94 9.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 30.1 m95 -88.74 38.82 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 109.246 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.419 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -103.01 151.22 38.39 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.39 -46.73 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.67 2.247 . . . . 0.0 110.327 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.14 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.62 -54.2 31.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.539 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 96' ' ' ASN . 31.5 mm -47.38 -24.51 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.46 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -52.65 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.614 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.48 -14.8 59.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.38 -48.16 24.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.786 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.3 -25.87 51.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -74.88 -21.81 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -37.69 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.603 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.32 -55.72 19.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.06 39.68 30.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 110' ' ' VAL . 7.2 t0 -111.64 103.97 12.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.641 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 109' ' ' ASP . 43.3 t 43.91 84.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 109.51 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.6 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.924 -1.036 . . . . 0.0 109.394 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.0 m -78.88 79.95 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.487 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -101.36 -163.35 1.01 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 0.9 OUTLIER 74.75 123.17 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 HD13 ' CD1' ' A' ' 108' ' ' LEU . 3.3 tt -131.67 156.67 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.454 ' HG2' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -111.47 127.5 55.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.831 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -128.34 169.7 13.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.87 . . . . 0.0 109.212 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -128.78 102.47 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.626 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 HG23 ' CE1' ' A' ' 17' ' ' TYR . 15.6 mt -100.09 143.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -73.62 -170.34 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.589 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 1.3 pt-20 -135.15 109.04 8.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.0 173.14 15.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.6 tm-20 -115.63 28.3 8.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 109.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.12 158.22 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 109.679 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.3 -9.97 38.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 16' ' ' ASP . 2.6 m-20 -72.39 -48.63 40.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.555 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CE1' HG23 ' A' ' 9' ' ' ILE . 11.6 t80 -65.12 -26.1 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -70.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.598 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.5 t -49.87 -31.96 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.479 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.518 ' CE1' ' CD1' ' A' ' 24' ' ' LEU . 31.6 t80 -68.02 -48.23 66.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -41.05 74.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.21 -33.74 76.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -15.69 59.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.518 ' CD1' ' CE1' ' A' ' 20' ' ' PHE . 1.7 tp -74.65 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 26' ' ' GLN . 2.4 pt-20 -59.9 -20.68 58.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -52.35 -41.03 62.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.287 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -26.9 60.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 102.21 -132.47 11.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER 62.75 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.124 . . . . 0.0 109.395 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 85.3 mt-10 -88.74 111.26 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -120.04 156.64 30.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -137.69 159.95 66.92 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.4 Cg_endo -77.79 130.8 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.653 2.235 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -116.63 -165.92 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -101.99 175.16 2.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.548 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.7 Cg_endo -77.62 -19.36 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.566 2.177 . . . . 0.0 110.405 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -112.39 -6.55 14.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -138.54 49.1 1.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' HA ' ' CB ' ' A' ' 34' ' ' ALA . . . -104.95 133.13 50.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -34.01 76.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 109.322 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -149.68 123.84 9.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 21.7 t -79.9 156.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 109.849 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG12 ' HB ' ' A' ' 71' ' ' ILE . 13.3 mt -147.05 102.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 108.98 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 t -112.97 137.34 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.748 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' N ' HD21 ' A' ' 45' ' ' LEU . 3.9 mm? -84.12 131.47 34.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -76.59 -36.7 57.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.95 34.56 3.89 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -125.41 -26.65 3.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.811 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 46' ' ' ALA . 1.7 p90 -57.67 -18.56 21.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.018 -1.051 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.538 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -42.27 -29.9 0.72 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -47.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.63 47.95 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -45.06 85.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -67.33 -31.47 71.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.899 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.94 -59.42 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.422 ' O ' HG21 ' A' ' 60' ' ' VAL . 3.0 mp -54.96 -57.79 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.24 -26.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.855 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.06 -68.16 1.73 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 63' ' ' ALA . . . -48.53 -37.0 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -1.12 . . . . 0.0 109.988 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 56' ' ' ILE . 58.8 t -59.62 -60.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.58 -58.65 6.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.433 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -50.53 -27.15 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 59' ' ' ALA . . . -70.93 -45.11 64.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -68.29 -7.59 32.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -57.37 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -79.69 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 p 179.01 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -87.04 154.72 55.19 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.434 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.455 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -77.9 116.87 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.701 2.268 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 95.6 mt -95.04 111.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.324 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' HB ' HG12 ' A' ' 43' ' ' ILE . 35.5 mm -94.33 91.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.722 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -88.06 128.86 35.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 45' ' ' LEU . 58.2 t -98.65 132.35 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -64.05 171.53 2.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 34.8 Cg_endo -77.31 163.49 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.62 2.213 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.2 -15.64 63.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.9 46.54 0.77 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 7.21 3.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -1.092 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -151.68 -143.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.237 -0.914 . . . . 0.0 108.995 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -145.6 153.79 41.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 97.5 t -104.6 134.87 19.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.382 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.84 150.33 23.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.502 2.135 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.12 -20.49 11.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.193 . . . . 0.0 110.467 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.27 -34.69 74.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.624 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.79 55.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.655 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -69.21 -18.75 63.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.01 -7.97 59.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.38 33.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 134.07 55.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -99.84 -31.59 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' OE2' ' HB2' ' A' ' 106' ' ' ASP . 4.0 mt-10 -136.14 118.54 15.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.595 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.6 m -117.99 128.57 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.248 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.526 ' CG1' ' HB1' ' A' ' 103' ' ' ALA . 2.8 m -123.93 165.28 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.71 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.72 -146.57 21.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.98 66.83 0.66 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -1.158 . . . . 0.0 109.586 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -138.44 152.57 71.47 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.31 -41.89 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.619 2.213 . . . . 0.0 110.554 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -76.93 -31.57 56.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.659 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -42.15 67.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.497 HD13 ' CE2' ' A' ' 20' ' ' PHE . 35.6 mt -59.22 -41.94 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.661 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -64.16 -42.09 96.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.725 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -31.09 63.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -0.86 . . . . 0.0 109.783 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 93' ' ' VAL . . . -74.21 -43.18 58.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.732 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.01 -33.55 73.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.675 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -51.94 -28.17 15.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.432 ' HB2' ' OE2' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -67.81 -49.83 60.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.877 . . . . 0.0 109.728 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.28 -43.24 67.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.651 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.448 ' CD1' HD13 ' A' ' 5' ' ' ILE . 1.2 tp -57.85 -44.64 86.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.03 117.13 21.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 111' ' ' ILE . 53.9 t -104.67 145.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.2 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.459 ' N ' HG13 ' A' ' 110' ' ' VAL . 9.9 tt . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 2' ' ' THR . 1.3 t -155.02 105.31 2.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.51 115.75 3.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.54 146.75 31.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' CG2' HD13 ' A' ' 7' ' ' LEU . 31.6 mt -119.08 139.25 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -92.56 112.29 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 109.319 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.416 ' CD2' HD13 ' A' ' 43' ' ' ILE . 3.7 mp -120.76 153.45 36.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 15.5 t80 -123.94 108.95 12.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 45' ' ' LEU . 1.7 mt -107.74 142.12 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -47.91 145.92 2.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.445 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.04 125.83 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.0 179.57 37.27 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -117.57 -3.74 11.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 109.736 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.9 170.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 109.55 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -77.75 -19.12 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.515 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.01 -50.76 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CE2' HD22 ' A' ' 21' ' ' LEU . 64.6 t80 -63.91 -28.17 69.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -58.32 5.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.27 -48.57 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -53.37 -37.52 62.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD22 ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -67.62 -61.53 1.84 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.662 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -51.19 -23.81 3.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -51.09 19.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -73.35 -6.17 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.19 -64.12 1.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.66 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.62 -8.28 26.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.952 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -57.07 9.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.87 -27.54 6.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.87 152.08 32.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.149 . . . . 0.0 109.519 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -99.98 50.97 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.852 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 35.5 p-90 -80.11 158.47 26.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.905 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -144.06 157.43 57.34 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.98 131.74 11.24 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.15 172.25 10.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.923 . . . . 0.0 109.588 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.19 162.04 4.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.499 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.527 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.7 Cg_endo -78.67 2.15 8.43 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.787 2.325 . . . . 0.0 110.668 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.43 15.99 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 109.638 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.18 38.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.527 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 131.78 52.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.84 -37.31 60.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.317 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.48 128.89 22.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.99 110.49 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 97.0 mt -97.23 104.7 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' CG1' HG23 ' A' ' 56' ' ' ILE . 9.2 t -84.95 137.97 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.7 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 9' ' ' ILE . 2.8 mm? -102.88 117.59 34.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.343 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -17.31 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.3 -16.99 37.12 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.84 40.64 3.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -1.221 . . . . 0.0 109.622 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 43.1 t-105 -81.49 -29.91 33.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.73 39.04 2.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -139.12 -50.52 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 56' ' ' ILE . 11.2 mtt180 -130.48 64.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -48.57 -22.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.05 -41.94 40.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 11.8 tt0 -69.31 -30.15 68.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 52' ' ' ARG . 4.3 mm -77.12 -63.74 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.885 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -55.48 -47.91 75.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.957 -179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -31.59 81.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 55' ' ' GLU . . . -63.03 -62.02 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -1.187 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.78 -46.48 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.418 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.89 -39.26 65.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 1.0 OUTLIER -61.42 -47.18 86.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.211 -0.93 . . . . 0.0 109.265 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.57 ' CB ' ' CG1' ' A' ' 70' ' ' ILE . . . -52.88 -49.19 66.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -26.23 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 15.3 21.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.991 . . . . 0.0 109.632 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' LEU . 43.8 m -143.69 -63.37 0.39 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.355 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 75.5 m -109.55 -91.71 0.45 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.208 -0.933 . . . . 0.0 109.022 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tttp 155.21 -47.19 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.831 -0.543 . . . . 0.0 110.237 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 68' ' ' LYS . 36.2 Cg_endo -78.2 119.16 4.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.092 1.861 . . . . 0.0 110.605 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.57 ' CG1' ' CB ' ' A' ' 63' ' ' ALA . 2.7 mp -125.61 104.86 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 4.0 mp -91.02 119.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.42 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.526 ' CG2' HG21 ' A' ' 92' ' ' VAL . 13.3 t -104.45 140.29 38.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 109.757 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -108.7 125.68 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.128 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.3 164.98 15.44 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 162.44 28.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.608 2.206 . . . . 0.0 110.144 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.93 -57.44 6.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.636 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.3 85.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.0 -67.12 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -1.175 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -115.54 -143.89 0.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.294 -0.879 . . . . 0.0 109.087 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.81 122.49 9.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.457 HG13 ' HD2' ' A' ' 82' ' ' PRO . 53.7 t -52.2 137.26 38.8 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.4 Cg_endo -78.07 165.41 26.12 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.476 2.118 . . . . 0.0 110.557 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.96 5.27 5.45 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.697 2.265 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.29 -35.07 23.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.96 -7.82 44.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.52 -9.46 41.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.579 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.59 -5.35 35.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.63 -41.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -46.6 156.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 m -123.06 -6.61 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.883 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' HB2' HG13 ' A' ' 71' ' ' ILE . 22.3 mt-10 -150.89 98.78 2.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.526 HG21 ' CG2' ' A' ' 72' ' ' THR . 59.4 t -102.36 128.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.89 168.53 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.16 -146.84 15.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -95.1 34.48 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.603 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.43 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.4 m-80 -106.11 146.0 32.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.21 -32.63 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.67 2.247 . . . . 0.0 110.594 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.35 -41.28 76.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -28.06 61.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 96' ' ' ASN . 67.7 mt -74.87 -31.55 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.012 . . . . 0.0 109.646 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -44.36 69.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.63 -17.83 64.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.554 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -59.16 2.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -21.17 66.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.98 -45.47 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 -1.52 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 109.786 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.11 -32.98 56.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mp -83.45 -53.71 5.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.639 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.08 168.39 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 111' ' ' ILE . 6.6 p -116.94 -40.06 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.532 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.444 ' OXT' HG13 ' A' ' 111' ' ' ILE . 27.9 pt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.505 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.8 t -107.31 -179.31 3.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.416 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.38 -8.92 13.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.47 172.82 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.774 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 5' ' ' ILE . 4.0 tt -151.17 155.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.048 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -91.57 104.86 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.941 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 31' ' ' TRP . 1.0 OUTLIER -130.19 164.85 23.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.959 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -131.29 147.44 52.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.823 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.522 HG23 ' CE1' ' A' ' 17' ' ' TYR . 3.3 mt -131.64 147.06 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.66 145.59 33.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.501 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.57 149.82 24.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.64 -155.93 14.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.23 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.2 m -112.82 167.99 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.945 . . . . 0.0 109.625 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.96 -25.62 66.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.548 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.63 -66.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' CE1' HG23 ' A' ' 9' ' ' ILE . 6.4 t80 -54.1 -26.77 28.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -69.86 -71.66 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.792 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t -42.11 -39.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -59.82 -54.51 45.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.638 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.75 -28.72 50.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.784 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 63.2 mm-40 -72.75 -45.02 60.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.878 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -23.28 64.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 109.91 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -56.15 24.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -59.44 -21.39 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -49.75 -33.45 16.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER -45.63 -50.6 13.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 109.533 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.25 64.41 0.28 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 tp 61.65 82.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.44 27.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.12 -0.988 . . . . 0.0 109.567 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.436 ' HB2' HD21 ' A' ' 7' ' ' LEU . 44.9 p-90 -158.06 155.99 30.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.95 . . . . 0.0 109.657 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -151.68 148.2 21.49 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.406 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HD2' ' HG2' ' A' ' 32' ' ' ARG . 35.1 Cg_endo -77.72 119.55 4.84 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.596 2.198 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.35 -168.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.676 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -97.61 165.25 15.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 109.404 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.7 Cg_endo -76.91 -23.39 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.478 2.119 . . . . 0.0 110.169 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -2.96 53.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.294 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.34 61.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.82 127.28 54.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -77.21 -39.85 47.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -124.02 134.06 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.37 144.21 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.2 mt -134.44 100.46 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.481 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.67 135.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.2 136.01 33.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.568 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.35 9.47 28.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.36 -24.15 29.66 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mp -85.3 12.71 7.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -1.126 . . . . 0.0 109.307 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.567 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 1.8 t-105 -68.43 -26.53 65.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.79 28.25 16.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -142.73 -64.84 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -1.094 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -120.41 57.37 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HG3' ' NE1' ' A' ' 49' ' ' TRP . 5.5 ttt180 -55.98 -35.24 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.39 -0.819 . . . . 0.0 109.727 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -52.18 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.696 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -50.25 -38.26 39.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 mt -71.85 -52.52 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.5 tp -47.11 -31.1 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.18 -48.77 57.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.02 -53.25 60.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -1.084 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.94 -40.24 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -36.39 82.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.679 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.13 -47.12 81.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . . . -67.88 -25.8 65.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 0.7 19.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 65' ' ' LYS . 1.6 tppt? -62.47 -48.76 78.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -73.4 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.1 p -178.67 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.059 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 4.8 mtmt -79.67 154.13 75.94 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.93 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 36.3 Cg_endo -78.95 100.94 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.31 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -103.26 115.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.523 ' CG2' HG23 ' A' ' 93' ' ' VAL . 1.6 mp -105.2 129.77 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.462 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 13.4 t -94.64 132.34 39.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.761 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.51 120.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.38 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -50.11 158.38 0.96 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.19 -164.25 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.72 2.28 . . . . 0.0 110.387 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -88.38 -62.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 109.222 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.8 61.57 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 -51.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.514 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.77 -143.82 0.34 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.299 -0.875 . . . . 0.0 109.104 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -140.76 148.7 41.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.652 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.534 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 15.2 t -74.45 140.68 75.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.339 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.0 Cg_endo -77.37 161.47 31.7 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.474 2.116 . . . . 0.0 110.539 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.03 7.37 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.782 2.321 . . . . 0.0 110.778 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -92.14 -44.66 8.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.37 -19.73 63.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.686 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 39.2 tt0 -84.99 -9.51 57.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 -1.47 25.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.694 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.06 -25.76 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.661 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 2.4 m -81.02 135.82 35.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.502 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -76.69 -23.82 53.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -150.6 167.11 28.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.47 112.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 HG22 ' CB ' ' A' ' 103' ' ' ALA . 2.6 t -96.31 151.38 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.07 -151.3 27.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -100.63 29.21 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -1.172 . . . . 0.0 109.38 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.61 159.95 27.67 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.4 -0.813 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.57 -53.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.65 2.234 . . . . 0.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -56.01 -30.94 62.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.443 ' HB3' HG11 ' A' ' 93' ' ' VAL . 2.7 t -68.27 -44.02 76.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.824 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.81 -32.62 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.881 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -60.25 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.623 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -45.61 82.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.691 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' CB ' HG22 ' A' ' 93' ' ' VAL . . . -60.82 -27.3 67.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.47 -45.6 58.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.295 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -17.77 61.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.264 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.51 -36.83 79.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.34 -42.99 42.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.85 -50.89 24.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 110' ' ' VAL . 25.1 t0 -94.94 136.76 34.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.382 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.462 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 47.7 t -132.24 100.02 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.365 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 110' ' ' VAL . 5.4 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.412 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ALA . 0.9 OUTLIER -96.52 -80.42 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.463 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' THR . . . 71.91 11.18 6.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.22 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 -174.77 4.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.9 mt -134.24 137.88 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -99.01 105.1 17.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.465 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -121.82 171.04 9.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.403 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.7 t80 -143.2 106.08 4.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.548 HG23 ' CE1' ' A' ' 17' ' ' TYR . 2.9 mt -104.61 135.83 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.41 167.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 109.141 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.38 102.4 5.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.16 -145.87 6.97 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -138.89 54.1 1.75 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.207 -1.173 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 48' ' ' LEU . 3.5 t -118.22 157.45 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.394 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 19' ' ' VAL . 37.1 tt0 -77.93 -11.9 59.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' OD1' HD12 ' A' ' 45' ' ' LEU . 1.5 t70 -69.62 -59.39 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CE1' HG23 ' A' ' 9' ' ' ILE . 12.3 t80 -60.52 -33.28 72.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -64.42 -41.96 96.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 109.832 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 15' ' ' GLU . 79.3 t -66.66 -50.55 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -51.03 -52.06 46.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.41 -26.1 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.52 -49.19 72.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.703 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.53 -26.13 59.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.528 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.515 ' CD1' HG23 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -76.69 -15.0 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.638 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.16 -57.19 4.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -72.34 -10.25 59.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.1 t -47.02 -46.1 21.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.386 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 121.67 -179.82 16.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER 61.6 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -1.126 . . . . 0.0 109.519 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.83 158.49 15.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.234 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -158.19 155.06 28.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.56 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -145.97 155.0 51.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.534 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 36.1 Cg_endo -78.29 133.71 12.22 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.639 2.226 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -125.29 154.01 42.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -44.1 162.27 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.528 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.96 -31.06 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.634 2.222 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -31.85 69.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -120.17 27.93 8.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.59 107.48 5.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 47.4 t0 -53.89 -37.34 63.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -131.73 129.95 41.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.19 110.78 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.524 ' CD1' HG12 ' A' ' 9' ' ' ILE . 8.0 mt -104.48 100.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.293 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 ' CG1' HG22 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -96.3 130.7 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.663 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -84.89 135.94 33.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' HB3' ' CG2' ' A' ' 72' ' ' THR . . . -100.95 25.63 7.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.965 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -110.76 -35.78 1.98 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 14' ' ' VAL . 3.8 pp -119.43 15.43 12.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -1.207 . . . . 0.0 109.625 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.607 ' CZ3' ' CD1' ' A' ' 85' ' ' LEU . 2.8 p-90 -76.65 -21.58 55.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.53 -13.38 55.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -98.86 -41.53 7.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -1.101 . . . . 0.0 109.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 56' ' ' ILE . 7.1 mtt180 -108.45 50.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.269 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NE ' ' CZ3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -71.22 -33.43 69.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.03 -51.17 70.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 56' ' ' ILE . 20.7 mt-10 -68.42 -58.33 4.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.505 HG22 ' CG1' ' A' ' 44' ' ' VAL . 34.0 mm -43.52 -26.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.747 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -59.77 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.665 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.37 -30.17 24.97 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -57.71 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 56' ' ' ILE . 66.6 t -49.98 -45.25 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.57 -48.62 74.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.02 -32.45 61.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' HD13 ' A' ' 70' ' ' ILE . . . -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -66.93 -21.44 65.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.99 -27.34 16.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 68' ' ' LYS . 47.6 t -109.33 15.98 22.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.9 p 45.26 40.23 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -83.26 152.52 64.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 35.5 Cg_endo -78.19 117.86 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.681 2.254 . . . . 0.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HD13 ' HB2' ' A' ' 63' ' ' ALA . 2.6 mt -107.81 90.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.514 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.552 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 3.0 mt -93.06 128.2 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.261 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.441 ' CG2' ' HB3' ' A' ' 46' ' ' ALA . 52.0 m -102.07 131.32 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.75 124.4 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -49.33 153.24 1.84 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 34.8 Cg_endo -77.43 -158.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.609 2.206 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' ' CZ2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -117.68 14.99 14.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.679 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.47 6.23 5.74 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -95.37 68.51 3.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -1.179 . . . . 0.0 109.416 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 5.5 tp10 67.27 137.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.886 0.851 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -78.53 -164.16 0.54 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.309 0.575 . . . . 0.0 109.568 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -91.22 150.8 42.18 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.05 173.12 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.644 2.229 . . . . 0.0 110.404 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.9 Cg_endo -77.8 -5.46 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 110.31 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -83.36 -49.37 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.607 ' CD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -69.11 -27.38 65.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.54 -12.13 56.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.358 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.7 -12.28 20.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' CG2' ' HA ' ' A' ' 85' ' ' LEU . 7.3 m -123.84 8.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.385 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 p -94.66 131.17 40.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -76.31 -38.58 55.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.11 173.44 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.799 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.54 155.74 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.401 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 3.1 t -123.57 146.25 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.28 -162.44 17.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' CD2' ' A' ' 76' ' ' TYR . 74.2 m95 -98.45 19.38 14.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.18 156.36 54.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.238 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.47 -34.62 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.586 2.19 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -20.67 55.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.593 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -10.14 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.943 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 HG23 ' CD1' ' A' ' 24' ' ' LEU . 28.2 mm -76.39 -64.27 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -32.26 69.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.47 -35.77 72.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.89 60.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.977 . . . . 0.0 109.853 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.73 -23.42 58.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 109.734 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.84 -22.61 63.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.17 -44.68 79.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.89 -18.91 64.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 15.71 27.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.389 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -146.32 111.44 5.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 0.0 109.713 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 96.5 t -109.07 -26.77 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 110' ' ' VAL . 15.0 tt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.84 48.32 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 4' ' ' GLU . . . -101.53 144.72 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 5.2 mt-10 74.3 170.95 0.29 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.65 164.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.39 119.82 36.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.639 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 1.3 pp -135.52 169.66 17.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.85 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -142.28 114.11 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.817 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.448 HG12 HD11 ' A' ' 43' ' ' ILE . 11.8 mt -94.44 148.84 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.205 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.91 155.14 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.43 156.96 16.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.6 -164.52 34.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -155.38 65.58 0.62 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -1.149 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.99 -170.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.53 -22.74 22.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.423 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -70.65 -52.64 19.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' OH ' HD21 ' A' ' 21' ' ' LEU . 14.1 t80 -65.75 -19.66 65.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -54.52 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.74 -36.35 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -65.82 -61.14 2.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD21 ' OH ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -54.15 -27.16 31.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.91 -36.39 64.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -22.05 54.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -43.88 74.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.63 -14.7 62.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -51.5 51.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.331 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 p -63.33 -47.65 81.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 114.52 -109.94 2.26 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 55.58 169.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.419 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 4.7 mt-10 -120.3 130.11 54.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' ' CE3' ' A' ' 31' ' ' TRP . 25.9 p-90 -160.04 148.46 17.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.512 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -133.07 156.99 79.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.448 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.63 129.92 10.38 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.65 2.233 . . . . 0.0 110.323 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.65 149.81 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.631 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.508 ' CG2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -46.6 160.05 0.33 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.354 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD2' ' CG2' ' A' ' 35' ' ' THR . 35.3 Cg_endo -77.99 0.29 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.656 2.238 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.93 -27.42 12.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -130.44 36.1 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.92 116.4 22.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -36.53 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.937 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -136.3 139.23 42.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.695 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -113.84 149.03 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.324 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 9' ' ' ILE . 4.1 mt -136.98 129.84 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 t -118.83 129.79 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -92.62 128.33 38.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 81' ' ' VAL . . . -87.46 -0.76 57.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 109.585 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.01 -13.25 61.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.52 46.28 2.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.221 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.525 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 44.9 t-105 -77.67 -16.89 58.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.797 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.23 19.47 29.52 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -132.75 -62.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -1.205 . . . . 0.0 109.701 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HB2' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -99.1 36.09 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -59.33 -40.09 85.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.32 -39.34 66.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.658 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -73.1 -45.33 57.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.904 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' O ' HG21 ' A' ' 60' ' ' VAL . 5.9 mt -59.93 -24.68 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.684 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.5 -55.77 8.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 109.507 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.06 65.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.71 24.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -1.173 . . . . 0.0 109.431 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 56' ' ' ILE . 51.4 t -56.01 -37.76 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 12.9 mt -63.97 -31.54 72.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.246 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.11 57.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -69.27 -9.04 51.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.1 tttm -61.38 -15.61 38.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' SER . 22.2 m -152.88 -75.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 169.56 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.86 . . . . 0.0 109.342 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.34 155.91 57.02 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.454 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.9 Cg_endo -78.36 114.11 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.631 2.221 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mt -103.01 117.35 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.438 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 mt -110.94 114.78 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 t -85.61 154.86 21.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.3 t -124.37 129.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.17 -0.956 . . . . 0.0 109.796 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.21 155.2 18.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.567 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 176.58 9.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.709 2.273 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 77' ' ' GLY . 6.4 t80 -70.75 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 76' ' ' TYR . . . -132.97 96.36 0.3 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' GLU . 2.4 tt 179.27 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -1.176 . . . . 0.0 109.289 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 78' ' ' LEU . 9.9 mt-10 61.02 126.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -179.53 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.508 HG21 ' CB ' ' A' ' 46' ' ' ALA . 80.2 t -104.82 130.75 22.63 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.525 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 34.9 Cg_endo -77.88 168.92 21.46 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.403 2.069 . . . . 0.0 110.38 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 -10.3 15.53 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.656 2.237 . . . . 0.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.7 tt0 -81.88 -2.86 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.48 ' HB2' ' CH2' ' A' ' 49' ' ' TRP . 40.7 tp -112.86 -15.99 12.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.17 -0.956 . . . . 0.0 109.204 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -82.63 -12.07 57.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.18 -36.42 9.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.772 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -79.91 -24.61 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 109.715 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 85' ' ' LEU . 2.0 p -68.17 94.18 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.427 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' SER . 50.6 m -43.69 -33.64 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.65 157.83 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.375 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.8 p -126.31 145.57 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 103' ' ' ALA . 85.4 t -129.22 147.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 109.568 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.29 -151.15 18.8 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -97.99 43.88 1.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -1.21 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.466 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -106.06 150.76 39.7 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.89 . . . . 0.0 109.703 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.11 -48.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.727 2.285 . . . . 0.0 110.332 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.61 -31.98 63.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.464 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 5.3 m -60.68 -18.89 56.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.563 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 96' ' ' ASN . 21.3 mm -70.91 -36.47 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.5 -51.52 12.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.58 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -53.0 -27.08 17.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.657 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB2' HG23 ' A' ' 93' ' ' VAL . . . -77.1 -55.82 5.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.774 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.422 HD11 ' N ' ' A' ' 104' ' ' LEU . 5.0 mp -54.46 -24.32 19.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.67 -42.22 61.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 102' ' ' ASP . 8.7 m-20 -50.13 -23.44 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 104' ' ' LEU . . . -58.61 -48.55 80.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.53 24.63 12.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.7 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.61 167.17 29.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.42 78.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.331 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.426 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 2' ' ' THR . 18.2 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.475 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 0.1 OUTLIER 167.19 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.297 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.02 118.99 4.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.3 155.7 38.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.543 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.09 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -112.96 109.95 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.258 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.523 HD23 ' CD2' ' A' ' 104' ' ' LEU . 1.4 mp -118.4 171.5 8.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.761 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.3 95.41 2.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.0 109.192 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.9 mp -79.79 132.68 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.65 140.04 19.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 109.547 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -56.41 131.24 47.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.29 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' CA ' HD23 ' A' ' 48' ' ' LEU . . . -142.46 153.65 24.62 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.5 22.81 5.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -1.12 . . . . 0.0 109.275 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.68 156.2 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -59.35 -19.29 45.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.375 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.81 -66.13 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' CE1' ' CG2' ' A' ' 9' ' ' ILE . 10.7 t80 -46.33 -31.28 2.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.269 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -52.08 51.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 77.6 t -57.69 -32.37 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.18 -35.76 76.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -52.95 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.617 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.51 -24.72 65.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -74.16 -31.22 62.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.704 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -35.38 65.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.716 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.03 -46.73 73.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -19.76 63.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.498 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -68.31 -28.96 67.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 97.94 -173.5 28.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 75.39 136.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 109.517 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -92.38 93.15 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -97.15 169.34 9.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -151.95 152.77 30.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.54 139.19 15.98 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.687 2.258 . . . . 0.0 110.525 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.91 145.09 50.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.462 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -51.44 172.42 0.15 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.99 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.724 2.283 . . . . 0.0 110.671 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -103.9 -52.86 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.109 -0.995 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -100.29 37.09 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.74 124.81 26.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -70.68 -36.27 73.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.517 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -149.2 121.6 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.03 136.48 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 9' ' ' ILE . 21.8 mt -116.33 88.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.78 126.8 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD11 ' HB ' ' A' ' 73' ' ' VAL . 0.6 OUTLIER -96.67 125.27 41.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.09 54.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.391 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.95 -19.53 69.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD23 ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -95.64 20.39 9.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.286 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 14.9 t-105 -69.91 -15.42 63.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.86 34.94 5.24 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -148.78 -52.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -1.165 . . . . 0.0 109.584 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 55' ' ' GLU . 10.7 mtt-85 -130.67 63.58 1.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -42.07 74.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.242 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -73.13 -35.69 66.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.35 -0.844 . . . . 0.0 109.319 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -65.39 -32.78 74.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.328 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 52' ' ' ARG . 31.5 mt -76.11 -51.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -47.51 -35.85 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -50.16 54.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 -34.55 58.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 109.297 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.81 -52.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.843 . . . . 0.0 109.276 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.74 -39.14 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 mt -70.29 -34.01 72.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.473 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.09 -54.85 42.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -70.88 -14.03 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -29.33 3.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.89 -79.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -178.5 65.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.0 149.14 37.23 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 34.7 Cg_endo -77.6 127.09 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.569 2.179 . . . . 0.0 110.162 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' SER . 53.5 mt -103.68 118.73 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 44.5 mm -108.53 119.42 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 93' ' ' VAL . 10.8 m -92.88 143.37 26.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.893 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.434 ' HB ' HD11 ' A' ' 45' ' ' LEU . 41.0 t -121.74 115.26 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -43.12 155.3 0.28 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 158.57 32.17 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.671 2.247 . . . . 0.0 110.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -109.16 18.06 20.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.45 13.52 62.79 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 52.09 48.47 22.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.407 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 -143.38 0.35 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.313 -0.867 . . . . 0.0 109.125 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -142.19 108.64 5.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.532 ' CG2' ' HD2' ' A' ' 82' ' ' PRO . 14.1 p -50.49 140.85 17.71 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.91 . . . . 0.0 109.241 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 81' ' ' VAL . 35.3 Cg_endo -77.73 156.46 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.468 2.112 . . . . 0.0 110.316 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.25 71.06 6.91 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.639 2.226 . . . . 0.0 110.716 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.21 -42.66 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.073 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.61 -29.74 22.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' OE2' ' CG1' ' A' ' 81' ' ' VAL . 6.3 mp0 -72.2 -20.39 61.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.24 83.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.37 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -122.41 48.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -106.78 129.22 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.388 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 5.4 m -71.33 -34.24 70.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -157.13 142.9 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.36 100.34 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 72' ' ' THR . 4.4 m -95.08 144.54 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.85 -146.73 17.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -92.11 13.53 18.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -1.095 . . . . 0.0 109.535 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -87.81 150.26 47.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.82 -35.27 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.654 2.236 . . . . 0.0 110.17 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.93 -26.89 69.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 92.1 m -77.42 -25.04 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.77 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.3 mm -66.97 -58.48 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.73 -33.36 75.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.95 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.741 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.24 76.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.523 ' CD2' HD23 ' A' ' 7' ' ' LEU . 14.4 mt -77.24 -22.41 52.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.718 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.08 91.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.3 98.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.15 60.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.296 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 mp -94.17 -7.67 41.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -67.3 0.78 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 14.4 m -100.28 -27.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 110' ' ' VAL . 3.4 mt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 2' ' ' THR . 5.0 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 1' ' ' VAL . 0.2 OUTLIER -43.57 105.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.72 87.5 2.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -157.41 132.78 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' CG2' ' N ' ' A' ' 6' ' ' ARG . 62.4 mt -122.08 165.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.686 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 66.8 mtt180 -127.86 120.0 26.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 1.5 pp -145.42 170.79 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.751 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -137.38 139.14 40.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.204 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 10' ' ' THR . 3.8 mt -121.63 147.89 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.459 ' N ' HG21 ' A' ' 9' ' ' ILE . 4.2 p -65.01 121.37 14.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.329 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.29 169.36 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.572 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.22 -166.27 36.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -146.03 36.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.88 163.21 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.148 -0.97 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -68.77 -31.94 71.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.04 -38.41 79.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -64.11 -46.66 83.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.47 -26.03 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -69.85 -55.23 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.577 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 24' ' ' LEU . 9.6 t80 -55.99 -47.27 78.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.356 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.49 -37.79 70.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.03 82.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.25 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -72.69 -28.51 62.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' CZ ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -72.4 -29.63 63.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -41.26 61.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -17.93 9.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.4 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.12 -13.9 11.19 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.37 172.3 13.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -126.02 114.09 17.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -0.844 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -127.1 154.66 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -115.76 149.35 42.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.302 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.9 Cg_endo -78.13 142.56 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.563 2.175 . . . . 0.0 110.683 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 -166.53 1.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.508 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -80.14 165.28 47.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.48 -4.54 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.58 2.187 . . . . 0.0 110.38 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.89 -37.35 3.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.253 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.3 33.39 3.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.229 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 35' ' ' THR . . . -102.14 142.96 32.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -66.06 -34.76 78.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.09 115.16 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 109.315 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.5 100.35 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.7 mt -92.26 99.83 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.249 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 70' ' ' ILE . 20.2 t -90.19 135.14 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' A' ' 73' ' ' VAL . 0.9 OUTLIER -89.62 124.62 34.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.426 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.06 -0.07 55.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.96 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.74 79.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 -81.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 109.493 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 48.75 22.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.846 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.86 -79.41 0.69 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' N ' ' A' ' 52' ' ' ARG . 9.5 t -87.97 -26.93 22.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.0 109.345 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.496 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -93.11 34.05 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -59.88 -43.84 94.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.271 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.41 -21.09 62.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.262 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -43.81 62.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 52' ' ' ARG . 1.8 mp -73.68 -58.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -20.76 66.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.435 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -73.93 -56.4 5.36 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.55 75.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -1.103 . . . . 0.0 109.335 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.35 -45.17 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -57.68 -37.2 73.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -68.3 -39.59 82.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -76.3 -11.31 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -73.08 -19.27 61.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -74.24 -25.86 59.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 0.0 109.884 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.62 9.81 4.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.955 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 t 54.17 59.78 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.416 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 9.9 mttm -81.66 169.63 18.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 35.7 Cg_endo -78.27 106.52 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.767 2.311 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.516 ' CG2' HG21 ' A' ' 44' ' ' VAL . 4.0 mt -108.04 98.0 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 93' ' ' VAL . 3.6 mp -81.58 114.33 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.2 p -91.88 140.58 29.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 45' ' ' LEU . 57.8 t -107.22 121.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.77 160.89 0.31 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 -175.93 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -42.58 90.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.63 44.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 -23.78 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.104 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.36 126.92 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 109.455 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.72 147.8 41.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.62 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.46 155.64 9.76 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 161.89 29.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.623 2.215 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 35.3 Cg_endo -77.58 -15.47 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.67 2.247 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -70.31 -27.54 64.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.34 -24.8 25.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 83' ' ' PRO . 4.0 mt-10 -58.21 -35.2 71.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.2 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.714 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.9 m -89.46 4.0 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.747 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -101.64 143.57 31.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 t -107.37 -17.48 14.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.77 135.0 14.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.517 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.61 110.09 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.458 HG12 ' CG2' ' A' ' 71' ' ' ILE . 34.5 m -107.14 137.47 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.3 -144.11 12.45 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.96 63.65 1.19 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.243 -1.151 . . . . 0.0 109.477 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -138.55 143.15 37.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.95 -27.64 4.49 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.658 2.239 . . . . 0.0 110.628 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.13 -32.25 64.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.5 m -74.99 -47.35 29.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 100' ' ' ILE . 12.7 mt -67.26 -13.1 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -76.27 -55.96 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.986 . . . . 0.0 109.617 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -72.94 -24.88 60.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.49 73.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.596 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.74 -41.63 62.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -34.39 64.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.606 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.05 -16.83 34.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -66.91 -44.57 80.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 110' ' ' VAL . 6.6 t70 -149.89 165.45 32.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 3.1 t -139.12 77.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 pt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.521 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.78 80.74 1.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.14 66.44 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.402 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' C ' HG13 ' A' ' 5' ' ' ILE . 3.4 mt-10 -132.4 139.13 47.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.433 HG13 ' C ' ' A' ' 4' ' ' GLU . 1.2 mp -131.66 153.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 20.7 mtt-85 -114.96 105.81 13.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -138.46 171.7 13.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -143.86 138.96 28.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.834 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' HD22 ' A' ' 45' ' ' LEU . 3.7 mt -120.85 133.82 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.353 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.466 ' O ' ' CE1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -58.35 111.89 1.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -52.44 135.37 33.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.84 148.78 19.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -77.9 -31.94 51.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 25.1 m -43.36 137.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.506 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 19' ' ' VAL . 19.3 pt-20 -64.51 -24.28 67.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.173 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' OD2' ' CG ' ' A' ' 76' ' ' TYR . 11.4 t70 -61.95 -31.06 71.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.102 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 11' ' ' GLU . 69.7 t80 -64.48 -42.75 95.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.42 91.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.258 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' GLU . 4.9 t -57.96 -56.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.185 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -51.14 -40.19 57.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.129 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.88 -58.14 8.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.548 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.69 -17.23 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -71.89 -55.82 6.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.568 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -21.7 30.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.558 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -74.29 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.609 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.37 -1.92 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -43.53 73.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.08 -71.53 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' CD1' ' CZ ' ' A' ' 101' ' ' ARG . 0.7 OUTLIER -66.55 157.5 32.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -1.137 . . . . 0.0 109.513 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -88.96 121.05 30.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -93.37 158.77 15.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.641 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.65 146.2 52.11 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.383 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.71 129.21 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.525 2.15 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.69 164.96 12.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.715 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.423 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -73.95 171.86 9.93 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 36.4 Cg_endo -80.28 42.23 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.805 2.337 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -159.32 -62.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 109.635 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.33 27.98 1.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' ' CE ' ' A' ' 68' ' ' LYS . . . -64.22 132.47 50.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.87 . . . . 0.0 109.286 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -71.2 -33.84 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.26 23.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.34 110.32 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 7' ' ' LEU . 65.6 mt -93.63 94.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -90.13 122.31 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 4.1 mm? -81.81 121.52 26.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.287 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' CB ' ' CZ3' ' A' ' 49' ' ' TRP . . . -71.22 -12.23 61.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.601 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.33 29.93 11.25 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.86 -19.1 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.925 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.618 ' CZ3' ' CB ' ' A' ' 46' ' ' ALA . 1.8 p90 -66.82 -21.79 66.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.032 -1.042 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -64.17 -15.52 58.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.72 -48.28 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -1.115 . . . . 0.0 109.274 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -129.37 63.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -23.33 6.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.2 -46.74 40.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -46.6 89.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.3 mm -58.31 -54.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.462 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 tp -50.6 -30.4 13.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -49.2 42.6 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.01 -46.53 64.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -1.132 . . . . 0.0 108.846 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.54 -29.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.25 -0.906 . . . . 0.0 109.037 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 16.8 t70 -59.16 -44.78 92.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.43 -38.23 65.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.339 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.7 -14.44 63.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' ASP . 4.6 mmm180 -65.5 -14.69 61.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -64.2 -11.95 35.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.945 . . . . 0.0 109.499 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 71.44 39.16 0.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.64 -67.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 39' ' ' ALA . 2.3 mmtt -92.95 153.17 41.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 142.65 19.52 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.661 2.241 . . . . 0.0 110.443 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -103.05 91.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG21 HG22 ' A' ' 93' ' ' VAL . 3.0 mt -80.12 115.77 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -98.73 139.84 33.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' ARG . 19.0 t -111.22 130.71 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 73' ' ' VAL . 9.0 mtt180 -43.75 157.57 0.27 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.557 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.48 145.56 23.7 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.675 2.25 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 16.1 t80 -66.98 -10.89 54.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 78' ' ' LEU . . . -68.45 -95.05 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 6.0 mp -135.87 -92.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 3.4 pt-20 -159.31 -142.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.13 -0.982 . . . . 0.0 108.925 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 2.0 m120 69.59 54.57 0.38 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -71.22 144.81 90.14 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.09 146.78 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.548 2.166 . . . . 0.0 110.398 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 86' ' ' GLU . 35.1 Cg_endo -77.75 -9.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.533 2.155 . . . . 0.0 110.229 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.26 -58.39 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.933 . . . . 0.0 109.394 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -72.63 -9.58 58.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.362 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -78.59 -11.25 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.484 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.66 -20.86 56.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.789 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -113.99 6.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t -81.77 105.25 12.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -30.55 57.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.99 152.19 34.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 109.499 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.59 154.95 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.445 HG22 HG21 ' A' ' 71' ' ' ILE . 51.8 t -138.72 144.26 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -161.85 29.31 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -91.56 36.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -1.182 . . . . 0.0 109.503 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -113.27 155.84 43.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.92 -60.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.345 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -51.13 -23.88 3.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.77 -51.83 24.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 101' ' ' ARG . 5.2 mt -57.31 -62.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -43.71 -32.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.566 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.21 -60.16 4.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.541 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 101' ' ' ARG . 17.0 mt -58.2 -56.36 23.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 0.0 109.636 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -73.17 -7.97 53.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.79 -24.66 52.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -16.88 64.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.631 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.37 -26.66 62.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.728 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.62 155.71 18.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.948 . . . . 0.0 109.643 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.05 121.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.537 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p -110.25 92.87 4.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.711 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.66 -80.32 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.89 172.04 13.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.947 . . . . 0.0 109.567 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG12 ' CD2' ' A' ' 7' ' ' LEU . 11.7 tt -150.01 124.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.0 109.329 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -91.76 129.12 37.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.628 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.515 ' CD2' HG12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -147.96 169.61 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.4 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -124.88 143.08 51.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mt -122.16 125.0 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.13 145.06 2.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.46 105.85 10.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.02 -146.06 7.22 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.23 47.16 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.21 150.17 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.41 -45.32 94.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.46 -24.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -75.99 -45.88 32.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 109.829 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -63.8 -35.38 80.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG12 ' CZ3' ' A' ' 95' ' ' TRP . 71.2 t -71.78 -39.06 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.289 -0.882 . . . . 0.0 109.718 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 24' ' ' LEU . 76.5 t80 -67.07 -62.72 1.29 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.9 tp -54.23 -49.39 69.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.435 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 18' ' ' ARG . 91.9 mt-10 -53.67 -33.96 57.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -35.27 65.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -48.26 -32.3 7.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.816 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.68 -42.69 86.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 0.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -72.15 -4.28 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.515 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -80.8 -12.91 59.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 70.33 -155.15 52.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 1.6 mt 61.68 171.41 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.408 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.19 108.12 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -117.88 153.23 33.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.175 -0.953 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -138.4 146.28 50.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.287 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.67 146.69 21.43 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.553 2.169 . . . . 0.0 110.405 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 -151.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.159 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.11 169.13 12.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 35.7 Cg_endo -77.85 71.12 6.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.596 2.198 . . . . 0.0 110.278 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 36' ' ' PRO . 2.0 mt-10 -173.66 -35.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.243 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.42 27.99 3.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.406 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.77 110.12 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -51.64 -47.51 63.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.685 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.77 149.83 41.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.79 109.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.83 118.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG13 HG21 ' A' ' 56' ' ' ILE . 6.5 t -102.97 126.35 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 3.5 mm? -92.04 131.82 37.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.81 5.14 51.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.37 -20.7 71.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD21 ' CB ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -110.6 38.15 2.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -1.097 . . . . 0.0 109.2 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.488 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 26.3 t-105 -80.96 -17.56 50.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.56 11.11 53.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -122.99 -59.47 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.181 . . . . 0.0 109.585 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.3 mpt_? -116.69 53.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -47.85 82.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.294 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.04 -41.23 59.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -0.867 . . . . 0.0 109.409 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -42.19 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.584 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 52' ' ' ARG . 25.2 mm -59.65 -62.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.65 -31.49 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.822 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.1 -61.92 4.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.49 -35.97 6.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -1.149 . . . . 0.0 109.768 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 80.9 t -67.96 -63.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 60' ' ' VAL . 21.0 t70 -43.14 -30.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.824 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.7 tp -76.92 -42.72 38.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.915 . . . . 0.0 109.595 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.02 -57.0 12.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -62.89 -13.58 35.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -46.82 -27.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -140.36 -71.1 0.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.88 33.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.509 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -71.24 147.02 92.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 35.6 Cg_endo -78.1 125.01 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.657 2.238 . . . . 0.0 110.589 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.94 124.27 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.419 ' HA ' HD12 ' A' ' 71' ' ' ILE . 2.8 mm -92.71 107.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.318 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 93' ' ' VAL . 52.2 m -81.6 109.1 15.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.704 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.2 106.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 18.6 ptt85 -48.86 161.98 0.39 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.496 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -78.02 -162.1 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.626 2.218 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' TYR . 9.0 t80 -108.14 15.33 24.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 17.86 47.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.2 mm? -93.06 -67.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -1.196 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -109.48 14.16 23.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' GLU . 1.3 m120 46.41 -173.62 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.463 HG21 ' HD2' ' A' ' 82' ' ' PRO . 14.9 p -126.28 138.32 32.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.346 -0.847 . . . . 0.0 109.057 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.9 Cg_endo -78.24 165.68 25.43 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.464 2.109 . . . . 0.0 110.437 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.19 4.72 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.57 2.18 . . . . 0.0 110.352 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.87 -10.45 59.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 -29.26 14.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -32.49 74.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.882 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 88' ' ' VAL . . . -70.99 -16.61 62.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.322 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 87' ' ' ALA . 17.0 m -144.75 52.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.374 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.37 130.26 52.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.537 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t -103.13 -38.68 7.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.35 140.68 49.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 93' ' ' VAL . 97.2 t -123.1 130.38 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.238 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 72' ' ' THR . 12.8 m -153.34 138.57 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.801 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.41 -145.74 16.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.417 ' CZ3' HG12 ' A' ' 19' ' ' VAL . 20.1 m95 -86.81 -4.69 59.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -1.154 . . . . 0.0 109.588 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -57.64 151.15 42.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.12 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.579 2.186 . . . . 0.0 110.551 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.478 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 11.3 m170 -56.2 -17.56 7.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -43.76 83.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.13 -24.13 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -74.32 -51.39 15.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 109.28 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.14 -35.99 76.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HB3' HG12 ' A' ' 93' ' ' VAL . . . -67.96 -61.99 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -45.75 -32.28 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.724 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.03 -43.18 68.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.94 -44.37 96.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.734 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.12 83.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -45.01 -39.73 5.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.617 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.31 167.3 10.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 109' ' ' ASP . 2.2 p 170.93 103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.352 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.404 ' OXT' HG13 ' A' ' 111' ' ' ILE . 18.2 pt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.86 154.94 33.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.315 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 4' ' ' GLU . . . -162.98 -67.21 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 56.9 mt-10 65.54 -176.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.9 mt -135.64 135.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 7.7 mpt_? -99.2 115.98 30.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.248 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.21 171.08 14.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.683 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -138.29 124.57 20.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.524 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG23 ' CE1' ' A' ' 17' ' ' TYR . 24.8 mt -114.29 139.19 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 m -63.06 134.78 56.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.77 164.84 13.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 169.62 40.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.29 47.6 1.69 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.221 -1.164 . . . . 0.0 109.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.79 172.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.39 -24.32 64.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.536 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.93 -55.28 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' CE1' HG23 ' A' ' 9' ' ' ILE . 13.5 t80 -51.57 -39.17 57.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -63.17 -42.26 99.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.594 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.0 t -61.47 -43.78 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.0 -47.72 83.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.558 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -65.68 -20.31 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' OE2' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -73.15 -55.6 6.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -58.04 -51.08 71.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.43 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -45.26 -44.04 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.92 -53.56 52.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.74 -19.2 5.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.424 ' CB ' HD23 ' A' ' 29' ' ' LEU . 6.0 m -65.6 -68.29 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.374 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.16 8.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.424 HD23 ' CB ' ' A' ' 27' ' ' SER . 1.6 pp -59.7 151.53 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -1.117 . . . . 0.0 109.521 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -99.59 106.15 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -105.42 167.47 9.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -147.45 145.4 21.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.21 105.69 2.03 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.613 2.209 . . . . 0.0 110.444 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.85 -154.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.2 p -100.63 158.12 32.48 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.443 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 -3.3 13.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.588 2.192 . . . . 0.0 110.573 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 4.1 mt-10 -102.27 -17.59 15.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 109.314 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -144.16 36.53 1.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.376 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.86 125.11 30.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.647 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.7 t70 -50.87 -31.9 18.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.417 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.41 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.379 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 t -91.94 107.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 73' ' ' VAL . 3.2 mt -90.28 102.28 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.31 132.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 73' ' ' VAL . 1.1 mm? -103.13 135.85 44.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.282 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.51 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.44 61.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 1.2 mp -90.94 32.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 109.54 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.472 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 32.0 t-105 -62.56 -16.97 58.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.594 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.38 35.45 3.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -144.31 -67.42 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -107.35 52.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 109.619 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.27 -47.74 81.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.309 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.61 -22.93 48.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -77.16 -50.61 12.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 56' ' ' ILE . 3.9 mt -62.41 -27.13 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.649 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.89 -32.68 67.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.28 -41.12 26.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' O ' ' HB1' ' A' ' 63' ' ' ALA . . . -68.51 -37.72 80.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -1.137 . . . . 0.0 109.854 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 56' ' ' ILE . 39.9 t -74.09 -34.89 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.9 -46.31 82.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 37' ' ' GLU . 62.2 mt -70.88 -41.88 70.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.003 . . . . 0.0 109.806 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 70' ' ' ILE . . . -64.5 -25.62 68.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.704 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -77.25 -20.2 55.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.76 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -79.71 -9.55 59.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 67' ' ' SER . 0.3 OUTLIER -125.67 3.52 7.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 66' ' ' SER . 17.9 m 60.62 38.38 18.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.9 mmpt? -71.28 161.36 78.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 0.0 109.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 34.2 Cg_endo -76.99 108.45 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.429 2.086 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 63' ' ' ALA . 15.2 mt -108.78 109.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.715 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 mt -97.83 117.2 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.258 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -80.54 147.65 30.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' HB ' HD23 ' A' ' 45' ' ' LEU . 74.4 t -122.16 113.17 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.423 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.89 159.35 1.86 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.452 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 36.2 Cg_endo -77.82 166.64 25.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.733 2.289 . . . . 0.0 110.246 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -74.49 -59.1 2.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -149.64 15.83 1.08 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.075 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 32.3 tp -71.83 -78.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -1.228 . . . . 0.0 109.354 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 tt0 -147.51 -143.05 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.041 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' OD1' ' OE1' ' A' ' 79' ' ' GLU . 2.9 p30 -124.59 176.65 6.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.91 134.95 20.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.17 173.04 14.48 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.435 2.09 . . . . 0.0 110.519 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.8 Cg_endo -77.37 -1.53 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.576 2.184 . . . . 0.0 110.596 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -73.91 -70.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.306 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -16.22 54.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.51 -42.96 61.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.16 68.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.94 38.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -128.7 105.63 8.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.539 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' A' ' 91' ' ' GLU . 1.5 m -56.52 -39.68 73.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 106' ' ' ASP . 13.1 mp0 -138.29 157.95 45.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.4 m -141.59 133.57 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.131 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 15.0 m -139.99 169.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.101 -0.999 . . . . 0.0 109.873 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.45 -144.37 11.94 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -93.06 47.63 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -1.143 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -100.73 146.47 32.14 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -38.73 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.551 2.168 . . . . 0.0 110.317 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -23.26 56.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -73.58 -15.44 61.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.63 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.9 mm -73.37 -40.23 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -76.81 -34.66 57.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -31.87 70.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.674 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.19 -44.96 28.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -28.7 69.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.874 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 2.4 tp10 -66.06 -21.31 66.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.884 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD2' ' OE2' ' A' ' 91' ' ' GLU . 1.1 t70 -63.17 -30.31 71.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.59 41.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.573 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 1.9 tp -58.17 -52.37 65.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.347 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 4.0 m-20 60.94 -95.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 m -77.54 162.37 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 109.379 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.582 -179.847 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' THR . 2.1 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.244 0.545 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 46.96 92.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.547 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.56 -56.55 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.9 . . . . 0.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 56.1 175.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.5 tt -146.7 141.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -97.64 104.38 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.6 mt -113.35 157.73 21.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -134.88 92.12 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' CG2' ' CE1' ' A' ' 17' ' ' TYR . 2.7 mp -89.28 162.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.46 ' O ' ' CE2' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -88.2 159.01 18.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.426 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.14 128.89 56.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.983 . . . . 0.0 109.61 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.21 -162.98 11.66 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -125.42 -4.67 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -1.147 . . . . 0.0 109.578 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.1 m -83.74 -178.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -92.2 -2.46 56.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.95 -69.54 0.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.509 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 17' ' ' TYR . 5.0 t80 -48.64 -29.15 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.664 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -51.5 65.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.096 -1.002 . . . . 0.0 109.427 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.0 t -62.67 -33.08 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.743 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -63.22 -57.95 8.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.65 -34.23 64.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.57 -40.03 95.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -40.52 74.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.929 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.83 71.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -34.69 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.672 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -68.96 -22.22 64.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -45.41 -45.99 13.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.475 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.04 -32.54 6.27 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.01 150.24 31.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -1.174 . . . . 0.0 109.533 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.91 151.5 22.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 109.453 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.425 ' C ' ' HG3' ' A' ' 32' ' ' ARG . 46.8 p-90 -153.43 160.84 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.434 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 24.2 mtt-85 -141.86 158.6 61.97 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.2 Cg_endo -78.18 95.47 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.677 2.251 . . . . 0.0 110.129 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -176.77 2.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.681 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.461 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -87.2 173.55 6.45 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.257 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.7 Cg_endo -78.23 -9.81 16.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.557 2.171 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -114.51 -6.48 12.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -139.38 48.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.255 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.83 127.61 48.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.658 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -67.41 -40.71 85.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.07 134.8 28.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.43 126.24 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 45' ' ' LEU . 2.5 mt -109.48 93.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.202 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.77 115.07 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.575 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.478 ' CD2' HG23 ' A' ' 73' ' ' VAL . 13.6 mt -85.59 127.15 34.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.94 -0.47 35.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.35 -15.52 70.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -105.87 29.41 6.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.331 -1.1 . . . . 0.0 109.21 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -72.5 -26.94 61.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.68 40.45 2.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.66 -55.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -1.182 . . . . 0.0 109.529 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.2 mpt_? -116.29 56.97 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -47.98 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.1 -36.77 75.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.56 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -69.61 -62.04 1.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLU . 16.1 mt -43.14 -36.08 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.04 -56.05 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.42 -47.67 62.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.45 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 0.0 109.585 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 2.7 t -71.89 -29.19 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -66.86 -38.7 86.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -75.83 -43.14 47.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 109.968 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.29 -27.64 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.952 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -77.24 -30.75 54.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 109.82 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 6.5 16.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 7.05 4.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.694 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 m 51.26 38.64 21.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 159.49 53.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.68 108.75 2.62 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.2 mt -108.66 114.71 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 mt -107.0 141.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.329 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 m -109.78 135.03 51.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.478 HG23 ' CD2' ' A' ' 45' ' ' LEU . 22.6 t -101.09 133.49 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -58.13 155.09 26.94 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 159.21 31.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.676 2.251 . . . . 0.0 110.403 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -81.57 -53.59 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.37 83.3 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.14 -35.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -1.155 . . . . 0.0 109.535 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 66.45 128.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' C ' ' HD3' ' A' ' 82' ' ' PRO . 1.8 m-20 171.96 39.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.15 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.5 t -118.04 79.06 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 36.1 Cg_endo -78.29 174.67 12.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.595 2.197 . . . . 0.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.2 Cg_endo -79.05 9.43 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.77 2.313 . . . . 0.0 110.613 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -56.47 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -11.23 60.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.51 -28.82 64.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.556 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.92 42.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.63 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.06 -59.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.97 150.47 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -106.38 -21.04 13.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.372 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -151.39 163.92 37.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.73 159.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 94' ' ' GLY . 54.1 t -128.3 160.25 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.11 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 93' ' ' VAL . . . -112.42 -152.71 11.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -107.14 50.24 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -125.49 162.19 45.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.07 -43.31 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.751 2.301 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -26.34 58.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.827 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.6 m -62.23 -64.57 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.422 HG12 HG13 ' A' ' 93' ' ' VAL . 67.9 mt -44.68 -25.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -46.93 39.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -0.995 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.86 -17.5 64.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.626 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . . . -71.13 -59.14 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.63 -37.56 86.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.562 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -51.4 -48.21 62.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -31.32 72.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.8 -62.22 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 35.06 2.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -46.51 131.79 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.531 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.432 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 14.6 p -107.87 -10.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 110' ' ' VAL . 3.4 mt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 1' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 p -110.9 114.0 27.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.31 106.07 6.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.519 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.65 141.94 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.968 . . . . 0.0 109.332 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.8 160.68 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.69 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 6.5 mpt_? -106.98 128.83 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.507 ' HG ' ' CB ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -137.61 166.98 22.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.695 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -151.13 115.42 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG21 ' CE1' ' A' ' 17' ' ' TYR . 36.0 mt -108.56 141.26 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.58 125.67 10.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.78 126.64 28.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.99 30.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.0 53.12 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 17' ' ' TYR . 15.4 m -112.62 143.23 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 19' ' ' VAL . 29.0 tt0 -54.31 -25.12 22.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.58 -65.37 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CE1' HD21 ' A' ' 21' ' ' LEU . 5.5 t80 -50.08 -28.36 7.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -48.4 55.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 15' ' ' GLU . 71.7 t -61.37 -29.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.852 . . . . 0.0 109.657 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -71.19 -45.93 62.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.358 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD21 ' CE1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -56.98 -46.17 82.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -36.79 84.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.51 71.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.566 ' CD2' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -75.69 -49.06 19.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -68.22 -17.97 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -70.67 -52.5 20.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.493 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -47.76 -35.85 10.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 125.58 -154.79 18.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 71.04 165.92 0.29 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.454 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.69 100.86 4.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' CD2' ' A' ' 24' ' ' LEU . 60.8 p-90 -115.36 157.93 23.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 109.28 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -125.17 152.46 70.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.46 125.64 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.699 2.266 . . . . 0.0 110.512 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.96 153.43 35.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.47 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -53.92 173.21 0.21 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.331 -0.856 . . . . 0.0 109.392 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -76.9 -0.34 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.541 2.161 . . . . 0.0 110.372 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -104.25 -6.09 21.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.303 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.34 30.07 1.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.82 98.96 12.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 6' ' ' ARG . 12.4 m-20 -50.76 -45.32 58.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.196 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' CB ' ' HG ' ' A' ' 7' ' ' LEU . . . -116.02 121.92 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.01 110.56 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 HD13 HD23 ' A' ' 7' ' ' LEU . 6.6 mt -103.23 123.25 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG22 ' CG2' ' A' ' 70' ' ' ILE . 2.4 t -113.77 120.89 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.0 mt -80.21 148.25 30.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.355 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.38 17.06 24.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -87.74 -29.85 19.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 24.14 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -1.152 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 41.8 t-105 -60.71 -14.21 19.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.55 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.91 37.96 2.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -150.31 -58.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -1.137 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HG3' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -116.24 46.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 109.725 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -57.84 -34.26 69.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -39.74 94.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.605 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 3.7 tt0 -65.59 -41.69 92.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG21 HG11 ' A' ' 44' ' ' VAL . 5.2 mt -70.82 -23.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.11 -52.65 13.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.71 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.98 73.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.91 -62.15 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -1.157 . . . . 0.0 109.599 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.8 t -55.62 -31.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -63.0 -55.3 26.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -60.47 -25.08 65.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.281 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.53 62.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -7.56 38.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.644 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HD3' HD22 ' A' ' 62' ' ' LEU . 12.4 tttm -49.21 -32.61 10.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' SER . 22.7 t -135.58 -69.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 66' ' ' SER . 0.1 OUTLIER 172.43 43.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.686 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.25 151.15 75.11 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.08 116.53 4.21 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.807 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 44' ' ' VAL . 4.4 mt -107.43 98.53 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 108.881 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 10.4 mt -90.22 112.75 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 15.0 p -89.41 141.51 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.13 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 84.6 t -115.68 132.36 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HG2' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -51.7 158.47 1.58 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 36.2 Cg_endo -78.96 169.7 19.0 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 0.0 110.507 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 76' ' ' TYR . 74.8 t80 -82.9 8.85 11.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.12 71.49 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.442 ' O ' ' CB ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -151.98 81.9 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.562 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' LEU . 3.1 mt-10 70.91 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.476 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.8 137.06 58.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 86.9 t -68.44 141.04 92.92 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HD2' ' CG1' ' A' ' 81' ' ' VAL . 35.5 Cg_endo -78.45 155.81 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.563 2.176 . . . . 0.0 110.412 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.16 -10.09 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.555 2.17 . . . . 0.0 110.312 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.87 -15.93 63.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.295 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.447 HD21 ' CG2' ' A' ' 72' ' ' THR . 42.2 tp -93.84 -18.79 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -24.47 43.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.13 61.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.7 -0.18 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 t -96.23 135.84 37.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 -33.01 54.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.82 168.99 24.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.71 156.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.897 . . . . 0.0 109.464 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 2.1 t -135.97 155.56 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' HA2' ' HG2' ' A' ' 74' ' ' ARG . . . -116.98 -155.69 10.33 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -88.89 37.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -1.199 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.1 149.05 39.53 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 -66.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.609 2.206 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.24 -32.28 1.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -53.11 59.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.6 mt -55.05 -23.56 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.988 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -69.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -28.08 50.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.993 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.33 -51.73 48.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.452 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.441 HD13 HD22 ' A' ' 7' ' ' LEU . 5.6 tt -72.46 -15.06 61.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.257 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -28.97 63.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.296 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -68.2 -12.53 61.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.429 -0.794 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -58.8 4.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.4 2.35 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.73 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.41 152.96 28.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.528 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.16 -4.46 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.014 . . . . 0.0 109.433 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 6' ' ' ARG . 57.2 mt -114.63 162.58 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.533 ' C ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -93.57 105.09 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.395 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD23 HD11 ' A' ' 43' ' ' ILE . 8.9 mp -112.35 168.24 9.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.699 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -153.09 142.19 21.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 mt -130.76 151.45 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 109.643 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 157.44 25.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -85.84 135.07 33.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.89 177.09 20.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -123.99 -12.57 7.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -1.095 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.9 m -67.81 165.97 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.02 -20.29 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.1 -32.78 73.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.46 18.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.08 -35.31 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 18.6 t80 -65.88 -47.99 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.85 -45.92 71.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -58.36 -49.94 75.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -59.74 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.96 . . . . 0.0 109.439 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CZ ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -45.5 -38.28 6.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.64 -44.65 93.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -23.07 67.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -51.74 38.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.25 -33.09 6.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 29' ' ' LEU . 1.4 mm? -57.76 148.63 24.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -82.16 131.76 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -138.56 145.37 40.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' NH2' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -130.53 147.8 67.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.188 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HD2' ' NH2' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.7 101.88 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.459 2.106 . . . . 0.0 110.529 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 6' ' ' ARG . . . -101.81 154.92 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -59.89 164.87 5.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.341 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -77.37 -7.6 17.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.497 2.131 . . . . 0.0 110.114 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -28.6 15.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.3 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.05 46.53 2.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -100.17 148.35 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -95.43 -26.68 15.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.437 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.581 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -142.9 119.21 10.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.502 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.6 t -110.11 100.28 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.659 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.698 HD11 HD23 ' A' ' 7' ' ' LEU . 1.4 mt -84.19 106.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 136.68 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -88.67 128.6 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 109.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.71 4.63 15.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.97 . . . . 0.0 109.486 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.33 -24.02 61.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.61 27.3 3.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.571 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 6.6 t-105 -76.83 -42.45 40.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.41 7.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.0 p -141.08 -58.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -117.28 50.55 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.331 -0.856 . . . . 0.0 109.601 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -30.09 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -38.14 82.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.44 -55.7 8.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -48.84 -43.29 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 57' ' ' LEU . 5.4 mt -45.78 -49.36 15.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' ALA . . . -56.17 -58.79 12.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . . . -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -1.129 . . . . 0.0 109.649 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.91 -53.84 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.24 -53.05 23.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.34 -33.14 73.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.554 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 68' ' ' LYS . . . -71.23 -21.67 62.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -71.73 -3.05 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.762 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' ARG . 0.5 OUTLIER -124.99 18.23 8.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.4 m -143.94 45.54 1.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.707 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' SER . 2.8 t 78.21 -3.59 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 109.723 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 50.34 60.01 15.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.301 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.4 Cg_endo -82.1 53.14 4.43 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.57 2.18 . . . . 0.0 109.764 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.98 117.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.265 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.9 mt -110.91 131.44 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 92' ' ' VAL . 55.1 m -96.93 129.82 44.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.25 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.72 116.84 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -46.51 154.57 0.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.69 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.11 161.64 29.31 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.751 2.3 . . . . 0.0 110.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.98 -23.75 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.17 37.08 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.02 -32.52 12.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.44 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.57 -143.24 0.14 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.295 -0.878 . . . . 0.0 109.076 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -148.28 140.48 24.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.905 . . . . 0.0 109.424 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.731 HG12 ' HD2' ' A' ' 82' ' ' PRO . 1.5 t -69.97 142.15 90.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.276 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.731 ' HD2' HG12 ' A' ' 81' ' ' VAL . 35.7 Cg_endo -79.33 173.0 13.81 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.524 2.149 . . . . 0.0 110.486 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.6 Cg_endo -80.23 19.35 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 111.065 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.76 -8.66 23.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.867 -1.146 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.505 HD22 ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -100.4 -49.41 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.01 . . . . 0.0 109.56 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -20.98 5.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.98 26.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 0.0 109.385 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -102.59 144.94 30.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -99.19 -29.45 12.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.235 -0.915 . . . . 0.0 109.231 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.21 155.32 36.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.581 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.1 m -142.24 130.55 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 28.2 m -134.37 -171.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.76 -146.9 5.35 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.463 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 83.7 m95 -89.64 69.87 7.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -1.127 . . . . 0.0 109.495 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 95' ' ' TRP . 6.6 m-20 -141.62 149.21 53.04 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 -38.65 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.681 2.254 . . . . 0.0 110.357 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -74.11 -41.4 61.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.863 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 1.2 m -56.88 -59.55 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 109.529 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.8 mt -51.81 -30.85 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 0.0 109.611 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -69.46 -37.95 77.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.13 -43.4 92.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.23 62.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 104' ' ' LEU . 18.6 tp -74.26 -62.01 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 109.577 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.82 -16.96 7.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -68.73 -38.72 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.13 -27.2 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.295 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 1.8 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 104' ' ' LEU . 13.2 mt -138.47 140.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.53 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 2.8 mpp_? -94.08 97.6 10.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 43' ' ' ILE . 1.5 mp -107.29 157.23 18.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.43 119.85 31.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.367 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' THR . 20.5 mt -111.54 132.6 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.35 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.99 156.8 44.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.11 -175.41 42.54 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.25 39.25 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -1.085 . . . . 0.0 109.182 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -115.43 -171.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.48 -10.25 57.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -76.51 -74.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.665 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.792 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.2 t80 -50.82 -26.15 5.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 109.635 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -72.28 -68.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.571 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 15' ' ' GLU . 98.8 t -43.34 -44.94 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.813 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CE2' HD12 ' A' ' 24' ' ' LEU . 66.1 t80 -60.52 -44.62 95.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.689 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -57.95 -41.16 82.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.72 -45.62 93.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -17.84 63.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.845 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -72.55 -56.34 5.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 109.506 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.34 -42.24 88.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.61 -20.57 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.6 m -69.73 -61.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.583 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.97 -153.23 19.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.62 159.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 2.6 mp0 -113.1 95.73 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.722 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.845 ' CZ2' HD22 ' A' ' 24' ' ' LEU . 31.0 p-90 -112.18 169.3 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.3 162.79 38.2 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.859 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 119.48 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.642 2.228 . . . . 0.0 110.273 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB2' ' CG ' ' A' ' 6' ' ' ARG . . . -106.37 -177.55 3.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.41 173.26 5.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -78.18 -6.47 15.73 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.607 2.204 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.18 -0.94 16.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.509 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.45 56.04 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -112.85 119.06 36.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 4.9 t70 -49.94 -41.74 47.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -145.7 154.55 42.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 109.19 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 7' ' ' LEU . 84.1 mt -92.74 94.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.33 130.68 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.864 . . . . 0.0 109.51 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.921 ' HB3' HD23 ' A' ' 48' ' ' LEU . 2.0 mm? -88.49 116.39 26.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -57.45 -22.19 41.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' HD22 ' A' ' 48' ' ' LEU . . . -89.28 34.8 3.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.921 HD23 ' HB3' ' A' ' 45' ' ' LEU . 2.2 mm? -121.08 -27.4 4.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -1.131 . . . . 0.0 109.765 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.9 p90 -65.31 -21.51 66.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.3 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.562 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -58.61 -18.44 37.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 p -110.08 -39.08 5.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -141.61 57.24 1.51 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' CG ' ' HB2' ' A' ' 49' ' ' TRP . 4.0 ttt180 -53.73 -22.07 8.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.385 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.94 -42.34 60.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -66.75 -47.9 70.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 49' ' ' TRP . 1.8 mp -60.69 -37.29 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.95 -54.61 44.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.13 64.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.64 74.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.244 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.55 -33.99 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -59.92 -52.4 65.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.31 -30.67 71.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.393 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.855 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -72.18 -20.23 61.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -10.13 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.358 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 66' ' ' SER . 11.4 tttp -68.05 -9.23 44.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 14.9 t 68.27 45.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.627 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -110.77 -37.41 5.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -127.25 155.62 76.02 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.092 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.445 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 35.0 Cg_endo -77.3 122.86 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.509 2.139 . . . . 0.0 110.547 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 63' ' ' ALA . 69.0 mt -91.92 127.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 93' ' ' VAL . 3.7 mp -124.09 113.9 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.336 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD23 ' A' ' 85' ' ' LEU . 19.0 p -96.01 121.53 37.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.478 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.939 HG22 ' HB ' ' A' ' 93' ' ' VAL . 92.3 t -98.91 121.48 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' CZ2' ' A' ' 95' ' ' TRP . 12.0 mmt180 -43.14 151.98 0.4 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.27 151.88 26.8 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.654 2.236 . . . . 0.0 110.525 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -49.22 -49.87 40.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.59 111.59 0.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -167.3 -46.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.362 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.86 -143.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.033 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.27 115.82 15.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 74' ' ' ARG . 78.9 t -50.24 134.27 23.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.26 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.7 Cg_endo -77.95 148.25 24.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.453 2.102 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.1 Cg_endo -77.62 -4.09 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.642 2.228 . . . . 0.0 110.47 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.63 -42.91 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 72' ' ' THR . 0.4 OUTLIER -67.71 -31.15 70.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.466 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.38 -0.59 42.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.28 28.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.125 -0.984 . . . . 0.0 109.646 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.85 -0.25 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 m -72.71 128.84 36.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 109.302 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.6 m -89.07 -18.85 26.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.57 142.94 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.863 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.41 115.26 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.014 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.939 ' HB ' HG22 ' A' ' 73' ' ' VAL . 86.6 t -88.95 149.94 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.834 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.29 -145.66 15.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.463 ' CZ2' ' O ' ' A' ' 74' ' ' ARG . 67.7 m95 -114.09 57.95 0.69 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 109.584 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -130.93 168.94 15.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.32 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.641 2.227 . . . . 0.0 110.636 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -10.27 56.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -62.68 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mt -51.07 -22.92 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -46.32 41.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 105' ' ' GLU . 72.9 m-20 -63.49 -12.86 35.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . . . -69.31 -60.89 2.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -68.22 -25.48 65.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.2 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.66 -47.35 67.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -22.63 61.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.293 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -19.62 61.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.503 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -143.49 149.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.1 126.91 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -134.96 159.41 41.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -112.75 97.52 6.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 17' ' ' TYR . 44.9 mt -94.94 124.05 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.512 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.59 128.55 29.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 142.46 58.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -0.997 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.69 170.38 32.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.75 57.73 1.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' ARG . 1.6 m -142.85 -176.45 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.63 -11.8 60.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -76.84 -55.24 5.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.671 ' CE1' HG21 ' A' ' 9' ' ' ILE . 3.2 t80 -67.7 -22.38 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.478 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 1.5 mpt_? -73.82 -55.41 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.39 -36.24 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -64.17 -52.78 57.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.75 -22.61 64.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -76.54 -39.12 53.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.9 65.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -49.32 65.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.95 -20.69 61.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 109.978 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.91 -39.83 95.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 109.658 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 p -49.92 -49.52 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.56 60.23 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.83 154.91 49.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 9.1 tp10 -91.73 59.6 3.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -86.4 160.79 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -151.97 154.49 32.73 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.65 153.95 26.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.683 2.255 . . . . 0.0 110.376 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.23 171.24 17.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.9 168.34 4.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.82 -9.25 16.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.634 2.223 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 -21.92 25.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 50.87 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.13 103.94 13.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -50.67 -46.73 58.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.315 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -122.25 137.72 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 70' ' ' ILE . 17.8 t -104.71 140.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -137.6 121.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 119.38 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 45' ' ' LEU . 5.7 mt -85.14 125.13 32.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.52 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.04 35.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.51 90.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 45' ' ' LEU . 2.4 mt -120.21 24.02 10.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -1.148 . . . . 0.0 109.438 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 1.5 t90 -81.18 4.72 19.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.97 -4.11 29.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -124.9 -38.8 2.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.126 -1.22 . . . . 0.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HG2' ' CB ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -114.11 72.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -74.43 -65.19 0.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.22 -19.1 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -77.24 -41.71 40.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.692 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 49' ' ' TRP . 45.4 mt -73.18 -35.46 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.19 -32.69 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -46.22 46.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.8 -54.35 47.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -1.124 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.71 -28.37 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 109.438 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -46.94 82.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.04 -32.87 72.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -74.62 -19.05 60.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.299 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -10.3 32.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' SER . 10.1 tptm -61.0 -14.08 20.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 5.6 t 73.7 68.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 p -154.06 -39.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -106.86 153.41 40.83 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -78.28 119.18 4.51 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.715 2.277 . . . . 0.0 110.356 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 63' ' ' ALA . 23.5 mt -94.13 122.64 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 mt -115.64 117.58 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 86.2 m -83.34 146.08 28.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 45' ' ' LEU . 43.3 t -120.2 114.96 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 59.5 mtt180 -55.72 146.63 45.41 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 36.1 Cg_endo -78.49 165.92 24.65 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.662 2.241 . . . . 0.0 110.49 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.431 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -79.33 -26.02 42.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 78' ' ' LEU . . . -89.2 -13.83 61.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 29.4 tp 61.29 90.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 17.18 21.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 81' ' ' VAL . 10.8 m-80 56.34 82.91 0.1 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -44.52 147.21 1.07 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 170.51 19.16 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.517 2.145 . . . . 0.0 110.435 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 2.71 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.619 2.213 . . . . 0.0 110.518 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -83.06 -44.6 14.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -5.65 59.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.08 -12.78 49.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.42 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.14 13.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 98.81 12.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -30.2 67.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -155.26 127.61 7.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.84 128.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 72' ' ' THR . 7.3 p -128.29 145.29 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.649 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.09 -145.77 10.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -91.2 17.47 8.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -1.165 . . . . 0.0 109.394 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 99' ' ' CYS . 2.5 m-20 -65.27 153.21 90.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.71 -57.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -77.06 -20.37 55.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.315 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -71.3 -13.0 61.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.07 -1.019 . . . . 0.0 109.901 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 96' ' ' ASN . 17.6 mm -75.74 -38.21 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -77.17 -31.45 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.3 -26.97 63.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.5 -67.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 76.9 mt -53.1 -35.09 59.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.927 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.01 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.614 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -20.85 3.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 104' ' ' LEU . . . -77.3 -39.96 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 109.599 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.706 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -145.42 143.06 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 40' ' ' ASP . 21.1 mtt85 -85.1 105.64 15.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.226 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 31' ' ' TRP . 8.0 mp -105.11 168.49 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.674 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 40.3 t80 -152.73 106.95 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.502 HD12 ' CD1' ' A' ' 21' ' ' LEU . 20.8 mt -102.67 135.79 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -51.68 136.4 27.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.161 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.477 ' O ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -58.78 131.75 51.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.504 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.892 ' HA2' HD21 ' A' ' 48' ' ' LEU . . . -120.91 146.6 17.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.85 17.1 17.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.12 -173.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.37 -11.2 38.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.5 m-20 -73.01 -32.36 65.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HE1' HD22 ' A' ' 21' ' ' LEU . 23.3 t80 -71.31 -29.73 65.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -75.29 -47.96 25.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.29 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 93.4 t -61.54 -40.61 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.382 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.671 ' CE2' HG11 ' A' ' 73' ' ' VAL . 3.0 t80 -64.53 -58.01 7.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 9' ' ' ILE . 3.9 tp -55.95 -22.58 27.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 19' ' ' VAL . 73.8 mt-10 -70.47 -55.13 9.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 26' ' ' GLN . 6.7 ttt85 -57.88 -32.7 67.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.06 -58.68 6.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.887 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -70.53 -19.09 62.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -60.54 -41.65 94.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.351 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 16.0 t 174.39 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.59 58.38 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.63 161.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.299 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 148.41 22.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 7' ' ' LEU . 67.5 p-90 -149.68 174.24 12.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -143.13 147.74 42.11 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.484 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.53 103.55 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.655 2.236 . . . . 0.0 110.348 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . -100.89 -169.61 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.93 168.2 24.52 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.5 Cg_endo -77.75 -8.37 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.615 2.21 . . . . 0.0 110.345 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.18 -6.97 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.21 53.98 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 8' ' ' TYR . . . -105.19 124.46 49.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.396 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 5' ' ' ILE . 12.6 t70 -52.02 -30.04 23.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -147.91 124.2 10.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.693 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -97.28 96.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.027 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CG2' ' A' ' 73' ' ' VAL . 76.7 mt -92.52 107.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.07 133.41 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.37 120.56 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.446 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -15.54 62.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -22.57 71.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' HA2' ' A' ' 12' ' ' GLY . 11.1 mp -89.28 13.69 12.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -1.18 . . . . 0.0 109.529 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.696 ' HZ3' HD13 ' A' ' 85' ' ' LEU . 4.8 t-105 -72.72 -30.33 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.64 27.28 21.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 48' ' ' LEU . 8.4 p -135.4 -39.02 0.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -1.179 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CB ' ' HB2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -141.47 71.69 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.298 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -52.9 -56.24 17.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -56.27 -38.47 71.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 109.614 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -56.65 -47.99 78.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.424 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 33.8 mm -62.06 -33.36 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 108.872 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 tp -73.75 -21.43 60.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.113 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.15 -54.95 4.98 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.51 89.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.173 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 70.2 t -58.44 -44.18 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.253 -0.904 . . . . 0.0 109.046 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -58.03 -40.57 81.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.37 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.3 mt -68.91 -28.25 66.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 70' ' ' ILE . . . -76.83 -28.18 55.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.407 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 40.3 mtp85 -75.92 0.1 19.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -84.02 -30.04 26.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.402 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.44 20.64 3.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.01 23.1 1.02 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.706 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -47.44 163.59 0.26 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 113.98 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.634 2.223 . . . . 0.0 110.603 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.688 HD11 ' HB1' ' A' ' 63' ' ' ALA . 2.1 mt -113.7 108.03 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.368 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 25.1 mt -96.36 124.83 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.689 HG21 HG11 ' A' ' 81' ' ' VAL . 21.9 m -89.77 156.13 18.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.671 HG11 ' CE2' ' A' ' 20' ' ' PHE . 3.4 t -123.89 121.76 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -50.71 150.41 5.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.51 178.13 8.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.499 2.133 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.3 -25.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.95 86.26 0.23 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.0 -82.89 0.48 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -136.82 17.61 3.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.98 -177.92 0.13 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.522 -0.736 . . . . 0.0 109.472 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 72' ' ' THR . 34.0 m -85.98 159.89 53.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 34.3 Cg_endo -77.72 174.36 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.658 2.238 . . . . 0.0 110.39 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 35.2 Cg_endo -77.43 -33.01 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.606 2.204 . . . . 0.0 110.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.31 -34.4 70.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.181 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.696 HD13 ' HZ3' ' A' ' 49' ' ' TRP . 1.7 tt -93.31 -20.03 20.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.98 -35.23 79.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.112 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.98 -11.82 61.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.227 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG11 HG13 ' A' ' 60' ' ' VAL . 2.2 t -111.56 7.8 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.1 t -105.59 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -44.09 74.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.467 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -146.95 154.56 41.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.3 p -117.68 119.15 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 100' ' ' ILE . 9.9 p -108.95 163.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 93' ' ' VAL . . . -125.53 -157.94 9.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 30.1 m95 -88.74 38.82 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 109.246 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.441 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -103.01 151.22 38.39 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.8 Cg_endo -78.39 -46.73 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.67 2.247 . . . . 0.0 110.327 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.14 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 96' ' ' ASN . 73.6 m -65.62 -54.2 31.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.823 HD13 HG21 ' A' ' 93' ' ' VAL . 31.5 mm -47.38 -24.51 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.46 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -52.65 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.614 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.48 -14.8 59.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.38 -48.16 24.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.786 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 5' ' ' ILE . 20.8 mt -77.3 -25.87 51.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -74.88 -21.81 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -37.69 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.603 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.32 -55.72 19.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.339 0.59 . . . . 0.0 109.655 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.441 HD12 ' CD1' ' A' ' 108' ' ' LEU . 3.3 tt -131.67 156.67 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG2' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -111.47 127.5 55.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.831 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.946 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -128.34 169.7 13.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.87 . . . . 0.0 109.212 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -128.78 102.47 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.626 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.519 HG21 ' HE1' ' A' ' 17' ' ' TYR . 15.6 mt -100.09 143.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -73.62 -170.34 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.589 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 1.3 pt-20 -135.15 109.04 8.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -121.0 173.14 15.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.6 tm-20 -115.63 28.3 8.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 109.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.12 158.22 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 109.679 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.3 -9.97 38.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.6 m-20 -72.39 -48.63 40.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.555 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HE1' HG21 ' A' ' 9' ' ' ILE . 11.6 t80 -65.12 -26.1 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -70.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.598 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.5 t -49.87 -31.96 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.479 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.985 ' CE1' HD13 ' A' ' 24' ' ' LEU . 31.6 t80 -68.02 -48.23 66.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -41.05 74.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.21 -33.74 76.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -15.69 59.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.985 HD13 ' CE1' ' A' ' 20' ' ' PHE . 1.7 tp -74.65 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 26' ' ' GLN . 2.4 pt-20 -59.9 -20.68 58.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -52.35 -41.03 62.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.287 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -26.9 60.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 102.21 -132.47 11.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER 62.75 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.124 . . . . 0.0 109.395 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 85.3 mt-10 -88.74 111.26 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.946 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.4 p-90 -120.04 156.64 30.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -137.69 159.95 66.92 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.4 Cg_endo -77.79 130.8 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.653 2.235 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -116.63 -165.92 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.708 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -101.99 175.16 2.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.548 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.7 Cg_endo -77.62 -19.36 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.566 2.177 . . . . 0.0 110.405 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -112.39 -6.55 14.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -138.54 49.1 1.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -104.95 133.13 50.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -34.01 76.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 109.322 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -149.68 123.84 9.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 21.7 t -79.9 156.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 109.849 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 71' ' ' ILE . 13.3 mt -147.05 102.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 108.98 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.97 HG11 HG23 ' A' ' 56' ' ' ILE . 2.2 t -112.97 137.34 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.748 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.9 mm? -84.12 131.47 34.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -76.59 -36.7 57.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.95 34.56 3.89 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD21 ' CA ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -125.41 -26.65 3.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.811 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.673 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.7 p90 -57.67 -18.56 21.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.018 -1.051 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.538 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -42.27 -29.9 0.72 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -47.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -88.63 47.95 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -45.06 85.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -67.33 -31.47 71.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.899 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.94 -59.42 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.97 HG23 HG11 ' A' ' 44' ' ' VAL . 3.0 mp -54.96 -57.79 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.24 -26.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.855 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.06 -68.16 1.73 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -37.0 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -1.12 . . . . 0.0 109.988 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 58.8 t -59.62 -60.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.58 -58.65 6.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.53 -27.15 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -70.93 -45.11 64.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -68.29 -7.59 32.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -57.37 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -79.69 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 p 179.01 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -87.04 154.72 55.19 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.434 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -77.9 116.87 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.701 2.268 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 95.6 mt -95.04 111.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.324 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 91' ' ' GLU . 35.5 mm -94.33 91.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.722 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.645 HG21 ' OG ' ' A' ' 89' ' ' SER . 7.6 p -88.06 128.86 35.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 45' ' ' LEU . 58.2 t -98.65 132.35 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.453 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -64.05 171.53 2.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 74' ' ' ARG . 34.8 Cg_endo -77.31 163.49 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.62 2.213 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.2 -15.64 63.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.9 46.54 0.77 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 7.21 3.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -1.092 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -151.68 -143.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.237 -0.914 . . . . 0.0 108.995 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -145.6 153.79 41.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 82' ' ' PRO . 97.5 t -104.6 134.87 19.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.9 Cg_endo -78.84 150.33 23.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.502 2.135 . . . . 0.0 110.328 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -78.12 -20.49 11.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.193 . . . . 0.0 110.467 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.27 -34.69 74.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.624 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.79 55.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.655 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -69.21 -18.75 63.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.01 -7.97 59.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.38 33.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -117.65 134.07 55.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -99.84 -31.59 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 71' ' ' ILE . 4.0 mt-10 -136.14 118.54 15.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.595 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.6 m -117.99 128.57 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.248 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 103' ' ' ALA . 2.8 m -123.93 165.28 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.71 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.72 -146.57 21.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.98 66.83 0.66 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -1.158 . . . . 0.0 109.586 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.661 ' O ' HD12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -138.44 152.57 71.47 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.31 -41.89 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.619 2.213 . . . . 0.0 110.554 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -76.93 -31.57 56.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.659 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -42.15 67.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ASN . 35.6 mt -59.22 -41.94 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.661 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -64.16 -42.09 96.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.725 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -31.09 63.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -0.86 . . . . 0.0 109.783 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . . . -74.21 -43.18 58.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.732 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.01 -33.55 73.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.675 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -51.94 -28.17 15.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.444 ' HB2' ' OE2' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -67.81 -49.83 60.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.877 . . . . 0.0 109.728 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.28 -43.24 67.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.651 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.2 tp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.276 0.56 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.6 mt -119.08 139.25 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -92.56 112.29 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 109.319 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.515 ' CD2' HD11 ' A' ' 43' ' ' ILE . 3.7 mp -120.76 153.45 36.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 15.5 t80 -123.94 108.95 12.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.74 142.12 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -47.91 145.92 2.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.445 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.04 125.83 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.0 179.57 37.27 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -117.57 -3.74 11.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 109.736 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -48.9 170.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 109.55 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -77.75 -19.12 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.515 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.01 -50.76 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.91 -28.17 69.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -58.32 5.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.27 -48.57 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.656 ' CZ ' HG21 ' A' ' 73' ' ' VAL . 1.8 t80 -53.37 -37.52 62.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -61.53 1.84 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.662 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -51.19 -23.81 3.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -51.09 19.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -73.35 -6.17 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.19 -64.12 1.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.66 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -66.62 -8.28 26.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.952 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -57.07 9.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.87 -27.54 6.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.87 152.08 32.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.149 . . . . 0.0 109.519 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -99.98 50.97 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.852 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 35.5 p-90 -80.11 158.47 26.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.905 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -144.06 157.43 57.34 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.98 131.74 11.24 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.15 172.25 10.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.923 . . . . 0.0 109.588 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.19 162.04 4.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.499 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.7 Cg_endo -78.67 2.15 8.43 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.787 2.325 . . . . 0.0 110.668 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.43 15.99 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 109.638 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.18 38.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.527 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 131.78 52.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.84 -37.31 60.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.317 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.48 128.89 22.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.99 110.49 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.515 HD11 ' CD2' ' A' ' 7' ' ' LEU . 97.0 mt -97.23 104.7 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.95 137.97 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.7 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.88 117.59 34.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.343 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -17.31 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.3 -16.99 37.12 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 48' ' ' LEU . 5.3 mp -118.84 40.64 3.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -1.221 . . . . 0.0 109.622 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.494 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 43.1 t-105 -81.49 -29.91 33.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.73 39.04 2.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -139.12 -50.52 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 56' ' ' ILE . 11.2 mtt180 -130.48 64.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -48.57 -22.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.05 -41.94 40.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 11.8 tt0 -69.31 -30.15 68.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.536 HD13 ' N ' ' A' ' 56' ' ' ILE . 4.3 mm -77.12 -63.74 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.885 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.91 75.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.957 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -31.59 81.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' GLU . . . -63.03 -62.02 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -1.187 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.78 -46.48 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.418 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.89 -39.26 65.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 1.0 OUTLIER -61.42 -47.18 86.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.211 -0.93 . . . . 0.0 109.265 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 70' ' ' ILE . . . -52.88 -49.19 66.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -26.23 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 15.3 21.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.991 . . . . 0.0 109.632 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' LEU . 43.8 m -143.69 -63.37 0.39 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.355 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 75.5 m -109.55 -91.71 0.45 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.208 -0.933 . . . . 0.0 109.022 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tttp 155.21 -47.19 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.831 -0.543 . . . . 0.0 110.237 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 68' ' ' LYS . 36.2 Cg_endo -78.2 119.16 4.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.092 1.861 . . . . 0.0 110.605 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 63' ' ' ALA . 2.7 mp -125.61 104.86 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 91' ' ' GLU . 4.0 mp -91.02 119.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.42 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.604 ' CG2' HG22 ' A' ' 92' ' ' VAL . 13.3 t -104.45 140.29 38.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 109.757 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.656 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 55.7 t -108.7 125.68 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.3 164.98 15.44 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 162.44 28.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.608 2.206 . . . . 0.0 110.144 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.93 -57.44 6.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.636 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.592 ' O ' HD22 ' A' ' 78' ' ' LEU . . . -179.3 85.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -148.0 -67.12 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -1.175 . . . . 0.0 109.517 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -115.54 -143.89 0.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.294 -0.879 . . . . 0.0 109.087 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.81 122.49 9.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 82' ' ' PRO . 53.7 t -52.2 137.26 38.8 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.4 Cg_endo -78.07 165.41 26.12 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.476 2.118 . . . . 0.0 110.557 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.96 5.27 5.45 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.697 2.265 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.29 -35.07 23.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.96 -7.82 44.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.52 -9.46 41.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.579 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.59 -5.35 35.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.63 -41.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -46.6 156.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 m -123.06 -6.61 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.883 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 71' ' ' ILE . 22.3 mt-10 -150.89 98.78 2.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 72' ' ' THR . 59.4 t -102.36 128.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.89 168.53 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.16 -146.84 15.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -95.1 34.48 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.603 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.4 m-80 -106.11 146.0 32.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.21 -32.63 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.67 2.247 . . . . 0.0 110.594 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.35 -41.28 76.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -28.06 61.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 96' ' ' ASN . 67.7 mt -74.87 -31.55 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.012 . . . . 0.0 109.646 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -44.36 69.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.63 -17.83 64.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.554 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -59.16 2.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -21.17 66.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.98 -45.47 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 -1.52 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 109.786 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.11 -32.98 56.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.639 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.797 HG23 HD23 ' A' ' 7' ' ' LEU . 4.0 tt -151.17 155.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.048 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -91.57 104.86 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.941 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.797 HD23 HG23 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -130.19 164.85 23.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.959 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -131.29 147.44 52.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.823 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.64 147.06 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.66 145.59 33.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.501 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.57 149.82 24.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.64 -155.93 14.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.23 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 17' ' ' TYR . 30.2 m -112.82 167.99 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.945 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -66.96 -25.62 66.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.548 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.63 -66.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.4 t80 -54.1 -26.77 28.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -69.86 -71.66 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.792 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 15' ' ' GLU . 26.1 t -42.11 -39.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 45' ' ' LEU . 22.9 t80 -59.82 -54.51 45.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.75 -28.72 50.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.784 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 63.2 mm-40 -72.75 -45.02 60.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.878 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -23.28 64.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 109.91 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -56.15 24.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -59.44 -21.39 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -49.75 -33.45 16.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER -45.63 -50.6 13.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 109.533 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.25 64.41 0.28 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 tp 61.65 82.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.44 27.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.12 -0.988 . . . . 0.0 109.567 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.79 ' HB2' HD21 ' A' ' 7' ' ' LEU . 44.9 p-90 -158.06 155.99 30.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.95 . . . . 0.0 109.657 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -151.68 148.2 21.49 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.406 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 32' ' ' ARG . 35.1 Cg_endo -77.72 119.55 4.84 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.596 2.198 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.35 -168.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.676 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -97.61 165.25 15.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 109.404 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.7 Cg_endo -76.91 -23.39 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.478 2.119 . . . . 0.0 110.169 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -2.96 53.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.294 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.34 61.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.82 127.28 54.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -77.21 -39.85 47.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -124.02 134.06 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.37 144.21 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' LEU . 9.2 mt -134.44 100.46 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.67 135.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 20' ' ' PHE . 1.1 mm? -92.2 136.01 33.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.568 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.35 9.47 28.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.36 -24.15 29.66 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 17' ' ' TYR . 1.4 mp -85.3 12.71 7.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -1.126 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.595 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 1.8 t-105 -68.43 -26.53 65.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.79 28.25 16.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -142.73 -64.84 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -1.094 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -120.41 57.37 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HG3' ' NE1' ' A' ' 49' ' ' TRP . 5.5 ttt180 -55.98 -35.24 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.39 -0.819 . . . . 0.0 109.727 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -52.18 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.696 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -50.25 -38.26 39.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 mt -71.85 -52.52 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.5 tp -47.11 -31.1 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.18 -48.77 57.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.02 -53.25 60.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -1.084 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.94 -40.24 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -36.39 82.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.679 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.13 -47.12 81.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -67.88 -25.8 65.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 0.7 19.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 65' ' ' LYS . 1.6 tppt? -62.47 -48.76 78.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -73.4 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.1 p -178.67 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.059 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.562 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 4.8 mtmt -79.67 154.13 75.94 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.93 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 36.3 Cg_endo -78.95 100.94 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.31 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -103.26 115.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 93' ' ' VAL . 1.6 mp -105.2 129.77 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' HD23 ' A' ' 85' ' ' LEU . 13.4 t -94.64 132.34 39.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.761 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.51 120.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.38 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -50.11 158.38 0.96 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.19 -164.25 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.72 2.28 . . . . 0.0 110.387 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -88.38 -62.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 109.222 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.8 61.57 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 -51.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.514 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.77 -143.82 0.34 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.299 -0.875 . . . . 0.0 109.104 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -140.76 148.7 41.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.652 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.54 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 15.2 t -74.45 140.68 75.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.339 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.0 Cg_endo -77.37 161.47 31.7 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.474 2.116 . . . . 0.0 110.539 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.03 7.37 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.782 2.321 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -92.14 -44.66 8.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.697 HD23 ' OG1' ' A' ' 72' ' ' THR . 3.5 tp -69.37 -19.73 63.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.686 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 39.2 tt0 -84.99 -9.51 57.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 -1.47 25.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.694 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.06 -25.76 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.661 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 2.4 m -81.02 135.82 35.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.502 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -76.69 -23.82 53.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -150.6 167.11 28.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.47 112.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.656 HG13 ' SG ' ' A' ' 99' ' ' CYS . 2.6 t -96.31 151.38 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.07 -151.3 27.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -100.63 29.21 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -1.172 . . . . 0.0 109.38 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.61 159.95 27.67 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.4 -0.813 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.57 -53.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.65 2.234 . . . . 0.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -56.01 -30.94 62.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.656 ' SG ' HG13 ' A' ' 93' ' ' VAL . 2.7 t -68.27 -44.02 76.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.824 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.81 -32.62 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.881 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -60.25 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.623 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -45.61 82.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.691 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -60.82 -27.3 67.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.47 -45.6 58.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.295 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -17.77 61.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.264 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.51 -36.83 79.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.34 -42.99 42.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.261 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.9 mt -134.24 137.88 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -99.01 105.1 17.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.465 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -121.82 171.04 9.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.403 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.7 t80 -143.2 106.08 4.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.938 HG12 HD12 ' A' ' 43' ' ' ILE . 2.9 mt -104.61 135.83 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.41 167.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 109.141 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.38 102.4 5.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.16 -145.87 6.97 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -138.89 54.1 1.75 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.207 -1.173 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.759 HG21 ' HB3' ' A' ' 48' ' ' LEU . 3.5 t -118.22 157.45 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.394 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 tt0 -77.93 -11.9 59.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' OD1' HD11 ' A' ' 45' ' ' LEU . 1.5 t70 -69.62 -59.39 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' OH ' HD12 ' A' ' 21' ' ' LEU . 12.3 t80 -60.52 -33.28 72.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -64.42 -41.96 96.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 109.832 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 15' ' ' GLU . 79.3 t -66.66 -50.55 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -51.03 -52.06 46.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.1 tt -67.41 -26.1 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.52 -49.19 72.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.703 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.53 -26.13 59.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.528 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -76.69 -15.0 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.638 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.16 -57.19 4.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -72.34 -10.25 59.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.1 t -47.02 -46.1 21.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.386 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 121.67 -179.82 16.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER 61.6 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -1.126 . . . . 0.0 109.519 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.83 158.49 15.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.234 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -158.19 155.06 28.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.56 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -145.97 155.0 51.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.534 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 36.1 Cg_endo -78.29 133.71 12.22 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.639 2.226 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' THR . . . -125.29 154.01 42.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -44.1 162.27 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.528 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.96 -31.06 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.634 2.222 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -31.85 69.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -120.17 27.93 8.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.59 107.48 5.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 47.4 t0 -53.89 -37.34 63.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -131.73 129.95 41.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.19 110.78 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 9' ' ' ILE . 8.0 mt -104.48 100.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.293 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.604 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -96.3 130.7 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.663 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -84.89 135.94 33.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 72' ' ' THR . . . -100.95 25.63 7.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.965 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -110.76 -35.78 1.98 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 14' ' ' VAL . 3.8 pp -119.43 15.43 12.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -1.207 . . . . 0.0 109.625 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.607 ' CZ3' ' CD1' ' A' ' 85' ' ' LEU . 2.8 p-90 -76.65 -21.58 55.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.53 -13.38 55.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -98.86 -41.53 7.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -1.101 . . . . 0.0 109.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' ILE . 7.1 mtt180 -108.45 50.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.269 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NE ' ' CZ3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -71.22 -33.43 69.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.03 -51.17 70.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 56' ' ' ILE . 20.7 mt-10 -68.42 -58.33 4.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.604 HD12 ' CG1' ' A' ' 44' ' ' VAL . 34.0 mm -43.52 -26.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.747 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -59.77 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.665 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.37 -30.17 24.97 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -57.71 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -49.98 -45.25 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.57 -48.62 74.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 62' ' ' LEU . 6.8 mt -55.02 -32.45 61.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -66.93 -21.44 65.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.99 -27.34 16.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.46 ' OG ' ' HD3' ' A' ' 68' ' ' LYS . 47.6 t -109.33 15.98 22.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.9 p 45.26 40.23 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -83.26 152.52 64.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.508 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 35.5 Cg_endo -78.19 117.86 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.681 2.254 . . . . 0.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.471 HD11 ' CB ' ' A' ' 63' ' ' ALA . 2.6 mt -107.81 90.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.514 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.552 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 3.0 mt -93.06 128.2 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.261 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 46' ' ' ALA . 52.0 m -102.07 131.32 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.75 124.4 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -49.33 153.24 1.84 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.44 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 34.8 Cg_endo -77.43 -158.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.609 2.206 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' ' CZ2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -117.68 14.99 14.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.679 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.47 6.23 5.74 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -95.37 68.51 3.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -1.179 . . . . 0.0 109.416 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 5.5 tp10 67.27 137.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.886 0.851 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -78.53 -164.16 0.54 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.309 0.575 . . . . 0.0 109.568 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 81' ' ' VAL . 3.6 m -91.22 150.8 42.18 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.05 173.12 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.644 2.229 . . . . 0.0 110.404 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.9 Cg_endo -77.8 -5.46 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 110.31 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -83.36 -49.37 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.607 ' CD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -69.11 -27.38 65.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.54 -12.13 56.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.358 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.7 -12.28 20.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 85' ' ' LEU . 7.3 m -123.84 8.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.385 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 p -94.66 131.17 40.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -76.31 -38.58 55.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.11 173.44 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.799 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.54 155.74 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.401 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 3.1 t -123.57 146.25 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.28 -162.44 17.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' CD2' ' A' ' 76' ' ' TYR . 74.2 m95 -98.45 19.38 14.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.18 156.36 54.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.238 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.47 -34.62 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.586 2.19 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -20.67 55.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.593 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -10.14 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.943 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 24' ' ' LEU . 28.2 mm -76.39 -64.27 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -32.26 69.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.47 -35.77 72.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.89 60.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.977 . . . . 0.0 109.853 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.73 -23.42 58.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 109.734 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.84 -22.61 63.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.17 -44.68 79.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.89 -18.91 64.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.389 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 5.2 mt-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.305 0.574 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.65 164.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -117.39 119.82 36.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.639 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 1.3 pp -135.52 169.66 17.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.85 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -142.28 114.11 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.817 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 43' ' ' ILE . 11.8 mt -94.44 148.84 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.205 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.91 155.14 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.43 156.96 16.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.6 -164.52 34.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -155.38 65.58 0.62 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -1.149 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.99 -170.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 19' ' ' VAL . 18.4 tt0 -89.53 -22.74 22.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.423 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -70.65 -52.64 19.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.79 ' CE1' HD23 ' A' ' 21' ' ' LEU . 14.1 t80 -65.75 -19.66 65.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -54.52 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 15' ' ' GLU . 6.5 t -63.74 -36.35 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -65.82 -61.14 2.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.79 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -54.15 -27.16 31.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.91 -36.39 64.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -22.05 54.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -43.88 74.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.63 -14.7 62.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -51.5 51.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.331 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 p -63.33 -47.65 81.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 114.52 -109.94 2.26 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 55.58 169.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.419 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 4.7 mt-10 -120.3 130.11 54.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' ' CE3' ' A' ' 31' ' ' TRP . 25.9 p-90 -160.04 148.46 17.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.512 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -133.07 156.99 79.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.448 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.4 Cg_endo -77.63 129.92 10.38 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.65 2.233 . . . . 0.0 110.323 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -121.65 149.81 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -46.6 160.05 0.33 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.354 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -77.99 0.29 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.656 2.238 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.93 -27.42 12.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -130.44 36.1 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.92 116.4 22.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -36.53 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.937 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -136.3 139.23 42.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.695 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -113.84 149.03 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.324 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HG12 ' A' ' 9' ' ' ILE . 4.1 mt -136.98 129.84 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 56' ' ' ILE . 1.3 t -118.83 129.79 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.8 mm? -92.62 128.33 38.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' ' 81' ' ' VAL . . . -87.46 -0.76 57.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 109.585 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.01 -13.25 61.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.52 46.28 2.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.221 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.782 ' CZ3' HD22 ' A' ' 85' ' ' LEU . 44.9 t-105 -77.67 -16.89 58.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.797 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.23 19.47 29.52 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -132.75 -62.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -1.205 . . . . 0.0 109.701 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.1 36.09 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -59.33 -40.09 85.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.32 -39.34 66.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.658 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -73.1 -45.33 57.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.904 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.9 mt -59.93 -24.68 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.684 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.5 -55.77 8.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 109.507 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.06 65.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.71 24.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -1.173 . . . . 0.0 109.431 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 56' ' ' ILE . 51.4 t -56.01 -37.76 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 62' ' ' LEU . 12.9 mt -63.97 -31.54 72.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.246 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.11 57.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -69.27 -9.04 51.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.1 tttm -61.38 -15.61 38.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' SER . 22.2 m -152.88 -75.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 169.56 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.86 . . . . 0.0 109.342 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.34 155.91 57.02 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.9 Cg_endo -78.36 114.11 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.631 2.221 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mt -103.01 117.35 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.438 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 mt -110.94 114.78 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 92' ' ' VAL . 8.5 t -85.61 154.86 21.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.301 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.719 ' HB ' HD13 ' A' ' 45' ' ' LEU . 47.3 t -124.37 129.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.17 -0.956 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.21 155.2 18.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.567 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 176.58 9.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.709 2.273 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 77' ' ' GLY . 6.4 t80 -70.75 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 76' ' ' TYR . . . -132.97 96.36 0.3 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' GLU . 2.4 tt 179.27 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -1.176 . . . . 0.0 109.289 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 78' ' ' LEU . 9.9 mt-10 61.02 126.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -179.53 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.812 HG22 ' HB1' ' A' ' 46' ' ' ALA . 80.2 t -104.82 130.75 22.63 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 34.9 Cg_endo -77.88 168.92 21.46 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.403 2.069 . . . . 0.0 110.38 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 -10.3 15.53 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.656 2.237 . . . . 0.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.7 tt0 -81.88 -2.86 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.782 HD22 ' CZ3' ' A' ' 49' ' ' TRP . 40.7 tp -112.86 -15.99 12.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.17 -0.956 . . . . 0.0 109.204 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -82.63 -12.07 57.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.18 -36.42 9.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.772 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -79.91 -24.61 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 109.715 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' SER . 2.0 p -68.17 94.18 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.427 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' SER . 50.6 m -43.69 -33.64 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.65 157.83 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.375 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 HG23 ' A' ' 72' ' ' THR . 14.8 p -126.31 145.57 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 103' ' ' ALA . 85.4 t -129.22 147.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 109.568 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.29 -151.15 18.8 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -97.99 43.88 1.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -1.21 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -106.06 150.76 39.7 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.89 . . . . 0.0 109.703 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 34.8 Cg_endo -78.11 -48.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.727 2.285 . . . . 0.0 110.332 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.61 -31.98 63.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 5.3 m -60.68 -18.89 56.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.563 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 96' ' ' ASN . 21.3 mm -70.91 -36.47 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.5 -51.52 12.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.58 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -53.0 -27.08 17.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.657 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -77.1 -55.82 5.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.774 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -54.46 -24.32 19.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.67 -42.22 61.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 102' ' ' ASP . 8.7 m-20 -50.13 -23.44 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.55 80.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.637 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.7 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 7' ' ' LEU . 9.0 pt -129.09 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -112.96 109.95 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.258 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 104' ' ' LEU . 1.4 mp -118.4 171.5 8.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.761 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.3 95.41 2.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.0 109.192 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.794 HG13 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -79.79 132.68 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.65 140.04 19.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 109.547 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -56.41 131.24 47.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.29 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -142.46 153.65 24.62 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.5 22.81 5.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -1.12 . . . . 0.0 109.275 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.68 156.2 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -59.35 -19.29 45.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.375 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.81 -66.13 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 9' ' ' ILE . 10.7 t80 -46.33 -31.28 2.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.269 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -52.08 51.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 77.6 t -57.69 -32.37 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.18 -35.76 76.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -52.95 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.617 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.51 -24.72 65.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -74.16 -31.22 62.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.704 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -35.38 65.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.716 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.03 -46.73 73.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -19.76 63.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.498 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -68.31 -28.96 67.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 97.94 -173.5 28.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 75.39 136.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 109.517 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' H ' HD13 ' A' ' 29' ' ' LEU . 1.2 mt-10 -92.38 93.15 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -97.15 169.34 9.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.0 mtp180 -151.95 152.77 30.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.7 Cg_endo -78.54 139.19 15.98 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.687 2.258 . . . . 0.0 110.525 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -125.91 145.09 50.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.474 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -51.44 172.42 0.15 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.99 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.724 2.283 . . . . 0.0 110.671 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -103.9 -52.86 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.109 -0.995 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -100.29 37.09 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.74 124.81 26.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -70.68 -36.27 73.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.517 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -149.2 121.6 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.03 136.48 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.794 HD12 HG13 ' A' ' 9' ' ' ILE . 21.8 mt -116.33 88.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.78 126.8 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -96.67 125.27 41.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.09 54.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.391 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.95 -19.53 69.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -95.64 20.39 9.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.286 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 14.9 t-105 -69.91 -15.42 63.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.86 34.94 5.24 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -148.78 -52.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -1.165 . . . . 0.0 109.584 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 55' ' ' GLU . 10.7 mtt-85 -130.67 63.58 1.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -42.07 74.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.242 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -73.13 -35.69 66.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.35 -0.844 . . . . 0.0 109.319 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -65.39 -32.78 74.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.328 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 52' ' ' ARG . 31.5 mt -76.11 -51.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -47.51 -35.85 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -50.16 54.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 -34.55 58.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 109.297 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.81 -52.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.843 . . . . 0.0 109.276 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.74 -39.14 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.5 mt -70.29 -34.01 72.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.09 -54.85 42.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -70.88 -14.03 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.79 -29.33 3.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.89 -79.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -178.5 65.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.0 149.14 37.23 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 34.7 Cg_endo -77.6 127.09 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.569 2.179 . . . . 0.0 110.162 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' SER . 53.5 mt -103.68 118.73 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.6 HD12 ' HB1' ' A' ' 103' ' ' ALA . 44.5 mm -108.53 119.42 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.001 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 93' ' ' VAL . 10.8 m -92.88 143.37 26.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.893 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' ARG . 41.0 t -121.74 115.26 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -43.12 155.3 0.28 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 158.57 32.17 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.671 2.247 . . . . 0.0 110.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -109.16 18.06 20.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.45 13.52 62.79 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 52.09 48.47 22.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.407 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 -143.38 0.35 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.313 -0.867 . . . . 0.0 109.125 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -142.19 108.64 5.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.899 HG11 ' OE2' ' A' ' 86' ' ' GLU . 14.1 p -50.49 140.85 17.71 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.91 . . . . 0.0 109.241 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 81' ' ' VAL . 35.3 Cg_endo -77.73 156.46 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.468 2.112 . . . . 0.0 110.316 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.9 Cg_endo -78.25 71.06 6.91 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.639 2.226 . . . . 0.0 110.716 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.21 -42.66 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.073 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.61 -29.74 22.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.899 ' OE2' HG11 ' A' ' 81' ' ' VAL . 6.3 mp0 -72.2 -20.39 61.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.24 83.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.37 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 m -122.41 48.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -106.78 129.22 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.388 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 5.4 m -71.33 -34.24 70.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -157.13 142.9 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.36 100.34 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' THR . 4.4 m -95.08 144.54 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.85 -146.73 17.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -92.11 13.53 18.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -1.095 . . . . 0.0 109.535 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 3.0 m-20 -87.81 150.26 47.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.3 Cg_endo -77.82 -35.27 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.654 2.236 . . . . 0.0 110.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.93 -26.89 69.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 92.1 m -77.42 -25.04 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.77 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 100' ' ' ILE . 22.3 mm -66.97 -58.48 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.73 -33.36 75.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.95 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.741 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -69.77 -37.24 76.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 7' ' ' LEU . 14.4 mt -77.24 -22.41 52.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.718 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.08 91.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.3 98.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.15 60.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.296 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 108' ' ' LEU . 62.4 mt -122.08 165.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.686 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.6 ' N ' HG22 ' A' ' 5' ' ' ILE . 66.8 mtt180 -127.86 120.0 26.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.063 HD13 HD12 ' A' ' 43' ' ' ILE . 1.5 pp -145.42 170.79 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.751 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -137.38 139.14 40.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.204 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 7' ' ' LEU . 3.8 mt -121.63 147.89 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -65.01 121.37 14.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.29 169.36 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.572 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.22 -166.27 36.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -146.03 36.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.88 163.21 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.148 -0.97 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.1 tp10 -68.77 -31.94 71.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.04 -38.41 79.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -64.11 -46.66 83.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.47 -26.03 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 15' ' ' GLU . 57.4 t -69.85 -55.23 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.577 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.477 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 9.6 t80 -55.99 -47.27 78.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.356 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.49 -37.79 70.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.03 82.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.25 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -72.69 -28.51 62.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -72.4 -29.63 63.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -41.26 61.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -17.93 9.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.4 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.12 -13.9 11.19 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.37 172.3 13.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -126.02 114.09 17.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -0.844 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -127.1 154.66 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -115.76 149.35 42.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.302 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.9 Cg_endo -78.13 142.56 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.563 2.175 . . . . 0.0 110.683 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 -166.53 1.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.887 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -80.14 165.28 47.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.48 -4.54 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.58 2.187 . . . . 0.0 110.38 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.89 -37.35 3.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.253 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.3 33.39 3.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.229 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -102.14 142.96 32.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -66.06 -34.76 78.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . . . -140.09 115.16 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 109.315 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.5 100.35 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.063 HD12 HD13 ' A' ' 7' ' ' LEU . 35.7 mt -92.26 99.83 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.249 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.723 HG11 HG23 ' A' ' 56' ' ' ILE . 20.2 t -90.19 135.14 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.62 124.62 34.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.426 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.06 -0.07 55.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.96 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.74 79.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 -81.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 109.493 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.55 ' CH2' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER 48.75 22.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.846 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.86 -79.41 0.69 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' HD2' ' A' ' 52' ' ' ARG . 9.5 t -87.97 -26.93 22.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.0 109.345 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -93.11 34.05 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -59.88 -43.84 94.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.271 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.41 -21.09 62.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.262 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -43.81 62.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -73.68 -58.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -20.76 66.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -73.93 -56.4 5.36 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.55 75.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -1.103 . . . . 0.0 109.335 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 70' ' ' ILE . 85.0 t -63.35 -45.17 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -57.68 -37.2 73.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -68.3 -39.59 82.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -76.3 -11.31 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -73.08 -19.27 61.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -74.24 -25.86 59.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 0.0 109.884 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.62 9.81 4.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.955 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 t 54.17 59.78 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.416 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 9.9 mttm -81.66 169.63 18.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 35.7 Cg_endo -78.27 106.52 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.767 2.311 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.423 HG21 HG22 ' A' ' 60' ' ' VAL . 4.0 mt -108.04 98.0 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.58 114.33 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.452 HG21 ' CD2' ' A' ' 85' ' ' LEU . 23.2 p -91.88 140.58 29.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.22 121.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.77 160.89 0.31 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 -175.93 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -42.58 90.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.63 44.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 -23.78 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.104 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.36 126.92 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 109.455 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.72 147.8 41.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.62 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.46 155.64 9.76 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 161.89 29.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.623 2.215 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 35.3 Cg_endo -77.58 -15.47 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.67 2.247 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -70.31 -27.54 64.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.55 HD13 ' CH2' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -86.34 -24.8 25.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 83' ' ' PRO . 4.0 mt-10 -58.21 -35.2 71.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.2 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.714 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 88' ' ' VAL . 18.9 m -89.46 4.0 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.747 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -101.64 143.57 31.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 t -107.37 -17.48 14.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.77 135.0 14.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.517 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.61 110.09 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 137.47 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.3 -144.11 12.45 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.96 63.65 1.19 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.243 -1.151 . . . . 0.0 109.477 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -138.55 143.15 37.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.95 -27.64 4.49 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.658 2.239 . . . . 0.0 110.628 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.13 -32.25 64.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.5 m -74.99 -47.35 29.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.26 -13.1 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -76.27 -55.96 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.986 . . . . 0.0 109.617 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -72.94 -24.88 60.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.49 73.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.596 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.74 -41.63 62.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -34.39 64.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.606 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.05 -16.83 34.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.481 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 5' ' ' ILE . 3.4 mt-10 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.016 HG21 HD22 ' A' ' 104' ' ' LEU . 1.2 mp -131.66 153.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 20.7 mtt-85 -114.96 105.81 13.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.46 171.7 13.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.569 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -143.86 138.96 28.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.834 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 mt -120.85 133.82 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.353 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -58.35 111.89 1.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -52.44 135.37 33.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.86 ' HA3' HD21 ' A' ' 48' ' ' LEU . . . -136.84 148.78 19.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -77.9 -31.94 51.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 17' ' ' TYR . 25.1 m -43.36 137.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.506 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.3 pt-20 -64.51 -24.28 67.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.173 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.502 ' OD2' ' CG ' ' A' ' 76' ' ' TYR . 11.4 t70 -61.95 -31.06 71.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.102 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 11' ' ' GLU . 69.7 t80 -64.48 -42.75 95.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.42 91.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.258 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 15' ' ' GLU . 4.9 t -57.96 -56.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.185 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.429 ' HE2' HG21 ' A' ' 43' ' ' ILE . 16.3 t80 -51.14 -40.19 57.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.129 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.88 -58.14 8.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.548 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.69 -17.23 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -71.89 -55.82 6.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.568 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -56.83 -21.7 30.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.558 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -74.29 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.609 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.37 -1.92 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -43.53 73.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.08 -71.53 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.631 HD13 ' CZ ' ' A' ' 101' ' ' ARG . 0.7 OUTLIER -66.55 157.5 32.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -1.137 . . . . 0.0 109.513 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -88.96 121.05 30.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -93.37 158.77 15.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.641 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.65 146.2 52.11 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.383 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.71 129.21 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.525 2.15 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.69 164.96 12.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.715 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.437 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -73.95 171.86 9.93 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 36.4 Cg_endo -80.28 42.23 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.805 2.337 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -159.32 -62.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 109.635 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.33 27.98 1.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' ' CE ' ' A' ' 68' ' ' LYS . . . -64.22 132.47 50.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.87 . . . . 0.0 109.286 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -71.2 -33.84 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.26 23.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.34 110.32 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 20' ' ' PHE . 65.6 mt -93.63 94.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 70' ' ' ILE . 1.5 t -90.13 122.31 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 73' ' ' VAL . 4.1 mm? -81.81 121.52 26.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.287 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -71.22 -12.23 61.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.601 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.33 29.93 11.25 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.86 HD21 ' HA3' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -124.86 -19.1 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.925 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.797 ' CZ3' ' HB1' ' A' ' 46' ' ' ALA . 1.8 p90 -66.82 -21.79 66.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.032 -1.042 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -64.17 -15.52 58.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.72 -48.28 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -1.115 . . . . 0.0 109.274 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -129.37 63.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -23.33 6.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.2 -46.74 40.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -46.6 89.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.485 HD13 HG21 ' A' ' 10' ' ' THR . 50.3 mm -58.31 -54.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 tp -50.6 -30.4 13.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -49.2 42.6 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.01 -46.53 64.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -1.132 . . . . 0.0 108.846 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.54 -29.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.25 -0.906 . . . . 0.0 109.037 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 16.8 t70 -59.16 -44.78 92.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.43 -38.23 65.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.339 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.445 ' HB1' HG12 ' A' ' 70' ' ' ILE . . . -68.7 -14.44 63.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' ASP . 4.6 mmm180 -65.5 -14.69 61.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -64.2 -11.95 35.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.945 . . . . 0.0 109.499 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 71.44 39.16 0.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.64 -67.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 39' ' ' ALA . 2.3 mmtt -92.95 153.17 41.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 142.65 19.52 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.661 2.241 . . . . 0.0 110.443 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.445 HG12 ' HB1' ' A' ' 63' ' ' ALA . 1.9 mt -103.05 91.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 93' ' ' VAL . 3.0 mt -80.12 115.77 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -98.73 139.84 33.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.683 ' HB ' HD13 ' A' ' 45' ' ' LEU . 19.0 t -111.22 130.71 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 73' ' ' VAL . 9.0 mtt180 -43.75 157.57 0.27 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.557 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.48 145.56 23.7 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.675 2.25 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 16.1 t80 -66.98 -10.89 54.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.923 ' C ' HD12 ' A' ' 78' ' ' LEU . . . -68.45 -95.05 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.923 HD12 ' C ' ' A' ' 77' ' ' GLY . 6.0 mp -135.87 -92.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 3.4 pt-20 -159.31 -142.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.13 -0.982 . . . . 0.0 108.925 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 3.8 m-20 69.59 54.57 0.38 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.2 m -71.22 144.81 90.14 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.3 Cg_endo -78.09 146.78 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.548 2.166 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' GLU . 35.1 Cg_endo -77.75 -9.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.533 2.155 . . . . 0.0 110.229 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.26 -58.39 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.933 . . . . 0.0 109.394 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.0 tt -72.63 -9.58 58.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -78.59 -11.25 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.484 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.66 -20.86 56.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.789 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -113.99 6.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t -81.77 105.25 12.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -30.55 57.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.99 152.19 34.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 109.499 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.59 154.95 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 HG23 ' A' ' 71' ' ' ILE . 51.8 t -138.72 144.26 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -161.85 29.31 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -91.56 36.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -1.182 . . . . 0.0 109.503 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -113.27 155.84 43.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 100' ' ' ILE . 35.4 Cg_endo -77.92 -60.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.345 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -51.13 -23.88 3.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.77 -51.83 24.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 24' ' ' LEU . 5.2 mt -57.31 -62.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.631 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -43.71 -32.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.566 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.21 -60.16 4.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.541 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.016 HD22 HG21 ' A' ' 5' ' ' ILE . 17.0 mt -58.2 -56.36 23.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 0.0 109.636 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -73.17 -7.97 53.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.79 -24.66 52.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -16.88 64.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.631 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.728 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.96 HG21 HD21 ' A' ' 104' ' ' LEU . 11.7 tt -150.01 124.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.0 109.329 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -91.76 129.12 37.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.628 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -147.96 169.61 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.4 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -124.88 143.08 51.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' A' ' 21' ' ' LEU . 3.3 mt -122.16 125.0 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.13 145.06 2.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.46 105.85 10.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.02 -146.06 7.22 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.23 47.16 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.21 150.17 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.41 -45.32 94.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.46 -24.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -75.99 -45.88 32.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 109.829 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -63.8 -35.38 80.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -71.78 -39.06 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.289 -0.882 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 76.5 t80 -67.07 -62.72 1.29 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' CD1' HD13 ' A' ' 9' ' ' ILE . 12.9 tp -54.23 -49.39 69.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.435 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 18' ' ' ARG . 91.9 mt-10 -53.67 -33.96 57.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -35.27 65.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -48.26 -32.3 7.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.816 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.68 -42.69 86.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 0.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -72.15 -4.28 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.515 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -80.8 -12.91 59.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 70.33 -155.15 52.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 1.6 mt 61.68 171.41 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.408 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.19 108.12 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -117.88 153.23 33.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.175 -0.953 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.1 mmt180 -138.4 146.28 50.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.287 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 Cg_endo -78.67 146.69 21.43 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.553 2.169 . . . . 0.0 110.405 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 -151.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.159 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.11 169.13 12.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 35.7 Cg_endo -77.85 71.12 6.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.596 2.198 . . . . 0.0 110.278 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 36' ' ' PRO . 2.0 mt-10 -173.66 -35.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.243 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.42 27.99 3.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.406 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.77 110.12 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -51.64 -47.51 63.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.685 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 7' ' ' LEU . . . -119.77 149.83 41.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.79 109.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 96.6 mt -90.83 118.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' A' ' 56' ' ' ILE . 6.5 t -102.97 126.35 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 48' ' ' LEU . 3.5 mm? -92.04 131.82 37.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.81 5.14 51.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.37 -20.7 71.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -110.6 38.15 2.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -1.097 . . . . 0.0 109.2 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 26.3 t-105 -80.96 -17.56 50.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.56 11.11 53.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -122.99 -59.47 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.181 . . . . 0.0 109.585 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.3 mpt_? -116.69 53.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -47.85 82.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.294 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.04 -41.23 59.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -0.867 . . . . 0.0 109.409 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -42.19 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.584 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 48' ' ' LEU . 25.2 mm -59.65 -62.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.65 -31.49 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.822 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.1 -61.92 4.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.49 -35.97 6.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -1.149 . . . . 0.0 109.768 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 80.9 t -67.96 -63.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 60' ' ' VAL . 21.0 t70 -43.14 -30.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.824 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.7 tp -76.92 -42.72 38.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.915 . . . . 0.0 109.595 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.02 -57.0 12.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -62.89 -13.58 35.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -46.82 -27.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -140.36 -71.1 0.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.88 33.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.509 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -71.24 147.02 92.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 35.6 Cg_endo -78.1 125.01 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.657 2.238 . . . . 0.0 110.589 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.94 124.27 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 71' ' ' ILE . 2.8 mm -92.71 107.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.318 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -81.6 109.1 15.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.704 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.2 106.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.478 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 18.6 ptt85 -48.86 161.98 0.39 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.496 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -78.02 -162.1 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.626 2.218 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 76' ' ' TYR . 9.0 t80 -108.14 15.33 24.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 17.86 47.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.2 mm? -93.06 -67.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -1.196 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -109.48 14.16 23.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' GLU . 1.3 m120 46.41 -173.62 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 ' HD2' ' A' ' 82' ' ' PRO . 14.9 p -126.28 138.32 32.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.346 -0.847 . . . . 0.0 109.057 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.9 Cg_endo -78.24 165.68 25.43 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.464 2.109 . . . . 0.0 110.437 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.19 4.72 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.57 2.18 . . . . 0.0 110.352 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.87 -10.45 59.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 -29.26 14.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -32.49 74.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.882 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 -16.61 62.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.322 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.0 m -144.75 52.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.37 130.26 52.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.537 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t -103.13 -38.68 7.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.35 140.68 49.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 93' ' ' VAL . 97.2 t -123.1 130.38 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.238 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.493 HG21 HG22 ' A' ' 71' ' ' ILE . 12.8 m -153.34 138.57 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.801 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.41 -145.74 16.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -86.81 -4.69 59.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -1.154 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -57.64 151.15 42.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.12 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.579 2.186 . . . . 0.0 110.551 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -56.2 -17.56 7.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -43.76 83.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.13 -24.13 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -74.32 -51.39 15.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 109.28 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.14 -35.99 76.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.96 -61.99 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.96 HD21 HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -45.75 -32.28 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.724 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.03 -43.18 68.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.94 -44.37 96.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.734 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.12 83.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.617 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' A' ' 104' ' ' LEU . 14.9 mt -135.64 135.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 7.7 mpt_? -99.2 115.98 30.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.248 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -141.21 171.08 14.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.683 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -138.29 124.57 20.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.524 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG22 ' HE1' ' A' ' 17' ' ' TYR . 24.8 mt -114.29 139.19 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 m -63.06 134.78 56.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.77 164.84 13.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 169.62 40.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.29 47.6 1.69 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.221 -1.164 . . . . 0.0 109.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.79 172.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 pt-20 -68.39 -24.32 64.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.536 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.93 -55.28 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' HE1' HG22 ' A' ' 9' ' ' ILE . 13.5 t80 -51.57 -39.17 57.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -63.17 -42.26 99.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.594 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.0 t -61.47 -43.78 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.837 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.0 -47.72 83.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.558 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -65.68 -20.31 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' OE2' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -73.15 -55.6 6.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -58.04 -51.08 71.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.43 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -45.26 -44.04 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.92 -53.56 52.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.74 -19.2 5.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -65.6 -68.29 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.374 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.16 8.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.7 151.53 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -1.117 . . . . 0.0 109.521 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -99.59 106.15 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.799 ' HB2' HD21 ' A' ' 7' ' ' LEU . 67.5 p-90 -105.42 167.47 9.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -147.45 145.4 21.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.21 105.69 2.03 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.613 2.209 . . . . 0.0 110.444 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.85 -154.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.654 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 19.2 p -100.63 158.12 32.48 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 -3.3 13.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.588 2.192 . . . . 0.0 110.573 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.494 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 4.1 mt-10 -102.27 -17.59 15.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 109.314 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -144.16 36.53 1.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.376 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.86 125.11 30.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.647 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.7 t70 -50.87 -31.9 18.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.417 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.41 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.379 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 39' ' ' ALA . 1.6 t -91.94 107.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.28 102.28 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.31 132.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD22 ' HB ' ' A' ' 73' ' ' VAL . 1.1 mm? -103.13 135.85 44.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.282 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.51 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.44 61.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 mp -90.94 32.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 109.54 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.472 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 32.0 t-105 -62.56 -16.97 58.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.594 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.38 35.45 3.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -144.31 -67.42 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.35 52.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 109.619 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.27 -47.74 81.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.309 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.61 -22.93 48.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -77.16 -50.61 12.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.9 mt -62.41 -27.13 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.649 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.89 -32.68 67.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.28 -41.12 26.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.72 80.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -1.137 . . . . 0.0 109.854 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 56' ' ' ILE . 39.9 t -74.09 -34.89 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.9 -46.31 82.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 37' ' ' GLU . 62.2 mt -70.88 -41.88 70.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.003 . . . . 0.0 109.806 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -25.62 68.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.704 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -77.25 -20.2 55.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.76 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -79.71 -9.55 59.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' SER . 0.3 OUTLIER -125.67 3.52 7.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' SER . 17.9 m 60.62 38.38 18.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.9 mmpt? -71.28 161.36 78.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 0.0 109.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 34.2 Cg_endo -76.99 108.45 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.429 2.086 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 70' ' ' ILE . 15.2 mt -108.78 109.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.715 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.6 HG12 ' HB1' ' A' ' 103' ' ' ALA . 3.2 mt -97.83 117.2 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.258 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -80.54 147.65 30.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 45' ' ' LEU . 74.4 t -122.16 113.17 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.423 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -52.89 159.35 1.86 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 36.2 Cg_endo -77.82 166.64 25.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.733 2.289 . . . . 0.0 110.246 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -74.49 -59.1 2.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -149.64 15.83 1.08 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.075 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 32.3 tp -71.83 -78.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -1.228 . . . . 0.0 109.354 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 tt0 -147.51 -143.05 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.041 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' OD1' ' OE1' ' A' ' 79' ' ' GLU . 2.9 p30 -124.59 176.65 6.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.91 134.95 20.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.17 173.04 14.48 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.435 2.09 . . . . 0.0 110.519 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.8 Cg_endo -77.37 -1.53 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.576 2.184 . . . . 0.0 110.596 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -73.91 -70.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.306 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -16.22 54.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.51 -42.96 61.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.16 68.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.6 m -102.94 38.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -128.7 105.63 8.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.539 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 91' ' ' GLU . 1.5 m -56.52 -39.68 73.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 106' ' ' ASP . 13.1 mp0 -138.29 157.95 45.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.59 133.57 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.131 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 15.0 m -139.99 169.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.101 -0.999 . . . . 0.0 109.873 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 74' ' ' ARG . . . -106.45 -144.37 11.94 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -93.06 47.63 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -1.143 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -100.73 146.47 32.14 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -38.73 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.551 2.168 . . . . 0.0 110.317 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -23.26 56.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -73.58 -15.44 61.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.63 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.9 mm -73.37 -40.23 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -76.81 -34.66 57.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -31.87 70.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.674 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HG12 ' A' ' 71' ' ' ILE . . . -77.19 -44.96 28.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.02 -28.7 69.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.874 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 2.4 tp10 -66.06 -21.31 66.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.884 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD2' ' OE2' ' A' ' 91' ' ' GLU . 1.1 t70 -63.17 -30.31 71.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.59 41.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.573 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.347 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.292 0.568 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' GLU . 7.5 tt -146.7 141.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.6 mtt-85 -97.64 104.38 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 41' ' ' ALA . 37.6 mt -113.35 157.73 21.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -134.88 92.12 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.742 HG21 ' CE1' ' A' ' 17' ' ' TYR . 2.7 mp -89.28 162.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.494 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.2 159.01 18.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.426 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.14 128.89 56.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.983 . . . . 0.0 109.61 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.21 -162.98 11.66 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -125.42 -4.67 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -1.147 . . . . 0.0 109.578 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 16' ' ' ASP . 18.1 m -83.74 -178.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 19' ' ' VAL . 13.3 pt-20 -92.2 -2.46 56.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.95 -69.54 0.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.509 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE1' HG21 ' A' ' 9' ' ' ILE . 5.0 t80 -48.64 -29.15 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.664 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -51.5 65.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.096 -1.002 . . . . 0.0 109.427 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 15' ' ' GLU . 20.0 t -62.67 -33.08 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.743 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -63.22 -57.95 8.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.65 -34.23 64.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.57 -40.03 95.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -40.52 74.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.929 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.83 71.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -34.69 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.672 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -68.96 -22.22 64.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -45.41 -45.99 13.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.475 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.04 -32.54 6.27 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.01 150.24 31.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -1.174 . . . . 0.0 109.533 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -87.91 151.5 22.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 109.453 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.435 ' C ' ' HG3' ' A' ' 32' ' ' ARG . 46.8 p-90 -153.43 160.84 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 24.2 mtt-85 -141.86 158.6 61.97 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.2 Cg_endo -78.18 95.47 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.677 2.251 . . . . 0.0 110.129 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -73.78 -176.77 2.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.681 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -87.2 173.55 6.45 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.257 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 62' ' ' LEU . 35.7 Cg_endo -78.23 -9.81 16.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.557 2.171 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -114.51 -6.48 12.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -139.38 48.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.255 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -101.83 127.61 48.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.658 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -67.41 -40.71 85.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -142.07 134.8 28.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.43 126.24 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' ILE . 2.5 mt -109.48 93.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.202 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.77 115.07 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.575 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 43' ' ' ILE . 13.6 mt -85.59 127.15 34.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.94 -0.47 35.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.35 -15.52 70.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -105.87 29.41 6.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.331 -1.1 . . . . 0.0 109.21 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -72.5 -26.94 61.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.68 40.45 2.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -159.66 -55.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -1.182 . . . . 0.0 109.529 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.688 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.2 mpt_? -116.29 56.97 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -47.98 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.1 -36.77 75.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.56 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -69.61 -62.04 1.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 60' ' ' VAL . 16.1 mt -43.14 -36.08 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.04 -56.05 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.42 -47.67 62.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.45 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 0.0 109.585 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 56' ' ' ILE . 2.7 t -71.89 -29.19 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -66.86 -38.7 86.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -75.83 -43.14 47.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 109.968 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -67.29 -27.64 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.952 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -77.24 -30.75 54.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 109.82 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 6.5 16.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 7.05 4.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.694 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 m 51.26 38.64 21.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 159.49 53.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.68 108.75 2.62 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 63' ' ' ALA . 17.2 mt -108.66 114.71 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 mt -107.0 141.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.329 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 m -109.78 135.03 51.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -101.09 133.49 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -58.13 155.09 26.94 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 159.21 31.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.676 2.251 . . . . 0.0 110.403 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -81.57 -53.59 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.37 83.3 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.14 -35.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -1.155 . . . . 0.0 109.535 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 66.45 128.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' C ' ' HD3' ' A' ' 82' ' ' PRO . 1.8 m-20 171.96 39.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.15 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.5 t -118.04 79.06 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 36.1 Cg_endo -78.29 174.67 12.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.595 2.197 . . . . 0.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.2 Cg_endo -79.05 9.43 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.77 2.313 . . . . 0.0 110.613 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -56.47 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -11.23 60.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.51 -28.82 64.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.556 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.92 42.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.63 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.06 -59.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.97 150.47 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -106.38 -21.04 13.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.372 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -151.39 163.92 37.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.73 159.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 103' ' ' ALA . 54.1 t -128.3 160.25 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.11 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 93' ' ' VAL . . . -112.42 -152.71 11.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -107.14 50.24 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -125.49 162.19 45.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.07 -43.31 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.751 2.301 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -26.34 58.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.827 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.6 m -62.23 -64.57 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.453 HG12 HG11 ' A' ' 93' ' ' VAL . 67.9 mt -44.68 -25.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -46.93 39.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -0.995 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.86 -17.5 64.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.626 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -71.13 -59.14 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.63 -37.56 86.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.562 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -51.4 -48.21 62.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -31.32 72.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.8 -62.22 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.8 160.68 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.69 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 6.5 mpt_? -106.98 128.83 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.999 ' HG ' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -137.61 166.98 22.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.695 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -151.13 115.42 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.56 141.26 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.58 125.67 10.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.78 126.64 28.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.99 30.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.0 53.12 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.731 HG23 ' H ' ' A' ' 17' ' ' TYR . 15.4 m -112.62 143.23 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 19' ' ' VAL . 29.0 tt0 -54.31 -25.12 22.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.58 -65.37 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 14' ' ' VAL . 5.5 t80 -50.08 -28.36 7.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -48.4 55.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 15' ' ' GLU . 71.7 t -61.37 -29.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.852 . . . . 0.0 109.657 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -71.19 -45.93 62.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.358 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.543 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -56.98 -46.17 82.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -36.79 84.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.51 71.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.566 ' CD2' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -75.69 -49.06 19.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -68.22 -17.97 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -70.67 -52.5 20.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.493 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -47.76 -35.85 10.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 125.58 -154.79 18.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 71.04 165.92 0.29 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.454 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.69 100.86 4.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' CD2' ' A' ' 24' ' ' LEU . 60.8 p-90 -115.36 157.93 23.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 109.28 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -125.17 152.46 70.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.46 125.64 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.699 2.266 . . . . 0.0 110.512 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.96 153.43 35.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.486 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -53.92 173.21 0.21 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.331 -0.856 . . . . 0.0 109.392 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -76.9 -0.34 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.541 2.161 . . . . 0.0 110.372 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -104.25 -6.09 21.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.303 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.34 30.07 1.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.82 98.96 12.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 6' ' ' ARG . 12.4 m-20 -50.76 -45.32 58.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.196 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.999 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -116.02 121.92 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.01 110.56 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 7' ' ' LEU . 6.6 mt -103.23 123.25 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.83 HG11 HG23 ' A' ' 56' ' ' ILE . 2.4 t -113.77 120.89 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 17' ' ' TYR . 53.0 mt -80.21 148.25 30.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.38 17.06 24.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -87.74 -29.85 19.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 24.14 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -1.152 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 41.8 t-105 -60.71 -14.21 19.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.55 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.91 37.96 2.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -150.31 -58.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -1.137 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -116.24 46.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 109.725 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HA ' HD12 ' A' ' 56' ' ' ILE . 2.1 ttt180 -57.84 -34.26 69.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -39.74 94.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.605 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 3.7 tt0 -65.59 -41.69 92.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.83 HG23 HG11 ' A' ' 44' ' ' VAL . 5.2 mt -70.82 -23.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.11 -52.65 13.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.71 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.98 73.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.91 -62.15 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -1.157 . . . . 0.0 109.599 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 70' ' ' ILE . 80.8 t -55.62 -31.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -63.0 -55.3 26.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -60.47 -25.08 65.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.281 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.53 62.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -7.56 38.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.644 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -49.21 -32.61 10.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -135.58 -69.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.43 43.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.686 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.25 151.15 75.11 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.08 116.53 4.21 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.807 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 60' ' ' VAL . 4.4 mt -107.43 98.53 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 108.881 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 10.4 mt -90.22 112.75 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 85' ' ' LEU . 15.0 p -89.41 141.51 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.13 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 93' ' ' VAL . 84.6 t -115.68 132.36 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HG2' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -51.7 158.47 1.58 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 36.2 Cg_endo -78.96 169.7 19.0 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 0.0 110.507 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 76' ' ' TYR . 74.8 t80 -82.9 8.85 11.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 122.12 71.49 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -151.98 81.9 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.562 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' LEU . 3.1 mt-10 70.91 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.476 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.8 137.06 58.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.613 HG13 ' HD2' ' A' ' 82' ' ' PRO . 86.9 t -68.44 141.04 92.92 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.5 Cg_endo -78.45 155.81 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.563 2.176 . . . . 0.0 110.412 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.16 -10.09 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.555 2.17 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.87 -15.93 63.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.295 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 72' ' ' THR . 42.2 tp -93.84 -18.79 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -24.47 43.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.13 61.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.7 -0.18 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 21.3 t -96.23 135.84 37.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 -33.01 54.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.82 168.99 24.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.2 m -130.71 156.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.897 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 73' ' ' VAL . 2.1 t -135.97 155.56 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 74' ' ' ARG . . . -116.98 -155.69 10.33 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -88.89 37.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -1.199 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.1 149.05 39.53 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 -66.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.609 2.206 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.24 -32.28 1.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -53.11 59.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.6 mt -55.05 -23.56 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.988 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -69.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -28.08 50.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.993 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.33 -51.73 48.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.452 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 7' ' ' LEU . 5.6 tt -72.46 -15.06 61.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.257 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -28.97 63.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.296 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -68.2 -12.53 61.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.429 -0.794 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -58.8 4.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.73 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 2' ' ' THR . 42.1 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.318 0.58 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.431 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.88 75.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.22 10.22 41.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -46.89 152.02 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 109.436 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 6' ' ' ARG . 57.2 mt -114.63 162.58 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' C ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -93.57 105.09 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.395 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD23 HD11 ' A' ' 43' ' ' ILE . 8.9 mp -112.35 168.24 9.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.699 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -153.09 142.19 21.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 mt -130.76 151.45 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 109.643 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 157.44 25.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -85.84 135.07 33.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.89 177.09 20.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -123.99 -12.57 7.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -1.095 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.9 m -67.81 165.97 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.02 -20.29 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.1 -32.78 73.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.46 18.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.08 -35.31 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 18.6 t80 -65.88 -47.99 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.85 -45.92 71.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -58.36 -49.94 75.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -59.74 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.96 . . . . 0.0 109.439 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CZ ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -45.5 -38.28 6.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.64 -44.65 93.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -23.07 67.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -51.74 38.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.25 -33.09 6.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 29' ' ' LEU . 1.4 mm? -57.76 148.63 24.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -82.16 131.76 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -138.56 145.37 40.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' NH2' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -130.53 147.8 67.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.188 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HD2' ' NH2' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.7 101.88 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.459 2.106 . . . . 0.0 110.529 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 6' ' ' ARG . . . -101.81 154.92 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -59.89 164.87 5.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.341 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -77.37 -7.6 17.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.497 2.131 . . . . 0.0 110.114 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -28.6 15.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.3 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.05 46.53 2.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -100.17 148.35 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -95.43 -26.68 15.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.437 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -142.9 119.21 10.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.502 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.6 t -110.11 100.28 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.659 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.698 HD11 HD23 ' A' ' 7' ' ' LEU . 1.4 mt -84.19 106.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 136.68 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -88.67 128.6 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 109.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.71 4.63 15.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.97 . . . . 0.0 109.486 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.33 -24.02 61.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.61 27.3 3.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.571 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 6.6 t-105 -76.83 -42.45 40.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.41 7.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.0 p -141.08 -58.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -117.28 50.55 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.331 -0.856 . . . . 0.0 109.601 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -30.09 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -38.14 82.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.44 -55.7 8.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -48.84 -43.29 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 57' ' ' LEU . 5.4 mt -45.78 -49.36 15.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' ALA . . . -56.17 -58.79 12.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . . . -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -1.129 . . . . 0.0 109.649 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.91 -53.84 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.24 -53.05 23.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.34 -33.14 73.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.554 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 68' ' ' LYS . . . -71.23 -21.67 62.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -71.73 -3.05 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.762 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' ARG . 0.5 OUTLIER -124.99 18.23 8.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.4 m -143.94 45.54 1.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.707 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' SER . 2.8 t 78.21 -3.59 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 109.723 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 50.34 60.01 15.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.301 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.4 Cg_endo -82.1 53.14 4.43 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.57 2.18 . . . . 0.0 109.764 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.98 117.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.265 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.9 mt -110.91 131.44 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 92' ' ' VAL . 55.1 m -96.93 129.82 44.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.25 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.72 116.84 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -46.51 154.57 0.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.69 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.11 161.64 29.31 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.751 2.3 . . . . 0.0 110.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.98 -23.75 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.17 37.08 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.02 -32.52 12.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.44 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.57 -143.24 0.14 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.295 -0.878 . . . . 0.0 109.076 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -148.28 140.48 24.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.905 . . . . 0.0 109.424 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.731 HG12 ' HD2' ' A' ' 82' ' ' PRO . 1.5 t -69.97 142.15 90.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.276 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.731 ' HD2' HG12 ' A' ' 81' ' ' VAL . 35.7 Cg_endo -79.33 173.0 13.81 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.524 2.149 . . . . 0.0 110.486 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.6 Cg_endo -80.23 19.35 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 111.065 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.76 -8.66 23.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.867 -1.146 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.505 HD22 ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -100.4 -49.41 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.01 . . . . 0.0 109.56 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -20.98 5.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.98 26.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 0.0 109.385 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -102.59 144.94 30.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -99.19 -29.45 12.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.235 -0.915 . . . . 0.0 109.231 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.21 155.32 36.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.581 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.1 m -142.24 130.55 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 28.2 m -134.37 -171.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.76 -146.9 5.35 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.463 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 83.7 m95 -89.64 69.87 7.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -1.127 . . . . 0.0 109.495 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 95' ' ' TRP . 6.6 m-20 -141.62 149.21 53.04 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 -38.65 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.681 2.254 . . . . 0.0 110.357 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -74.11 -41.4 61.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.863 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 1.2 m -56.88 -59.55 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 109.529 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.8 mt -51.81 -30.85 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 0.0 109.611 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -69.46 -37.95 77.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.13 -43.4 92.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.23 62.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 104' ' ' LEU . 18.6 tp -74.26 -62.01 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 109.577 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.82 -16.96 7.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -68.73 -38.72 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.13 -27.2 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -66.36 -71.2 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.295 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -57.83 97.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.606 ' O ' HG22 ' A' ' 110' ' ' VAL . 12.5 p -99.7 11.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.601 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.413 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 2' ' ' THR . 29.4 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.307 0.575 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 44.33 71.67 0.24 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.73 27.02 4.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 1.8 mt-10 63.33 171.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 104' ' ' LEU . 13.2 mt -138.47 140.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.53 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 2.8 mpp_? -94.08 97.6 10.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 43' ' ' ILE . 1.5 mp -107.29 157.23 18.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.43 119.85 31.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.367 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' THR . 20.5 mt -111.54 132.6 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.35 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.99 156.8 44.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.11 -175.41 42.54 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.25 39.25 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -1.085 . . . . 0.0 109.182 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -115.43 -171.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.48 -10.25 57.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -76.51 -74.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.665 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.792 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.2 t80 -50.82 -26.15 5.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 109.635 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -72.28 -68.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.571 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 15' ' ' GLU . 98.8 t -43.34 -44.94 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.813 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CE2' HD12 ' A' ' 24' ' ' LEU . 66.1 t80 -60.52 -44.62 95.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.689 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -57.95 -41.16 82.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.72 -45.62 93.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -17.84 63.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.845 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -72.55 -56.34 5.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 109.506 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.34 -42.24 88.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.61 -20.57 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.6 m -69.73 -61.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.583 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.97 -153.23 19.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.62 159.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 2.6 mp0 -113.1 95.73 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.722 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.845 ' CZ2' HD22 ' A' ' 24' ' ' LEU . 31.0 p-90 -112.18 169.3 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.3 162.79 38.2 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.859 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 119.48 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.642 2.228 . . . . 0.0 110.273 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB2' ' CG ' ' A' ' 6' ' ' ARG . . . -106.37 -177.55 3.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.41 173.26 5.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -78.18 -6.47 15.73 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.607 2.204 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.18 -0.94 16.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.509 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.45 56.04 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -112.85 119.06 36.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 4.9 t70 -49.94 -41.74 47.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -145.7 154.55 42.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 109.19 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 7' ' ' LEU . 84.1 mt -92.74 94.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.33 130.68 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.864 . . . . 0.0 109.51 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.921 ' HB3' HD23 ' A' ' 48' ' ' LEU . 2.0 mm? -88.49 116.39 26.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -57.45 -22.19 41.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' HD22 ' A' ' 48' ' ' LEU . . . -89.28 34.8 3.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.921 HD23 ' HB3' ' A' ' 45' ' ' LEU . 2.2 mm? -121.08 -27.4 4.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -1.131 . . . . 0.0 109.765 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.9 p90 -65.31 -21.51 66.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.3 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.562 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -58.61 -18.44 37.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 p -110.08 -39.08 5.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -141.61 57.24 1.51 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' CG ' ' HB2' ' A' ' 49' ' ' TRP . 4.0 ttt180 -53.73 -22.07 8.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.385 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.94 -42.34 60.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -66.75 -47.9 70.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 49' ' ' TRP . 1.8 mp -60.69 -37.29 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.95 -54.61 44.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.13 64.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.64 74.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.244 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.55 -33.99 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -59.92 -52.4 65.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.31 -30.67 71.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.393 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.855 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -72.18 -20.23 61.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -10.13 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.358 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 66' ' ' SER . 11.4 tttp -68.05 -9.23 44.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 14.9 t 68.27 45.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.627 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -110.77 -37.41 5.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -127.25 155.62 76.02 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.092 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.445 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 35.0 Cg_endo -77.3 122.86 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.509 2.139 . . . . 0.0 110.547 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 63' ' ' ALA . 69.0 mt -91.92 127.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 93' ' ' VAL . 3.7 mp -124.09 113.9 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.336 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD23 ' A' ' 85' ' ' LEU . 19.0 p -96.01 121.53 37.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.478 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.939 HG22 ' HB ' ' A' ' 93' ' ' VAL . 92.3 t -98.91 121.48 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' CZ2' ' A' ' 95' ' ' TRP . 12.0 mmt180 -43.14 151.98 0.4 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.27 151.88 26.8 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.654 2.236 . . . . 0.0 110.525 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -49.22 -49.87 40.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.59 111.59 0.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -167.3 -46.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.362 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.86 -143.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.033 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.27 115.82 15.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 74' ' ' ARG . 78.9 t -50.24 134.27 23.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.26 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.7 Cg_endo -77.95 148.25 24.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.453 2.102 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.1 Cg_endo -77.62 -4.09 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.642 2.228 . . . . 0.0 110.47 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.63 -42.91 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 72' ' ' THR . 0.4 OUTLIER -67.71 -31.15 70.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.466 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.38 -0.59 42.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.28 28.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.125 -0.984 . . . . 0.0 109.646 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.85 -0.25 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 m -72.71 128.84 36.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 109.302 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.6 m -89.07 -18.85 26.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.57 142.94 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.863 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.41 115.26 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.014 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.939 ' HB ' HG22 ' A' ' 73' ' ' VAL . 86.6 t -88.95 149.94 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.834 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.29 -145.66 15.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.463 ' CZ2' ' O ' ' A' ' 74' ' ' ARG . 67.7 m95 -114.09 57.95 0.69 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 109.584 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -130.93 168.94 15.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.32 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.641 2.227 . . . . 0.0 110.636 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -10.27 56.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -62.68 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mt -51.07 -22.92 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -46.32 41.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 105' ' ' GLU . 72.9 m-20 -63.49 -12.86 35.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . . . -69.31 -60.89 2.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -68.22 -25.48 65.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.2 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.66 -47.35 67.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -22.63 61.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.293 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -19.62 61.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.503 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -85.81 -23.32 27.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.461 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.3 p30 -118.33 141.17 48.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.42 -14.85 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.474 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.499 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 1' ' ' VAL . 98.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.292 0.568 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 -4.02 53.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -134.75 128.02 32.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER 75.65 119.59 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.402 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -143.49 149.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.1 126.91 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -134.96 159.41 41.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -112.75 97.52 6.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 17' ' ' TYR . 44.9 mt -94.94 124.05 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.512 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.59 128.55 29.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 142.46 58.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -0.997 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.69 170.38 32.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.75 57.73 1.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' ARG . 1.6 m -142.85 -176.45 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.63 -11.8 60.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -76.84 -55.24 5.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.671 ' CE1' HG21 ' A' ' 9' ' ' ILE . 3.2 t80 -67.7 -22.38 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.478 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 1.5 mpt_? -73.82 -55.41 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.39 -36.24 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -64.17 -52.78 57.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.75 -22.61 64.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -76.54 -39.12 53.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.9 65.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -49.32 65.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.95 -20.69 61.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 109.978 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.91 -39.83 95.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 109.658 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 p -49.92 -49.52 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.56 60.23 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.83 154.91 49.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 9.1 tp10 -91.73 59.6 3.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -86.4 160.79 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -151.97 154.49 32.73 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.65 153.95 26.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.683 2.255 . . . . 0.0 110.376 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.23 171.24 17.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.9 168.34 4.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.82 -9.25 16.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.634 2.223 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 -21.92 25.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 50.87 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.13 103.94 13.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -50.67 -46.73 58.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.315 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -122.25 137.72 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 70' ' ' ILE . 17.8 t -104.71 140.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -137.6 121.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 119.38 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 45' ' ' LEU . 5.7 mt -85.14 125.13 32.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.52 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.04 35.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.51 90.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 45' ' ' LEU . 2.4 mt -120.21 24.02 10.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -1.148 . . . . 0.0 109.438 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 1.5 t90 -81.18 4.72 19.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.97 -4.11 29.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -124.9 -38.8 2.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.126 -1.22 . . . . 0.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HG2' ' CB ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -114.11 72.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -74.43 -65.19 0.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.22 -19.1 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -77.24 -41.71 40.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.692 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 49' ' ' TRP . 45.4 mt -73.18 -35.46 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.19 -32.69 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -46.22 46.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.8 -54.35 47.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -1.124 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.71 -28.37 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 109.438 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -46.94 82.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.04 -32.87 72.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -74.62 -19.05 60.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.299 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -10.3 32.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' SER . 10.1 tptm -61.0 -14.08 20.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 5.6 t 73.7 68.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 p -154.06 -39.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -106.86 153.41 40.83 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -78.28 119.18 4.51 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.715 2.277 . . . . 0.0 110.356 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 63' ' ' ALA . 23.5 mt -94.13 122.64 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 mt -115.64 117.58 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 86.2 m -83.34 146.08 28.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 45' ' ' LEU . 43.3 t -120.2 114.96 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 59.5 mtt180 -55.72 146.63 45.41 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 36.1 Cg_endo -78.49 165.92 24.65 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.662 2.241 . . . . 0.0 110.49 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.431 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -79.33 -26.02 42.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 78' ' ' LEU . . . -89.2 -13.83 61.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 29.4 tp 61.29 90.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 17.18 21.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 81' ' ' VAL . 10.8 m-80 56.34 82.91 0.1 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -44.52 147.21 1.07 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 170.51 19.16 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.517 2.145 . . . . 0.0 110.435 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 2.71 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.619 2.213 . . . . 0.0 110.518 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -83.06 -44.6 14.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -5.65 59.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.08 -12.78 49.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.42 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.14 13.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 98.81 12.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -30.2 67.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -155.26 127.61 7.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.84 128.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 72' ' ' THR . 7.3 p -128.29 145.29 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.649 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.09 -145.77 10.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -91.2 17.47 8.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -1.165 . . . . 0.0 109.394 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 99' ' ' CYS . 2.5 m-20 -65.27 153.21 90.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.71 -57.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -77.06 -20.37 55.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.315 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -71.3 -13.0 61.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.07 -1.019 . . . . 0.0 109.901 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 96' ' ' ASN . 17.6 mm -75.74 -38.21 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -77.17 -31.45 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.3 -26.97 63.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.5 -67.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 76.9 mt -53.1 -35.09 59.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.927 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.01 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.614 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -20.85 3.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 104' ' ' LEU . . . -77.3 -39.96 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 109.599 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mt -54.52 -49.25 70.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.706 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.32 69.19 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.603 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.6 p -69.96 120.91 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.446 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.48 168.03 10.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.3 61.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.955 . . . . 0.0 109.64 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -160.89 -172.36 3.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -145.42 143.06 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 40' ' ' ASP . 21.1 mtt85 -85.1 105.64 15.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.226 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 31' ' ' TRP . 8.0 mp -105.11 168.49 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.674 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 40.3 t80 -152.73 106.95 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.502 HD12 ' CD1' ' A' ' 21' ' ' LEU . 20.8 mt -102.67 135.79 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -51.68 136.4 27.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.161 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.477 ' O ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -58.78 131.75 51.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.504 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.892 ' HA2' HD21 ' A' ' 48' ' ' LEU . . . -120.91 146.6 17.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.85 17.1 17.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.12 -173.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.37 -11.2 38.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.5 m-20 -73.01 -32.36 65.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HE1' HD22 ' A' ' 21' ' ' LEU . 23.3 t80 -71.31 -29.73 65.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -75.29 -47.96 25.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.29 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 93.4 t -61.54 -40.61 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.382 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.671 ' CE2' HG11 ' A' ' 73' ' ' VAL . 3.0 t80 -64.53 -58.01 7.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 9' ' ' ILE . 3.9 tp -55.95 -22.58 27.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 19' ' ' VAL . 73.8 mt-10 -70.47 -55.13 9.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 26' ' ' GLN . 6.7 ttt85 -57.88 -32.7 67.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.06 -58.68 6.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.887 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -70.53 -19.09 62.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -60.54 -41.65 94.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.351 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 16.0 t 174.39 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.59 58.38 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.63 161.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.299 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 148.41 22.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 7' ' ' LEU . 67.5 p-90 -149.68 174.24 12.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -143.13 147.74 42.11 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.484 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.53 103.55 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.655 2.236 . . . . 0.0 110.348 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . -100.89 -169.61 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.93 168.2 24.52 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.5 Cg_endo -77.75 -8.37 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.615 2.21 . . . . 0.0 110.345 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.18 -6.97 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.21 53.98 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 8' ' ' TYR . . . -105.19 124.46 49.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.396 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 5' ' ' ILE . 12.6 t70 -52.02 -30.04 23.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -147.91 124.2 10.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.693 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -97.28 96.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.027 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CG2' ' A' ' 73' ' ' VAL . 76.7 mt -92.52 107.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.07 133.41 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.37 120.56 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.446 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -15.54 62.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -22.57 71.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' HA2' ' A' ' 12' ' ' GLY . 11.1 mp -89.28 13.69 12.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -1.18 . . . . 0.0 109.529 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.696 ' HZ3' HD13 ' A' ' 85' ' ' LEU . 4.8 t-105 -72.72 -30.33 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.64 27.28 21.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 48' ' ' LEU . 8.4 p -135.4 -39.02 0.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -1.179 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CB ' ' HB2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -141.47 71.69 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.298 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -52.9 -56.24 17.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -56.27 -38.47 71.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 109.614 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -56.65 -47.99 78.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.424 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 33.8 mm -62.06 -33.36 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 108.872 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 tp -73.75 -21.43 60.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.113 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.15 -54.95 4.98 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.51 89.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.173 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 70.2 t -58.44 -44.18 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.253 -0.904 . . . . 0.0 109.046 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -58.03 -40.57 81.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.37 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.3 mt -68.91 -28.25 66.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 70' ' ' ILE . . . -76.83 -28.18 55.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.407 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 40.3 mtp85 -75.92 0.1 19.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -84.02 -30.04 26.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.402 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.44 20.64 3.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.01 23.1 1.02 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.706 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -47.44 163.59 0.26 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 113.98 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.634 2.223 . . . . 0.0 110.603 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.688 HD11 ' HB1' ' A' ' 63' ' ' ALA . 2.1 mt -113.7 108.03 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.368 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 25.1 mt -96.36 124.83 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.689 HG21 HG11 ' A' ' 81' ' ' VAL . 21.9 m -89.77 156.13 18.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.671 HG11 ' CE2' ' A' ' 20' ' ' PHE . 3.4 t -123.89 121.76 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -50.71 150.41 5.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.51 178.13 8.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.499 2.133 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.3 -25.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.95 86.26 0.23 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.0 -82.89 0.48 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -136.82 17.61 3.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.98 -177.92 0.13 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.522 -0.736 . . . . 0.0 109.472 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 72' ' ' THR . 34.0 m -85.98 159.89 53.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 34.3 Cg_endo -77.72 174.36 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.658 2.238 . . . . 0.0 110.39 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 35.2 Cg_endo -77.43 -33.01 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.606 2.204 . . . . 0.0 110.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.31 -34.4 70.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.181 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.696 HD13 ' HZ3' ' A' ' 49' ' ' TRP . 1.7 tt -93.31 -20.03 20.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.98 -35.23 79.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.112 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.98 -11.82 61.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.227 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG11 HG13 ' A' ' 60' ' ' VAL . 2.2 t -111.56 7.8 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.1 t -105.59 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -44.09 74.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.467 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -146.95 154.56 41.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.3 p -117.68 119.15 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 100' ' ' ILE . 9.9 p -108.95 163.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 93' ' ' VAL . . . -125.53 -157.94 9.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 30.1 m95 -88.74 38.82 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 109.246 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.441 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -103.01 151.22 38.39 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.8 Cg_endo -78.39 -46.73 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.67 2.247 . . . . 0.0 110.327 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.14 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 96' ' ' ASN . 73.6 m -65.62 -54.2 31.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.823 HD13 HG21 ' A' ' 93' ' ' VAL . 31.5 mm -47.38 -24.51 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.46 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -52.65 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.614 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.48 -14.8 59.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.38 -48.16 24.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.786 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 5' ' ' ILE . 20.8 mt -77.3 -25.87 51.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -74.88 -21.81 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -37.69 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.603 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.32 -55.72 19.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.06 39.68 30.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 110' ' ' VAL . 7.2 t0 -111.64 103.97 12.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.641 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 109' ' ' ASP . 43.3 t 43.91 84.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 109.51 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.6 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.924 -1.036 . . . . 0.0 109.394 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 2' ' ' THR . 42.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.503 ' N ' HG12 ' A' ' 1' ' ' VAL . 47.0 m -78.88 79.95 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.487 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -101.36 -163.35 1.01 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 0.9 OUTLIER 74.75 123.17 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.441 HD12 ' CD1' ' A' ' 108' ' ' LEU . 3.3 tt -131.67 156.67 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG2' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -111.47 127.5 55.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.831 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.946 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -128.34 169.7 13.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.87 . . . . 0.0 109.212 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -128.78 102.47 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.626 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 HG21 ' HE1' ' A' ' 17' ' ' TYR . 15.6 mt -100.09 143.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -73.62 -170.34 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.589 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 1.3 pt-20 -135.15 109.04 8.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -121.0 173.14 15.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.6 tm-20 -115.63 28.3 8.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 109.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.12 158.22 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 109.679 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.3 -9.97 38.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.6 m-20 -72.39 -48.63 40.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.555 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HE1' HG21 ' A' ' 9' ' ' ILE . 11.6 t80 -65.12 -26.1 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -70.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.598 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.5 t -49.87 -31.96 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.479 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.985 ' CE1' HD13 ' A' ' 24' ' ' LEU . 31.6 t80 -68.02 -48.23 66.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -41.05 74.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.21 -33.74 76.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -15.69 59.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.985 HD13 ' CE1' ' A' ' 20' ' ' PHE . 1.7 tp -74.65 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 26' ' ' GLN . 2.4 pt-20 -59.9 -20.68 58.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -52.35 -41.03 62.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.287 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -26.9 60.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 102.21 -132.47 11.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER 62.75 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.124 . . . . 0.0 109.395 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 85.3 mt-10 -88.74 111.26 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.946 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.4 p-90 -120.04 156.64 30.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -137.69 159.95 66.92 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.4 Cg_endo -77.79 130.8 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.653 2.235 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -116.63 -165.92 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.708 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -101.99 175.16 2.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.548 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.7 Cg_endo -77.62 -19.36 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.566 2.177 . . . . 0.0 110.405 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -112.39 -6.55 14.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -138.54 49.1 1.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -104.95 133.13 50.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -34.01 76.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 109.322 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -149.68 123.84 9.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 21.7 t -79.9 156.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 109.849 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 71' ' ' ILE . 13.3 mt -147.05 102.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 108.98 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.97 HG11 HG23 ' A' ' 56' ' ' ILE . 2.2 t -112.97 137.34 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.748 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.9 mm? -84.12 131.47 34.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -76.59 -36.7 57.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.95 34.56 3.89 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD21 ' CA ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -125.41 -26.65 3.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.811 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.673 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.7 p90 -57.67 -18.56 21.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.018 -1.051 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.538 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -42.27 -29.9 0.72 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -47.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -88.63 47.95 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -45.06 85.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -67.33 -31.47 71.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.899 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.94 -59.42 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.97 HG23 HG11 ' A' ' 44' ' ' VAL . 3.0 mp -54.96 -57.79 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.24 -26.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.855 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.06 -68.16 1.73 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -37.0 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -1.12 . . . . 0.0 109.988 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 58.8 t -59.62 -60.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.58 -58.65 6.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.53 -27.15 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -70.93 -45.11 64.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -68.29 -7.59 32.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -57.37 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -79.69 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 p 179.01 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -87.04 154.72 55.19 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.434 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -77.9 116.87 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.701 2.268 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 95.6 mt -95.04 111.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.324 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 91' ' ' GLU . 35.5 mm -94.33 91.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.722 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.645 HG21 ' OG ' ' A' ' 89' ' ' SER . 7.6 p -88.06 128.86 35.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 45' ' ' LEU . 58.2 t -98.65 132.35 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.453 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -64.05 171.53 2.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 74' ' ' ARG . 34.8 Cg_endo -77.31 163.49 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.62 2.213 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.2 -15.64 63.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.9 46.54 0.77 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 7.21 3.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -1.092 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -151.68 -143.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.237 -0.914 . . . . 0.0 108.995 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -145.6 153.79 41.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 82' ' ' PRO . 97.5 t -104.6 134.87 19.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.9 Cg_endo -78.84 150.33 23.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.502 2.135 . . . . 0.0 110.328 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -78.12 -20.49 11.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.193 . . . . 0.0 110.467 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.27 -34.69 74.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.624 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.79 55.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.655 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -69.21 -18.75 63.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.01 -7.97 59.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.38 33.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -117.65 134.07 55.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -99.84 -31.59 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 71' ' ' ILE . 4.0 mt-10 -136.14 118.54 15.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.595 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.6 m -117.99 128.57 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.248 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 103' ' ' ALA . 2.8 m -123.93 165.28 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.71 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.72 -146.57 21.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.98 66.83 0.66 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -1.158 . . . . 0.0 109.586 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.661 ' O ' HD12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -138.44 152.57 71.47 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.31 -41.89 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.619 2.213 . . . . 0.0 110.554 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -76.93 -31.57 56.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.659 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -42.15 67.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ASN . 35.6 mt -59.22 -41.94 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.661 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -64.16 -42.09 96.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.725 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -31.09 63.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -0.86 . . . . 0.0 109.783 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . . . -74.21 -43.18 58.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.732 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.01 -33.55 73.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.675 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -51.94 -28.17 15.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.444 ' HB2' ' OE2' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -67.81 -49.83 60.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.877 . . . . 0.0 109.728 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.28 -43.24 67.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.651 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.2 tp -57.85 -44.64 86.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.03 117.13 21.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' O ' ' OXT' ' A' ' 111' ' ' ILE . 53.9 t -104.67 145.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.2 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 111' ' ' ILE . 9.9 tt . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 2' ' ' THR . 12.6 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 1' ' ' VAL . 1.3 t -155.02 105.31 2.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.51 115.75 3.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.54 146.75 31.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.6 mt -119.08 139.25 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -92.56 112.29 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 109.319 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.515 ' CD2' HD11 ' A' ' 43' ' ' ILE . 3.7 mp -120.76 153.45 36.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 15.5 t80 -123.94 108.95 12.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.74 142.12 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -47.91 145.92 2.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.445 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.04 125.83 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.0 179.57 37.27 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -117.57 -3.74 11.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 109.736 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -48.9 170.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 109.55 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -77.75 -19.12 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.515 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.01 -50.76 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.91 -28.17 69.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -58.32 5.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.27 -48.57 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.656 ' CZ ' HG21 ' A' ' 73' ' ' VAL . 1.8 t80 -53.37 -37.52 62.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -61.53 1.84 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.662 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -51.19 -23.81 3.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -51.09 19.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -73.35 -6.17 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.19 -64.12 1.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.66 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -66.62 -8.28 26.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.952 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -57.07 9.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.87 -27.54 6.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.87 152.08 32.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.149 . . . . 0.0 109.519 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -99.98 50.97 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.852 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 35.5 p-90 -80.11 158.47 26.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.905 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -144.06 157.43 57.34 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.98 131.74 11.24 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.15 172.25 10.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.923 . . . . 0.0 109.588 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.19 162.04 4.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.499 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.7 Cg_endo -78.67 2.15 8.43 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.787 2.325 . . . . 0.0 110.668 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.43 15.99 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 109.638 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.18 38.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.527 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 131.78 52.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.84 -37.31 60.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.317 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.48 128.89 22.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.99 110.49 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.515 HD11 ' CD2' ' A' ' 7' ' ' LEU . 97.0 mt -97.23 104.7 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.95 137.97 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.7 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.88 117.59 34.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.343 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -17.31 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.3 -16.99 37.12 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 48' ' ' LEU . 5.3 mp -118.84 40.64 3.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -1.221 . . . . 0.0 109.622 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.494 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 43.1 t-105 -81.49 -29.91 33.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.73 39.04 2.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -139.12 -50.52 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 56' ' ' ILE . 11.2 mtt180 -130.48 64.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -48.57 -22.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.05 -41.94 40.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 11.8 tt0 -69.31 -30.15 68.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.536 HD13 ' N ' ' A' ' 56' ' ' ILE . 4.3 mm -77.12 -63.74 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.885 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.91 75.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.957 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -31.59 81.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' GLU . . . -63.03 -62.02 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -1.187 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.78 -46.48 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.418 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.89 -39.26 65.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 1.0 OUTLIER -61.42 -47.18 86.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.211 -0.93 . . . . 0.0 109.265 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 70' ' ' ILE . . . -52.88 -49.19 66.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -26.23 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 15.3 21.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.991 . . . . 0.0 109.632 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' LEU . 43.8 m -143.69 -63.37 0.39 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.355 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 75.5 m -109.55 -91.71 0.45 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.208 -0.933 . . . . 0.0 109.022 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tttp 155.21 -47.19 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.831 -0.543 . . . . 0.0 110.237 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 68' ' ' LYS . 36.2 Cg_endo -78.2 119.16 4.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.092 1.861 . . . . 0.0 110.605 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 63' ' ' ALA . 2.7 mp -125.61 104.86 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 91' ' ' GLU . 4.0 mp -91.02 119.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.42 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.604 ' CG2' HG22 ' A' ' 92' ' ' VAL . 13.3 t -104.45 140.29 38.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 109.757 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.656 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 55.7 t -108.7 125.68 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.3 164.98 15.44 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 162.44 28.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.608 2.206 . . . . 0.0 110.144 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.93 -57.44 6.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.636 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.592 ' O ' HD22 ' A' ' 78' ' ' LEU . . . -179.3 85.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -148.0 -67.12 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -1.175 . . . . 0.0 109.517 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -115.54 -143.89 0.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.294 -0.879 . . . . 0.0 109.087 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.81 122.49 9.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 82' ' ' PRO . 53.7 t -52.2 137.26 38.8 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.4 Cg_endo -78.07 165.41 26.12 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.476 2.118 . . . . 0.0 110.557 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.96 5.27 5.45 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.697 2.265 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.29 -35.07 23.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.96 -7.82 44.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.52 -9.46 41.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.579 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.59 -5.35 35.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.63 -41.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -46.6 156.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 m -123.06 -6.61 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.883 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 71' ' ' ILE . 22.3 mt-10 -150.89 98.78 2.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 72' ' ' THR . 59.4 t -102.36 128.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.89 168.53 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.16 -146.84 15.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -95.1 34.48 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.603 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.4 m-80 -106.11 146.0 32.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.21 -32.63 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.67 2.247 . . . . 0.0 110.594 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.35 -41.28 76.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -28.06 61.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 96' ' ' ASN . 67.7 mt -74.87 -31.55 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.012 . . . . 0.0 109.646 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -44.36 69.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.63 -17.83 64.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.554 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -59.16 2.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -21.17 66.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.98 -45.47 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 -1.52 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 109.786 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.11 -32.98 56.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mp -83.45 -53.71 5.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.639 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.08 168.39 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 111' ' ' ILE . 6.6 p -116.94 -40.06 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.532 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.46 ' N ' HG13 ' A' ' 110' ' ' VAL . 27.9 pt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.505 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.433 HG23 ' OE2' ' A' ' 30' ' ' GLU . 13.8 t -107.31 -179.31 3.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.416 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.38 -8.92 13.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.47 172.82 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.774 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.797 HG23 HD23 ' A' ' 7' ' ' LEU . 4.0 tt -151.17 155.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.048 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -91.57 104.86 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.941 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.797 HD23 HG23 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -130.19 164.85 23.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.959 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -131.29 147.44 52.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.823 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.64 147.06 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.66 145.59 33.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.501 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.57 149.82 24.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.64 -155.93 14.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.23 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 17' ' ' TYR . 30.2 m -112.82 167.99 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.945 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -66.96 -25.62 66.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.548 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.63 -66.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.4 t80 -54.1 -26.77 28.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -69.86 -71.66 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.792 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 15' ' ' GLU . 26.1 t -42.11 -39.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 45' ' ' LEU . 22.9 t80 -59.82 -54.51 45.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.75 -28.72 50.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.784 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 63.2 mm-40 -72.75 -45.02 60.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.878 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -23.28 64.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 109.91 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -56.15 24.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -59.44 -21.39 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -49.75 -33.45 16.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER -45.63 -50.6 13.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 109.533 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.25 64.41 0.28 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 tp 61.65 82.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' OE2' HG23 ' A' ' 2' ' ' THR . 0.4 OUTLIER -160.44 27.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.12 -0.988 . . . . 0.0 109.567 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.79 ' HB2' HD21 ' A' ' 7' ' ' LEU . 44.9 p-90 -158.06 155.99 30.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.95 . . . . 0.0 109.657 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -151.68 148.2 21.49 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.406 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 32' ' ' ARG . 35.1 Cg_endo -77.72 119.55 4.84 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.596 2.198 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.35 -168.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.676 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -97.61 165.25 15.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 109.404 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.7 Cg_endo -76.91 -23.39 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.478 2.119 . . . . 0.0 110.169 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -2.96 53.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.294 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.34 61.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.82 127.28 54.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -77.21 -39.85 47.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -124.02 134.06 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.37 144.21 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' LEU . 9.2 mt -134.44 100.46 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.67 135.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 20' ' ' PHE . 1.1 mm? -92.2 136.01 33.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.568 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.35 9.47 28.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.36 -24.15 29.66 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 17' ' ' TYR . 1.4 mp -85.3 12.71 7.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -1.126 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.595 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 1.8 t-105 -68.43 -26.53 65.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.79 28.25 16.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -142.73 -64.84 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -1.094 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -120.41 57.37 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HG3' ' NE1' ' A' ' 49' ' ' TRP . 5.5 ttt180 -55.98 -35.24 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.39 -0.819 . . . . 0.0 109.727 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -52.18 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.696 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -50.25 -38.26 39.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 mt -71.85 -52.52 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.5 tp -47.11 -31.1 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.18 -48.77 57.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.02 -53.25 60.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -1.084 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.94 -40.24 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -36.39 82.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.679 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.13 -47.12 81.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -67.88 -25.8 65.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 0.7 19.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 65' ' ' LYS . 1.6 tppt? -62.47 -48.76 78.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -73.4 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.1 p -178.67 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.059 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.562 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 4.8 mtmt -79.67 154.13 75.94 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.93 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 36.3 Cg_endo -78.95 100.94 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.31 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -103.26 115.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 93' ' ' VAL . 1.6 mp -105.2 129.77 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' HD23 ' A' ' 85' ' ' LEU . 13.4 t -94.64 132.34 39.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.761 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.51 120.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.38 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -50.11 158.38 0.96 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.19 -164.25 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.72 2.28 . . . . 0.0 110.387 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -88.38 -62.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 109.222 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.8 61.57 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 -51.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.514 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.77 -143.82 0.34 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.299 -0.875 . . . . 0.0 109.104 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -140.76 148.7 41.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.652 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.54 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 15.2 t -74.45 140.68 75.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.339 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.0 Cg_endo -77.37 161.47 31.7 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.474 2.116 . . . . 0.0 110.539 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.03 7.37 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.782 2.321 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -92.14 -44.66 8.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.697 HD23 ' OG1' ' A' ' 72' ' ' THR . 3.5 tp -69.37 -19.73 63.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.686 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 39.2 tt0 -84.99 -9.51 57.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 -1.47 25.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.694 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.06 -25.76 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.661 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 2.4 m -81.02 135.82 35.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.502 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -76.69 -23.82 53.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -150.6 167.11 28.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.47 112.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.656 HG13 ' SG ' ' A' ' 99' ' ' CYS . 2.6 t -96.31 151.38 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.07 -151.3 27.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -100.63 29.21 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -1.172 . . . . 0.0 109.38 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.61 159.95 27.67 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.4 -0.813 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.57 -53.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.65 2.234 . . . . 0.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -56.01 -30.94 62.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.656 ' SG ' HG13 ' A' ' 93' ' ' VAL . 2.7 t -68.27 -44.02 76.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.824 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.81 -32.62 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.881 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -60.25 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.623 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -45.61 82.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.691 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -60.82 -27.3 67.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.47 -45.6 58.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.295 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -17.77 61.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.264 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.51 -36.83 79.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.34 -42.99 42.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.85 -50.89 24.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 110' ' ' VAL . 25.1 t0 -94.94 136.76 34.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.382 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.462 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 47.7 t -132.24 100.02 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.365 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.412 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.9 OUTLIER -96.52 -80.42 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.463 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 2' ' ' THR . . . 71.91 11.18 6.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.22 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 -174.77 4.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.9 mt -134.24 137.88 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -99.01 105.1 17.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.465 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -121.82 171.04 9.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.403 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.7 t80 -143.2 106.08 4.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.938 HG12 HD12 ' A' ' 43' ' ' ILE . 2.9 mt -104.61 135.83 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.41 167.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 109.141 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.38 102.4 5.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.16 -145.87 6.97 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -138.89 54.1 1.75 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.207 -1.173 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.759 HG21 ' HB3' ' A' ' 48' ' ' LEU . 3.5 t -118.22 157.45 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.394 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 tt0 -77.93 -11.9 59.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' OD1' HD11 ' A' ' 45' ' ' LEU . 1.5 t70 -69.62 -59.39 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' OH ' HD12 ' A' ' 21' ' ' LEU . 12.3 t80 -60.52 -33.28 72.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -64.42 -41.96 96.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 109.832 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 15' ' ' GLU . 79.3 t -66.66 -50.55 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -51.03 -52.06 46.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.1 tt -67.41 -26.1 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.52 -49.19 72.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.703 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.53 -26.13 59.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.528 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -76.69 -15.0 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.638 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.16 -57.19 4.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -72.34 -10.25 59.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.1 t -47.02 -46.1 21.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.386 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 121.67 -179.82 16.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER 61.6 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -1.126 . . . . 0.0 109.519 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.83 158.49 15.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.234 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -158.19 155.06 28.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.56 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -145.97 155.0 51.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.534 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 36.1 Cg_endo -78.29 133.71 12.22 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.639 2.226 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' THR . . . -125.29 154.01 42.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -44.1 162.27 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.528 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.96 -31.06 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.634 2.222 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -31.85 69.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -120.17 27.93 8.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.59 107.48 5.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 47.4 t0 -53.89 -37.34 63.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -131.73 129.95 41.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.19 110.78 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 9' ' ' ILE . 8.0 mt -104.48 100.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.293 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.604 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -96.3 130.7 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.663 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -84.89 135.94 33.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 72' ' ' THR . . . -100.95 25.63 7.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.965 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -110.76 -35.78 1.98 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 14' ' ' VAL . 3.8 pp -119.43 15.43 12.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -1.207 . . . . 0.0 109.625 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.607 ' CZ3' ' CD1' ' A' ' 85' ' ' LEU . 2.8 p-90 -76.65 -21.58 55.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.53 -13.38 55.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -98.86 -41.53 7.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -1.101 . . . . 0.0 109.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' ILE . 7.1 mtt180 -108.45 50.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.269 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NE ' ' CZ3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -71.22 -33.43 69.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.03 -51.17 70.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 56' ' ' ILE . 20.7 mt-10 -68.42 -58.33 4.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.604 HD12 ' CG1' ' A' ' 44' ' ' VAL . 34.0 mm -43.52 -26.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.747 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -59.77 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.665 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.37 -30.17 24.97 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -57.71 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -49.98 -45.25 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.57 -48.62 74.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 62' ' ' LEU . 6.8 mt -55.02 -32.45 61.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -66.93 -21.44 65.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.99 -27.34 16.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.46 ' OG ' ' HD3' ' A' ' 68' ' ' LYS . 47.6 t -109.33 15.98 22.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.9 p 45.26 40.23 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -83.26 152.52 64.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.508 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 35.5 Cg_endo -78.19 117.86 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.681 2.254 . . . . 0.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.471 HD11 ' CB ' ' A' ' 63' ' ' ALA . 2.6 mt -107.81 90.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.514 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.552 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 3.0 mt -93.06 128.2 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.261 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 46' ' ' ALA . 52.0 m -102.07 131.32 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.75 124.4 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -49.33 153.24 1.84 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.44 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 34.8 Cg_endo -77.43 -158.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.609 2.206 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' ' CZ2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -117.68 14.99 14.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.679 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.47 6.23 5.74 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -95.37 68.51 3.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -1.179 . . . . 0.0 109.416 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 5.5 tp10 67.27 137.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.886 0.851 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -78.53 -164.16 0.54 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.309 0.575 . . . . 0.0 109.568 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 81' ' ' VAL . 3.6 m -91.22 150.8 42.18 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.05 173.12 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.644 2.229 . . . . 0.0 110.404 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.9 Cg_endo -77.8 -5.46 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 110.31 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -83.36 -49.37 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.607 ' CD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -69.11 -27.38 65.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.54 -12.13 56.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.358 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.7 -12.28 20.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 85' ' ' LEU . 7.3 m -123.84 8.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.385 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 p -94.66 131.17 40.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -76.31 -38.58 55.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.11 173.44 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.799 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.54 155.74 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.401 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 3.1 t -123.57 146.25 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.28 -162.44 17.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' CD2' ' A' ' 76' ' ' TYR . 74.2 m95 -98.45 19.38 14.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.18 156.36 54.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.238 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.47 -34.62 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.586 2.19 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -20.67 55.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.593 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -10.14 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.943 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 24' ' ' LEU . 28.2 mm -76.39 -64.27 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -32.26 69.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.47 -35.77 72.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.89 60.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.977 . . . . 0.0 109.853 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.73 -23.42 58.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 109.734 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.84 -22.61 63.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.17 -44.68 79.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.89 -18.91 64.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 15.71 27.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.389 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -146.32 111.44 5.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 0.0 109.713 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 96.5 t -109.07 -26.77 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 110' ' ' VAL . 15.0 tt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 1' ' ' VAL . 23.6 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.84 48.32 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -101.53 144.72 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 5.2 mt-10 74.3 170.95 0.29 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.65 164.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -117.39 119.82 36.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.639 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 1.3 pp -135.52 169.66 17.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.85 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -142.28 114.11 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.817 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 43' ' ' ILE . 11.8 mt -94.44 148.84 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.205 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.91 155.14 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.43 156.96 16.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.6 -164.52 34.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -155.38 65.58 0.62 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -1.149 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.99 -170.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 19' ' ' VAL . 18.4 tt0 -89.53 -22.74 22.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.423 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -70.65 -52.64 19.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.79 ' CE1' HD23 ' A' ' 21' ' ' LEU . 14.1 t80 -65.75 -19.66 65.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -54.52 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 15' ' ' GLU . 6.5 t -63.74 -36.35 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -65.82 -61.14 2.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.79 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -54.15 -27.16 31.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.91 -36.39 64.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -22.05 54.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -43.88 74.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.63 -14.7 62.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -51.5 51.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.331 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 p -63.33 -47.65 81.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 114.52 -109.94 2.26 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 55.58 169.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.419 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 4.7 mt-10 -120.3 130.11 54.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' ' CE3' ' A' ' 31' ' ' TRP . 25.9 p-90 -160.04 148.46 17.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.512 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -133.07 156.99 79.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.448 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.4 Cg_endo -77.63 129.92 10.38 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.65 2.233 . . . . 0.0 110.323 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -121.65 149.81 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -46.6 160.05 0.33 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.354 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -77.99 0.29 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.656 2.238 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.93 -27.42 12.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -130.44 36.1 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.92 116.4 22.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -36.53 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.937 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -136.3 139.23 42.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.695 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -113.84 149.03 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.324 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HG12 ' A' ' 9' ' ' ILE . 4.1 mt -136.98 129.84 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 56' ' ' ILE . 1.3 t -118.83 129.79 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.8 mm? -92.62 128.33 38.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' ' 81' ' ' VAL . . . -87.46 -0.76 57.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 109.585 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.01 -13.25 61.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.52 46.28 2.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.221 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.782 ' CZ3' HD22 ' A' ' 85' ' ' LEU . 44.9 t-105 -77.67 -16.89 58.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.797 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.23 19.47 29.52 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -132.75 -62.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -1.205 . . . . 0.0 109.701 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.1 36.09 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -59.33 -40.09 85.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.32 -39.34 66.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.658 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -73.1 -45.33 57.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.904 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.9 mt -59.93 -24.68 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.684 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.5 -55.77 8.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 109.507 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.06 65.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.71 24.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -1.173 . . . . 0.0 109.431 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 56' ' ' ILE . 51.4 t -56.01 -37.76 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 62' ' ' LEU . 12.9 mt -63.97 -31.54 72.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.246 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.11 57.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -69.27 -9.04 51.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.1 tttm -61.38 -15.61 38.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' SER . 22.2 m -152.88 -75.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 169.56 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.86 . . . . 0.0 109.342 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.34 155.91 57.02 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.9 Cg_endo -78.36 114.11 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.631 2.221 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mt -103.01 117.35 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.438 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 mt -110.94 114.78 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 92' ' ' VAL . 8.5 t -85.61 154.86 21.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.301 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.719 ' HB ' HD13 ' A' ' 45' ' ' LEU . 47.3 t -124.37 129.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.17 -0.956 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.21 155.2 18.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.567 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 176.58 9.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.709 2.273 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 77' ' ' GLY . 6.4 t80 -70.75 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 76' ' ' TYR . . . -132.97 96.36 0.3 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' GLU . 2.4 tt 179.27 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -1.176 . . . . 0.0 109.289 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 78' ' ' LEU . 9.9 mt-10 61.02 126.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -179.53 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.812 HG22 ' HB1' ' A' ' 46' ' ' ALA . 80.2 t -104.82 130.75 22.63 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 34.9 Cg_endo -77.88 168.92 21.46 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.403 2.069 . . . . 0.0 110.38 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 -10.3 15.53 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.656 2.237 . . . . 0.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.7 tt0 -81.88 -2.86 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.782 HD22 ' CZ3' ' A' ' 49' ' ' TRP . 40.7 tp -112.86 -15.99 12.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.17 -0.956 . . . . 0.0 109.204 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -82.63 -12.07 57.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.18 -36.42 9.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.772 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -79.91 -24.61 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 109.715 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' SER . 2.0 p -68.17 94.18 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.427 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' SER . 50.6 m -43.69 -33.64 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.65 157.83 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.375 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 HG23 ' A' ' 72' ' ' THR . 14.8 p -126.31 145.57 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 103' ' ' ALA . 85.4 t -129.22 147.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 109.568 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.29 -151.15 18.8 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -97.99 43.88 1.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -1.21 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -106.06 150.76 39.7 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.89 . . . . 0.0 109.703 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 34.8 Cg_endo -78.11 -48.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.727 2.285 . . . . 0.0 110.332 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.61 -31.98 63.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 5.3 m -60.68 -18.89 56.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.563 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 96' ' ' ASN . 21.3 mm -70.91 -36.47 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.5 -51.52 12.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.58 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -53.0 -27.08 17.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.657 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -77.1 -55.82 5.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.774 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -54.46 -24.32 19.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.67 -42.22 61.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 102' ' ' ASP . 8.7 m-20 -50.13 -23.44 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.55 80.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.637 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.53 24.63 12.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.7 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.61 167.17 29.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 110' ' ' VAL . 53.4 t -144.42 78.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.331 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 111' ' ' ILE . 14.9 pt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.426 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.565 ' C ' HG22 ' A' ' 2' ' ' THR . 18.2 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.565 HG22 ' C ' ' A' ' 1' ' ' VAL . 0.1 OUTLIER 167.19 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.297 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.02 118.99 4.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.3 155.7 38.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.543 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 7' ' ' LEU . 9.0 pt -129.09 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -112.96 109.95 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.258 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 104' ' ' LEU . 1.4 mp -118.4 171.5 8.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.761 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.3 95.41 2.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.0 109.192 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.794 HG13 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -79.79 132.68 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.65 140.04 19.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 109.547 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -56.41 131.24 47.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.29 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -142.46 153.65 24.62 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.5 22.81 5.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -1.12 . . . . 0.0 109.275 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.68 156.2 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -59.35 -19.29 45.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.375 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.81 -66.13 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 9' ' ' ILE . 10.7 t80 -46.33 -31.28 2.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.269 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -52.08 51.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 77.6 t -57.69 -32.37 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.18 -35.76 76.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -52.95 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.617 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.51 -24.72 65.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -74.16 -31.22 62.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.704 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -35.38 65.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.716 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.03 -46.73 73.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -19.76 63.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.498 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -68.31 -28.96 67.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 97.94 -173.5 28.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 75.39 136.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 109.517 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' H ' HD13 ' A' ' 29' ' ' LEU . 1.2 mt-10 -92.38 93.15 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -97.15 169.34 9.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.0 mtp180 -151.95 152.77 30.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.7 Cg_endo -78.54 139.19 15.98 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.687 2.258 . . . . 0.0 110.525 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -125.91 145.09 50.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.474 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -51.44 172.42 0.15 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.99 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.724 2.283 . . . . 0.0 110.671 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -103.9 -52.86 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.109 -0.995 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -100.29 37.09 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.74 124.81 26.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -70.68 -36.27 73.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.517 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -149.2 121.6 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.03 136.48 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.794 HD12 HG13 ' A' ' 9' ' ' ILE . 21.8 mt -116.33 88.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.78 126.8 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -96.67 125.27 41.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.09 54.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.391 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.95 -19.53 69.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -95.64 20.39 9.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.286 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 14.9 t-105 -69.91 -15.42 63.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.86 34.94 5.24 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -148.78 -52.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -1.165 . . . . 0.0 109.584 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 55' ' ' GLU . 10.7 mtt-85 -130.67 63.58 1.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -42.07 74.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.242 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -73.13 -35.69 66.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.35 -0.844 . . . . 0.0 109.319 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -65.39 -32.78 74.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.328 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 52' ' ' ARG . 31.5 mt -76.11 -51.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -47.51 -35.85 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -50.16 54.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 -34.55 58.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 109.297 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.81 -52.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.843 . . . . 0.0 109.276 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.74 -39.14 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.5 mt -70.29 -34.01 72.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.09 -54.85 42.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -70.88 -14.03 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.79 -29.33 3.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.89 -79.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -178.5 65.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.0 149.14 37.23 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 34.7 Cg_endo -77.6 127.09 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.569 2.179 . . . . 0.0 110.162 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' SER . 53.5 mt -103.68 118.73 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.6 HD12 ' HB1' ' A' ' 103' ' ' ALA . 44.5 mm -108.53 119.42 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.001 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 93' ' ' VAL . 10.8 m -92.88 143.37 26.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.893 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' ARG . 41.0 t -121.74 115.26 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -43.12 155.3 0.28 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 158.57 32.17 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.671 2.247 . . . . 0.0 110.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -109.16 18.06 20.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.45 13.52 62.79 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 52.09 48.47 22.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.407 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 -143.38 0.35 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.313 -0.867 . . . . 0.0 109.125 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -142.19 108.64 5.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.899 HG11 ' OE2' ' A' ' 86' ' ' GLU . 14.1 p -50.49 140.85 17.71 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.91 . . . . 0.0 109.241 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 81' ' ' VAL . 35.3 Cg_endo -77.73 156.46 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.468 2.112 . . . . 0.0 110.316 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.9 Cg_endo -78.25 71.06 6.91 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.639 2.226 . . . . 0.0 110.716 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.21 -42.66 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.073 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.61 -29.74 22.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.899 ' OE2' HG11 ' A' ' 81' ' ' VAL . 6.3 mp0 -72.2 -20.39 61.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.24 83.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.37 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 m -122.41 48.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -106.78 129.22 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.388 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 5.4 m -71.33 -34.24 70.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -157.13 142.9 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.36 100.34 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' THR . 4.4 m -95.08 144.54 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.85 -146.73 17.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -92.11 13.53 18.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -1.095 . . . . 0.0 109.535 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 3.0 m-20 -87.81 150.26 47.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.3 Cg_endo -77.82 -35.27 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.654 2.236 . . . . 0.0 110.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.93 -26.89 69.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 92.1 m -77.42 -25.04 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.77 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 100' ' ' ILE . 22.3 mm -66.97 -58.48 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.73 -33.36 75.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.95 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.741 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -69.77 -37.24 76.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 7' ' ' LEU . 14.4 mt -77.24 -22.41 52.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.718 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.08 91.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.3 98.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.15 60.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.296 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 mp -94.17 -7.67 41.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -67.3 0.78 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 14.4 m -100.28 -27.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 111' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 1' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 1' ' ' VAL . 0.2 OUTLIER -43.57 105.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.72 87.5 2.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -157.41 132.78 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 108' ' ' LEU . 62.4 mt -122.08 165.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.686 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.6 ' N ' HG22 ' A' ' 5' ' ' ILE . 66.8 mtt180 -127.86 120.0 26.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.063 HD13 HD12 ' A' ' 43' ' ' ILE . 1.5 pp -145.42 170.79 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.751 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -137.38 139.14 40.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.204 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 7' ' ' LEU . 3.8 mt -121.63 147.89 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -65.01 121.37 14.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.29 169.36 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.572 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.22 -166.27 36.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -146.03 36.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.88 163.21 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.148 -0.97 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.1 tp10 -68.77 -31.94 71.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.04 -38.41 79.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -64.11 -46.66 83.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.47 -26.03 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 15' ' ' GLU . 57.4 t -69.85 -55.23 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.577 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.477 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 9.6 t80 -55.99 -47.27 78.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.356 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.49 -37.79 70.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.03 82.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.25 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -72.69 -28.51 62.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -72.4 -29.63 63.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -41.26 61.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -17.93 9.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.4 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.12 -13.9 11.19 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.37 172.3 13.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -126.02 114.09 17.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -0.844 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -127.1 154.66 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -115.76 149.35 42.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.302 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.9 Cg_endo -78.13 142.56 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.563 2.175 . . . . 0.0 110.683 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 -166.53 1.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.887 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -80.14 165.28 47.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.48 -4.54 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.58 2.187 . . . . 0.0 110.38 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.89 -37.35 3.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.253 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.3 33.39 3.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.229 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -102.14 142.96 32.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -66.06 -34.76 78.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . . . -140.09 115.16 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 109.315 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.5 100.35 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.063 HD12 HD13 ' A' ' 7' ' ' LEU . 35.7 mt -92.26 99.83 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.249 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.723 HG11 HG23 ' A' ' 56' ' ' ILE . 20.2 t -90.19 135.14 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.62 124.62 34.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.426 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.06 -0.07 55.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.96 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.74 79.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 -81.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 109.493 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.55 ' CH2' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER 48.75 22.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.846 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.86 -79.41 0.69 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' HD2' ' A' ' 52' ' ' ARG . 9.5 t -87.97 -26.93 22.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.0 109.345 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -93.11 34.05 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -59.88 -43.84 94.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.271 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.41 -21.09 62.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.262 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -43.81 62.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -73.68 -58.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -20.76 66.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -73.93 -56.4 5.36 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.55 75.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -1.103 . . . . 0.0 109.335 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 70' ' ' ILE . 85.0 t -63.35 -45.17 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -57.68 -37.2 73.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -68.3 -39.59 82.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -76.3 -11.31 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -73.08 -19.27 61.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -74.24 -25.86 59.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 0.0 109.884 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.62 9.81 4.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.955 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 t 54.17 59.78 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.416 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 9.9 mttm -81.66 169.63 18.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 35.7 Cg_endo -78.27 106.52 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.767 2.311 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.423 HG21 HG22 ' A' ' 60' ' ' VAL . 4.0 mt -108.04 98.0 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.58 114.33 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.452 HG21 ' CD2' ' A' ' 85' ' ' LEU . 23.2 p -91.88 140.58 29.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.22 121.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.77 160.89 0.31 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 -175.93 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -42.58 90.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.63 44.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 -23.78 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.104 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.36 126.92 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 109.455 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.72 147.8 41.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.62 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.46 155.64 9.76 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 161.89 29.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.623 2.215 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 35.3 Cg_endo -77.58 -15.47 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.67 2.247 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -70.31 -27.54 64.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.55 HD13 ' CH2' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -86.34 -24.8 25.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 83' ' ' PRO . 4.0 mt-10 -58.21 -35.2 71.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.2 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.714 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 88' ' ' VAL . 18.9 m -89.46 4.0 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.747 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -101.64 143.57 31.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 t -107.37 -17.48 14.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.77 135.0 14.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.517 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.61 110.09 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 137.47 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.3 -144.11 12.45 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.96 63.65 1.19 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.243 -1.151 . . . . 0.0 109.477 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -138.55 143.15 37.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.95 -27.64 4.49 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.658 2.239 . . . . 0.0 110.628 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.13 -32.25 64.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.5 m -74.99 -47.35 29.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.26 -13.1 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -76.27 -55.96 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.986 . . . . 0.0 109.617 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -72.94 -24.88 60.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.49 73.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.596 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.74 -41.63 62.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -34.39 64.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.606 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.05 -16.83 34.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.481 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -66.91 -44.57 80.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.537 ' OD1' HG23 ' A' ' 111' ' ' ILE . 6.6 t70 -149.89 165.45 32.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 3.1 t -139.12 77.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.537 HG23 ' OD1' ' A' ' 109' ' ' ASP . 1.2 pt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.521 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.78 80.74 1.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 29' ' ' LEU . . . -118.14 66.44 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.402 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 5' ' ' ILE . 3.4 mt-10 -132.4 139.13 47.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.016 HG21 HD22 ' A' ' 104' ' ' LEU . 1.2 mp -131.66 153.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 20.7 mtt-85 -114.96 105.81 13.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.46 171.7 13.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.569 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -143.86 138.96 28.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.834 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 mt -120.85 133.82 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.353 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -58.35 111.89 1.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -52.44 135.37 33.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.86 ' HA3' HD21 ' A' ' 48' ' ' LEU . . . -136.84 148.78 19.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -77.9 -31.94 51.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 17' ' ' TYR . 25.1 m -43.36 137.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.506 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.3 pt-20 -64.51 -24.28 67.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.173 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' OD2' ' CG ' ' A' ' 76' ' ' TYR . 11.4 t70 -61.95 -31.06 71.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.102 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 11' ' ' GLU . 69.7 t80 -64.48 -42.75 95.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.42 91.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.258 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 15' ' ' GLU . 4.9 t -57.96 -56.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.185 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.429 ' HE2' HG21 ' A' ' 43' ' ' ILE . 16.3 t80 -51.14 -40.19 57.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.129 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.88 -58.14 8.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.548 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.69 -17.23 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -71.89 -55.82 6.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.568 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -56.83 -21.7 30.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.558 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -74.29 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.609 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.37 -1.92 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -43.53 73.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.08 -71.53 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.631 HD13 ' CZ ' ' A' ' 101' ' ' ARG . 0.7 OUTLIER -66.55 157.5 32.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -1.137 . . . . 0.0 109.513 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -88.96 121.05 30.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -93.37 158.77 15.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.641 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.65 146.2 52.11 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.383 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.71 129.21 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.525 2.15 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.69 164.96 12.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.715 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.437 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -73.95 171.86 9.93 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 36.4 Cg_endo -80.28 42.23 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.805 2.337 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -159.32 -62.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 109.635 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.33 27.98 1.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' ' CE ' ' A' ' 68' ' ' LYS . . . -64.22 132.47 50.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.87 . . . . 0.0 109.286 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -71.2 -33.84 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.26 23.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.34 110.32 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 20' ' ' PHE . 65.6 mt -93.63 94.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 70' ' ' ILE . 1.5 t -90.13 122.31 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 73' ' ' VAL . 4.1 mm? -81.81 121.52 26.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.287 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -71.22 -12.23 61.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.601 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.33 29.93 11.25 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.86 HD21 ' HA3' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -124.86 -19.1 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.925 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.797 ' CZ3' ' HB1' ' A' ' 46' ' ' ALA . 1.8 p90 -66.82 -21.79 66.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.032 -1.042 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -64.17 -15.52 58.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.72 -48.28 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -1.115 . . . . 0.0 109.274 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -129.37 63.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -23.33 6.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.2 -46.74 40.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -46.6 89.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.485 HD13 HG21 ' A' ' 10' ' ' THR . 50.3 mm -58.31 -54.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 tp -50.6 -30.4 13.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -49.2 42.6 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.01 -46.53 64.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -1.132 . . . . 0.0 108.846 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.54 -29.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.25 -0.906 . . . . 0.0 109.037 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 16.8 t70 -59.16 -44.78 92.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.43 -38.23 65.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.339 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.445 ' HB1' HG12 ' A' ' 70' ' ' ILE . . . -68.7 -14.44 63.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' ASP . 4.6 mmm180 -65.5 -14.69 61.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -64.2 -11.95 35.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.945 . . . . 0.0 109.499 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 71.44 39.16 0.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.64 -67.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 39' ' ' ALA . 2.3 mmtt -92.95 153.17 41.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 142.65 19.52 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.661 2.241 . . . . 0.0 110.443 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.445 HG12 ' HB1' ' A' ' 63' ' ' ALA . 1.9 mt -103.05 91.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 93' ' ' VAL . 3.0 mt -80.12 115.77 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -98.73 139.84 33.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.683 ' HB ' HD13 ' A' ' 45' ' ' LEU . 19.0 t -111.22 130.71 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 73' ' ' VAL . 9.0 mtt180 -43.75 157.57 0.27 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.557 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.48 145.56 23.7 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.675 2.25 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 16.1 t80 -66.98 -10.89 54.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.923 ' C ' HD12 ' A' ' 78' ' ' LEU . . . -68.45 -95.05 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.923 HD12 ' C ' ' A' ' 77' ' ' GLY . 6.0 mp -135.87 -92.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 3.4 pt-20 -159.31 -142.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.13 -0.982 . . . . 0.0 108.925 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 3.8 m-20 69.59 54.57 0.38 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.2 m -71.22 144.81 90.14 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.3 Cg_endo -78.09 146.78 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.548 2.166 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' GLU . 35.1 Cg_endo -77.75 -9.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.533 2.155 . . . . 0.0 110.229 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.26 -58.39 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.933 . . . . 0.0 109.394 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.0 tt -72.63 -9.58 58.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -78.59 -11.25 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.484 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.66 -20.86 56.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.789 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -113.99 6.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t -81.77 105.25 12.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -30.55 57.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.99 152.19 34.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 109.499 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.59 154.95 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 HG23 ' A' ' 71' ' ' ILE . 51.8 t -138.72 144.26 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -161.85 29.31 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -91.56 36.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -1.182 . . . . 0.0 109.503 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -113.27 155.84 43.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 100' ' ' ILE . 35.4 Cg_endo -77.92 -60.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.345 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -51.13 -23.88 3.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.77 -51.83 24.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 24' ' ' LEU . 5.2 mt -57.31 -62.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.631 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -43.71 -32.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.566 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.21 -60.16 4.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.541 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.016 HD22 HG21 ' A' ' 5' ' ' ILE . 17.0 mt -58.2 -56.36 23.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 0.0 109.636 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -73.17 -7.97 53.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.79 -24.66 52.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -16.88 64.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.631 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.37 -26.66 62.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.728 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.62 155.71 18.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.948 . . . . 0.0 109.643 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.05 121.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.537 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p -110.25 92.87 4.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.711 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.66 -80.32 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.89 172.04 13.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.947 . . . . 0.0 109.567 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.96 HG21 HD21 ' A' ' 104' ' ' LEU . 11.7 tt -150.01 124.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.0 109.329 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -91.76 129.12 37.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.628 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -147.96 169.61 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.4 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -124.88 143.08 51.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' A' ' 21' ' ' LEU . 3.3 mt -122.16 125.0 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.13 145.06 2.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.46 105.85 10.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.02 -146.06 7.22 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.23 47.16 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.21 150.17 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.41 -45.32 94.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.46 -24.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -75.99 -45.88 32.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 109.829 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -63.8 -35.38 80.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -71.78 -39.06 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.289 -0.882 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 76.5 t80 -67.07 -62.72 1.29 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' CD1' HD13 ' A' ' 9' ' ' ILE . 12.9 tp -54.23 -49.39 69.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.435 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 18' ' ' ARG . 91.9 mt-10 -53.67 -33.96 57.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -35.27 65.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -48.26 -32.3 7.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.816 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.68 -42.69 86.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 0.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -72.15 -4.28 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.515 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -80.8 -12.91 59.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 70.33 -155.15 52.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 1.6 mt 61.68 171.41 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.408 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.19 108.12 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -117.88 153.23 33.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.175 -0.953 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.1 mmt180 -138.4 146.28 50.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.287 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 Cg_endo -78.67 146.69 21.43 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.553 2.169 . . . . 0.0 110.405 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 -151.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.159 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.11 169.13 12.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 35.7 Cg_endo -77.85 71.12 6.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.596 2.198 . . . . 0.0 110.278 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 36' ' ' PRO . 2.0 mt-10 -173.66 -35.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.243 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.42 27.99 3.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.406 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.77 110.12 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -51.64 -47.51 63.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.685 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 7' ' ' LEU . . . -119.77 149.83 41.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.79 109.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 96.6 mt -90.83 118.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' A' ' 56' ' ' ILE . 6.5 t -102.97 126.35 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 48' ' ' LEU . 3.5 mm? -92.04 131.82 37.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.81 5.14 51.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.37 -20.7 71.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -110.6 38.15 2.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -1.097 . . . . 0.0 109.2 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 26.3 t-105 -80.96 -17.56 50.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.56 11.11 53.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -122.99 -59.47 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.181 . . . . 0.0 109.585 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.3 mpt_? -116.69 53.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -47.85 82.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.294 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.04 -41.23 59.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -0.867 . . . . 0.0 109.409 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -42.19 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.584 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 48' ' ' LEU . 25.2 mm -59.65 -62.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.65 -31.49 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.822 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.1 -61.92 4.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.49 -35.97 6.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -1.149 . . . . 0.0 109.768 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 80.9 t -67.96 -63.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 60' ' ' VAL . 21.0 t70 -43.14 -30.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.824 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.7 tp -76.92 -42.72 38.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.915 . . . . 0.0 109.595 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.02 -57.0 12.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -62.89 -13.58 35.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -46.82 -27.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -140.36 -71.1 0.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.88 33.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.509 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -71.24 147.02 92.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 35.6 Cg_endo -78.1 125.01 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.657 2.238 . . . . 0.0 110.589 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.94 124.27 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 71' ' ' ILE . 2.8 mm -92.71 107.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.318 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -81.6 109.1 15.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.704 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.2 106.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.478 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 18.6 ptt85 -48.86 161.98 0.39 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.496 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -78.02 -162.1 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.626 2.218 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 76' ' ' TYR . 9.0 t80 -108.14 15.33 24.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 17.86 47.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.2 mm? -93.06 -67.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -1.196 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -109.48 14.16 23.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' GLU . 1.3 m120 46.41 -173.62 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 ' HD2' ' A' ' 82' ' ' PRO . 14.9 p -126.28 138.32 32.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.346 -0.847 . . . . 0.0 109.057 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.9 Cg_endo -78.24 165.68 25.43 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.464 2.109 . . . . 0.0 110.437 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.19 4.72 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.57 2.18 . . . . 0.0 110.352 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.87 -10.45 59.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 -29.26 14.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -32.49 74.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.882 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 -16.61 62.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.322 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.0 m -144.75 52.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.37 130.26 52.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.537 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t -103.13 -38.68 7.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.35 140.68 49.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 93' ' ' VAL . 97.2 t -123.1 130.38 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.238 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.493 HG21 HG22 ' A' ' 71' ' ' ILE . 12.8 m -153.34 138.57 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.801 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.41 -145.74 16.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -86.81 -4.69 59.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -1.154 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -57.64 151.15 42.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.12 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.579 2.186 . . . . 0.0 110.551 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -56.2 -17.56 7.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -43.76 83.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.13 -24.13 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -74.32 -51.39 15.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 109.28 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.14 -35.99 76.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.96 -61.99 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.96 HD21 HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -45.75 -32.28 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.724 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.03 -43.18 68.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.94 -44.37 96.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.734 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.12 83.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -45.01 -39.73 5.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.617 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.31 167.3 10.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 110' ' ' VAL . 2.2 p 170.93 103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.352 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.423 ' OXT' HG13 ' A' ' 111' ' ' ILE . 18.2 pt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.86 154.94 33.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.315 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 4' ' ' GLU . . . -162.98 -67.21 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 56.9 mt-10 65.54 -176.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' A' ' 104' ' ' LEU . 14.9 mt -135.64 135.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 7.7 mpt_? -99.2 115.98 30.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.248 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -141.21 171.08 14.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.683 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -138.29 124.57 20.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.524 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG22 ' HE1' ' A' ' 17' ' ' TYR . 24.8 mt -114.29 139.19 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 m -63.06 134.78 56.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.77 164.84 13.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 169.62 40.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.29 47.6 1.69 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.221 -1.164 . . . . 0.0 109.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.79 172.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 pt-20 -68.39 -24.32 64.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.536 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.93 -55.28 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' HE1' HG22 ' A' ' 9' ' ' ILE . 13.5 t80 -51.57 -39.17 57.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -63.17 -42.26 99.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.594 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.0 t -61.47 -43.78 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.837 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.0 -47.72 83.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.558 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -65.68 -20.31 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' OE2' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -73.15 -55.6 6.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -58.04 -51.08 71.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.43 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -45.26 -44.04 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.92 -53.56 52.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.74 -19.2 5.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -65.6 -68.29 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.374 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.16 8.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.7 151.53 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -1.117 . . . . 0.0 109.521 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -99.59 106.15 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.799 ' HB2' HD21 ' A' ' 7' ' ' LEU . 67.5 p-90 -105.42 167.47 9.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -147.45 145.4 21.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.21 105.69 2.03 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.613 2.209 . . . . 0.0 110.444 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.85 -154.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.654 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 19.2 p -100.63 158.12 32.48 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 -3.3 13.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.588 2.192 . . . . 0.0 110.573 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.494 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 4.1 mt-10 -102.27 -17.59 15.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 109.314 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -144.16 36.53 1.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.376 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.86 125.11 30.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.647 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.7 t70 -50.87 -31.9 18.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.417 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.41 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.379 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 39' ' ' ALA . 1.6 t -91.94 107.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.28 102.28 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.31 132.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD22 ' HB ' ' A' ' 73' ' ' VAL . 1.1 mm? -103.13 135.85 44.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.282 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.51 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.44 61.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 mp -90.94 32.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 109.54 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.472 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 32.0 t-105 -62.56 -16.97 58.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.594 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.38 35.45 3.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -144.31 -67.42 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.35 52.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 109.619 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.27 -47.74 81.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.309 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.61 -22.93 48.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -77.16 -50.61 12.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.9 mt -62.41 -27.13 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.649 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.89 -32.68 67.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.28 -41.12 26.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.72 80.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -1.137 . . . . 0.0 109.854 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 56' ' ' ILE . 39.9 t -74.09 -34.89 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.9 -46.31 82.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 37' ' ' GLU . 62.2 mt -70.88 -41.88 70.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.003 . . . . 0.0 109.806 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -25.62 68.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.704 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -77.25 -20.2 55.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.76 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -79.71 -9.55 59.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' SER . 0.3 OUTLIER -125.67 3.52 7.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' SER . 17.9 m 60.62 38.38 18.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.9 mmpt? -71.28 161.36 78.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 0.0 109.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 34.2 Cg_endo -76.99 108.45 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.429 2.086 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 70' ' ' ILE . 15.2 mt -108.78 109.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.715 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.6 HG12 ' HB1' ' A' ' 103' ' ' ALA . 3.2 mt -97.83 117.2 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.258 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -80.54 147.65 30.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 45' ' ' LEU . 74.4 t -122.16 113.17 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.423 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -52.89 159.35 1.86 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 36.2 Cg_endo -77.82 166.64 25.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.733 2.289 . . . . 0.0 110.246 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -74.49 -59.1 2.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -149.64 15.83 1.08 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.075 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 32.3 tp -71.83 -78.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -1.228 . . . . 0.0 109.354 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 tt0 -147.51 -143.05 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.041 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' OD1' ' OE1' ' A' ' 79' ' ' GLU . 2.9 p30 -124.59 176.65 6.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.91 134.95 20.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.17 173.04 14.48 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.435 2.09 . . . . 0.0 110.519 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.8 Cg_endo -77.37 -1.53 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.576 2.184 . . . . 0.0 110.596 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -73.91 -70.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.306 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -16.22 54.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.51 -42.96 61.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.16 68.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.6 m -102.94 38.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -128.7 105.63 8.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.539 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 91' ' ' GLU . 1.5 m -56.52 -39.68 73.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 106' ' ' ASP . 13.1 mp0 -138.29 157.95 45.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.59 133.57 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.131 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 15.0 m -139.99 169.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.101 -0.999 . . . . 0.0 109.873 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 74' ' ' ARG . . . -106.45 -144.37 11.94 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -93.06 47.63 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -1.143 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -100.73 146.47 32.14 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -38.73 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.551 2.168 . . . . 0.0 110.317 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -23.26 56.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -73.58 -15.44 61.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.63 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.9 mm -73.37 -40.23 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -76.81 -34.66 57.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -31.87 70.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.674 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HG12 ' A' ' 71' ' ' ILE . . . -77.19 -44.96 28.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.02 -28.7 69.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.874 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 2.4 tp10 -66.06 -21.31 66.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.884 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD2' ' OE2' ' A' ' 91' ' ' GLU . 1.1 t70 -63.17 -30.31 71.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.59 41.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.573 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 1.9 tp -58.17 -52.37 65.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.347 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 4.0 m-20 60.94 -95.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 110' ' ' VAL . 2.8 m -77.54 162.37 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 109.379 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.582 -179.847 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' THR . 2.1 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.244 0.545 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 46.96 92.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.547 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.56 -56.55 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.9 . . . . 0.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 56.1 175.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' GLU . 7.5 tt -146.7 141.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.6 mtt-85 -97.64 104.38 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 41' ' ' ALA . 37.6 mt -113.35 157.73 21.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -134.88 92.12 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.742 HG21 ' CE1' ' A' ' 17' ' ' TYR . 2.7 mp -89.28 162.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.494 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.2 159.01 18.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.426 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.14 128.89 56.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.983 . . . . 0.0 109.61 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.21 -162.98 11.66 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -125.42 -4.67 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -1.147 . . . . 0.0 109.578 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 16' ' ' ASP . 18.1 m -83.74 -178.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 19' ' ' VAL . 13.3 pt-20 -92.2 -2.46 56.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.95 -69.54 0.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.509 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE1' HG21 ' A' ' 9' ' ' ILE . 5.0 t80 -48.64 -29.15 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.664 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -51.5 65.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.096 -1.002 . . . . 0.0 109.427 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 15' ' ' GLU . 20.0 t -62.67 -33.08 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.743 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -63.22 -57.95 8.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.65 -34.23 64.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.57 -40.03 95.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -40.52 74.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.929 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.83 71.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -34.69 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.672 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -68.96 -22.22 64.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -45.41 -45.99 13.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.475 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.04 -32.54 6.27 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.01 150.24 31.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -1.174 . . . . 0.0 109.533 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -87.91 151.5 22.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 109.453 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.435 ' C ' ' HG3' ' A' ' 32' ' ' ARG . 46.8 p-90 -153.43 160.84 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 24.2 mtt-85 -141.86 158.6 61.97 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.2 Cg_endo -78.18 95.47 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.677 2.251 . . . . 0.0 110.129 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -73.78 -176.77 2.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.681 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -87.2 173.55 6.45 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.257 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 62' ' ' LEU . 35.7 Cg_endo -78.23 -9.81 16.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.557 2.171 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -114.51 -6.48 12.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -139.38 48.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.255 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -101.83 127.61 48.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.658 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -67.41 -40.71 85.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -142.07 134.8 28.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.43 126.24 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' ILE . 2.5 mt -109.48 93.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.202 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.77 115.07 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.575 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 43' ' ' ILE . 13.6 mt -85.59 127.15 34.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.94 -0.47 35.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.35 -15.52 70.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -105.87 29.41 6.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.331 -1.1 . . . . 0.0 109.21 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -72.5 -26.94 61.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.68 40.45 2.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -159.66 -55.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -1.182 . . . . 0.0 109.529 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.688 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.2 mpt_? -116.29 56.97 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -47.98 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.1 -36.77 75.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.56 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -69.61 -62.04 1.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 60' ' ' VAL . 16.1 mt -43.14 -36.08 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.04 -56.05 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.42 -47.67 62.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.45 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 0.0 109.585 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 56' ' ' ILE . 2.7 t -71.89 -29.19 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -66.86 -38.7 86.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -75.83 -43.14 47.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 109.968 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -67.29 -27.64 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.952 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -77.24 -30.75 54.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 109.82 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 6.5 16.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 7.05 4.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.694 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 m 51.26 38.64 21.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 159.49 53.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.68 108.75 2.62 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 63' ' ' ALA . 17.2 mt -108.66 114.71 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 mt -107.0 141.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.329 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 m -109.78 135.03 51.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -101.09 133.49 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -58.13 155.09 26.94 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 159.21 31.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.676 2.251 . . . . 0.0 110.403 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -81.57 -53.59 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.37 83.3 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.14 -35.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -1.155 . . . . 0.0 109.535 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 66.45 128.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' C ' ' HD3' ' A' ' 82' ' ' PRO . 1.8 m-20 171.96 39.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.15 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.5 t -118.04 79.06 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 36.1 Cg_endo -78.29 174.67 12.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.595 2.197 . . . . 0.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.2 Cg_endo -79.05 9.43 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.77 2.313 . . . . 0.0 110.613 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -56.47 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -11.23 60.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.51 -28.82 64.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.556 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.92 42.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.63 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.06 -59.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.97 150.47 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -106.38 -21.04 13.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.372 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -151.39 163.92 37.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.73 159.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 103' ' ' ALA . 54.1 t -128.3 160.25 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.11 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 93' ' ' VAL . . . -112.42 -152.71 11.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -107.14 50.24 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -125.49 162.19 45.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.07 -43.31 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.751 2.301 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -26.34 58.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.827 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.6 m -62.23 -64.57 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.453 HG12 HG11 ' A' ' 93' ' ' VAL . 67.9 mt -44.68 -25.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -46.93 39.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -0.995 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.86 -17.5 64.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.626 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -71.13 -59.14 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.63 -37.56 86.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.562 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -51.4 -48.21 62.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -31.32 72.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.8 -62.22 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 35.06 2.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -46.51 131.79 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.531 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 14.6 p -107.87 -10.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.441 ' OXT' HG22 ' A' ' 111' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 1' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 p -110.9 114.0 27.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.31 106.07 6.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.519 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.65 141.94 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.968 . . . . 0.0 109.332 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.8 160.68 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.69 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 6.5 mpt_? -106.98 128.83 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.999 ' HG ' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -137.61 166.98 22.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.695 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -151.13 115.42 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.56 141.26 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.58 125.67 10.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.78 126.64 28.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.99 30.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.0 53.12 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.731 HG23 ' H ' ' A' ' 17' ' ' TYR . 15.4 m -112.62 143.23 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 19' ' ' VAL . 29.0 tt0 -54.31 -25.12 22.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.58 -65.37 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 14' ' ' VAL . 5.5 t80 -50.08 -28.36 7.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -48.4 55.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 15' ' ' GLU . 71.7 t -61.37 -29.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.852 . . . . 0.0 109.657 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -71.19 -45.93 62.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.358 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -56.98 -46.17 82.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -36.79 84.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.51 71.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.566 ' CD2' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -75.69 -49.06 19.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -68.22 -17.97 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -70.67 -52.5 20.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.493 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -47.76 -35.85 10.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 125.58 -154.79 18.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 71.04 165.92 0.29 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.454 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.69 100.86 4.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' CD2' ' A' ' 24' ' ' LEU . 60.8 p-90 -115.36 157.93 23.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 109.28 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -125.17 152.46 70.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.46 125.64 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.699 2.266 . . . . 0.0 110.512 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.96 153.43 35.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.486 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -53.92 173.21 0.21 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.331 -0.856 . . . . 0.0 109.392 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -76.9 -0.34 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.541 2.161 . . . . 0.0 110.372 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -104.25 -6.09 21.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.303 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.34 30.07 1.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.82 98.96 12.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 6' ' ' ARG . 12.4 m-20 -50.76 -45.32 58.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.196 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.999 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -116.02 121.92 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.01 110.56 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 7' ' ' LEU . 6.6 mt -103.23 123.25 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.83 HG11 HG23 ' A' ' 56' ' ' ILE . 2.4 t -113.77 120.89 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 17' ' ' TYR . 53.0 mt -80.21 148.25 30.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.38 17.06 24.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -87.74 -29.85 19.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 24.14 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -1.152 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 41.8 t-105 -60.71 -14.21 19.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.55 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.91 37.96 2.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -150.31 -58.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -1.137 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -116.24 46.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 109.725 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HA ' HD12 ' A' ' 56' ' ' ILE . 2.1 ttt180 -57.84 -34.26 69.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -39.74 94.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.605 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 3.7 tt0 -65.59 -41.69 92.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.83 HG23 HG11 ' A' ' 44' ' ' VAL . 5.2 mt -70.82 -23.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.11 -52.65 13.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.71 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.98 73.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.91 -62.15 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -1.157 . . . . 0.0 109.599 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 70' ' ' ILE . 80.8 t -55.62 -31.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -63.0 -55.3 26.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -60.47 -25.08 65.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.281 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.53 62.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -7.56 38.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.644 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -49.21 -32.61 10.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -135.58 -69.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.43 43.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.686 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.25 151.15 75.11 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.08 116.53 4.21 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.807 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 60' ' ' VAL . 4.4 mt -107.43 98.53 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 108.881 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 10.4 mt -90.22 112.75 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 85' ' ' LEU . 15.0 p -89.41 141.51 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.13 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 93' ' ' VAL . 84.6 t -115.68 132.36 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HG2' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -51.7 158.47 1.58 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 36.2 Cg_endo -78.96 169.7 19.0 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 0.0 110.507 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 76' ' ' TYR . 74.8 t80 -82.9 8.85 11.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 122.12 71.49 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -151.98 81.9 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.562 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' LEU . 3.1 mt-10 70.91 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.476 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.8 137.06 58.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.613 HG13 ' HD2' ' A' ' 82' ' ' PRO . 86.9 t -68.44 141.04 92.92 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.5 Cg_endo -78.45 155.81 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.563 2.176 . . . . 0.0 110.412 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.16 -10.09 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.555 2.17 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.87 -15.93 63.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.295 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 72' ' ' THR . 42.2 tp -93.84 -18.79 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -24.47 43.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.13 61.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.7 -0.18 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 21.3 t -96.23 135.84 37.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 -33.01 54.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.82 168.99 24.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.2 m -130.71 156.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.897 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 73' ' ' VAL . 2.1 t -135.97 155.56 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 74' ' ' ARG . . . -116.98 -155.69 10.33 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -88.89 37.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -1.199 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.1 149.05 39.53 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 -66.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.609 2.206 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.24 -32.28 1.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -53.11 59.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.6 mt -55.05 -23.56 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.988 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -69.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -28.08 50.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.993 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.33 -51.73 48.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.452 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 7' ' ' LEU . 5.6 tt -72.46 -15.06 61.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.257 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -28.97 63.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.296 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -68.2 -12.53 61.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.429 -0.794 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -58.8 4.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.4 2.35 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.73 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.41 152.96 28.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.528 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.16 -4.46 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.014 . . . . 0.0 109.433 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 6' ' ' ARG . 57.2 mt -114.63 162.58 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.533 ' C ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -93.57 105.09 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.395 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD23 HD11 ' A' ' 43' ' ' ILE . 8.9 mp -112.35 168.24 9.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.699 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -153.09 142.19 21.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 mt -130.76 151.45 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 109.643 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 157.44 25.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -85.84 135.07 33.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.89 177.09 20.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -123.99 -12.57 7.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -1.095 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.9 m -67.81 165.97 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.02 -20.29 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.1 -32.78 73.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.46 18.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.08 -35.31 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 18.6 t80 -65.88 -47.99 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.85 -45.92 71.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -58.36 -49.94 75.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -59.74 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.96 . . . . 0.0 109.439 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CZ ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -45.5 -38.28 6.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.64 -44.65 93.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -23.07 67.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -51.74 38.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.25 -33.09 6.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 29' ' ' LEU . 1.4 mm? -57.76 148.63 24.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -82.16 131.76 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -138.56 145.37 40.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' NH2' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -130.53 147.8 67.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.188 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HD2' ' NH2' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.7 101.88 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.459 2.106 . . . . 0.0 110.529 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 6' ' ' ARG . . . -101.81 154.92 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -59.89 164.87 5.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.341 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -77.37 -7.6 17.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.497 2.131 . . . . 0.0 110.114 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -28.6 15.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.3 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.05 46.53 2.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -100.17 148.35 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -95.43 -26.68 15.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.437 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.581 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -142.9 119.21 10.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.502 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.6 t -110.11 100.28 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.659 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.698 HD11 HD23 ' A' ' 7' ' ' LEU . 1.4 mt -84.19 106.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 136.68 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -88.67 128.6 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 109.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.71 4.63 15.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.97 . . . . 0.0 109.486 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.33 -24.02 61.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.61 27.3 3.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.571 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 6.6 t-105 -76.83 -42.45 40.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.41 7.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.0 p -141.08 -58.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -117.28 50.55 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.331 -0.856 . . . . 0.0 109.601 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -30.09 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -38.14 82.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.44 -55.7 8.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -48.84 -43.29 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 57' ' ' LEU . 5.4 mt -45.78 -49.36 15.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' ALA . . . -56.17 -58.79 12.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . . . -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -1.129 . . . . 0.0 109.649 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.91 -53.84 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.24 -53.05 23.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.34 -33.14 73.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.554 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 68' ' ' LYS . . . -71.23 -21.67 62.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -71.73 -3.05 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.762 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' ARG . 0.5 OUTLIER -124.99 18.23 8.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.4 m -143.94 45.54 1.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.707 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' SER . 2.8 t 78.21 -3.59 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 109.723 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 50.34 60.01 15.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.301 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.4 Cg_endo -82.1 53.14 4.43 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.57 2.18 . . . . 0.0 109.764 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.98 117.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.265 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.9 mt -110.91 131.44 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 92' ' ' VAL . 55.1 m -96.93 129.82 44.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.25 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.72 116.84 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -46.51 154.57 0.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.69 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.11 161.64 29.31 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.751 2.3 . . . . 0.0 110.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.98 -23.75 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.17 37.08 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.02 -32.52 12.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.44 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.57 -143.24 0.14 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.295 -0.878 . . . . 0.0 109.076 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -148.28 140.48 24.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.905 . . . . 0.0 109.424 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.731 HG12 ' HD2' ' A' ' 82' ' ' PRO . 1.5 t -69.97 142.15 90.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.276 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.731 ' HD2' HG12 ' A' ' 81' ' ' VAL . 35.7 Cg_endo -79.33 173.0 13.81 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.524 2.149 . . . . 0.0 110.486 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.6 Cg_endo -80.23 19.35 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 111.065 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.76 -8.66 23.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.867 -1.146 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.505 HD22 ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -100.4 -49.41 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.01 . . . . 0.0 109.56 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -20.98 5.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.98 26.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 0.0 109.385 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -102.59 144.94 30.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -99.19 -29.45 12.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.235 -0.915 . . . . 0.0 109.231 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.21 155.32 36.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.581 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.1 m -142.24 130.55 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 28.2 m -134.37 -171.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.76 -146.9 5.35 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.463 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 83.7 m95 -89.64 69.87 7.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -1.127 . . . . 0.0 109.495 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 95' ' ' TRP . 6.6 m-20 -141.62 149.21 53.04 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 -38.65 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.681 2.254 . . . . 0.0 110.357 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -74.11 -41.4 61.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.863 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 1.2 m -56.88 -59.55 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 109.529 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.8 mt -51.81 -30.85 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 0.0 109.611 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -69.46 -37.95 77.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.13 -43.4 92.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.23 62.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 104' ' ' LEU . 18.6 tp -74.26 -62.01 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 109.577 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.82 -16.96 7.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -68.73 -38.72 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.13 -27.2 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.295 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 1.8 mt-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 104' ' ' LEU . 13.2 mt -138.47 140.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.53 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 2.8 mpp_? -94.08 97.6 10.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 43' ' ' ILE . 1.5 mp -107.29 157.23 18.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.43 119.85 31.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.367 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' THR . 20.5 mt -111.54 132.6 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.35 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.99 156.8 44.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.11 -175.41 42.54 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.25 39.25 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -1.085 . . . . 0.0 109.182 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -115.43 -171.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.48 -10.25 57.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -76.51 -74.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.665 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.792 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.2 t80 -50.82 -26.15 5.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 109.635 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -72.28 -68.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.571 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 15' ' ' GLU . 98.8 t -43.34 -44.94 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.813 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CE2' HD12 ' A' ' 24' ' ' LEU . 66.1 t80 -60.52 -44.62 95.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.689 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -57.95 -41.16 82.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.72 -45.62 93.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -17.84 63.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.845 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -72.55 -56.34 5.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 109.506 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.34 -42.24 88.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.61 -20.57 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.6 m -69.73 -61.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.583 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.97 -153.23 19.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.62 159.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 2.6 mp0 -113.1 95.73 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.722 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.845 ' CZ2' HD22 ' A' ' 24' ' ' LEU . 31.0 p-90 -112.18 169.3 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.3 162.79 38.2 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.859 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 119.48 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.642 2.228 . . . . 0.0 110.273 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB2' ' CG ' ' A' ' 6' ' ' ARG . . . -106.37 -177.55 3.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.41 173.26 5.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -78.18 -6.47 15.73 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.607 2.204 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.18 -0.94 16.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.509 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.45 56.04 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -112.85 119.06 36.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 4.9 t70 -49.94 -41.74 47.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -145.7 154.55 42.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 109.19 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 7' ' ' LEU . 84.1 mt -92.74 94.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.33 130.68 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.864 . . . . 0.0 109.51 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.921 ' HB3' HD23 ' A' ' 48' ' ' LEU . 2.0 mm? -88.49 116.39 26.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -57.45 -22.19 41.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' HD22 ' A' ' 48' ' ' LEU . . . -89.28 34.8 3.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.921 HD23 ' HB3' ' A' ' 45' ' ' LEU . 2.2 mm? -121.08 -27.4 4.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -1.131 . . . . 0.0 109.765 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.9 p90 -65.31 -21.51 66.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.3 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.562 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -58.61 -18.44 37.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 p -110.08 -39.08 5.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -141.61 57.24 1.51 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' CG ' ' HB2' ' A' ' 49' ' ' TRP . 4.0 ttt180 -53.73 -22.07 8.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.385 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.94 -42.34 60.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -66.75 -47.9 70.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 49' ' ' TRP . 1.8 mp -60.69 -37.29 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.95 -54.61 44.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.13 64.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.64 74.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.244 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.55 -33.99 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -59.92 -52.4 65.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.31 -30.67 71.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.393 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.855 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -72.18 -20.23 61.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -10.13 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.358 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 66' ' ' SER . 11.4 tttp -68.05 -9.23 44.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 14.9 t 68.27 45.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.627 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -110.77 -37.41 5.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -127.25 155.62 76.02 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.092 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.445 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 35.0 Cg_endo -77.3 122.86 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.509 2.139 . . . . 0.0 110.547 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 63' ' ' ALA . 69.0 mt -91.92 127.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 93' ' ' VAL . 3.7 mp -124.09 113.9 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.336 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD23 ' A' ' 85' ' ' LEU . 19.0 p -96.01 121.53 37.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.478 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.939 HG22 ' HB ' ' A' ' 93' ' ' VAL . 92.3 t -98.91 121.48 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' CZ2' ' A' ' 95' ' ' TRP . 12.0 mmt180 -43.14 151.98 0.4 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.27 151.88 26.8 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.654 2.236 . . . . 0.0 110.525 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -49.22 -49.87 40.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.59 111.59 0.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -167.3 -46.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.362 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.86 -143.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.033 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.27 115.82 15.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 74' ' ' ARG . 78.9 t -50.24 134.27 23.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.26 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.7 Cg_endo -77.95 148.25 24.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.453 2.102 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.1 Cg_endo -77.62 -4.09 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.642 2.228 . . . . 0.0 110.47 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.63 -42.91 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 72' ' ' THR . 0.4 OUTLIER -67.71 -31.15 70.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.466 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.38 -0.59 42.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.28 28.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.125 -0.984 . . . . 0.0 109.646 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.85 -0.25 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 m -72.71 128.84 36.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 109.302 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.6 m -89.07 -18.85 26.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.57 142.94 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.863 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.41 115.26 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.014 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.939 ' HB ' HG22 ' A' ' 73' ' ' VAL . 86.6 t -88.95 149.94 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.834 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.29 -145.66 15.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.463 ' CZ2' ' O ' ' A' ' 74' ' ' ARG . 67.7 m95 -114.09 57.95 0.69 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 109.584 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -130.93 168.94 15.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.32 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.641 2.227 . . . . 0.0 110.636 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -10.27 56.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -62.68 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mt -51.07 -22.92 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -46.32 41.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 105' ' ' GLU . 72.9 m-20 -63.49 -12.86 35.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . . . -69.31 -60.89 2.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -68.22 -25.48 65.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.2 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.66 -47.35 67.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -22.63 61.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.293 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -19.62 61.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.503 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.461 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -143.49 149.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.1 126.91 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -134.96 159.41 41.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -112.75 97.52 6.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 17' ' ' TYR . 44.9 mt -94.94 124.05 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.512 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.59 128.55 29.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 142.46 58.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -0.997 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.69 170.38 32.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.75 57.73 1.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' ARG . 1.6 m -142.85 -176.45 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.63 -11.8 60.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -76.84 -55.24 5.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.671 ' CE1' HG21 ' A' ' 9' ' ' ILE . 3.2 t80 -67.7 -22.38 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.478 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 1.5 mpt_? -73.82 -55.41 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.39 -36.24 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -64.17 -52.78 57.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.75 -22.61 64.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -76.54 -39.12 53.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.9 65.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -49.32 65.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.95 -20.69 61.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 109.978 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.91 -39.83 95.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 109.658 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 p -49.92 -49.52 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.56 60.23 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.83 154.91 49.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 9.1 tp10 -91.73 59.6 3.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -86.4 160.79 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -151.97 154.49 32.73 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.65 153.95 26.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.683 2.255 . . . . 0.0 110.376 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.23 171.24 17.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.9 168.34 4.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.82 -9.25 16.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.634 2.223 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 -21.92 25.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 50.87 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.13 103.94 13.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -50.67 -46.73 58.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.315 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -122.25 137.72 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 70' ' ' ILE . 17.8 t -104.71 140.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -137.6 121.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 119.38 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 45' ' ' LEU . 5.7 mt -85.14 125.13 32.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.52 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.04 35.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.51 90.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 45' ' ' LEU . 2.4 mt -120.21 24.02 10.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -1.148 . . . . 0.0 109.438 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 1.5 t90 -81.18 4.72 19.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.97 -4.11 29.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -124.9 -38.8 2.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.126 -1.22 . . . . 0.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HG2' ' CB ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -114.11 72.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -74.43 -65.19 0.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.22 -19.1 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -77.24 -41.71 40.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.692 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 49' ' ' TRP . 45.4 mt -73.18 -35.46 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.19 -32.69 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -46.22 46.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.8 -54.35 47.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -1.124 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.71 -28.37 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 109.438 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -46.94 82.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.04 -32.87 72.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -74.62 -19.05 60.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.299 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -10.3 32.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' SER . 10.1 tptm -61.0 -14.08 20.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 5.6 t 73.7 68.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 p -154.06 -39.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -106.86 153.41 40.83 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -78.28 119.18 4.51 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.715 2.277 . . . . 0.0 110.356 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 63' ' ' ALA . 23.5 mt -94.13 122.64 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 mt -115.64 117.58 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 86.2 m -83.34 146.08 28.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 45' ' ' LEU . 43.3 t -120.2 114.96 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 59.5 mtt180 -55.72 146.63 45.41 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 36.1 Cg_endo -78.49 165.92 24.65 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.662 2.241 . . . . 0.0 110.49 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.431 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -79.33 -26.02 42.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 78' ' ' LEU . . . -89.2 -13.83 61.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 29.4 tp 61.29 90.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 17.18 21.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 81' ' ' VAL . 10.8 m-80 56.34 82.91 0.1 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -44.52 147.21 1.07 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 170.51 19.16 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.517 2.145 . . . . 0.0 110.435 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 2.71 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.619 2.213 . . . . 0.0 110.518 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -83.06 -44.6 14.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -5.65 59.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.08 -12.78 49.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.42 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.14 13.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 98.81 12.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -30.2 67.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -155.26 127.61 7.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.84 128.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 72' ' ' THR . 7.3 p -128.29 145.29 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.649 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.09 -145.77 10.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -91.2 17.47 8.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -1.165 . . . . 0.0 109.394 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 99' ' ' CYS . 2.5 m-20 -65.27 153.21 90.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.71 -57.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -77.06 -20.37 55.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.315 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -71.3 -13.0 61.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.07 -1.019 . . . . 0.0 109.901 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 96' ' ' ASN . 17.6 mm -75.74 -38.21 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -77.17 -31.45 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.3 -26.97 63.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.5 -67.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 76.9 mt -53.1 -35.09 59.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.927 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.01 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.614 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -20.85 3.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 104' ' ' LEU . . . -77.3 -39.96 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 109.599 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.706 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -145.42 143.06 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 40' ' ' ASP . 21.1 mtt85 -85.1 105.64 15.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.226 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 31' ' ' TRP . 8.0 mp -105.11 168.49 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.674 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 40.3 t80 -152.73 106.95 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.502 HD12 ' CD1' ' A' ' 21' ' ' LEU . 20.8 mt -102.67 135.79 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -51.68 136.4 27.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.161 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.477 ' O ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -58.78 131.75 51.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.504 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.892 ' HA2' HD21 ' A' ' 48' ' ' LEU . . . -120.91 146.6 17.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.85 17.1 17.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.12 -173.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.37 -11.2 38.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.5 m-20 -73.01 -32.36 65.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HE1' HD22 ' A' ' 21' ' ' LEU . 23.3 t80 -71.31 -29.73 65.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -75.29 -47.96 25.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.29 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 93.4 t -61.54 -40.61 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.382 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.671 ' CE2' HG11 ' A' ' 73' ' ' VAL . 3.0 t80 -64.53 -58.01 7.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 9' ' ' ILE . 3.9 tp -55.95 -22.58 27.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 19' ' ' VAL . 73.8 mt-10 -70.47 -55.13 9.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 26' ' ' GLN . 6.7 ttt85 -57.88 -32.7 67.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.06 -58.68 6.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.887 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -70.53 -19.09 62.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -60.54 -41.65 94.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.351 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 16.0 t 174.39 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.59 58.38 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.63 161.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.299 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 148.41 22.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 7' ' ' LEU . 67.5 p-90 -149.68 174.24 12.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -143.13 147.74 42.11 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.484 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.53 103.55 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.655 2.236 . . . . 0.0 110.348 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . -100.89 -169.61 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.93 168.2 24.52 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.5 Cg_endo -77.75 -8.37 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.615 2.21 . . . . 0.0 110.345 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.18 -6.97 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.21 53.98 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 8' ' ' TYR . . . -105.19 124.46 49.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.396 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 5' ' ' ILE . 12.6 t70 -52.02 -30.04 23.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -147.91 124.2 10.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.693 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -97.28 96.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.027 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CG2' ' A' ' 73' ' ' VAL . 76.7 mt -92.52 107.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.07 133.41 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.37 120.56 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.446 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -15.54 62.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -22.57 71.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' HA2' ' A' ' 12' ' ' GLY . 11.1 mp -89.28 13.69 12.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -1.18 . . . . 0.0 109.529 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.696 ' HZ3' HD13 ' A' ' 85' ' ' LEU . 4.8 t-105 -72.72 -30.33 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.64 27.28 21.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 48' ' ' LEU . 8.4 p -135.4 -39.02 0.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -1.179 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CB ' ' HB2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -141.47 71.69 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.298 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -52.9 -56.24 17.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -56.27 -38.47 71.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 109.614 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -56.65 -47.99 78.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.424 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 33.8 mm -62.06 -33.36 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 108.872 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 tp -73.75 -21.43 60.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.113 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.15 -54.95 4.98 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.51 89.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.173 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 70.2 t -58.44 -44.18 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.253 -0.904 . . . . 0.0 109.046 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -58.03 -40.57 81.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.37 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.3 mt -68.91 -28.25 66.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 70' ' ' ILE . . . -76.83 -28.18 55.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.407 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 40.3 mtp85 -75.92 0.1 19.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -84.02 -30.04 26.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.402 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.44 20.64 3.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.01 23.1 1.02 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.706 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -47.44 163.59 0.26 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 113.98 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.634 2.223 . . . . 0.0 110.603 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.688 HD11 ' HB1' ' A' ' 63' ' ' ALA . 2.1 mt -113.7 108.03 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.368 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 25.1 mt -96.36 124.83 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.689 HG21 HG11 ' A' ' 81' ' ' VAL . 21.9 m -89.77 156.13 18.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.671 HG11 ' CE2' ' A' ' 20' ' ' PHE . 3.4 t -123.89 121.76 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -50.71 150.41 5.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.51 178.13 8.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.499 2.133 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.3 -25.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.95 86.26 0.23 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.0 -82.89 0.48 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -136.82 17.61 3.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 -177.92 0.13 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.522 -0.736 . . . . 0.0 109.472 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 72' ' ' THR . 34.0 m -85.98 159.89 53.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 34.3 Cg_endo -77.72 174.36 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.658 2.238 . . . . 0.0 110.39 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 35.2 Cg_endo -77.43 -33.01 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.606 2.204 . . . . 0.0 110.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.31 -34.4 70.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.181 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.696 HD13 ' HZ3' ' A' ' 49' ' ' TRP . 1.7 tt -93.31 -20.03 20.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.98 -35.23 79.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.112 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.98 -11.82 61.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.227 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG11 HG13 ' A' ' 60' ' ' VAL . 2.2 t -111.56 7.8 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.1 t -105.59 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -44.09 74.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.467 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -146.95 154.56 41.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.3 p -117.68 119.15 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 100' ' ' ILE . 9.9 p -108.95 163.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 93' ' ' VAL . . . -125.53 -157.94 9.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 30.1 m95 -88.74 38.82 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 109.246 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.441 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -103.01 151.22 38.39 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.8 Cg_endo -78.39 -46.73 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.67 2.247 . . . . 0.0 110.327 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.14 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 96' ' ' ASN . 73.6 m -65.62 -54.2 31.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.823 HD13 HG21 ' A' ' 93' ' ' VAL . 31.5 mm -47.38 -24.51 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.46 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -52.65 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.614 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.48 -14.8 59.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.38 -48.16 24.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.786 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 5' ' ' ILE . 20.8 mt -77.3 -25.87 51.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -74.88 -21.81 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -37.69 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.603 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.32 -55.72 19.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.339 0.59 . . . . 0.0 109.655 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.441 HD12 ' CD1' ' A' ' 108' ' ' LEU . 3.3 tt -131.67 156.67 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG2' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -111.47 127.5 55.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.831 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.946 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -128.34 169.7 13.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.87 . . . . 0.0 109.212 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -128.78 102.47 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.626 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.519 HG21 ' HE1' ' A' ' 17' ' ' TYR . 15.6 mt -100.09 143.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -73.62 -170.34 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.589 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 1.3 pt-20 -135.15 109.04 8.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -121.0 173.14 15.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.6 tm-20 -115.63 28.3 8.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 109.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.12 158.22 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 109.679 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.3 -9.97 38.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.6 m-20 -72.39 -48.63 40.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.555 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HE1' HG21 ' A' ' 9' ' ' ILE . 11.6 t80 -65.12 -26.1 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -70.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.598 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.5 t -49.87 -31.96 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.479 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.985 ' CE1' HD13 ' A' ' 24' ' ' LEU . 31.6 t80 -68.02 -48.23 66.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -41.05 74.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.21 -33.74 76.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -15.69 59.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.985 HD13 ' CE1' ' A' ' 20' ' ' PHE . 1.7 tp -74.65 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 26' ' ' GLN . 2.4 pt-20 -59.9 -20.68 58.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -52.35 -41.03 62.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.287 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -26.9 60.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 102.21 -132.47 11.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER 62.75 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.124 . . . . 0.0 109.395 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 85.3 mt-10 -88.74 111.26 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.946 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.4 p-90 -120.04 156.64 30.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -137.69 159.95 66.92 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.4 Cg_endo -77.79 130.8 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.653 2.235 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -116.63 -165.92 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.708 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -101.99 175.16 2.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.548 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.7 Cg_endo -77.62 -19.36 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.566 2.177 . . . . 0.0 110.405 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -112.39 -6.55 14.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -138.54 49.1 1.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -104.95 133.13 50.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -34.01 76.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 109.322 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -149.68 123.84 9.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 21.7 t -79.9 156.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 109.849 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 71' ' ' ILE . 13.3 mt -147.05 102.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 108.98 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.97 HG11 HG23 ' A' ' 56' ' ' ILE . 2.2 t -112.97 137.34 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.748 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.9 mm? -84.12 131.47 34.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -76.59 -36.7 57.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.95 34.56 3.89 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD21 ' CA ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -125.41 -26.65 3.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.811 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.673 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.7 p90 -57.67 -18.56 21.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.018 -1.051 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.538 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -42.27 -29.9 0.72 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -47.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -88.63 47.95 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -45.06 85.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -67.33 -31.47 71.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.899 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.94 -59.42 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.97 HG23 HG11 ' A' ' 44' ' ' VAL . 3.0 mp -54.96 -57.79 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.24 -26.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.855 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.06 -68.16 1.73 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -37.0 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -1.12 . . . . 0.0 109.988 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 58.8 t -59.62 -60.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.58 -58.65 6.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.53 -27.15 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -70.93 -45.11 64.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -68.29 -7.59 32.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -57.37 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -79.69 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 p 179.01 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -87.04 154.72 55.19 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.434 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -77.9 116.87 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.701 2.268 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 95.6 mt -95.04 111.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.324 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 91' ' ' GLU . 35.5 mm -94.33 91.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.722 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.645 HG21 ' OG ' ' A' ' 89' ' ' SER . 7.6 p -88.06 128.86 35.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 45' ' ' LEU . 58.2 t -98.65 132.35 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.453 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -64.05 171.53 2.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 74' ' ' ARG . 34.8 Cg_endo -77.31 163.49 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.62 2.213 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.2 -15.64 63.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.9 46.54 0.77 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 7.21 3.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -1.092 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -151.68 -143.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.237 -0.914 . . . . 0.0 108.995 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -145.6 153.79 41.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 82' ' ' PRO . 97.5 t -104.6 134.87 19.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.9 Cg_endo -78.84 150.33 23.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.502 2.135 . . . . 0.0 110.328 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -78.12 -20.49 11.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.193 . . . . 0.0 110.467 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.27 -34.69 74.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.624 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.79 55.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.655 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -69.21 -18.75 63.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.01 -7.97 59.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.38 33.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -117.65 134.07 55.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -99.84 -31.59 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 71' ' ' ILE . 4.0 mt-10 -136.14 118.54 15.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.595 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.6 m -117.99 128.57 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.248 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 103' ' ' ALA . 2.8 m -123.93 165.28 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.71 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.72 -146.57 21.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.98 66.83 0.66 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -1.158 . . . . 0.0 109.586 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.661 ' O ' HD12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -138.44 152.57 71.47 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.31 -41.89 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.619 2.213 . . . . 0.0 110.554 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -76.93 -31.57 56.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.659 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -42.15 67.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ASN . 35.6 mt -59.22 -41.94 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.661 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -64.16 -42.09 96.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.725 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -31.09 63.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -0.86 . . . . 0.0 109.783 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . . . -74.21 -43.18 58.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.732 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.01 -33.55 73.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.675 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -51.94 -28.17 15.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.444 ' HB2' ' OE2' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -67.81 -49.83 60.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.877 . . . . 0.0 109.728 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.28 -43.24 67.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.651 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.2 tp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.276 0.56 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.6 mt -119.08 139.25 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -92.56 112.29 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 109.319 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.515 ' CD2' HD11 ' A' ' 43' ' ' ILE . 3.7 mp -120.76 153.45 36.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 15.5 t80 -123.94 108.95 12.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.74 142.12 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -47.91 145.92 2.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.445 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.04 125.83 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.0 179.57 37.27 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -117.57 -3.74 11.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 109.736 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -48.9 170.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 109.55 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -77.75 -19.12 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.515 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.01 -50.76 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.91 -28.17 69.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -58.32 5.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.27 -48.57 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.656 ' CZ ' HG21 ' A' ' 73' ' ' VAL . 1.8 t80 -53.37 -37.52 62.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -61.53 1.84 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.662 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -51.19 -23.81 3.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -51.09 19.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -73.35 -6.17 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.19 -64.12 1.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.66 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.62 -8.28 26.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.952 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -57.07 9.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.87 -27.54 6.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.87 152.08 32.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.149 . . . . 0.0 109.519 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -99.98 50.97 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.852 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 35.5 p-90 -80.11 158.47 26.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.905 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -144.06 157.43 57.34 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.98 131.74 11.24 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.15 172.25 10.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.923 . . . . 0.0 109.588 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.19 162.04 4.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.499 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.7 Cg_endo -78.67 2.15 8.43 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.787 2.325 . . . . 0.0 110.668 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.43 15.99 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 109.638 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.18 38.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.527 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 131.78 52.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.84 -37.31 60.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.317 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.48 128.89 22.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.99 110.49 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.515 HD11 ' CD2' ' A' ' 7' ' ' LEU . 97.0 mt -97.23 104.7 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.95 137.97 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.7 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.88 117.59 34.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.343 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -17.31 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.3 -16.99 37.12 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 48' ' ' LEU . 5.3 mp -118.84 40.64 3.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -1.221 . . . . 0.0 109.622 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.494 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 43.1 t-105 -81.49 -29.91 33.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.73 39.04 2.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -139.12 -50.52 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 56' ' ' ILE . 11.2 mtt180 -130.48 64.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -48.57 -22.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.05 -41.94 40.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 11.8 tt0 -69.31 -30.15 68.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.536 HD13 ' N ' ' A' ' 56' ' ' ILE . 4.3 mm -77.12 -63.74 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.885 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.91 75.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.957 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -31.59 81.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' GLU . . . -63.03 -62.02 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -1.187 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.78 -46.48 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.418 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.89 -39.26 65.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 1.0 OUTLIER -61.42 -47.18 86.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.211 -0.93 . . . . 0.0 109.265 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 70' ' ' ILE . . . -52.88 -49.19 66.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -26.23 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 15.3 21.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.991 . . . . 0.0 109.632 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' LEU . 43.8 m -143.69 -63.37 0.39 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.355 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 75.5 m -109.55 -91.71 0.45 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.208 -0.933 . . . . 0.0 109.022 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tttp 155.21 -47.19 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.831 -0.543 . . . . 0.0 110.237 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 68' ' ' LYS . 36.2 Cg_endo -78.2 119.16 4.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.092 1.861 . . . . 0.0 110.605 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 63' ' ' ALA . 2.7 mp -125.61 104.86 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 91' ' ' GLU . 4.0 mp -91.02 119.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.42 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.604 ' CG2' HG22 ' A' ' 92' ' ' VAL . 13.3 t -104.45 140.29 38.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 109.757 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.656 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 55.7 t -108.7 125.68 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.3 164.98 15.44 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 162.44 28.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.608 2.206 . . . . 0.0 110.144 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.93 -57.44 6.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.636 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.592 ' O ' HD22 ' A' ' 78' ' ' LEU . . . -179.3 85.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -148.0 -67.12 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -1.175 . . . . 0.0 109.517 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -115.54 -143.89 0.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.294 -0.879 . . . . 0.0 109.087 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.81 122.49 9.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 82' ' ' PRO . 53.7 t -52.2 137.26 38.8 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.4 Cg_endo -78.07 165.41 26.12 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.476 2.118 . . . . 0.0 110.557 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.96 5.27 5.45 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.697 2.265 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.29 -35.07 23.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.96 -7.82 44.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.52 -9.46 41.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.579 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.59 -5.35 35.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.63 -41.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -46.6 156.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 m -123.06 -6.61 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.883 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 71' ' ' ILE . 22.3 mt-10 -150.89 98.78 2.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 72' ' ' THR . 59.4 t -102.36 128.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.89 168.53 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.16 -146.84 15.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -95.1 34.48 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.603 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.4 m-80 -106.11 146.0 32.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.21 -32.63 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.67 2.247 . . . . 0.0 110.594 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.35 -41.28 76.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -28.06 61.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 96' ' ' ASN . 67.7 mt -74.87 -31.55 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.012 . . . . 0.0 109.646 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -44.36 69.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.63 -17.83 64.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.554 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -59.16 2.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -21.17 66.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.98 -45.47 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 -1.52 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 109.786 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.11 -32.98 56.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.639 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.443 0.639 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.797 HG23 HD23 ' A' ' 7' ' ' LEU . 4.0 tt -151.17 155.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.048 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -91.57 104.86 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.941 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.797 HD23 HG23 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -130.19 164.85 23.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.959 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -131.29 147.44 52.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.823 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.64 147.06 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.66 145.59 33.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.501 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.57 149.82 24.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.64 -155.93 14.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.23 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 17' ' ' TYR . 30.2 m -112.82 167.99 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.945 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -66.96 -25.62 66.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.548 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.63 -66.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.4 t80 -54.1 -26.77 28.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -69.86 -71.66 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.792 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 15' ' ' GLU . 26.1 t -42.11 -39.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 45' ' ' LEU . 22.9 t80 -59.82 -54.51 45.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.75 -28.72 50.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.784 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 63.2 mm-40 -72.75 -45.02 60.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.878 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -23.28 64.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 109.91 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -56.15 24.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -59.44 -21.39 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -49.75 -33.45 16.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER -45.63 -50.6 13.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 109.533 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.25 64.41 0.28 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 tp 61.65 82.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.44 27.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.12 -0.988 . . . . 0.0 109.567 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.79 ' HB2' HD21 ' A' ' 7' ' ' LEU . 44.9 p-90 -158.06 155.99 30.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.95 . . . . 0.0 109.657 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -151.68 148.2 21.49 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.406 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 32' ' ' ARG . 35.1 Cg_endo -77.72 119.55 4.84 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.596 2.198 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.35 -168.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.676 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -97.61 165.25 15.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 109.404 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.7 Cg_endo -76.91 -23.39 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.478 2.119 . . . . 0.0 110.169 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -2.96 53.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.294 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.34 61.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.82 127.28 54.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -77.21 -39.85 47.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -124.02 134.06 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.37 144.21 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' LEU . 9.2 mt -134.44 100.46 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.67 135.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 20' ' ' PHE . 1.1 mm? -92.2 136.01 33.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.568 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.35 9.47 28.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.36 -24.15 29.66 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 17' ' ' TYR . 1.4 mp -85.3 12.71 7.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -1.126 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.595 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 1.8 t-105 -68.43 -26.53 65.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.79 28.25 16.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -142.73 -64.84 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -1.094 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -120.41 57.37 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HG3' ' NE1' ' A' ' 49' ' ' TRP . 5.5 ttt180 -55.98 -35.24 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.39 -0.819 . . . . 0.0 109.727 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -52.18 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.696 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -50.25 -38.26 39.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 mt -71.85 -52.52 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.5 tp -47.11 -31.1 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.18 -48.77 57.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.02 -53.25 60.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -1.084 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.94 -40.24 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -36.39 82.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.679 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.13 -47.12 81.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -67.88 -25.8 65.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 0.7 19.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 65' ' ' LYS . 1.6 tppt? -62.47 -48.76 78.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -73.4 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.1 p -178.67 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.059 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.562 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 4.8 mtmt -79.67 154.13 75.94 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.93 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 36.3 Cg_endo -78.95 100.94 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.31 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -103.26 115.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 93' ' ' VAL . 1.6 mp -105.2 129.77 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' HD23 ' A' ' 85' ' ' LEU . 13.4 t -94.64 132.34 39.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.761 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.51 120.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.38 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -50.11 158.38 0.96 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.19 -164.25 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.72 2.28 . . . . 0.0 110.387 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -88.38 -62.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 109.222 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.8 61.57 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 -51.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.514 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.77 -143.82 0.34 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.299 -0.875 . . . . 0.0 109.104 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -140.76 148.7 41.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.652 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.54 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 15.2 t -74.45 140.68 75.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.339 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.0 Cg_endo -77.37 161.47 31.7 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.474 2.116 . . . . 0.0 110.539 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.03 7.37 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.782 2.321 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -92.14 -44.66 8.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.697 HD23 ' OG1' ' A' ' 72' ' ' THR . 3.5 tp -69.37 -19.73 63.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.686 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 39.2 tt0 -84.99 -9.51 57.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 -1.47 25.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.694 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.06 -25.76 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.661 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 2.4 m -81.02 135.82 35.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.502 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -76.69 -23.82 53.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -150.6 167.11 28.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.47 112.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.656 HG13 ' SG ' ' A' ' 99' ' ' CYS . 2.6 t -96.31 151.38 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.07 -151.3 27.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -100.63 29.21 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -1.172 . . . . 0.0 109.38 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.61 159.95 27.67 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.4 -0.813 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.57 -53.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.65 2.234 . . . . 0.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -56.01 -30.94 62.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.656 ' SG ' HG13 ' A' ' 93' ' ' VAL . 2.7 t -68.27 -44.02 76.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.824 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.81 -32.62 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.881 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -60.25 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.623 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -45.61 82.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.691 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -60.82 -27.3 67.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.47 -45.6 58.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.295 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -17.77 61.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.264 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.51 -36.83 79.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.34 -42.99 42.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.261 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.9 mt -134.24 137.88 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -99.01 105.1 17.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.465 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -121.82 171.04 9.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.403 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.7 t80 -143.2 106.08 4.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.938 HG12 HD12 ' A' ' 43' ' ' ILE . 2.9 mt -104.61 135.83 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.41 167.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 109.141 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.38 102.4 5.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.16 -145.87 6.97 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -138.89 54.1 1.75 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.207 -1.173 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.759 HG21 ' HB3' ' A' ' 48' ' ' LEU . 3.5 t -118.22 157.45 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.394 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 tt0 -77.93 -11.9 59.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' OD1' HD11 ' A' ' 45' ' ' LEU . 1.5 t70 -69.62 -59.39 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' OH ' HD12 ' A' ' 21' ' ' LEU . 12.3 t80 -60.52 -33.28 72.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -64.42 -41.96 96.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 109.832 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 15' ' ' GLU . 79.3 t -66.66 -50.55 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -51.03 -52.06 46.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.1 tt -67.41 -26.1 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.52 -49.19 72.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.703 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.53 -26.13 59.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.528 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -76.69 -15.0 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.638 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.16 -57.19 4.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -72.34 -10.25 59.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.1 t -47.02 -46.1 21.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.386 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 121.67 -179.82 16.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER 61.6 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -1.126 . . . . 0.0 109.519 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.83 158.49 15.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.234 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -158.19 155.06 28.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.56 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -145.97 155.0 51.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.534 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 36.1 Cg_endo -78.29 133.71 12.22 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.639 2.226 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' THR . . . -125.29 154.01 42.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -44.1 162.27 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.528 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.96 -31.06 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.634 2.222 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -31.85 69.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -120.17 27.93 8.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.59 107.48 5.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 47.4 t0 -53.89 -37.34 63.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -131.73 129.95 41.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.19 110.78 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 9' ' ' ILE . 8.0 mt -104.48 100.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.293 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.604 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -96.3 130.7 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.663 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -84.89 135.94 33.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 72' ' ' THR . . . -100.95 25.63 7.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.965 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -110.76 -35.78 1.98 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 14' ' ' VAL . 3.8 pp -119.43 15.43 12.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -1.207 . . . . 0.0 109.625 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.607 ' CZ3' ' CD1' ' A' ' 85' ' ' LEU . 2.8 p-90 -76.65 -21.58 55.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.53 -13.38 55.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -98.86 -41.53 7.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -1.101 . . . . 0.0 109.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' ILE . 7.1 mtt180 -108.45 50.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.269 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NE ' ' CZ3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -71.22 -33.43 69.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.03 -51.17 70.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 56' ' ' ILE . 20.7 mt-10 -68.42 -58.33 4.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.604 HD12 ' CG1' ' A' ' 44' ' ' VAL . 34.0 mm -43.52 -26.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.747 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -59.77 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.665 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.37 -30.17 24.97 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -57.71 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -49.98 -45.25 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.57 -48.62 74.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 62' ' ' LEU . 6.8 mt -55.02 -32.45 61.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -66.93 -21.44 65.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.99 -27.34 16.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.46 ' OG ' ' HD3' ' A' ' 68' ' ' LYS . 47.6 t -109.33 15.98 22.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.9 p 45.26 40.23 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -83.26 152.52 64.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.508 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 35.5 Cg_endo -78.19 117.86 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.681 2.254 . . . . 0.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.471 HD11 ' CB ' ' A' ' 63' ' ' ALA . 2.6 mt -107.81 90.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.514 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.552 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 3.0 mt -93.06 128.2 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.261 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 46' ' ' ALA . 52.0 m -102.07 131.32 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.75 124.4 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -49.33 153.24 1.84 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.44 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 34.8 Cg_endo -77.43 -158.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.609 2.206 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' ' CZ2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -117.68 14.99 14.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.679 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.47 6.23 5.74 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -95.37 68.51 3.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -1.179 . . . . 0.0 109.416 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 5.5 tp10 67.27 137.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.886 0.851 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -78.53 -164.16 0.54 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.309 0.575 . . . . 0.0 109.568 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 81' ' ' VAL . 3.6 m -91.22 150.8 42.18 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.05 173.12 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.644 2.229 . . . . 0.0 110.404 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.9 Cg_endo -77.8 -5.46 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 110.31 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -83.36 -49.37 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.607 ' CD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -69.11 -27.38 65.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.54 -12.13 56.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.358 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.7 -12.28 20.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 85' ' ' LEU . 7.3 m -123.84 8.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.385 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 p -94.66 131.17 40.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -76.31 -38.58 55.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.11 173.44 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.799 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.54 155.74 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.401 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 3.1 t -123.57 146.25 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.28 -162.44 17.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' CD2' ' A' ' 76' ' ' TYR . 74.2 m95 -98.45 19.38 14.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.18 156.36 54.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.238 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.47 -34.62 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.586 2.19 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -20.67 55.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.593 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -10.14 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.943 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 24' ' ' LEU . 28.2 mm -76.39 -64.27 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -32.26 69.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.47 -35.77 72.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.89 60.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.977 . . . . 0.0 109.853 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.73 -23.42 58.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 109.734 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.84 -22.61 63.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.17 -44.68 79.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.89 -18.91 64.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.389 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 5.2 mt-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.305 0.574 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.65 164.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -117.39 119.82 36.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.639 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 1.3 pp -135.52 169.66 17.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.85 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -142.28 114.11 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.817 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 43' ' ' ILE . 11.8 mt -94.44 148.84 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.205 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.91 155.14 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.43 156.96 16.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.6 -164.52 34.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -155.38 65.58 0.62 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -1.149 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.99 -170.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 19' ' ' VAL . 18.4 tt0 -89.53 -22.74 22.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.423 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -70.65 -52.64 19.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.79 ' CE1' HD23 ' A' ' 21' ' ' LEU . 14.1 t80 -65.75 -19.66 65.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -54.52 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 15' ' ' GLU . 6.5 t -63.74 -36.35 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -65.82 -61.14 2.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.79 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -54.15 -27.16 31.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.91 -36.39 64.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -22.05 54.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -43.88 74.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.63 -14.7 62.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -51.5 51.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.331 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 p -63.33 -47.65 81.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 114.52 -109.94 2.26 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 55.58 169.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.419 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 4.7 mt-10 -120.3 130.11 54.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' ' CE3' ' A' ' 31' ' ' TRP . 25.9 p-90 -160.04 148.46 17.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.512 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -133.07 156.99 79.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.448 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.4 Cg_endo -77.63 129.92 10.38 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.65 2.233 . . . . 0.0 110.323 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -121.65 149.81 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -46.6 160.05 0.33 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.354 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -77.99 0.29 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.656 2.238 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.93 -27.42 12.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -130.44 36.1 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.92 116.4 22.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -36.53 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.937 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -136.3 139.23 42.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.695 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -113.84 149.03 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.324 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HG12 ' A' ' 9' ' ' ILE . 4.1 mt -136.98 129.84 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 56' ' ' ILE . 1.3 t -118.83 129.79 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.8 mm? -92.62 128.33 38.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' ' 81' ' ' VAL . . . -87.46 -0.76 57.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 109.585 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.01 -13.25 61.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.52 46.28 2.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.221 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.782 ' CZ3' HD22 ' A' ' 85' ' ' LEU . 44.9 t-105 -77.67 -16.89 58.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.797 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.23 19.47 29.52 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -132.75 -62.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -1.205 . . . . 0.0 109.701 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.1 36.09 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -59.33 -40.09 85.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.32 -39.34 66.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.658 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -73.1 -45.33 57.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.904 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.9 mt -59.93 -24.68 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.684 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.5 -55.77 8.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 109.507 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.06 65.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.71 24.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -1.173 . . . . 0.0 109.431 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 56' ' ' ILE . 51.4 t -56.01 -37.76 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 62' ' ' LEU . 12.9 mt -63.97 -31.54 72.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.246 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.11 57.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -69.27 -9.04 51.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.1 tttm -61.38 -15.61 38.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' SER . 22.2 m -152.88 -75.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 169.56 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.86 . . . . 0.0 109.342 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.34 155.91 57.02 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.9 Cg_endo -78.36 114.11 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.631 2.221 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mt -103.01 117.35 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.438 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 mt -110.94 114.78 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 92' ' ' VAL . 8.5 t -85.61 154.86 21.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.301 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.719 ' HB ' HD13 ' A' ' 45' ' ' LEU . 47.3 t -124.37 129.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.17 -0.956 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.21 155.2 18.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.567 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 176.58 9.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.709 2.273 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 77' ' ' GLY . 6.4 t80 -70.75 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 76' ' ' TYR . . . -132.97 96.36 0.3 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' GLU . 2.4 tt 179.27 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -1.176 . . . . 0.0 109.289 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 78' ' ' LEU . 9.9 mt-10 61.02 126.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -179.53 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.812 HG22 ' HB1' ' A' ' 46' ' ' ALA . 80.2 t -104.82 130.75 22.63 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 34.9 Cg_endo -77.88 168.92 21.46 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.403 2.069 . . . . 0.0 110.38 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 -10.3 15.53 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.656 2.237 . . . . 0.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.7 tt0 -81.88 -2.86 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.782 HD22 ' CZ3' ' A' ' 49' ' ' TRP . 40.7 tp -112.86 -15.99 12.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.17 -0.956 . . . . 0.0 109.204 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -82.63 -12.07 57.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.18 -36.42 9.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.772 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -79.91 -24.61 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 109.715 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' SER . 2.0 p -68.17 94.18 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.427 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' SER . 50.6 m -43.69 -33.64 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.65 157.83 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.375 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 HG23 ' A' ' 72' ' ' THR . 14.8 p -126.31 145.57 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 103' ' ' ALA . 85.4 t -129.22 147.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 109.568 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.29 -151.15 18.8 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -97.99 43.88 1.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -1.21 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -106.06 150.76 39.7 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.89 . . . . 0.0 109.703 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 34.8 Cg_endo -78.11 -48.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.727 2.285 . . . . 0.0 110.332 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.61 -31.98 63.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 5.3 m -60.68 -18.89 56.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.563 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 96' ' ' ASN . 21.3 mm -70.91 -36.47 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.5 -51.52 12.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.58 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -53.0 -27.08 17.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.657 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -77.1 -55.82 5.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.774 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -54.46 -24.32 19.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.67 -42.22 61.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 102' ' ' ASP . 8.7 m-20 -50.13 -23.44 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.55 80.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.637 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.7 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.308 0.575 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 7' ' ' LEU . 9.0 pt -129.09 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -112.96 109.95 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.258 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 104' ' ' LEU . 1.4 mp -118.4 171.5 8.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.761 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.3 95.41 2.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.0 109.192 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.794 HG13 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -79.79 132.68 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.65 140.04 19.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 109.547 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -56.41 131.24 47.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.29 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -142.46 153.65 24.62 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.5 22.81 5.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -1.12 . . . . 0.0 109.275 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.68 156.2 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -59.35 -19.29 45.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.375 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.81 -66.13 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 9' ' ' ILE . 10.7 t80 -46.33 -31.28 2.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.269 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -52.08 51.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 77.6 t -57.69 -32.37 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.18 -35.76 76.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -52.95 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.617 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.51 -24.72 65.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -74.16 -31.22 62.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.704 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -35.38 65.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.716 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.03 -46.73 73.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -19.76 63.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.498 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -68.31 -28.96 67.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 97.94 -173.5 28.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 75.39 136.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 109.517 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' H ' HD13 ' A' ' 29' ' ' LEU . 1.2 mt-10 -92.38 93.15 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -97.15 169.34 9.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.0 mtp180 -151.95 152.77 30.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.7 Cg_endo -78.54 139.19 15.98 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.687 2.258 . . . . 0.0 110.525 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -125.91 145.09 50.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.474 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -51.44 172.42 0.15 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.99 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.724 2.283 . . . . 0.0 110.671 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -103.9 -52.86 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.109 -0.995 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -100.29 37.09 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.74 124.81 26.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -70.68 -36.27 73.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.517 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -149.2 121.6 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.03 136.48 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.794 HD12 HG13 ' A' ' 9' ' ' ILE . 21.8 mt -116.33 88.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.78 126.8 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -96.67 125.27 41.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.09 54.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.391 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.95 -19.53 69.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -95.64 20.39 9.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.286 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 14.9 t-105 -69.91 -15.42 63.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.86 34.94 5.24 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -148.78 -52.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -1.165 . . . . 0.0 109.584 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 55' ' ' GLU . 10.7 mtt-85 -130.67 63.58 1.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -42.07 74.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.242 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -73.13 -35.69 66.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.35 -0.844 . . . . 0.0 109.319 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -65.39 -32.78 74.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.328 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 52' ' ' ARG . 31.5 mt -76.11 -51.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -47.51 -35.85 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -50.16 54.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 -34.55 58.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 109.297 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.81 -52.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.843 . . . . 0.0 109.276 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.74 -39.14 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.5 mt -70.29 -34.01 72.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.09 -54.85 42.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -70.88 -14.03 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.79 -29.33 3.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.89 -79.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -178.5 65.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.0 149.14 37.23 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 34.7 Cg_endo -77.6 127.09 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.569 2.179 . . . . 0.0 110.162 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' SER . 53.5 mt -103.68 118.73 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.6 HD12 ' HB1' ' A' ' 103' ' ' ALA . 44.5 mm -108.53 119.42 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.001 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 93' ' ' VAL . 10.8 m -92.88 143.37 26.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.893 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' ARG . 41.0 t -121.74 115.26 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -43.12 155.3 0.28 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 158.57 32.17 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.671 2.247 . . . . 0.0 110.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -109.16 18.06 20.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.45 13.52 62.79 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 52.09 48.47 22.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.407 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 -143.38 0.35 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.313 -0.867 . . . . 0.0 109.125 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -142.19 108.64 5.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.899 HG11 ' OE2' ' A' ' 86' ' ' GLU . 14.1 p -50.49 140.85 17.71 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.91 . . . . 0.0 109.241 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 81' ' ' VAL . 35.3 Cg_endo -77.73 156.46 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.468 2.112 . . . . 0.0 110.316 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.9 Cg_endo -78.25 71.06 6.91 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.639 2.226 . . . . 0.0 110.716 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.21 -42.66 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.073 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.61 -29.74 22.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.899 ' OE2' HG11 ' A' ' 81' ' ' VAL . 6.3 mp0 -72.2 -20.39 61.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.24 83.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.37 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 m -122.41 48.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -106.78 129.22 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.388 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 5.4 m -71.33 -34.24 70.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -157.13 142.9 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.36 100.34 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' THR . 4.4 m -95.08 144.54 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.85 -146.73 17.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -92.11 13.53 18.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -1.095 . . . . 0.0 109.535 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 3.0 m-20 -87.81 150.26 47.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.3 Cg_endo -77.82 -35.27 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.654 2.236 . . . . 0.0 110.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.93 -26.89 69.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 92.1 m -77.42 -25.04 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.77 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 100' ' ' ILE . 22.3 mm -66.97 -58.48 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.73 -33.36 75.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.95 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.741 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -69.77 -37.24 76.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 7' ' ' LEU . 14.4 mt -77.24 -22.41 52.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.718 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.08 91.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.3 98.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.15 60.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.296 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 108' ' ' LEU . 62.4 mt -122.08 165.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.686 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.6 ' N ' HG22 ' A' ' 5' ' ' ILE . 66.8 mtt180 -127.86 120.0 26.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.063 HD13 HD12 ' A' ' 43' ' ' ILE . 1.5 pp -145.42 170.79 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.751 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -137.38 139.14 40.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.204 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 7' ' ' LEU . 3.8 mt -121.63 147.89 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -65.01 121.37 14.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.29 169.36 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.572 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.22 -166.27 36.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -146.03 36.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.88 163.21 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.148 -0.97 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.1 tp10 -68.77 -31.94 71.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.04 -38.41 79.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -64.11 -46.66 83.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.47 -26.03 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 15' ' ' GLU . 57.4 t -69.85 -55.23 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.577 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.477 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 9.6 t80 -55.99 -47.27 78.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.356 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.49 -37.79 70.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.03 82.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.25 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -72.69 -28.51 62.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -72.4 -29.63 63.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -41.26 61.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -17.93 9.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.4 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.12 -13.9 11.19 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.37 172.3 13.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -126.02 114.09 17.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -0.844 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -127.1 154.66 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -115.76 149.35 42.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.302 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.9 Cg_endo -78.13 142.56 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.563 2.175 . . . . 0.0 110.683 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 -166.53 1.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.887 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -80.14 165.28 47.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.48 -4.54 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.58 2.187 . . . . 0.0 110.38 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.89 -37.35 3.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.253 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.3 33.39 3.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.229 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -102.14 142.96 32.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -66.06 -34.76 78.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . . . -140.09 115.16 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 109.315 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.5 100.35 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.063 HD12 HD13 ' A' ' 7' ' ' LEU . 35.7 mt -92.26 99.83 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.249 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.723 HG11 HG23 ' A' ' 56' ' ' ILE . 20.2 t -90.19 135.14 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.62 124.62 34.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.426 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.06 -0.07 55.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.96 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.74 79.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 -81.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 109.493 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.55 ' CH2' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER 48.75 22.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.846 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.86 -79.41 0.69 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' HD2' ' A' ' 52' ' ' ARG . 9.5 t -87.97 -26.93 22.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.0 109.345 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -93.11 34.05 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -59.88 -43.84 94.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.271 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.41 -21.09 62.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.262 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -43.81 62.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -73.68 -58.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -20.76 66.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -73.93 -56.4 5.36 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.55 75.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -1.103 . . . . 0.0 109.335 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 70' ' ' ILE . 85.0 t -63.35 -45.17 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -57.68 -37.2 73.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -68.3 -39.59 82.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -76.3 -11.31 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -73.08 -19.27 61.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -74.24 -25.86 59.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 0.0 109.884 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.62 9.81 4.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.955 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 t 54.17 59.78 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.416 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 9.9 mttm -81.66 169.63 18.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 35.7 Cg_endo -78.27 106.52 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.767 2.311 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.423 HG21 HG22 ' A' ' 60' ' ' VAL . 4.0 mt -108.04 98.0 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.58 114.33 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.452 HG21 ' CD2' ' A' ' 85' ' ' LEU . 23.2 p -91.88 140.58 29.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.22 121.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.77 160.89 0.31 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 -175.93 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -42.58 90.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.63 44.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 -23.78 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.104 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.36 126.92 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 109.455 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.72 147.8 41.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.62 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.46 155.64 9.76 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 161.89 29.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.623 2.215 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 35.3 Cg_endo -77.58 -15.47 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.67 2.247 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -70.31 -27.54 64.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.55 HD13 ' CH2' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -86.34 -24.8 25.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 83' ' ' PRO . 4.0 mt-10 -58.21 -35.2 71.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.2 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.714 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 88' ' ' VAL . 18.9 m -89.46 4.0 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.747 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -101.64 143.57 31.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 t -107.37 -17.48 14.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.77 135.0 14.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.517 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.61 110.09 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 137.47 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.3 -144.11 12.45 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.96 63.65 1.19 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.243 -1.151 . . . . 0.0 109.477 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -138.55 143.15 37.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.95 -27.64 4.49 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.658 2.239 . . . . 0.0 110.628 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.13 -32.25 64.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.5 m -74.99 -47.35 29.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.26 -13.1 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -76.27 -55.96 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.986 . . . . 0.0 109.617 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -72.94 -24.88 60.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.49 73.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.596 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.74 -41.63 62.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -34.39 64.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.606 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.05 -16.83 34.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.481 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 5' ' ' ILE . 3.4 mt-10 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.016 HG21 HD22 ' A' ' 104' ' ' LEU . 1.2 mp -131.66 153.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 20.7 mtt-85 -114.96 105.81 13.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.46 171.7 13.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.569 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -143.86 138.96 28.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.834 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 mt -120.85 133.82 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.353 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -58.35 111.89 1.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -52.44 135.37 33.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.86 ' HA3' HD21 ' A' ' 48' ' ' LEU . . . -136.84 148.78 19.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -77.9 -31.94 51.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 17' ' ' TYR . 25.1 m -43.36 137.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.506 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.3 pt-20 -64.51 -24.28 67.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.173 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.502 ' OD2' ' CG ' ' A' ' 76' ' ' TYR . 11.4 t70 -61.95 -31.06 71.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.102 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 11' ' ' GLU . 69.7 t80 -64.48 -42.75 95.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.42 91.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.258 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 15' ' ' GLU . 4.9 t -57.96 -56.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.185 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.429 ' HE2' HG21 ' A' ' 43' ' ' ILE . 16.3 t80 -51.14 -40.19 57.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.129 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.88 -58.14 8.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.548 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.69 -17.23 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -71.89 -55.82 6.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.568 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -56.83 -21.7 30.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.558 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -74.29 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.609 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.37 -1.92 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -43.53 73.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.08 -71.53 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.631 HD13 ' CZ ' ' A' ' 101' ' ' ARG . 0.7 OUTLIER -66.55 157.5 32.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -1.137 . . . . 0.0 109.513 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -88.96 121.05 30.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -93.37 158.77 15.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.641 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.65 146.2 52.11 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.383 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.71 129.21 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.525 2.15 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.69 164.96 12.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.715 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.437 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -73.95 171.86 9.93 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 36.4 Cg_endo -80.28 42.23 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.805 2.337 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -159.32 -62.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 109.635 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.33 27.98 1.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' ' CE ' ' A' ' 68' ' ' LYS . . . -64.22 132.47 50.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.87 . . . . 0.0 109.286 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -71.2 -33.84 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.26 23.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.34 110.32 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 20' ' ' PHE . 65.6 mt -93.63 94.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 70' ' ' ILE . 1.5 t -90.13 122.31 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 73' ' ' VAL . 4.1 mm? -81.81 121.52 26.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.287 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -71.22 -12.23 61.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.601 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.33 29.93 11.25 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.86 HD21 ' HA3' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -124.86 -19.1 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.925 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.797 ' CZ3' ' HB1' ' A' ' 46' ' ' ALA . 1.8 p90 -66.82 -21.79 66.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.032 -1.042 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -64.17 -15.52 58.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.72 -48.28 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -1.115 . . . . 0.0 109.274 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -129.37 63.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -23.33 6.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.2 -46.74 40.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -46.6 89.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.485 HD13 HG21 ' A' ' 10' ' ' THR . 50.3 mm -58.31 -54.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 tp -50.6 -30.4 13.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -49.2 42.6 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.01 -46.53 64.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -1.132 . . . . 0.0 108.846 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.54 -29.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.25 -0.906 . . . . 0.0 109.037 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 16.8 t70 -59.16 -44.78 92.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.43 -38.23 65.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.339 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.445 ' HB1' HG12 ' A' ' 70' ' ' ILE . . . -68.7 -14.44 63.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' ASP . 4.6 mmm180 -65.5 -14.69 61.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -64.2 -11.95 35.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.945 . . . . 0.0 109.499 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 71.44 39.16 0.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.64 -67.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 39' ' ' ALA . 2.3 mmtt -92.95 153.17 41.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 142.65 19.52 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.661 2.241 . . . . 0.0 110.443 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.445 HG12 ' HB1' ' A' ' 63' ' ' ALA . 1.9 mt -103.05 91.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 93' ' ' VAL . 3.0 mt -80.12 115.77 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -98.73 139.84 33.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.683 ' HB ' HD13 ' A' ' 45' ' ' LEU . 19.0 t -111.22 130.71 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 73' ' ' VAL . 9.0 mtt180 -43.75 157.57 0.27 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.557 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.48 145.56 23.7 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.675 2.25 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 16.1 t80 -66.98 -10.89 54.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.923 ' C ' HD12 ' A' ' 78' ' ' LEU . . . -68.45 -95.05 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.923 HD12 ' C ' ' A' ' 77' ' ' GLY . 6.0 mp -135.87 -92.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 3.4 pt-20 -159.31 -142.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.13 -0.982 . . . . 0.0 108.925 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 2.0 m120 69.59 54.57 0.38 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.2 m -71.22 144.81 90.14 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.3 Cg_endo -78.09 146.78 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.548 2.166 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' GLU . 35.1 Cg_endo -77.75 -9.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.533 2.155 . . . . 0.0 110.229 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.26 -58.39 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.933 . . . . 0.0 109.394 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.0 tt -72.63 -9.58 58.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -78.59 -11.25 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.484 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.66 -20.86 56.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.789 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -113.99 6.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t -81.77 105.25 12.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -30.55 57.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.99 152.19 34.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 109.499 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.59 154.95 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 HG23 ' A' ' 71' ' ' ILE . 51.8 t -138.72 144.26 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -161.85 29.31 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -91.56 36.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -1.182 . . . . 0.0 109.503 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -113.27 155.84 43.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 100' ' ' ILE . 35.4 Cg_endo -77.92 -60.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.345 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -51.13 -23.88 3.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.77 -51.83 24.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 24' ' ' LEU . 5.2 mt -57.31 -62.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.631 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -43.71 -32.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.566 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.21 -60.16 4.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.541 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.016 HD22 HG21 ' A' ' 5' ' ' ILE . 17.0 mt -58.2 -56.36 23.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 0.0 109.636 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -73.17 -7.97 53.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.79 -24.66 52.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -16.88 64.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.631 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.728 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.96 HG21 HD21 ' A' ' 104' ' ' LEU . 11.7 tt -150.01 124.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.0 109.329 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -91.76 129.12 37.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.628 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -147.96 169.61 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.4 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -124.88 143.08 51.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' A' ' 21' ' ' LEU . 3.3 mt -122.16 125.0 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.13 145.06 2.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.46 105.85 10.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.02 -146.06 7.22 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.23 47.16 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.21 150.17 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.41 -45.32 94.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.46 -24.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -75.99 -45.88 32.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 109.829 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -63.8 -35.38 80.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -71.78 -39.06 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.289 -0.882 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 76.5 t80 -67.07 -62.72 1.29 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' CD1' HD13 ' A' ' 9' ' ' ILE . 12.9 tp -54.23 -49.39 69.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.435 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 18' ' ' ARG . 91.9 mt-10 -53.67 -33.96 57.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -35.27 65.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -48.26 -32.3 7.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.816 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.68 -42.69 86.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 0.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -72.15 -4.28 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.515 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -80.8 -12.91 59.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 70.33 -155.15 52.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 1.6 mt 61.68 171.41 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.408 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.19 108.12 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -117.88 153.23 33.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.175 -0.953 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.1 mmt180 -138.4 146.28 50.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.287 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 Cg_endo -78.67 146.69 21.43 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.553 2.169 . . . . 0.0 110.405 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 -151.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.159 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.11 169.13 12.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 35.7 Cg_endo -77.85 71.12 6.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.596 2.198 . . . . 0.0 110.278 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 36' ' ' PRO . 2.0 mt-10 -173.66 -35.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.243 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.42 27.99 3.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.406 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.77 110.12 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -51.64 -47.51 63.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.685 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 7' ' ' LEU . . . -119.77 149.83 41.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.79 109.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 96.6 mt -90.83 118.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' A' ' 56' ' ' ILE . 6.5 t -102.97 126.35 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 48' ' ' LEU . 3.5 mm? -92.04 131.82 37.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.81 5.14 51.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.37 -20.7 71.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -110.6 38.15 2.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -1.097 . . . . 0.0 109.2 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 26.3 t-105 -80.96 -17.56 50.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.56 11.11 53.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -122.99 -59.47 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.181 . . . . 0.0 109.585 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.3 mpt_? -116.69 53.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -47.85 82.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.294 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.04 -41.23 59.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -0.867 . . . . 0.0 109.409 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -42.19 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.584 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 48' ' ' LEU . 25.2 mm -59.65 -62.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.65 -31.49 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.822 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.1 -61.92 4.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.49 -35.97 6.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -1.149 . . . . 0.0 109.768 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 80.9 t -67.96 -63.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 60' ' ' VAL . 21.0 t70 -43.14 -30.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.824 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.7 tp -76.92 -42.72 38.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.915 . . . . 0.0 109.595 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.02 -57.0 12.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -62.89 -13.58 35.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -46.82 -27.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -140.36 -71.1 0.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.88 33.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.509 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -71.24 147.02 92.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 35.6 Cg_endo -78.1 125.01 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.657 2.238 . . . . 0.0 110.589 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.94 124.27 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 71' ' ' ILE . 2.8 mm -92.71 107.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.318 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -81.6 109.1 15.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.704 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.2 106.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.478 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 18.6 ptt85 -48.86 161.98 0.39 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.496 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -78.02 -162.1 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.626 2.218 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 76' ' ' TYR . 9.0 t80 -108.14 15.33 24.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 17.86 47.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.2 mm? -93.06 -67.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -1.196 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -109.48 14.16 23.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' GLU . 1.3 m120 46.41 -173.62 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 ' HD2' ' A' ' 82' ' ' PRO . 14.9 p -126.28 138.32 32.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.346 -0.847 . . . . 0.0 109.057 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.9 Cg_endo -78.24 165.68 25.43 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.464 2.109 . . . . 0.0 110.437 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.19 4.72 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.57 2.18 . . . . 0.0 110.352 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.87 -10.45 59.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 -29.26 14.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -32.49 74.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.882 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 -16.61 62.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.322 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.0 m -144.75 52.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.37 130.26 52.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.537 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t -103.13 -38.68 7.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.35 140.68 49.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 93' ' ' VAL . 97.2 t -123.1 130.38 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.238 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.493 HG21 HG22 ' A' ' 71' ' ' ILE . 12.8 m -153.34 138.57 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.801 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.41 -145.74 16.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -86.81 -4.69 59.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -1.154 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -57.64 151.15 42.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.12 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.579 2.186 . . . . 0.0 110.551 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.478 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 11.3 m170 -56.2 -17.56 7.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -43.76 83.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.13 -24.13 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -74.32 -51.39 15.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 109.28 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.14 -35.99 76.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.96 -61.99 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.96 HD21 HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -45.75 -32.28 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.724 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.03 -43.18 68.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.94 -44.37 96.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.734 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.12 83.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.617 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' A' ' 104' ' ' LEU . 14.9 mt -135.64 135.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 7.7 mpt_? -99.2 115.98 30.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.248 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -141.21 171.08 14.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.683 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -138.29 124.57 20.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.524 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG22 ' HE1' ' A' ' 17' ' ' TYR . 24.8 mt -114.29 139.19 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 m -63.06 134.78 56.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.77 164.84 13.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 169.62 40.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.29 47.6 1.69 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.221 -1.164 . . . . 0.0 109.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.79 172.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 pt-20 -68.39 -24.32 64.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.536 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.93 -55.28 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' HE1' HG22 ' A' ' 9' ' ' ILE . 13.5 t80 -51.57 -39.17 57.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -63.17 -42.26 99.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.594 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.0 t -61.47 -43.78 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.837 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.0 -47.72 83.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.558 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -65.68 -20.31 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' OE2' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -73.15 -55.6 6.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -58.04 -51.08 71.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.43 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -45.26 -44.04 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.92 -53.56 52.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.74 -19.2 5.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -65.6 -68.29 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.374 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.16 8.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.7 151.53 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -1.117 . . . . 0.0 109.521 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -99.59 106.15 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.799 ' HB2' HD21 ' A' ' 7' ' ' LEU . 67.5 p-90 -105.42 167.47 9.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -147.45 145.4 21.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.21 105.69 2.03 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.613 2.209 . . . . 0.0 110.444 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.85 -154.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.654 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 19.2 p -100.63 158.12 32.48 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 -3.3 13.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.588 2.192 . . . . 0.0 110.573 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.494 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 4.1 mt-10 -102.27 -17.59 15.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 109.314 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -144.16 36.53 1.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.376 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.86 125.11 30.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.647 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.7 t70 -50.87 -31.9 18.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.417 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.41 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.379 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 39' ' ' ALA . 1.6 t -91.94 107.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.28 102.28 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.31 132.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD22 ' HB ' ' A' ' 73' ' ' VAL . 1.1 mm? -103.13 135.85 44.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.282 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.51 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.44 61.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 mp -90.94 32.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 109.54 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.472 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 32.0 t-105 -62.56 -16.97 58.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.594 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.38 35.45 3.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -144.31 -67.42 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.35 52.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 109.619 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.27 -47.74 81.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.309 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.61 -22.93 48.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -77.16 -50.61 12.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.9 mt -62.41 -27.13 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.649 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.89 -32.68 67.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.28 -41.12 26.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.72 80.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -1.137 . . . . 0.0 109.854 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 56' ' ' ILE . 39.9 t -74.09 -34.89 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.9 -46.31 82.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 37' ' ' GLU . 62.2 mt -70.88 -41.88 70.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.003 . . . . 0.0 109.806 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -25.62 68.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.704 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -77.25 -20.2 55.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.76 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -79.71 -9.55 59.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' SER . 0.3 OUTLIER -125.67 3.52 7.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' SER . 17.9 m 60.62 38.38 18.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.9 mmpt? -71.28 161.36 78.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 0.0 109.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 34.2 Cg_endo -76.99 108.45 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.429 2.086 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 70' ' ' ILE . 15.2 mt -108.78 109.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.715 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.6 HG12 ' HB1' ' A' ' 103' ' ' ALA . 3.2 mt -97.83 117.2 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.258 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -80.54 147.65 30.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 45' ' ' LEU . 74.4 t -122.16 113.17 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.423 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -52.89 159.35 1.86 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 36.2 Cg_endo -77.82 166.64 25.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.733 2.289 . . . . 0.0 110.246 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -74.49 -59.1 2.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -149.64 15.83 1.08 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.075 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 32.3 tp -71.83 -78.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -1.228 . . . . 0.0 109.354 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 tt0 -147.51 -143.05 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.041 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.4 ' OD1' ' OE1' ' A' ' 79' ' ' GLU . 2.9 p30 -124.59 176.65 6.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.91 134.95 20.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.17 173.04 14.48 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.435 2.09 . . . . 0.0 110.519 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.8 Cg_endo -77.37 -1.53 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.576 2.184 . . . . 0.0 110.596 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -73.91 -70.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.306 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -16.22 54.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.51 -42.96 61.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.16 68.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.6 m -102.94 38.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -128.7 105.63 8.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.539 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 91' ' ' GLU . 1.5 m -56.52 -39.68 73.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 106' ' ' ASP . 13.1 mp0 -138.29 157.95 45.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.59 133.57 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.131 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 15.0 m -139.99 169.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.101 -0.999 . . . . 0.0 109.873 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 74' ' ' ARG . . . -106.45 -144.37 11.94 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -93.06 47.63 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -1.143 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -100.73 146.47 32.14 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -38.73 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.551 2.168 . . . . 0.0 110.317 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -23.26 56.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -73.58 -15.44 61.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.63 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.9 mm -73.37 -40.23 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -76.81 -34.66 57.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -31.87 70.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.674 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HG12 ' A' ' 71' ' ' ILE . . . -77.19 -44.96 28.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.02 -28.7 69.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.874 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 2.4 tp10 -66.06 -21.31 66.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.884 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD2' ' OE2' ' A' ' 91' ' ' GLU . 1.1 t70 -63.17 -30.31 71.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.59 41.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.573 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.347 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.292 0.568 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' GLU . 7.5 tt -146.7 141.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.6 mtt-85 -97.64 104.38 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 41' ' ' ALA . 37.6 mt -113.35 157.73 21.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -134.88 92.12 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.742 HG21 ' CE1' ' A' ' 17' ' ' TYR . 2.7 mp -89.28 162.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.494 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.2 159.01 18.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.426 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.14 128.89 56.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.983 . . . . 0.0 109.61 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.21 -162.98 11.66 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -125.42 -4.67 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -1.147 . . . . 0.0 109.578 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 16' ' ' ASP . 18.1 m -83.74 -178.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 19' ' ' VAL . 13.3 pt-20 -92.2 -2.46 56.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.95 -69.54 0.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.509 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE1' HG21 ' A' ' 9' ' ' ILE . 5.0 t80 -48.64 -29.15 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.664 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -51.5 65.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.096 -1.002 . . . . 0.0 109.427 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 15' ' ' GLU . 20.0 t -62.67 -33.08 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.743 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -63.22 -57.95 8.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.65 -34.23 64.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.57 -40.03 95.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -40.52 74.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.929 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.83 71.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -34.69 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.672 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -68.96 -22.22 64.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -45.41 -45.99 13.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.475 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.04 -32.54 6.27 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.01 150.24 31.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -1.174 . . . . 0.0 109.533 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -87.91 151.5 22.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 109.453 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.435 ' C ' ' HG3' ' A' ' 32' ' ' ARG . 46.8 p-90 -153.43 160.84 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 24.2 mtt-85 -141.86 158.6 61.97 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.2 Cg_endo -78.18 95.47 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.677 2.251 . . . . 0.0 110.129 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -73.78 -176.77 2.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.681 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -87.2 173.55 6.45 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.257 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 62' ' ' LEU . 35.7 Cg_endo -78.23 -9.81 16.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.557 2.171 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -114.51 -6.48 12.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -139.38 48.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.255 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -101.83 127.61 48.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.658 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -67.41 -40.71 85.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -142.07 134.8 28.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.43 126.24 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' ILE . 2.5 mt -109.48 93.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.202 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.77 115.07 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.575 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 43' ' ' ILE . 13.6 mt -85.59 127.15 34.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.94 -0.47 35.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.35 -15.52 70.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -105.87 29.41 6.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.331 -1.1 . . . . 0.0 109.21 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -72.5 -26.94 61.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.68 40.45 2.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -159.66 -55.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -1.182 . . . . 0.0 109.529 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.688 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.2 mpt_? -116.29 56.97 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -47.98 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.1 -36.77 75.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.56 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -69.61 -62.04 1.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 60' ' ' VAL . 16.1 mt -43.14 -36.08 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.04 -56.05 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.42 -47.67 62.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.45 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 0.0 109.585 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 56' ' ' ILE . 2.7 t -71.89 -29.19 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -66.86 -38.7 86.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -75.83 -43.14 47.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 109.968 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -67.29 -27.64 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.952 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -77.24 -30.75 54.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 109.82 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 6.5 16.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 7.05 4.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.694 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 m 51.26 38.64 21.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 159.49 53.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.68 108.75 2.62 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 63' ' ' ALA . 17.2 mt -108.66 114.71 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 mt -107.0 141.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.329 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 m -109.78 135.03 51.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -101.09 133.49 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -58.13 155.09 26.94 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 159.21 31.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.676 2.251 . . . . 0.0 110.403 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -81.57 -53.59 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.37 83.3 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.14 -35.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -1.155 . . . . 0.0 109.535 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 66.45 128.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' C ' ' HD3' ' A' ' 82' ' ' PRO . 1.8 m-20 171.96 39.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.15 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.5 t -118.04 79.06 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 36.1 Cg_endo -78.29 174.67 12.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.595 2.197 . . . . 0.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.2 Cg_endo -79.05 9.43 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.77 2.313 . . . . 0.0 110.613 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -56.47 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -11.23 60.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.51 -28.82 64.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.556 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.92 42.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.63 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.06 -59.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.97 150.47 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -106.38 -21.04 13.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.372 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -151.39 163.92 37.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.73 159.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 103' ' ' ALA . 54.1 t -128.3 160.25 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.11 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 93' ' ' VAL . . . -112.42 -152.71 11.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -107.14 50.24 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -125.49 162.19 45.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.07 -43.31 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.751 2.301 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -26.34 58.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.827 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.6 m -62.23 -64.57 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.453 HG12 HG11 ' A' ' 93' ' ' VAL . 67.9 mt -44.68 -25.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -46.93 39.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -0.995 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.86 -17.5 64.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.626 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -71.13 -59.14 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.63 -37.56 86.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.562 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -51.4 -48.21 62.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -31.32 72.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.8 -62.22 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.8 160.68 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.69 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 6.5 mpt_? -106.98 128.83 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.999 ' HG ' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -137.61 166.98 22.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.695 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -151.13 115.42 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.56 141.26 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.58 125.67 10.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.78 126.64 28.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.99 30.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.0 53.12 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.731 HG23 ' H ' ' A' ' 17' ' ' TYR . 15.4 m -112.62 143.23 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 19' ' ' VAL . 29.0 tt0 -54.31 -25.12 22.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.58 -65.37 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 14' ' ' VAL . 5.5 t80 -50.08 -28.36 7.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -48.4 55.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 15' ' ' GLU . 71.7 t -61.37 -29.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.852 . . . . 0.0 109.657 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -71.19 -45.93 62.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.358 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.543 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -56.98 -46.17 82.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -36.79 84.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.51 71.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.566 ' CD2' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -75.69 -49.06 19.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -68.22 -17.97 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -70.67 -52.5 20.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.493 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -47.76 -35.85 10.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 125.58 -154.79 18.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 71.04 165.92 0.29 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.454 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.69 100.86 4.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' CD2' ' A' ' 24' ' ' LEU . 60.8 p-90 -115.36 157.93 23.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 109.28 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -125.17 152.46 70.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.46 125.64 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.699 2.266 . . . . 0.0 110.512 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.96 153.43 35.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.486 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -53.92 173.21 0.21 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.331 -0.856 . . . . 0.0 109.392 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -76.9 -0.34 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.541 2.161 . . . . 0.0 110.372 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -104.25 -6.09 21.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.303 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.34 30.07 1.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.82 98.96 12.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 6' ' ' ARG . 12.4 m-20 -50.76 -45.32 58.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.196 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.999 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -116.02 121.92 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.01 110.56 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 7' ' ' LEU . 6.6 mt -103.23 123.25 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.83 HG11 HG23 ' A' ' 56' ' ' ILE . 2.4 t -113.77 120.89 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 17' ' ' TYR . 53.0 mt -80.21 148.25 30.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.38 17.06 24.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -87.74 -29.85 19.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 24.14 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -1.152 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 41.8 t-105 -60.71 -14.21 19.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.55 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.91 37.96 2.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -150.31 -58.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -1.137 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -116.24 46.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 109.725 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HA ' HD12 ' A' ' 56' ' ' ILE . 2.1 ttt180 -57.84 -34.26 69.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -39.74 94.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.605 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 3.7 tt0 -65.59 -41.69 92.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.83 HG23 HG11 ' A' ' 44' ' ' VAL . 5.2 mt -70.82 -23.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.11 -52.65 13.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.71 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.98 73.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.91 -62.15 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -1.157 . . . . 0.0 109.599 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 70' ' ' ILE . 80.8 t -55.62 -31.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -63.0 -55.3 26.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -60.47 -25.08 65.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.281 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.53 62.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -7.56 38.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.644 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -49.21 -32.61 10.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -135.58 -69.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.43 43.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.686 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.25 151.15 75.11 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.08 116.53 4.21 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.807 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 60' ' ' VAL . 4.4 mt -107.43 98.53 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 108.881 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 10.4 mt -90.22 112.75 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 85' ' ' LEU . 15.0 p -89.41 141.51 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.13 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 93' ' ' VAL . 84.6 t -115.68 132.36 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HG2' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -51.7 158.47 1.58 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 36.2 Cg_endo -78.96 169.7 19.0 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 0.0 110.507 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 76' ' ' TYR . 74.8 t80 -82.9 8.85 11.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 122.12 71.49 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -151.98 81.9 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.562 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' LEU . 3.1 mt-10 70.91 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.476 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.8 137.06 58.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.613 HG13 ' HD2' ' A' ' 82' ' ' PRO . 86.9 t -68.44 141.04 92.92 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.5 Cg_endo -78.45 155.81 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.563 2.176 . . . . 0.0 110.412 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.16 -10.09 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.555 2.17 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.87 -15.93 63.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.295 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 72' ' ' THR . 42.2 tp -93.84 -18.79 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -24.47 43.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.13 61.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.7 -0.18 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 21.3 t -96.23 135.84 37.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 -33.01 54.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.82 168.99 24.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.2 m -130.71 156.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.897 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 73' ' ' VAL . 2.1 t -135.97 155.56 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 74' ' ' ARG . . . -116.98 -155.69 10.33 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -88.89 37.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -1.199 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.1 149.05 39.53 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 -66.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.609 2.206 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.24 -32.28 1.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -53.11 59.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.6 mt -55.05 -23.56 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.988 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -69.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -28.08 50.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.993 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.33 -51.73 48.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.452 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 7' ' ' LEU . 5.6 tt -72.46 -15.06 61.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.257 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -28.97 63.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.296 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -68.2 -12.53 61.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.429 -0.794 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -58.8 4.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.73 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 2' ' ' THR . 42.1 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.318 0.58 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.431 ' N ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -122.88 75.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.462 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.22 10.22 41.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -46.89 152.02 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.213 -0.93 . . . . 0.0 109.436 179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 6' ' ' ARG . 57.2 mt -114.63 162.58 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.533 ' C ' HD12 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -93.57 105.09 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.395 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD23 HD11 ' A' ' 43' ' ' ILE . 8.9 mp -112.35 168.24 9.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.145 -0.972 . . . . 0.0 109.699 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -153.09 142.19 21.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 mt -130.76 151.45 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.163 -0.961 . . . . 0.0 109.643 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.25 157.44 25.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 109.491 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -85.84 135.07 33.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.442 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.89 177.09 20.0 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -123.99 -12.57 7.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -1.095 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.9 m -67.81 165.97 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 0.0 109.503 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.02 -20.29 49.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.1 -32.78 73.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.177 -0.952 . . . . 0.0 109.355 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -61.48 -44.58 96.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.46 18.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.08 -35.31 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CZ ' HD12 ' A' ' 24' ' ' LEU . 18.6 t80 -65.88 -47.99 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.85 -45.92 71.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 109.633 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -58.36 -49.94 75.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.721 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -59.74 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.96 . . . . 0.0 109.439 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CZ ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -45.5 -38.28 6.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.468 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.64 -44.65 93.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -23.07 67.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.91 -51.74 38.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.25 -33.09 6.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 29' ' ' LEU . 1.4 mm? -57.76 148.63 24.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -1.133 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -82.16 131.76 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -138.56 145.37 40.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' NH2' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -130.53 147.8 67.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.188 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.441 ' HD2' ' NH2' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.7 101.88 1.53 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.459 2.106 . . . . 0.0 110.529 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 6' ' ' ARG . . . -101.81 154.92 18.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.333 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -59.89 164.87 5.28 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.174 -0.954 . . . . 0.0 109.341 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -77.37 -7.6 17.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.497 2.131 . . . . 0.0 110.114 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -28.6 15.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.3 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -127.05 46.53 2.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.296 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -100.17 148.35 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -95.43 -26.68 15.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.286 -0.883 . . . . 0.0 109.437 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -142.9 119.21 10.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.502 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.6 t -110.11 100.28 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -0.866 . . . . 0.0 109.659 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.698 HD11 HD23 ' A' ' 7' ' ' LEU . 1.4 mt -84.19 106.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.277 -0.889 . . . . 0.0 109.554 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 136.68 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 4.2 mm? -88.67 128.6 35.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.889 . . . . 0.0 109.441 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.71 4.63 15.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.97 . . . . 0.0 109.486 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.33 -24.02 61.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.61 27.3 3.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.602 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.571 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 6.6 t-105 -76.83 -42.45 40.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.368 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.41 7.06 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.0 p -141.08 -58.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.497 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -117.28 50.55 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.331 -0.856 . . . . 0.0 109.601 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -30.09 69.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -38.14 82.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.476 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.44 -55.7 8.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -48.84 -43.29 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' HA ' HD23 ' A' ' 57' ' ' LEU . 5.4 mt -45.78 -49.36 15.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.642 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 59' ' ' ALA . . . -56.17 -58.79 12.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 58' ' ' GLY . . . -43.53 -34.09 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -1.129 . . . . 0.0 109.649 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.3 t -69.91 -53.84 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -0.984 . . . . 0.0 109.634 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -49.24 -53.05 23.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.644 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.34 -33.14 73.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.554 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 68' ' ' LYS . . . -71.23 -21.67 62.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -71.73 -3.05 19.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.762 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' ARG . 0.5 OUTLIER -124.99 18.23 8.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.4 m -143.94 45.54 1.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.106 -0.996 . . . . 0.0 109.707 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' SER . 2.8 t 78.21 -3.59 2.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.363 -0.836 . . . . 0.0 109.723 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 50.34 60.01 15.61 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.301 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 37.4 Cg_endo -82.1 53.14 4.43 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.57 2.18 . . . . 0.0 109.764 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mt -99.98 117.93 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.265 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.9 mt -110.91 131.44 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 92' ' ' VAL . 55.1 m -96.93 129.82 44.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.986 -1.071 . . . . 0.0 110.25 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.72 116.84 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -46.51 154.57 0.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 109.69 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.11 161.64 29.31 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.751 2.3 . . . . 0.0 110.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -48.98 -23.75 1.25 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.614 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 128.17 37.08 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -96.02 -32.52 12.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.44 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -148.57 -143.24 0.14 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.295 -0.878 . . . . 0.0 109.076 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -148.28 140.48 24.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.905 . . . . 0.0 109.424 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.731 HG12 ' HD2' ' A' ' 82' ' ' PRO . 1.5 t -69.97 142.15 90.24 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 109.276 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.731 ' HD2' HG12 ' A' ' 81' ' ' VAL . 35.7 Cg_endo -79.33 173.0 13.81 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.524 2.149 . . . . 0.0 110.486 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.6 Cg_endo -80.23 19.35 1.06 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.796 2.331 . . . . 0.0 111.065 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -99.76 -8.66 23.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.867 -1.146 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.505 HD22 ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -100.4 -49.41 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.01 . . . . 0.0 109.56 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -20.98 5.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.81 -54.96 6.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.412 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.98 26.37 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.955 . . . . 0.0 109.385 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.7 m -102.59 144.94 30.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -99.19 -29.45 12.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.235 -0.915 . . . . 0.0 109.231 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.21 155.32 36.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.193 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.581 HG12 ' HB ' ' A' ' 72' ' ' THR . 11.1 m -142.24 130.55 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 28.2 m -134.37 -171.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -135.76 -146.9 5.35 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.463 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 83.7 m95 -89.64 69.87 7.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -1.127 . . . . 0.0 109.495 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 95' ' ' TRP . 6.6 m-20 -141.62 149.21 53.04 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.465 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.17 -38.65 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.681 2.254 . . . . 0.0 110.357 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -74.11 -41.4 61.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.32 -0.863 . . . . 0.0 109.537 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 1.2 m -56.88 -59.55 4.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 109.529 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.8 mt -51.81 -30.85 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.216 -0.928 . . . . 0.0 109.611 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -69.46 -37.95 77.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.704 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -65.13 -43.4 92.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.717 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.23 62.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.902 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 104' ' ' LEU . 18.6 tp -74.26 -62.01 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.0 109.577 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.82 -16.96 7.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -68.73 -38.72 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.423 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.13 -27.2 66.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -66.36 -71.2 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.295 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -57.83 97.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.606 ' O ' HG22 ' A' ' 110' ' ' VAL . 12.5 p -99.7 11.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.601 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.413 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 2' ' ' THR . 29.4 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.307 0.575 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 44.33 71.67 0.24 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.73 27.02 4.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' OE1' ' HB3' ' A' ' 30' ' ' GLU . 1.8 mt-10 63.33 171.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.499 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 HD12 HD13 ' A' ' 104' ' ' LEU . 13.2 mt -138.47 140.42 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.53 ' CG ' ' HB2' ' A' ' 34' ' ' ALA . 2.8 mpp_? -94.08 97.6 10.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 43' ' ' ILE . 1.5 mp -107.29 157.23 18.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.888 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -123.43 119.85 31.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.367 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 10' ' ' THR . 20.5 mt -111.54 132.6 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -57.35 -162.58 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.99 156.8 44.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.11 -175.41 42.54 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.25 39.25 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -1.085 . . . . 0.0 109.182 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -115.43 -171.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -84.48 -10.25 57.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -76.51 -74.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.665 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.792 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.2 t80 -50.82 -26.15 5.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.148 -0.97 . . . . 0.0 109.635 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -72.28 -68.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.925 . . . . 0.0 109.571 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 15' ' ' GLU . 98.8 t -43.34 -44.94 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.813 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CE2' HD12 ' A' ' 24' ' ' LEU . 66.1 t80 -60.52 -44.62 95.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.689 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -57.95 -41.16 82.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.66 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.72 -45.62 93.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.127 -0.983 . . . . 0.0 109.622 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -17.84 63.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.166 -0.959 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.845 HD22 ' CZ2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -72.55 -56.34 5.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.945 . . . . 0.0 109.506 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.34 -42.24 88.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.507 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.61 -20.57 14.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 109.413 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.6 m -69.73 -61.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.583 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.97 -153.23 19.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.62 159.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -1.157 . . . . 0.0 109.437 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 2.6 mp0 -113.1 95.73 5.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.722 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.845 ' CZ2' HD22 ' A' ' 24' ' ' LEU . 31.0 p-90 -112.18 169.3 8.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 108.983 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.3 162.79 38.2 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.122 -0.986 . . . . 0.0 109.859 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 119.48 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.642 2.228 . . . . 0.0 110.273 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB2' ' CG ' ' A' ' 6' ' ' ARG . . . -106.37 -177.55 3.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.41 173.26 5.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -78.18 -6.47 15.73 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.607 2.204 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.18 -0.94 16.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.888 . . . . 0.0 109.509 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.45 56.04 0.45 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -112.85 119.06 36.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 4.9 t70 -49.94 -41.74 47.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -145.7 154.55 42.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 109.372 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 109.19 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.388 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 7' ' ' LEU . 84.1 mt -92.74 94.28 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.33 130.68 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.864 . . . . 0.0 109.51 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.921 ' HB3' HD23 ' A' ' 48' ' ' LEU . 2.0 mm? -88.49 116.39 26.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' CH2' ' A' ' 49' ' ' TRP . . . -57.45 -22.19 41.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' HD22 ' A' ' 48' ' ' LEU . . . -89.28 34.8 3.86 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.921 HD23 ' HB3' ' A' ' 45' ' ' LEU . 2.2 mm? -121.08 -27.4 4.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -1.131 . . . . 0.0 109.765 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.9 p90 -65.31 -21.51 66.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.021 . . . . 0.0 109.3 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.562 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -58.61 -18.44 37.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 p -110.08 -39.08 5.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -141.61 57.24 1.51 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 109.549 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' CG ' ' HB2' ' A' ' 49' ' ' TRP . 4.0 ttt180 -53.73 -22.07 8.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.385 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.94 -42.34 60.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 109.501 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -66.75 -47.9 70.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.462 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 49' ' ' TRP . 1.8 mp -60.69 -37.29 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.351 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.95 -54.61 44.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.39 -42.13 64.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.39 -40.64 74.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -1.14 . . . . 0.0 109.244 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.55 -33.99 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.322 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -59.92 -52.4 65.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.31 -30.67 71.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.339 -0.85 . . . . 0.0 109.393 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.855 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -72.18 -20.23 61.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.392 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -10.13 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.358 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 66' ' ' SER . 11.4 tttp -68.05 -9.23 44.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.529 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 14.9 t 68.27 45.94 1.16 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.627 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -110.77 -37.41 5.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -127.25 155.62 76.02 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.092 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.445 ' CD ' ' O ' ' A' ' 40' ' ' ASP . 35.0 Cg_endo -77.3 122.86 6.3 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.509 2.139 . . . . 0.0 110.547 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.855 HD11 ' CB ' ' A' ' 63' ' ' ALA . 69.0 mt -91.92 127.76 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' CG2' HG23 ' A' ' 93' ' ' VAL . 3.7 mp -124.09 113.9 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.336 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.518 HG21 HD23 ' A' ' 85' ' ' LEU . 19.0 p -96.01 121.53 37.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.478 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.939 HG22 ' HB ' ' A' ' 93' ' ' VAL . 92.3 t -98.91 121.48 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.353 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.463 ' O ' ' CZ2' ' A' ' 95' ' ' TRP . 12.0 mmt180 -43.14 151.98 0.4 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.27 151.88 26.8 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.654 2.236 . . . . 0.0 110.525 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -49.22 -49.87 40.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.305 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.59 111.59 0.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -167.3 -46.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.362 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.86 -143.75 0.27 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.033 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.27 115.82 15.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.188 -0.945 . . . . 0.0 109.539 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 74' ' ' ARG . 78.9 t -50.24 134.27 23.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.26 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.7 Cg_endo -77.95 148.25 24.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.453 2.102 . . . . 0.0 110.394 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.1 Cg_endo -77.62 -4.09 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.642 2.228 . . . . 0.0 110.47 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -85.63 -42.91 13.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.946 . . . . 0.0 109.56 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 72' ' ' THR . 0.4 OUTLIER -67.71 -31.15 70.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.466 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -81.38 -0.59 42.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.265 -0.897 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.28 28.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.125 -0.984 . . . . 0.0 109.646 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.7 m -95.85 -0.25 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 m -72.71 128.84 36.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 109.302 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.6 m -89.07 -18.85 26.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.109 -0.994 . . . . 0.0 109.928 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.57 142.94 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.863 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.41 115.26 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.014 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.939 ' HB ' HG22 ' A' ' 73' ' ' VAL . 86.6 t -88.95 149.94 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.834 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -103.29 -145.66 15.6 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.463 ' CZ2' ' O ' ' A' ' 74' ' ' ARG . 67.7 m95 -114.09 57.95 0.69 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -1.197 . . . . 0.0 109.584 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -130.93 168.94 15.06 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.913 . . . . 0.0 109.391 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.32 -57.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.641 2.227 . . . . 0.0 110.636 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.89 -10.27 56.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.787 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -62.68 1.48 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.963 . . . . 0.0 109.46 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.3 mt -51.07 -22.92 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.462 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -46.32 41.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.465 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 105' ' ' GLU . 72.9 m-20 -63.49 -12.86 35.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.474 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HB2' ' CG2' ' A' ' 93' ' ' VAL . . . -69.31 -60.89 2.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.465 HD13 HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -68.22 -25.48 65.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.154 -0.966 . . . . 0.0 109.2 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.66 -47.35 67.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -22.63 61.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.293 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.67 -19.62 61.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 0.0 109.503 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 108' ' ' LEU . 0.2 OUTLIER -85.81 -23.32 27.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.933 . . . . 0.0 109.461 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.3 p30 -118.33 141.17 48.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 t -116.42 -14.85 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.474 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.499 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 1' ' ' VAL . 98.7 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.292 0.568 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -80.87 -4.02 53.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.479 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -134.75 128.02 32.09 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER 75.65 119.59 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 109.402 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 pt -143.49 149.7 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.918 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.1 126.91 50.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -134.96 159.41 41.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.775 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -112.75 97.52 6.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.671 HG21 ' CE1' ' A' ' 17' ' ' TYR . 44.9 mt -94.94 124.05 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.512 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.59 128.55 29.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.6 142.46 58.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -0.997 . . . . 0.0 109.345 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.69 170.38 32.42 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.75 57.73 1.5 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 18' ' ' ARG . 1.6 m -142.85 -176.45 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.75 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -75.63 -11.8 60.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.414 -0.804 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 76' ' ' TYR . 0.4 OUTLIER -76.84 -55.24 5.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.671 ' CE1' HG21 ' A' ' 9' ' ' ILE . 3.2 t80 -67.7 -22.38 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.478 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 1.5 mpt_? -73.82 -55.41 6.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.309 -0.869 . . . . 0.0 109.401 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.39 -36.24 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -64.17 -52.78 57.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.75 -22.61 64.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -76.54 -39.12 53.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.9 65.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.256 -0.902 . . . . 0.0 109.566 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.75 -49.32 65.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.252 -0.905 . . . . 0.0 109.934 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.95 -20.69 61.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.259 -0.901 . . . . 0.0 109.978 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -63.91 -39.83 95.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 109.658 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.0 p -49.92 -49.52 49.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.228 -0.92 . . . . 0.0 109.516 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.56 60.23 0.43 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.83 154.91 49.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.41 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 4' ' ' GLU . 9.1 tp10 -91.73 59.6 3.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -86.4 160.79 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -151.97 154.49 32.73 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.65 153.95 26.76 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.683 2.255 . . . . 0.0 110.376 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.23 171.24 17.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -62.9 168.34 4.72 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.205 -0.934 . . . . 0.0 109.441 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.82 -9.25 16.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.634 2.223 . . . . 0.0 110.549 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 -21.92 25.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.495 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 50.87 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -0.906 . . . . 0.0 109.35 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.13 103.94 13.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -50.67 -46.73 58.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.229 -0.919 . . . . 0.0 109.315 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -122.25 137.72 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.278 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 70' ' ' ILE . 17.8 t -104.71 140.08 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.443 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -137.6 121.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 119.38 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.263 -0.898 . . . . 0.0 109.533 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD23 ' N ' ' A' ' 45' ' ' LEU . 5.7 mt -85.14 125.13 32.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.9 . . . . 0.0 109.52 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.04 35.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.326 -0.859 . . . . 0.0 109.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.7 -2.51 90.56 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 45' ' ' LEU . 2.4 mt -120.21 24.02 10.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -1.148 . . . . 0.0 109.438 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 1.5 t90 -81.18 4.72 19.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.905 . . . . 0.0 109.51 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.97 -4.11 29.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -124.9 -38.8 2.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.126 -1.22 . . . . 0.0 109.438 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' HG2' ' CB ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -114.11 72.67 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.452 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -74.43 -65.19 0.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.22 -19.1 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -77.24 -41.71 40.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.692 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 49' ' ' TRP . 45.4 mt -73.18 -35.46 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.927 . . . . 0.0 109.679 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.19 -32.69 73.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -46.22 46.96 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.8 -54.35 47.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -1.124 . . . . 0.0 109.557 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.71 -28.37 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.926 . . . . 0.0 109.438 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -46.94 82.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -69.04 -32.87 72.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -74.62 -19.05 60.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.299 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -10.3 32.42 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 66' ' ' SER . 10.1 tptm -61.0 -14.08 20.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -0.919 . . . . 0.0 109.512 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 5.6 t 73.7 68.75 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 p -154.06 -39.13 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.161 -0.962 . . . . 0.0 109.482 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -106.86 153.41 40.83 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -78.28 119.18 4.51 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.715 2.277 . . . . 0.0 110.356 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 63' ' ' ALA . 23.5 mt -94.13 122.64 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.528 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.5 mt -115.64 117.58 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.538 ' O ' HG12 ' A' ' 93' ' ' VAL . 86.2 m -83.34 146.08 28.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.197 -0.939 . . . . 0.0 109.36 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 45' ' ' LEU . 43.3 t -120.2 114.96 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 59.5 mtt180 -55.72 146.63 45.41 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.309 -0.869 . . . . 0.0 109.361 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 36.1 Cg_endo -78.49 165.92 24.65 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.662 2.241 . . . . 0.0 110.49 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.431 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -79.33 -26.02 42.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.499 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 78' ' ' LEU . . . -89.2 -13.83 61.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' GLY . 29.4 tp 61.29 90.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -1.214 . . . . 0.0 109.392 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 17.18 21.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.519 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 81' ' ' VAL . 10.8 m-80 56.34 82.91 0.1 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -44.52 147.21 1.07 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.255 -0.903 . . . . 0.0 109.343 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.53 170.51 19.16 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.517 2.145 . . . . 0.0 110.435 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.85 2.71 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.619 2.213 . . . . 0.0 110.518 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -83.06 -44.6 14.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -5.65 59.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.08 -12.78 49.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -93.45 8.42 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -146.14 13.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -90.61 98.81 12.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.378 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -30.2 67.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.41 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -155.26 127.61 7.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.84 128.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.371 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 72' ' ' THR . 7.3 p -128.29 145.29 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.226 -0.921 . . . . 0.0 109.649 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.09 -145.77 10.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -91.2 17.47 8.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -1.165 . . . . 0.0 109.394 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 99' ' ' CYS . 2.5 m-20 -65.27 153.21 90.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.71 -57.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -77.06 -20.37 55.92 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.268 -0.895 . . . . 0.0 110.315 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.544 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -71.3 -13.0 61.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.07 -1.019 . . . . 0.0 109.901 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 96' ' ' ASN . 17.6 mm -75.74 -38.21 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -77.17 -31.45 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.3 -26.97 63.64 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.5 -67.84 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.783 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 76.9 mt -53.1 -35.09 59.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.927 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.01 -62.43 1.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.614 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -20.85 3.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 104' ' ' LEU . . . -77.3 -39.96 46.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.281 -0.887 . . . . 0.0 109.599 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 mt -54.52 -49.25 70.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.706 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.32 69.19 1.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 0.0 109.603 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.6 p -69.96 120.91 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -0.917 . . . . 0.0 109.359 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.446 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.48 168.03 10.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.419 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.3 61.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.955 . . . . 0.0 109.64 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -160.89 -172.36 3.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.444 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 104' ' ' LEU . 10.9 mt -145.42 143.06 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 40' ' ' ASP . 21.1 mtt85 -85.1 105.64 15.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.226 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 31' ' ' TRP . 8.0 mp -105.11 168.49 9.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.136 -0.977 . . . . 0.0 109.674 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.486 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . 40.3 t80 -152.73 106.95 3.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.235 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.502 HD12 ' CD1' ' A' ' 21' ' ' LEU . 20.8 mt -102.67 135.79 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.754 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m -51.68 136.4 27.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 0.0 109.161 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.477 ' O ' HD21 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -58.78 131.75 51.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.18 -0.95 . . . . 0.0 109.504 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.892 ' HA2' HD21 ' A' ' 48' ' ' LEU . . . -120.91 146.6 17.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.85 17.1 17.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.12 -173.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.512 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.37 -11.2 38.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.275 -0.89 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.5 m-20 -73.01 -32.36 65.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.528 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HE1' HD22 ' A' ' 21' ' ' LEU . 23.3 t80 -71.31 -29.73 65.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -75.29 -47.96 25.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 109.29 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HA ' ' OE1' ' A' ' 22' ' ' GLU . 93.4 t -61.54 -40.61 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -0.91 . . . . 0.0 109.382 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.671 ' CE2' HG11 ' A' ' 73' ' ' VAL . 3.0 t80 -64.53 -58.01 7.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 9' ' ' ILE . 3.9 tp -55.95 -22.58 27.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 19' ' ' VAL . 73.8 mt-10 -70.47 -55.13 9.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 109.369 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 26' ' ' GLN . 6.7 ttt85 -57.88 -32.7 67.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.423 -0.798 . . . . 0.0 109.492 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 tp -56.06 -58.68 6.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.887 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -70.53 -19.09 62.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 27' ' ' SER . 0.7 OUTLIER -60.54 -41.65 94.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.351 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 16.0 t 174.39 77.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.59 58.38 0.4 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.63 161.5 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -1.105 . . . . 0.0 109.299 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 148.41 22.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.699 ' HB2' HD13 ' A' ' 7' ' ' LEU . 67.5 p-90 -149.68 174.24 12.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -143.13 147.74 42.11 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.343 -0.848 . . . . 0.0 109.484 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.0 Cg_endo -77.53 103.55 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.655 2.236 . . . . 0.0 110.348 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . -100.89 -169.61 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.582 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.93 168.2 24.52 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.901 . . . . 0.0 109.61 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.5 Cg_endo -77.75 -8.37 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.615 2.21 . . . . 0.0 110.345 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.18 -6.97 18.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.21 53.98 1.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 8' ' ' TYR . . . -105.19 124.46 49.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.396 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 5' ' ' ILE . 12.6 t70 -52.02 -30.04 23.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.92 . . . . 0.0 109.619 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -147.91 124.2 10.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.693 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -97.28 96.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.027 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' CG2' ' A' ' 73' ' ' VAL . 76.7 mt -92.52 107.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 110.016 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.07 133.41 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.328 -0.857 . . . . 0.0 109.528 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.37 120.56 28.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.446 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.16 -15.54 62.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.463 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.56 -22.57 71.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' HA2' ' A' ' 12' ' ' GLY . 11.1 mp -89.28 13.69 12.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -1.18 . . . . 0.0 109.529 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.696 ' HZ3' HD13 ' A' ' 85' ' ' LEU . 4.8 t-105 -72.72 -30.33 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.64 27.28 21.19 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 48' ' ' LEU . 8.4 p -135.4 -39.02 0.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -1.179 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' CB ' ' HB2' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -141.47 71.69 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.336 -0.853 . . . . 0.0 109.298 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -52.9 -56.24 17.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -56.27 -38.47 71.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.181 -0.949 . . . . 0.0 109.614 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.53 ' HB2' ' CB ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -56.65 -47.99 78.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.424 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 60' ' ' VAL . 33.8 mm -62.06 -33.36 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 108.872 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 57' ' ' LEU . 4.1 tp -73.75 -21.43 60.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.113 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.15 -54.95 4.98 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.63 -45.51 89.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -1.142 . . . . 0.0 109.173 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 70.2 t -58.44 -44.18 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.253 -0.904 . . . . 0.0 109.046 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -58.03 -40.57 81.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.354 -0.841 . . . . 0.0 109.37 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.3 mt -68.91 -28.25 66.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 70' ' ' ILE . . . -76.83 -28.18 55.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.407 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' VAL . 40.3 mtp85 -75.92 0.1 19.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -84.02 -30.04 26.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.402 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.44 20.64 3.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.01 23.1 1.02 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.706 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -47.44 163.59 0.26 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.178 -0.951 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.38 113.98 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.634 2.223 . . . . 0.0 110.603 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.688 HD11 ' HB1' ' A' ' 63' ' ' ALA . 2.1 mt -113.7 108.03 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.368 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 43' ' ' ILE . 25.1 mt -96.36 124.83 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.689 HG21 HG11 ' A' ' 81' ' ' VAL . 21.9 m -89.77 156.13 18.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.167 -0.958 . . . . 0.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.671 HG11 ' CE2' ' A' ' 20' ' ' PHE . 3.4 t -123.89 121.76 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.606 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -50.71 150.41 5.08 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.51 178.13 8.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.499 2.133 . . . . 0.0 110.148 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.3 -25.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 134.95 86.26 0.23 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.0 -82.89 0.48 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -1.124 . . . . 0.0 109.464 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -136.82 17.61 3.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 -177.92 0.13 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.522 -0.736 . . . . 0.0 109.472 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.689 HG11 HG21 ' A' ' 72' ' ' THR . 34.0 m -85.98 159.89 53.46 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.442 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 34.3 Cg_endo -77.72 174.36 12.72 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.658 2.238 . . . . 0.0 110.39 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 35.2 Cg_endo -77.43 -33.01 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.606 2.204 . . . . 0.0 110.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.31 -34.4 70.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.181 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.696 HD13 ' HZ3' ' A' ' 49' ' ' TRP . 1.7 tt -93.31 -20.03 20.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.107 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.98 -35.23 79.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.112 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.98 -11.82 61.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.227 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG11 HG13 ' A' ' 60' ' ' VAL . 2.2 t -111.56 7.8 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.405 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.1 t -105.59 107.56 18.61 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.99 -44.09 74.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.467 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -146.95 154.56 41.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.518 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.3 p -117.68 119.15 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.233 -0.917 . . . . 0.0 109.411 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.823 HG21 HD13 ' A' ' 100' ' ' ILE . 9.9 p -108.95 163.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 93' ' ' VAL . . . -125.53 -157.94 9.81 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 30.1 m95 -88.74 38.82 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 109.246 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.441 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -103.01 151.22 38.39 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.513 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.8 Cg_endo -78.39 -46.73 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.67 2.247 . . . . 0.0 110.327 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.14 63.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.506 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 96' ' ' ASN . 73.6 m -65.62 -54.2 31.0 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.823 HD13 HG21 ' A' ' 93' ' ' VAL . 31.5 mm -47.38 -24.51 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.46 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -52.65 12.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.614 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.48 -14.8 59.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.38 -48.16 24.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.786 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 5' ' ' ILE . 20.8 mt -77.3 -25.87 51.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.669 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -74.88 -21.81 59.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.612 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -37.69 54.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.603 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.32 -55.72 19.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.06 39.68 30.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 109.354 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 110' ' ' VAL . 7.2 t0 -111.64 103.97 12.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.165 -0.959 . . . . 0.0 109.641 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 109' ' ' ASP . 43.3 t 43.91 84.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.845 . . . . 0.0 109.51 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.6 mm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.924 -1.036 . . . . 0.0 109.394 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 2' ' ' THR . 42.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.503 ' N ' HG12 ' A' ' 1' ' ' VAL . 47.0 m -78.88 79.95 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.487 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -101.36 -163.35 1.01 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 0.9 OUTLIER 74.75 123.17 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.655 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.441 HD12 ' CD1' ' A' ' 108' ' ' LEU . 3.3 tt -131.67 156.67 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.219 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.568 ' HG2' ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -111.47 127.5 55.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.831 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.946 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -128.34 169.7 13.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.87 . . . . 0.0 109.212 179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -128.78 102.47 6.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 0.0 109.626 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 HG21 ' HE1' ' A' ' 17' ' ' TYR . 15.6 mt -100.09 143.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -73.62 -170.34 0.83 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.589 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 1.3 pt-20 -135.15 109.04 8.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.642 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -121.0 173.14 15.4 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.6 tm-20 -115.63 28.3 8.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -1.119 . . . . 0.0 109.389 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -100.12 158.22 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 109.679 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.3 -9.97 38.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.677 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 2.6 m-20 -72.39 -48.63 40.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.555 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' HE1' HG21 ' A' ' 9' ' ' ILE . 11.6 t80 -65.12 -26.1 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.04 -70.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.598 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.5 t -49.87 -31.96 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.951 . . . . 0.0 109.479 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.985 ' CE1' HD13 ' A' ' 24' ' ' LEU . 31.6 t80 -68.02 -48.23 66.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -41.05 74.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -67.21 -33.74 76.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -15.69 59.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.423 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.985 HD13 ' CE1' ' A' ' 20' ' ' PHE . 1.7 tp -74.65 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 26' ' ' GLN . 2.4 pt-20 -59.9 -20.68 58.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' N ' ' HG3' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -52.35 -41.03 62.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.287 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -26.9 60.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.378 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 102.21 -132.47 11.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER 62.75 131.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.124 . . . . 0.0 109.395 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' GLU . 85.3 mt-10 -88.74 111.26 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 109.442 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.946 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.4 p-90 -120.04 156.64 30.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -137.69 159.95 66.92 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.4 Cg_endo -77.79 130.8 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.653 2.235 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -116.63 -165.92 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.708 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -101.99 175.16 2.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.548 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.7 Cg_endo -77.62 -19.36 12.94 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.566 2.177 . . . . 0.0 110.405 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -112.39 -6.55 14.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.475 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -138.54 49.1 1.91 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.465 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -104.95 133.13 50.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.88 -34.01 76.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 109.322 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -149.68 123.84 9.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 21.7 t -79.9 156.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 109.849 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 71' ' ' ILE . 13.3 mt -147.05 102.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.461 -0.774 . . . . 0.0 108.98 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.97 HG11 HG23 ' A' ' 56' ' ' ILE . 2.2 t -112.97 137.34 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.748 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.9 mm? -84.12 131.47 34.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' CE3' ' A' ' 49' ' ' TRP . . . -76.59 -36.7 57.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.95 34.56 3.89 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD21 ' CA ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -125.41 -26.65 3.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -1.15 . . . . 0.0 109.811 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.673 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.7 p90 -57.67 -18.56 21.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.018 -1.051 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.538 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -42.27 -29.9 0.72 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -47.12 1.98 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -1.172 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -88.63 47.95 1.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.427 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.57 -45.06 85.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.896 . . . . 0.0 109.647 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -67.33 -31.47 71.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.899 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.94 -59.42 3.86 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 109.69 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.97 HG23 HG11 ' A' ' 44' ' ' VAL . 3.0 mp -54.96 -57.79 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.754 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.24 -26.73 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 109.855 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.06 -68.16 1.73 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.53 -37.0 16.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.295 -1.12 . . . . 0.0 109.988 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 58.8 t -59.62 -60.67 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.58 -58.65 6.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.118 -0.989 . . . . 0.0 109.571 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.53 -27.15 6.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -70.93 -45.11 64.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.473 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.5 mtp85 -68.29 -7.59 32.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.673 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -57.37 10.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.58 -79.69 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.9 p 179.01 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.602 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -87.04 154.72 55.19 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.981 . . . . 0.0 109.434 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.6 Cg_endo -77.9 116.87 4.07 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.701 2.268 . . . . 0.0 110.614 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 95.6 mt -95.04 111.96 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 0.0 109.324 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 91' ' ' GLU . 35.5 mm -94.33 91.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.722 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.645 HG21 ' OG ' ' A' ' 89' ' ' SER . 7.6 p -88.06 128.86 35.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.371 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 45' ' ' LEU . 58.2 t -98.65 132.35 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.488 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.453 ' CB ' ' HD2' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -64.05 171.53 2.47 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.339 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 74' ' ' ARG . 34.8 Cg_endo -77.31 163.49 30.05 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.62 2.213 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.2 -15.64 63.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.9 46.54 0.77 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.45 7.21 3.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -1.092 . . . . 0.0 109.526 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -151.68 -143.62 0.14 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.237 -0.914 . . . . 0.0 108.995 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -145.6 153.79 41.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 109.285 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 82' ' ' PRO . 97.5 t -104.6 134.87 19.44 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.382 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.9 Cg_endo -78.84 150.33 23.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.502 2.135 . . . . 0.0 110.328 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -78.12 -20.49 11.39 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.193 . . . . 0.0 110.467 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.27 -34.69 74.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.624 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.79 55.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.655 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -69.21 -18.75 63.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.01 -7.97 59.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.481 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.38 33.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -117.65 134.07 55.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.472 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 t -99.84 -31.59 11.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.538 ' HB2' HD13 ' A' ' 71' ' ' ILE . 4.0 mt-10 -136.14 118.54 15.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.595 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 92' ' ' VAL . 33.6 m -117.99 128.57 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.248 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 103' ' ' ALA . 2.8 m -123.93 165.28 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.71 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -97.72 -146.57 21.0 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.98 66.83 0.66 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -1.158 . . . . 0.0 109.586 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.661 ' O ' HD12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -138.44 152.57 71.47 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.435 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.31 -41.89 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.619 2.213 . . . . 0.0 110.554 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -76.93 -31.57 56.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.925 . . . . 0.0 109.659 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -42.15 67.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.178 -0.951 . . . . 0.0 109.677 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ASN . 35.6 mt -59.22 -41.94 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.661 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -64.16 -42.09 96.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.725 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -31.09 63.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -0.86 . . . . 0.0 109.783 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HB2' ' CG1' ' A' ' 93' ' ' VAL . . . -74.21 -43.18 58.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 109.732 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.01 -33.55 73.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.675 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -51.94 -28.17 15.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.444 ' HB2' ' OE2' ' A' ' 91' ' ' GLU . 0.4 OUTLIER -67.81 -49.83 60.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.877 . . . . 0.0 109.728 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.28 -43.24 67.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.651 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.2 tp -57.85 -44.64 86.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.659 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.03 117.13 21.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' O ' ' OXT' ' A' ' 111' ' ' ILE . 53.9 t -104.67 145.65 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.2 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 111' ' ' ILE . 9.9 tt . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 2' ' ' THR . 12.6 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.537 ' N ' HG23 ' A' ' 1' ' ' VAL . 1.3 t -155.02 105.31 2.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.51 115.75 3.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.54 146.75 31.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.6 mt -119.08 139.25 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.365 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.412 ' NH1' ' HG2' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -92.56 112.29 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 109.319 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.515 ' CD2' HD11 ' A' ' 43' ' ' ILE . 3.7 mp -120.76 153.45 36.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 36' ' ' PRO . 15.5 t80 -123.94 108.95 12.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.259 -0.901 . . . . 0.0 109.187 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mt -107.74 142.12 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -47.91 145.92 2.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.445 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.04 125.83 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.0 179.57 37.27 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -117.57 -3.74 11.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -1.17 . . . . 0.0 109.736 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -48.9 170.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 109.55 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -77.75 -19.12 55.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.515 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.01 -50.76 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -63.91 -28.17 69.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.518 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -58.32 5.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -0.849 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -58.27 -48.57 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.705 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.656 ' CZ ' HG21 ' A' ' 73' ' ' VAL . 1.8 t80 -53.37 -37.52 62.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -61.53 1.84 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.953 . . . . 0.0 109.662 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -51.19 -23.81 3.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -51.09 19.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -73.35 -6.17 44.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -77.19 -64.12 1.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.66 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.62 -8.28 26.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.893 . . . . 0.0 109.952 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.91 -57.07 9.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 0.0 109.456 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.87 -27.54 6.45 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.87 152.08 32.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.149 . . . . 0.0 109.519 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -99.98 50.97 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.852 . . . . 0.0 109.538 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.442 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 35.5 p-90 -80.11 158.47 26.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.905 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -144.06 157.43 57.34 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.98 131.74 11.24 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.666 2.244 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.15 172.25 10.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.923 . . . . 0.0 109.588 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.19 162.04 4.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.499 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 35.7 Cg_endo -78.67 2.15 8.43 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.787 2.325 . . . . 0.0 110.668 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.43 15.99 8.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.038 -1.039 . . . . 0.0 109.638 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.18 38.65 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.527 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.5 131.78 52.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.402 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.84 -37.31 60.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.312 -0.867 . . . . 0.0 109.317 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.48 128.89 22.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.99 110.49 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.413 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.515 HD11 ' CD2' ' A' ' 7' ' ' LEU . 97.0 mt -97.23 104.7 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.95 137.97 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.7 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.88 117.59 34.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.343 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.35 -17.31 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 109.577 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.3 -16.99 37.12 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 48' ' ' LEU . 5.3 mp -118.84 40.64 3.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.124 -1.221 . . . . 0.0 109.622 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.494 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 43.1 t-105 -81.49 -29.91 33.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.73 39.04 2.89 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -139.12 -50.52 0.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 109.532 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 56' ' ' ILE . 11.2 mtt180 -130.48 64.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -48.57 -22.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.677 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -77.05 -41.94 40.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 0.0 109.728 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.581 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 11.8 tt0 -69.31 -30.15 68.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.536 HD13 ' N ' ' A' ' 56' ' ' ILE . 4.3 mm -77.12 -63.74 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.885 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -47.91 75.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.957 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -31.59 81.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 55' ' ' GLU . . . -63.03 -62.02 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -1.187 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -52.78 -46.48 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.418 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.89 -39.26 65.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.326 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 1.0 OUTLIER -61.42 -47.18 86.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.211 -0.93 . . . . 0.0 109.265 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.676 ' HB3' HD11 ' A' ' 70' ' ' ILE . . . -52.88 -49.19 66.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.705 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -26.23 68.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.8 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 15.3 21.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.991 . . . . 0.0 109.632 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' LEU . 43.8 m -143.69 -63.37 0.39 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.355 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 75.5 m -109.55 -91.71 0.45 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.208 -0.933 . . . . 0.0 109.022 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.1 tttp 155.21 -47.19 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.831 -0.543 . . . . 0.0 110.237 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 68' ' ' LYS . 36.2 Cg_endo -78.2 119.16 4.53 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.092 1.861 . . . . 0.0 110.605 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 63' ' ' ALA . 2.7 mp -125.61 104.86 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.3 -0.875 . . . . 0.0 109.387 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 91' ' ' GLU . 4.0 mp -91.02 119.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.42 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.604 ' CG2' HG22 ' A' ' 92' ' ' VAL . 13.3 t -104.45 140.29 38.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.151 -0.968 . . . . 0.0 109.757 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.656 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 55.7 t -108.7 125.68 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.361 -0.837 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.3 164.98 15.44 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.689 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 162.44 28.18 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.608 2.206 . . . . 0.0 110.144 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.93 -57.44 6.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.636 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.592 ' O ' HD22 ' A' ' 78' ' ' LEU . . . -179.3 85.16 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -148.0 -67.12 0.24 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -1.175 . . . . 0.0 109.517 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -115.54 -143.89 0.38 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.294 -0.879 . . . . 0.0 109.087 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.81 122.49 9.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.554 HG13 ' HD2' ' A' ' 82' ' ' PRO . 53.7 t -52.2 137.26 38.8 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.252 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.4 Cg_endo -78.07 165.41 26.12 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.476 2.118 . . . . 0.0 110.557 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.96 5.27 5.45 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.697 2.265 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -84.29 -35.07 23.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.451 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.96 -7.82 44.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.52 -9.46 41.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.579 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.59 -5.35 35.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -0.897 . . . . 0.0 109.583 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.63 -41.49 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.498 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -46.6 156.56 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.955 . . . . 0.0 109.39 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.2 m -123.06 -6.61 8.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.883 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HB2' HG13 ' A' ' 71' ' ' ILE . 22.3 mt-10 -150.89 98.78 2.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.507 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 72' ' ' THR . 59.4 t -102.36 128.68 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.434 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.89 168.53 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -105.16 -146.84 15.19 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -95.1 34.48 1.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -1.125 . . . . 0.0 109.603 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.412 ' O ' HG13 ' A' ' 100' ' ' ILE . 1.4 m-80 -106.11 146.0 32.07 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.932 . . . . 0.0 109.521 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.21 -32.63 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.67 2.247 . . . . 0.0 110.594 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.35 -41.28 76.81 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.582 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -28.06 61.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 96' ' ' ASN . 67.7 mt -74.87 -31.55 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.08 -1.012 . . . . 0.0 109.646 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -44.36 69.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.63 -17.83 64.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.554 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -59.16 2.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -21.17 66.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -69.98 -45.47 67.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.613 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.01 -1.52 29.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.95 . . . . 0.0 109.786 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.11 -32.98 56.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.637 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 mp -83.45 -53.71 5.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.92 . . . . 0.0 109.639 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.08 168.39 17.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 111' ' ' ILE . 6.6 p -116.94 -40.06 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.532 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.46 ' N ' HG13 ' A' ' 110' ' ' VAL . 27.9 pt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.505 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.433 HG23 ' OE2' ' A' ' 30' ' ' GLU . 13.8 t -107.31 -179.31 3.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.416 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.38 -8.92 13.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.47 172.82 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 109.774 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.797 HG23 HD23 ' A' ' 7' ' ' LEU . 4.0 tt -151.17 155.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 109.048 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -91.57 104.86 17.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.941 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.797 HD23 HG23 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -130.19 164.85 23.61 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 108.959 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -131.29 147.44 52.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.823 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.64 147.06 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.66 145.59 33.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.153 -0.967 . . . . 0.0 109.501 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.57 149.82 24.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.169 -0.957 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.64 -155.93 14.45 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.23 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -1.175 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 17' ' ' TYR . 30.2 m -112.82 167.99 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.187 -0.945 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -66.96 -25.62 66.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.548 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.63 -66.7 0.63 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.4 t80 -54.1 -26.77 28.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.554 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -69.86 -71.66 0.23 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.219 -0.926 . . . . 0.0 109.792 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 15' ' ' GLU . 26.1 t -42.11 -39.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 109.882 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' HD21 ' A' ' 45' ' ' LEU . 22.9 t80 -59.82 -54.51 45.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.75 -28.72 50.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.784 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 63.2 mm-40 -72.75 -45.02 60.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.878 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.03 -23.28 64.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 109.91 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.8 -56.15 24.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.465 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -59.44 -21.39 59.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.413 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -49.75 -33.45 16.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.496 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 26' ' ' GLN . 0.8 OUTLIER -45.63 -50.6 13.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 109.533 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.25 64.41 0.28 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.7 tp 61.65 82.41 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.473 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' OE2' HG23 ' A' ' 2' ' ' THR . 0.4 OUTLIER -160.44 27.41 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.12 -0.988 . . . . 0.0 109.567 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.79 ' HB2' HD21 ' A' ' 7' ' ' LEU . 44.9 p-90 -158.06 155.99 30.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.95 . . . . 0.0 109.657 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -151.68 148.2 21.49 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 109.406 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 32' ' ' ARG . 35.1 Cg_endo -77.72 119.55 4.84 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.596 2.198 . . . . 0.0 110.306 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.35 -168.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.676 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 1.0 OUTLIER -97.61 165.25 15.91 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.347 -0.846 . . . . 0.0 109.404 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 34.7 Cg_endo -76.91 -23.39 10.8 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.478 2.119 . . . . 0.0 110.169 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -2.96 53.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.871 . . . . 0.0 109.294 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.34 61.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.396 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -116.82 127.28 54.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -77.21 -39.85 47.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.498 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 7' ' ' LEU . . . -124.02 134.06 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.37 144.21 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.511 ' CD1' HD13 ' A' ' 7' ' ' LEU . 9.2 mt -134.44 100.46 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.67 135.05 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD21 ' CE2' ' A' ' 20' ' ' PHE . 1.1 mm? -92.2 136.01 33.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 109.568 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.35 9.47 28.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 109.544 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.36 -24.15 29.66 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 17' ' ' TYR . 1.4 mp -85.3 12.71 7.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -1.126 . . . . 0.0 109.307 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.595 ' CH2' ' HG2' ' A' ' 82' ' ' PRO . 1.8 t-105 -68.43 -26.53 65.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.79 28.25 16.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.0 p -142.73 -64.84 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -1.094 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -120.41 57.37 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.92 . . . . 0.0 109.344 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HG3' ' NE1' ' A' ' 49' ' ' TRP . 5.5 ttt180 -55.98 -35.24 66.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.39 -0.819 . . . . 0.0 109.727 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.24 -52.18 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.696 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -50.25 -38.26 39.88 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.91 . . . . 0.0 109.6 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 mt -71.85 -52.52 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.5 tp -47.11 -31.1 3.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.18 -48.77 57.39 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.02 -53.25 60.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -1.084 . . . . 0.0 109.456 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.94 -40.24 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.327 -0.858 . . . . 0.0 109.6 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -36.39 82.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.679 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.13 -47.12 81.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -67.88 -25.8 65.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.936 . . . . 0.0 109.505 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 0.7 19.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -0.963 . . . . 0.0 109.568 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 65' ' ' LYS . 1.6 tppt? -62.47 -48.76 78.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -73.4 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 0.0 109.515 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.1 p -178.67 58.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.389 -0.819 . . . . 0.0 109.059 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.562 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 4.8 mtmt -79.67 154.13 75.94 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.93 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 36.3 Cg_endo -78.95 100.94 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.684 2.256 . . . . 0.0 110.31 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.4 mt -103.26 115.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 93' ' ' VAL . 1.6 mp -105.2 129.77 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 109.299 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.697 ' OG1' HD23 ' A' ' 85' ' ' LEU . 13.4 t -94.64 132.34 39.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.761 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.51 120.86 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.38 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -50.11 158.38 0.96 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.494 -0.754 . . . . 0.0 109.686 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.19 -164.25 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.72 2.28 . . . . 0.0 110.387 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -88.38 -62.42 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 109.222 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.8 61.57 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 -51.46 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.514 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.77 -143.82 0.34 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.299 -0.875 . . . . 0.0 109.104 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -140.76 148.7 41.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.652 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.54 ' CG1' ' HD2' ' A' ' 82' ' ' PRO . 15.2 t -74.45 140.68 75.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.339 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HG2' ' CH2' ' A' ' 49' ' ' TRP . 35.0 Cg_endo -77.37 161.47 31.7 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.474 2.116 . . . . 0.0 110.539 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.03 7.37 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.782 2.321 . . . . 0.0 110.778 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -92.14 -44.66 8.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.697 HD23 ' OG1' ' A' ' 72' ' ' THR . 3.5 tp -69.37 -19.73 63.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.686 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 39.2 tt0 -84.99 -9.51 57.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -105.09 -1.47 25.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 109.694 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.06 -25.76 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.661 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.472 ' OG ' ' HB ' ' A' ' 72' ' ' THR . 2.4 m -81.02 135.82 35.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.181 -0.949 . . . . 0.0 109.502 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -76.69 -23.82 53.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -150.6 167.11 28.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.585 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.47 112.86 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.294 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.656 HG13 ' SG ' ' A' ' 99' ' ' CYS . 2.6 t -96.31 151.38 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.93 . . . . 0.0 109.626 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.07 -151.3 27.12 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -100.63 29.21 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -1.172 . . . . 0.0 109.38 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -103.61 159.95 27.67 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.4 -0.813 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.57 -53.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.65 2.234 . . . . 0.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -56.01 -30.94 62.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.656 ' SG ' HG13 ' A' ' 93' ' ' VAL . 2.7 t -68.27 -44.02 76.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.824 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.7 mt -65.81 -32.62 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.881 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -60.25 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.623 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.79 -45.61 82.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 109.691 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -60.82 -27.3 67.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.47 -45.6 58.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -0.923 . . . . 0.0 109.295 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.31 -17.77 61.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 109.264 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.51 -36.83 79.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.387 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.34 -42.99 42.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.85 -50.89 24.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.261 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 110' ' ' VAL . 25.1 t0 -94.94 136.76 34.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -0.859 . . . . 0.0 109.382 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.462 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 47.7 t -132.24 100.02 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.365 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.412 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 0.9 OUTLIER -96.52 -80.42 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.463 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 2' ' ' THR . . . 71.91 11.18 6.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.22 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.83 -174.77 4.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.823 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.9 mt -134.24 137.88 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -99.01 105.1 17.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.465 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -121.82 171.04 9.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.403 ' C ' ' CD1' ' A' ' 8' ' ' TYR . 2.7 t80 -143.2 106.08 4.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.938 HG12 HD12 ' A' ' 43' ' ' ILE . 2.9 mt -104.61 135.83 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.317 -0.865 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.41 167.08 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 109.141 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.38 102.4 5.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.583 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.16 -145.87 6.97 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -138.89 54.1 1.75 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.207 -1.173 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.759 HG21 ' HB3' ' A' ' 48' ' ' LEU . 3.5 t -118.22 157.45 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.394 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.1 tt0 -77.93 -11.9 59.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' OD1' HD11 ' A' ' 45' ' ' LEU . 1.5 t70 -69.62 -59.39 2.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 109.612 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' OH ' HD12 ' A' ' 21' ' ' LEU . 12.3 t80 -60.52 -33.28 72.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.873 . . . . 0.0 109.723 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -64.42 -41.96 96.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.167 -0.958 . . . . 0.0 109.832 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 15' ' ' GLU . 79.3 t -66.66 -50.55 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -51.03 -52.06 46.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 109.766 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.738 ' O ' HD23 ' A' ' 21' ' ' LEU . 4.1 tt -67.41 -26.1 66.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.52 -49.19 72.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.703 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -74.53 -26.13 59.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.528 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 100' ' ' ILE . 0.4 OUTLIER -76.69 -15.0 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.638 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.16 -57.19 4.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.454 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -72.34 -10.25 59.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.47 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.1 t -47.02 -46.1 21.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.386 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 121.67 -179.82 16.17 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER 61.6 148.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -1.126 . . . . 0.0 109.519 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.83 158.49 15.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.234 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -158.19 155.06 28.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.56 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -145.97 155.0 51.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.534 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 36.1 Cg_endo -78.29 133.71 12.22 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.639 2.226 . . . . 0.0 110.48 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 35' ' ' THR . . . -125.29 154.01 42.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -44.1 162.27 0.2 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.311 -0.868 . . . . 0.0 109.528 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.96 -31.06 3.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.634 2.222 . . . . 0.0 110.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.19 -31.85 69.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -120.17 27.93 8.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.59 107.48 5.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 47.4 t0 -53.89 -37.34 63.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -131.73 129.95 41.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.19 110.78 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.57 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.938 HD12 HG12 ' A' ' 9' ' ' ILE . 8.0 mt -104.48 100.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.293 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.604 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -96.3 130.7 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.663 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -84.89 135.94 33.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.448 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HB2' ' CG2' ' A' ' 72' ' ' THR . . . -100.95 25.63 7.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.965 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -110.76 -35.78 1.98 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 14' ' ' VAL . 3.8 pp -119.43 15.43 12.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -1.207 . . . . 0.0 109.625 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.607 ' CZ3' ' CD1' ' A' ' 85' ' ' LEU . 2.8 p-90 -76.65 -21.58 55.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.53 -13.38 55.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -98.86 -41.53 7.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -1.101 . . . . 0.0 109.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 56' ' ' ILE . 7.1 mtt180 -108.45 50.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.269 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' NE ' ' CZ3' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -71.22 -33.43 69.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -57.03 -51.17 70.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.607 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 56' ' ' ILE . 20.7 mt-10 -68.42 -58.33 4.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.412 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.604 HD12 ' CG1' ' A' ' 44' ' ' VAL . 34.0 mm -43.52 -26.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.393 -0.817 . . . . 0.0 109.747 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -59.77 2.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.665 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.37 -30.17 24.97 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.22 -57.71 5.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.6 t -49.98 -45.25 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.57 -48.62 74.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 62' ' ' LEU . 6.8 mt -55.02 -32.45 61.85 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.56 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -66.93 -21.44 65.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.99 -27.34 16.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.952 . . . . 0.0 109.534 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.46 ' OG ' ' HD3' ' A' ' 68' ' ' LYS . 47.6 t -109.33 15.98 22.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.176 -0.953 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 97.9 p 45.26 40.23 4.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.911 . . . . 0.0 109.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -83.26 152.52 64.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.508 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 35.5 Cg_endo -78.19 117.86 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.681 2.254 . . . . 0.0 110.385 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.471 HD11 ' CB ' ' A' ' 63' ' ' ALA . 2.6 mt -107.81 90.21 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 0.0 109.514 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.552 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 3.0 mt -93.06 128.2 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.261 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.603 ' CG2' ' HB2' ' A' ' 46' ' ' ALA . 52.0 m -102.07 131.32 48.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.75 124.4 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -49.33 153.24 1.84 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.44 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 34.8 Cg_endo -77.43 -158.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.609 2.206 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CD2' ' CZ2' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -117.68 14.99 14.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.049 -1.032 . . . . 0.0 109.679 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.47 6.23 5.74 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -95.37 68.51 3.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -1.179 . . . . 0.0 109.416 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 5.5 tp10 67.27 137.8 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.886 0.851 . . . . 0.0 109.767 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -78.53 -164.16 0.54 Allowed 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.309 0.575 . . . . 0.0 109.568 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 81' ' ' VAL . 3.6 m -91.22 150.8 42.18 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.368 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.05 173.12 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.644 2.229 . . . . 0.0 110.404 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.9 Cg_endo -77.8 -5.46 15.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 110.31 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -83.36 -49.37 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.354 -0.841 . . . . 0.0 109.374 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.607 ' CD1' ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -69.11 -27.38 65.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.54 -12.13 56.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.358 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -99.7 -12.28 20.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.334 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 85' ' ' LEU . 7.3 m -123.84 8.84 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.385 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.5 p -94.66 131.17 40.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -76.31 -38.58 55.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.32 -0.863 . . . . 0.0 109.581 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.11 173.44 15.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.799 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.54 155.74 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.762 . . . . 0.0 109.401 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 3.1 t -123.57 146.25 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -111.28 -162.44 17.52 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CZ2' ' CD2' ' A' ' 76' ' ' TYR . 74.2 m95 -98.45 19.38 14.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.326 -1.102 . . . . 0.0 109.426 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -87.18 156.36 54.48 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.238 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.47 -34.62 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.586 2.19 . . . . 0.0 110.502 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -20.67 55.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.593 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -71.06 -10.14 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.943 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 24' ' ' LEU . 28.2 mm -76.39 -64.27 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.552 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.32 -32.26 69.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.74 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.47 -35.77 72.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.89 60.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -0.977 . . . . 0.0 109.853 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mt -74.73 -23.42 58.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 0.0 109.734 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.84 -22.61 63.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.17 -44.68 79.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.89 -18.91 64.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 15.71 27.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.249 -0.907 . . . . 0.0 109.389 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -146.32 111.44 5.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 0.0 109.713 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 96.5 t -109.07 -26.77 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -0.901 . . . . 0.0 109.353 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 110' ' ' VAL . 15.0 tt . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 1' ' ' VAL . 23.6 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.84 48.32 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.357 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 4' ' ' GLU . . . -101.53 144.72 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 3' ' ' ALA . 5.2 mt-10 74.3 170.95 0.29 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.609 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.1 tt -141.65 164.88 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -0.847 . . . . 0.0 109.202 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.412 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -117.39 119.82 36.26 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.955 . . . . 0.0 109.639 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 1.3 pp -135.52 169.66 17.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.85 . . . . 0.0 109.119 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -142.28 114.11 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.817 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG12 HD12 ' A' ' 43' ' ' ILE . 11.8 mt -94.44 148.84 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.205 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.91 155.14 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.377 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -99.43 156.96 16.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.6 -164.52 34.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -155.38 65.58 0.62 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -1.149 . . . . 0.0 109.392 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.99 -170.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.535 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.555 ' O ' HG23 ' A' ' 19' ' ' VAL . 18.4 tt0 -89.53 -22.74 22.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.423 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -70.65 -52.64 19.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.79 ' CE1' HD23 ' A' ' 21' ' ' LEU . 14.1 t80 -65.75 -19.66 65.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.286 -0.884 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -54.52 7.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.171 -0.955 . . . . 0.0 109.69 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 15' ' ' GLU . 6.5 t -63.74 -36.35 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -65.82 -61.14 2.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.593 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.79 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -54.15 -27.16 31.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.91 -36.39 64.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -22.05 54.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 109.515 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.79 -43.88 74.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.63 -14.7 62.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -51.5 51.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.331 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 p -63.33 -47.65 81.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 29' ' ' LEU . . . 114.52 -109.94 2.26 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 55.58 169.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.419 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' HB3' ' OE1' ' A' ' 4' ' ' GLU . 4.7 mt-10 -120.3 130.11 54.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' ' CE3' ' A' ' 31' ' ' TRP . 25.9 p-90 -160.04 148.46 17.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.512 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -133.07 156.99 79.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.448 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.4 Cg_endo -77.63 129.92 10.38 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.65 2.233 . . . . 0.0 110.323 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -121.65 149.81 42.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.631 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.915 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -46.6 160.05 0.33 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.354 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.915 ' HD2' HG22 ' A' ' 35' ' ' THR . 35.3 Cg_endo -77.99 0.29 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.656 2.238 . . . . 0.0 110.222 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.93 -27.42 12.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -130.44 36.1 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.92 116.4 22.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -36.53 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.937 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HA ' ' HG2' ' A' ' 69' ' ' PRO . . . -136.3 139.23 42.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.695 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 t -113.84 149.03 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.324 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HG12 ' A' ' 9' ' ' ILE . 4.1 mt -136.98 129.84 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 56' ' ' ILE . 1.3 t -118.83 129.79 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 ' HB ' ' A' ' 73' ' ' VAL . 3.8 mm? -92.62 128.33 38.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.812 ' HB1' HG22 ' A' ' 81' ' ' VAL . . . -87.46 -0.76 57.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 109.585 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.01 -13.25 61.53 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.52 46.28 2.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -1.109 . . . . 0.0 109.221 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.782 ' CZ3' HD22 ' A' ' 85' ' ' LEU . 44.9 t-105 -77.67 -16.89 58.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 0.0 109.797 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.23 19.47 29.52 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 48' ' ' LEU . 35.0 p -132.75 -62.99 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -1.205 . . . . 0.0 109.701 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.1 36.09 1.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -59.33 -40.09 85.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.32 -39.34 66.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 109.658 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -73.1 -45.33 57.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.904 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' VAL . 5.9 mt -59.93 -24.68 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.684 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.5 -55.77 8.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.103 -0.998 . . . . 0.0 109.507 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.06 65.11 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.71 24.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -1.173 . . . . 0.0 109.431 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 56' ' ' ILE . 51.4 t -56.01 -37.76 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -67.06 -39.19 86.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.312 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 62' ' ' LEU . 12.9 mt -63.97 -31.54 72.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.246 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.11 57.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -69.27 -9.04 51.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.1 tttm -61.38 -15.61 38.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 67' ' ' SER . 22.2 m -152.88 -75.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.517 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 169.56 52.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.86 . . . . 0.0 109.342 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.34 155.91 57.02 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 35.9 Cg_endo -78.36 114.11 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.631 2.221 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 mt -103.01 117.35 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.938 . . . . 0.0 109.438 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.8 mt -110.94 114.78 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 92' ' ' VAL . 8.5 t -85.61 154.86 21.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.189 -0.944 . . . . 0.0 109.301 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.719 ' HB ' HD13 ' A' ' 45' ' ' LEU . 47.3 t -124.37 129.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.17 -0.956 . . . . 0.0 109.796 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.21 155.2 18.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.567 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.63 176.58 9.73 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.709 2.273 . . . . 0.0 110.28 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 77' ' ' GLY . 6.4 t80 -70.75 -93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.674 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' N ' ' CG ' ' A' ' 76' ' ' TYR . . . -132.97 96.36 0.3 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' GLU . 2.4 tt 179.27 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -1.176 . . . . 0.0 109.289 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 78' ' ' LEU . 9.9 mt-10 61.02 126.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -179.53 40.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.403 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.812 HG22 ' HB1' ' A' ' 46' ' ' ALA . 80.2 t -104.82 130.75 22.63 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.912 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 34.9 Cg_endo -77.88 168.92 21.46 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.403 2.069 . . . . 0.0 110.38 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 -10.3 15.53 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.656 2.237 . . . . 0.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 6.7 tt0 -81.88 -2.86 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.988 . . . . 0.0 109.72 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.782 HD22 ' CZ3' ' A' ' 49' ' ' TRP . 40.7 tp -112.86 -15.99 12.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.17 -0.956 . . . . 0.0 109.204 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -82.63 -12.07 57.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.18 -36.42 9.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.772 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 m -79.91 -24.61 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 109.715 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' SER . 2.0 p -68.17 94.18 0.5 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.427 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' SER . 50.6 m -43.69 -33.64 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.588 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.65 157.83 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.375 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 HG23 ' A' ' 72' ' ' THR . 14.8 p -126.31 145.57 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.273 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 103' ' ' ALA . 85.4 t -129.22 147.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.94 . . . . 0.0 109.568 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.29 -151.15 18.8 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -97.99 43.88 1.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.143 -1.21 . . . . 0.0 109.335 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' HG12 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -106.06 150.76 39.7 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.275 -0.89 . . . . 0.0 109.703 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 34.8 Cg_endo -78.11 -48.61 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.727 2.285 . . . . 0.0 110.332 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.61 -31.98 63.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.463 ' HB2' ' CB ' ' A' ' 96' ' ' ASN . 5.3 m -60.68 -18.89 56.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.563 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 96' ' ' ASN . 21.3 mm -70.91 -36.47 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.501 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.5 -51.52 12.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.58 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 106' ' ' ASP . 0.3 OUTLIER -53.0 -27.08 17.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.657 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -77.1 -55.82 5.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.0 109.774 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.0 mp -54.46 -24.32 19.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.842 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -73.67 -42.22 61.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.968 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.459 ' OD2' ' O ' ' A' ' 102' ' ' ASP . 8.7 m-20 -50.13 -23.44 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.55 80.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.637 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.53 24.63 12.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.7 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -159.61 167.17 29.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.573 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 110' ' ' VAL . 53.4 t -144.42 78.67 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.904 . . . . 0.0 109.331 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 111' ' ' ILE . 14.9 pt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.426 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.565 ' C ' HG22 ' A' ' 2' ' ' THR . 18.2 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.565 HG22 ' C ' ' A' ' 1' ' ' VAL . 0.1 OUTLIER 167.19 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.297 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.02 118.99 4.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.421 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.3 155.7 38.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 109.543 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 7' ' ' LEU . 9.0 pt -129.09 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.541 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -112.96 109.95 19.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.258 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 104' ' ' LEU . 1.4 mp -118.4 171.5 8.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.899 . . . . 0.0 109.761 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -146.3 95.41 2.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.0 109.192 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.794 HG13 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -79.79 132.68 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.65 140.04 19.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.342 -0.849 . . . . 0.0 109.547 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -56.41 131.24 47.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.29 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' CA ' HD21 ' A' ' 48' ' ' LEU . . . -142.46 153.65 24.62 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.5 22.81 5.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -1.12 . . . . 0.0 109.275 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -95.68 156.2 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -59.35 -19.29 45.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.375 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.81 -66.13 0.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.252 -0.905 . . . . 0.0 109.376 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 9' ' ' ILE . 10.7 t80 -46.33 -31.28 2.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 109.269 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -52.08 51.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.396 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 77.6 t -57.69 -32.37 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -69.18 -35.76 76.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.36 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -52.95 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.867 . . . . 0.0 109.617 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.51 -24.72 65.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -0.891 . . . . 0.0 109.743 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -74.16 -31.22 62.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.704 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.45 -35.38 65.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.716 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.03 -46.73 73.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -19.76 63.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.498 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 t -68.31 -28.96 67.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.304 -0.873 . . . . 0.0 109.422 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 97.94 -173.5 28.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 75.39 136.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -1.112 . . . . 0.0 109.517 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' H ' HD13 ' A' ' 29' ' ' LEU . 1.2 mt-10 -92.38 93.15 8.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -97.15 169.34 9.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 109.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 3.0 mtp180 -151.95 152.77 30.51 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 35.7 Cg_endo -78.54 139.19 15.98 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.687 2.258 . . . . 0.0 110.525 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 39' ' ' ALA . . . -125.91 145.09 50.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.474 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -51.44 172.42 0.15 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 35.6 Cg_endo -77.99 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.724 2.283 . . . . 0.0 110.671 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -103.9 -52.86 2.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.109 -0.995 . . . . 0.0 109.46 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -100.29 37.09 1.73 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.256 -0.902 . . . . 0.0 109.401 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -72.74 124.81 26.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -70.68 -36.27 73.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.517 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -149.2 121.6 8.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.449 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -84.03 136.48 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.536 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.794 HD12 HG13 ' A' ' 9' ' ' ILE . 21.8 mt -116.33 88.5 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 t -80.78 126.8 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.41 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -96.67 125.27 41.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.08 -19.09 54.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.391 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.95 -19.53 69.87 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -95.64 20.39 9.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.12 . . . . 0.0 109.286 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.537 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 14.9 t-105 -69.91 -15.42 63.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.86 34.94 5.24 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -148.78 -52.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -1.165 . . . . 0.0 109.584 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 55' ' ' GLU . 10.7 mtt-85 -130.67 63.58 1.58 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -42.07 74.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.242 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -73.13 -35.69 66.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.35 -0.844 . . . . 0.0 109.319 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -65.39 -32.78 74.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.292 -0.88 . . . . 0.0 109.328 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 52' ' ' ARG . 31.5 mt -76.11 -51.64 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 tp -47.51 -35.85 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -50.16 54.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 -34.55 58.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -1.151 . . . . 0.0 109.297 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -65.81 -52.03 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -0.843 . . . . 0.0 109.276 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -50.74 -39.14 51.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.188 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 1.5 mt -70.29 -34.01 72.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.352 -0.843 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.09 -54.85 42.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -70.88 -14.03 62.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.681 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -47.79 -29.33 3.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.89 -79.02 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -178.5 65.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 109.432 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.0 149.14 37.23 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.526 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HG2' ' HA ' ' A' ' 41' ' ' ALA . 34.7 Cg_endo -77.6 127.09 8.64 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.569 2.179 . . . . 0.0 110.162 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' SER . 53.5 mt -103.68 118.73 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.6 HD12 ' HB1' ' A' ' 103' ' ' ALA . 44.5 mm -108.53 119.42 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.001 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.496 ' O ' HG22 ' A' ' 93' ' ' VAL . 10.8 m -92.88 143.37 26.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.893 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' ARG . 41.0 t -121.74 115.26 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 109.181 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 73' ' ' VAL . 0.0 OUTLIER -43.12 155.3 0.28 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.6 158.57 32.17 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.671 2.247 . . . . 0.0 110.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -109.16 18.06 20.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.902 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -98.45 13.52 62.79 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 52.09 48.47 22.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.407 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.04 -143.38 0.35 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.313 -0.867 . . . . 0.0 109.125 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -142.19 108.64 5.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.13 -0.981 . . . . 0.0 109.612 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.899 HG11 ' OE2' ' A' ' 86' ' ' GLU . 14.1 p -50.49 140.85 17.71 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.91 . . . . 0.0 109.241 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 81' ' ' VAL . 35.3 Cg_endo -77.73 156.46 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.468 2.112 . . . . 0.0 110.316 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.9 Cg_endo -78.25 71.06 6.91 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.639 2.226 . . . . 0.0 110.716 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.21 -42.66 0.18 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.073 179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.61 -29.74 22.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.899 ' OE2' HG11 ' A' ' 81' ' ' VAL . 6.3 mp0 -72.2 -20.39 61.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.335 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.24 83.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.37 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 m -122.41 48.0 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.5 p -106.78 129.22 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.388 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 5.4 m -71.33 -34.24 70.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -157.13 142.9 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.504 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.36 100.34 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.287 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 72' ' ' THR . 4.4 m -95.08 144.54 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.85 -146.73 17.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -92.11 13.53 18.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -1.095 . . . . 0.0 109.535 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 3.0 m-20 -87.81 150.26 47.68 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 96' ' ' ASN . 35.3 Cg_endo -77.82 -35.27 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.654 2.236 . . . . 0.0 110.17 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.93 -26.89 69.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 92.1 m -77.42 -25.04 50.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.77 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 100' ' ' ILE . 22.3 mm -66.97 -58.48 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.681 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.73 -33.36 75.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.608 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.95 -33.57 76.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.741 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD12 ' A' ' 71' ' ' ILE . . . -69.77 -37.24 76.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.755 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.814 HD21 HD21 ' A' ' 7' ' ' LEU . 14.4 mt -77.24 -22.41 52.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.0 109.718 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.08 91.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.469 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -42.3 98.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.15 60.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.296 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.5 mp -94.17 -7.67 41.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -67.3 0.78 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 14.4 m -100.28 -27.3 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 111' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 1' ' ' VAL . 5.0 p . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 1' ' ' VAL . 0.2 OUTLIER -43.57 105.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.72 87.5 2.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -157.41 132.78 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 0.0 109.2 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.617 HG12 HD12 ' A' ' 108' ' ' LEU . 62.4 mt -122.08 165.76 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 109.686 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.6 ' N ' HG22 ' A' ' 5' ' ' ILE . 66.8 mtt180 -127.86 120.0 26.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.063 HD13 HD12 ' A' ' 43' ' ' ILE . 1.5 pp -145.42 170.79 15.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.751 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -137.38 139.14 40.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.204 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 7' ' ' LEU . 3.8 mt -121.63 147.89 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.693 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -65.01 121.37 14.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.329 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.29 169.36 12.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.177 -0.952 . . . . 0.0 109.572 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 178.22 -166.27 36.18 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -146.03 36.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -1.201 . . . . 0.0 109.488 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.88 163.21 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.148 -0.97 . . . . 0.0 109.521 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.835 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.1 tp10 -68.77 -31.94 71.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -59.04 -38.41 79.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -64.11 -46.66 83.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.679 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.47 -26.03 66.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.917 . . . . 0.0 109.679 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 15' ' ' GLU . 57.4 t -69.85 -55.23 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.577 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.477 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 9.6 t80 -55.99 -47.27 78.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.356 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.49 -37.79 70.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.92 -36.03 82.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.357 -0.839 . . . . 0.0 109.25 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -72.69 -28.51 62.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -72.4 -29.63 63.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.36 -41.26 61.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -17.93 9.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.4 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.58 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.12 -13.9 11.19 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.37 172.3 13.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -126.02 114.09 17.99 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -0.844 . . . . 0.0 109.456 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -127.1 154.66 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.465 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -115.76 149.35 42.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.302 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 35.9 Cg_endo -78.13 142.56 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.563 2.175 . . . . 0.0 110.683 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 -166.53 1.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.367 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.887 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -80.14 165.28 47.87 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 109.39 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.48 -4.54 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.58 2.187 . . . . 0.0 110.38 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.89 -37.35 3.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.253 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.3 33.39 3.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.229 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.887 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -102.14 142.96 32.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 0.2 OUTLIER -66.06 -34.76 78.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.498 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . . . -140.09 115.16 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 109.315 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.5 t -90.5 100.35 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.063 HD12 HD13 ' A' ' 7' ' ' LEU . 35.7 mt -92.26 99.83 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -0.872 . . . . 0.0 109.249 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.723 HG11 HG23 ' A' ' 56' ' ' ILE . 20.2 t -90.19 135.14 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.659 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.62 124.62 34.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.426 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.06 -0.07 55.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.165 -0.96 . . . . 0.0 109.575 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.16 -33.74 79.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.77 -81.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -1.116 . . . . 0.0 109.493 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.55 ' CH2' HD13 ' A' ' 85' ' ' LEU . 0.2 OUTLIER 48.75 22.41 0.53 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.846 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -117.86 -79.41 0.69 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.413 HG23 ' HD2' ' A' ' 52' ' ' ARG . 9.5 t -87.97 -26.93 22.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.328 -1.101 . . . . 0.0 109.345 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' O ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -93.11 34.05 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -59.88 -43.84 94.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.146 -0.971 . . . . 0.0 109.271 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.41 -21.09 62.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.262 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -43.81 62.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.454 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.723 HG23 HG11 ' A' ' 44' ' ' VAL . 1.8 mp -73.68 -58.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.86 -20.76 66.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 62' ' ' LEU . . . -73.93 -56.4 5.36 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.09 -39.55 75.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.325 -1.103 . . . . 0.0 109.335 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 70' ' ' ILE . 85.0 t -63.35 -45.17 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.532 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -57.68 -37.2 73.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.427 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD12 ' O ' ' A' ' 58' ' ' GLY . 1.2 mt -68.3 -39.59 82.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.539 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' A' ' 68' ' ' LYS . . . -76.3 -11.31 59.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.582 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -73.08 -19.27 61.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -74.24 -25.86 59.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.897 . . . . 0.0 109.884 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.62 9.81 4.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.144 -0.972 . . . . 0.0 109.955 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 t 54.17 59.78 4.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.005 . . . . 0.0 109.416 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 9.9 mttm -81.66 169.63 18.1 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 35.7 Cg_endo -78.27 106.52 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.767 2.311 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.423 HG21 HG22 ' A' ' 60' ' ' VAL . 4.0 mt -108.04 98.0 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.415 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.58 114.33 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.452 HG21 ' CD2' ' A' ' 85' ' ' LEU . 23.2 p -91.88 140.58 29.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -107.22 121.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.77 160.89 0.31 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.346 -0.846 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 -175.93 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.249 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.09 -42.58 90.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.478 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 147.63 44.6 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.76 -23.78 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -1.104 . . . . 0.0 109.444 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.36 126.92 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 109.455 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -60.72 147.8 41.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.355 -0.84 . . . . 0.0 109.62 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 m -55.46 155.64 9.76 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.371 -0.831 . . . . 0.0 109.475 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 161.89 29.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.623 2.215 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 86' ' ' GLU . 35.3 Cg_endo -77.58 -15.47 15.46 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.67 2.247 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -70.31 -27.54 64.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.55 HD13 ' CH2' ' A' ' 49' ' ' TRP . 0.6 OUTLIER -86.34 -24.8 25.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.541 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 83' ' ' PRO . 4.0 mt-10 -58.21 -35.2 71.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.1 -41.2 86.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.714 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 88' ' ' VAL . 18.9 m -89.46 4.0 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.747 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.1 t -101.64 143.57 31.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 t -107.37 -17.48 14.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.234 -0.916 . . . . 0.0 109.477 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.77 135.0 14.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.517 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.61 110.09 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.309 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.14 137.47 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.669 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -91.3 -144.11 12.45 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.96 63.65 1.19 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.243 -1.151 . . . . 0.0 109.477 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -138.55 143.15 37.04 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 109.357 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.95 -27.64 4.49 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.658 2.239 . . . . 0.0 110.628 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -73.13 -32.25 64.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.5 m -74.99 -47.35 29.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 109.862 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 12.7 mt -67.26 -13.1 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.748 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -76.27 -55.96 5.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.986 . . . . 0.0 109.617 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -72.94 -24.88 60.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.792 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.89 -42.49 73.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.596 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.74 -41.63 62.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.631 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -34.39 64.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.606 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.17 -31.8 69.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.0 109.597 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 41' ' ' ALA . . . -60.05 -16.83 34.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.94 . . . . 0.0 109.481 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.617 HD12 HG12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -66.91 -44.57 80.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.537 ' OD1' HG23 ' A' ' 111' ' ' ILE . 6.6 t70 -149.89 165.45 32.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.347 -0.846 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 3.1 t -139.12 77.1 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 109.426 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.537 HG23 ' OD1' ' A' ' 109' ' ' ASP . 1.2 pt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.521 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.78 80.74 1.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 29' ' ' LEU . . . -118.14 66.44 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.402 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' C ' HG13 ' A' ' 5' ' ' ILE . 3.4 mt-10 -132.4 139.13 47.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.016 HG21 HD22 ' A' ' 104' ' ' LEU . 1.2 mp -131.66 153.99 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 40' ' ' ASP . 20.7 mtt-85 -114.96 105.81 13.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.978 . . . . 0.0 109.395 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.46 171.7 13.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.965 . . . . 0.0 109.569 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -143.86 138.96 28.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.834 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 mt -120.85 133.82 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.353 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -58.35 111.89 1.38 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.217 -0.927 . . . . 0.0 109.35 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.499 ' HA ' ' CZ ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -52.44 135.37 33.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.86 ' HA3' HD21 ' A' ' 48' ' ' LEU . . . -136.84 148.78 19.92 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -77.9 -31.94 51.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 17' ' ' TYR . 25.1 m -43.36 137.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.506 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 19' ' ' VAL . 19.3 pt-20 -64.51 -24.28 67.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -0.925 . . . . 0.0 109.173 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' OD2' ' CG ' ' A' ' 76' ' ' TYR . 11.4 t70 -61.95 -31.06 71.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.102 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' ' HA ' ' A' ' 11' ' ' GLU . 69.7 t80 -64.48 -42.75 95.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -40.42 91.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.258 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 15' ' ' GLU . 4.9 t -57.96 -56.97 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.185 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.429 ' HE2' HG21 ' A' ' 43' ' ' ILE . 16.3 t80 -51.14 -40.19 57.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.232 -0.918 . . . . 0.0 109.129 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -54.88 -58.14 8.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.357 -0.84 . . . . 0.0 109.548 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.69 -17.23 60.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.558 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -71.89 -55.82 6.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.568 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.692 HD11 HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -56.83 -21.7 30.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.558 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -74.29 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.609 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.37 -1.92 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.91 -43.53 73.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 145.08 -71.53 0.36 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.631 HD13 ' CZ ' ' A' ' 101' ' ' ARG . 0.7 OUTLIER -66.55 157.5 32.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -1.137 . . . . 0.0 109.513 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -88.96 121.05 30.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -93.37 158.77 15.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 109.641 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.65 146.2 52.11 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.383 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.71 129.21 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.525 2.15 . . . . 0.0 110.104 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.69 164.96 12.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.933 . . . . 0.0 109.715 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.437 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -73.95 171.86 9.93 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.432 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 36.4 Cg_endo -80.28 42.23 1.28 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.805 2.337 . . . . 0.0 110.767 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -159.32 -62.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.958 -1.089 . . . . 0.0 109.635 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.33 27.98 1.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' ' CE ' ' A' ' 68' ' ' LYS . . . -64.22 132.47 50.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.87 . . . . 0.0 109.286 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -71.2 -33.84 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.26 23.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.34 110.32 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 20' ' ' PHE . 65.6 mt -93.63 94.72 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.519 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 70' ' ' ILE . 1.5 t -90.13 122.31 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 73' ' ' VAL . 4.1 mm? -81.81 121.52 26.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 0.0 109.287 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.797 ' HB1' ' CZ3' ' A' ' 49' ' ' TRP . . . -71.22 -12.23 61.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.601 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.33 29.93 11.25 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.86 HD21 ' HA3' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -124.86 -19.1 5.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.244 -1.151 . . . . 0.0 109.925 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.797 ' CZ3' ' HB1' ' A' ' 46' ' ' ALA . 1.8 p90 -66.82 -21.79 66.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.032 -1.042 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TRP . . . -64.17 -15.52 58.76 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.72 -48.28 3.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -1.115 . . . . 0.0 109.274 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -129.37 63.0 1.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.436 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.77 -23.33 6.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -74.2 -46.74 40.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.587 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -46.6 89.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.485 HD13 HG21 ' A' ' 10' ' ' THR . 50.3 mm -58.31 -54.24 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.462 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.0 tp -50.6 -30.4 13.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.02 -49.2 42.6 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.01 -46.53 64.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.276 -1.132 . . . . 0.0 108.846 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.54 -29.41 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.25 -0.906 . . . . 0.0 109.037 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' ARG . 16.8 t70 -59.16 -44.78 92.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.312 -0.867 . . . . 0.0 109.072 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.43 -38.23 65.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.339 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.445 ' HB1' HG12 ' A' ' 70' ' ' ILE . . . -68.7 -14.44 63.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' ASP . 4.6 mmm180 -65.5 -14.69 61.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.431 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' CB ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -64.2 -11.95 35.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.945 . . . . 0.0 109.499 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 71.44 39.16 0.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.64 -67.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.329 -0.857 . . . . 0.0 109.481 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 39' ' ' ALA . 2.3 mmtt -92.95 153.17 41.92 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.441 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 142.65 19.52 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.661 2.241 . . . . 0.0 110.443 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.445 HG12 ' HB1' ' A' ' 63' ' ' ALA . 1.9 mt -103.05 91.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.404 HG23 HG23 ' A' ' 93' ' ' VAL . 3.0 mt -80.12 115.77 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.272 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.9 p -98.73 139.84 33.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.683 ' HB ' HD13 ' A' ' 45' ' ' LEU . 19.0 t -111.22 130.71 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.176 -0.952 . . . . 0.0 109.43 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 73' ' ' VAL . 9.0 mtt180 -43.75 157.57 0.27 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.95 . . . . 0.0 109.557 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.48 145.56 23.7 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.675 2.25 . . . . 0.0 110.467 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 16.1 t80 -66.98 -10.89 54.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.42 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.923 ' C ' HD12 ' A' ' 78' ' ' LEU . . . -68.45 -95.05 0.05 OUTLIER Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.923 HD12 ' C ' ' A' ' 77' ' ' GLY . 6.0 mp -135.87 -92.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 3.4 pt-20 -159.31 -142.88 0.09 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.13 -0.982 . . . . 0.0 108.925 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 79' ' ' GLU . 2.0 m120 69.59 54.57 0.38 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.562 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 12.2 m -71.22 144.81 90.14 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 109.298 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 35.3 Cg_endo -78.09 146.78 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.548 2.166 . . . . 0.0 110.398 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 86' ' ' GLU . 35.1 Cg_endo -77.75 -9.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.533 2.155 . . . . 0.0 110.229 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -71.26 -58.39 3.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.206 -0.933 . . . . 0.0 109.394 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' O ' HD23 ' A' ' 85' ' ' LEU . 2.0 tt -72.63 -9.58 58.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 83' ' ' PRO . 0.6 OUTLIER -78.59 -11.25 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.484 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.66 -20.86 56.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.789 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -113.99 6.85 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.625 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 t -81.77 105.25 12.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.421 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -30.55 57.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.191 -0.943 . . . . 0.0 109.553 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.99 152.19 34.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.0 109.499 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -117.59 154.95 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.464 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.404 HG23 HG23 ' A' ' 71' ' ' ILE . 51.8 t -138.72 144.26 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.678 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -99.35 -161.85 29.31 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -91.56 36.72 0.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.19 -1.182 . . . . 0.0 109.503 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -113.27 155.84 43.95 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 109.43 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 100' ' ' ILE . 35.4 Cg_endo -77.92 -60.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.629 2.219 . . . . 0.0 110.345 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -51.13 -23.88 3.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.485 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.7 m -70.77 -51.83 24.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.536 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.692 HG21 HD11 ' A' ' 24' ' ' LEU . 5.2 mt -57.31 -62.98 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.631 ' CZ ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -43.71 -32.29 0.97 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.566 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.21 -60.16 4.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.541 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.016 HD22 HG21 ' A' ' 5' ' ' ILE . 17.0 mt -58.2 -56.36 23.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 0.0 109.636 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -73.17 -7.97 53.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -76.79 -24.66 52.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.661 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.61 -16.88 64.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 109.631 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 108' ' ' LEU . 0.5 OUTLIER -71.37 -26.66 62.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.313 -0.867 . . . . 0.0 109.728 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.62 155.71 18.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.182 -0.948 . . . . 0.0 109.643 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.05 121.9 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.331 -0.856 . . . . 0.0 109.303 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.537 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.7 p -110.25 92.87 4.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.711 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.66 -80.32 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.89 172.04 13.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.947 . . . . 0.0 109.567 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.96 HG21 HD21 ' A' ' 104' ' ' LEU . 11.7 tt -150.01 124.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.0 109.329 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -91.76 129.12 37.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.628 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -147.96 169.61 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.21 -0.931 . . . . 0.0 109.4 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -124.88 143.08 51.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' A' ' 21' ' ' LEU . 3.3 mt -122.16 125.0 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.13 145.06 2.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.46 105.85 10.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.211 -0.931 . . . . 0.0 109.764 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.02 -146.06 7.22 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.23 47.16 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.457 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.21 150.17 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.191 -0.943 . . . . 0.0 109.573 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -60.41 -45.32 94.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.918 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.46 -24.77 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.92 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -75.99 -45.88 32.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -0.993 . . . . 0.0 109.829 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -63.8 -35.38 80.42 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.105 -0.997 . . . . 0.0 109.614 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.2 t -71.78 -39.06 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.289 -0.882 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.651 ' CZ ' HG21 ' A' ' 43' ' ' ILE . 76.5 t80 -67.07 -62.72 1.29 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.115 -0.991 . . . . 0.0 109.796 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' CD1' HD13 ' A' ' 9' ' ' ILE . 12.9 tp -54.23 -49.39 69.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.435 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 18' ' ' ARG . 91.9 mt-10 -53.67 -33.96 57.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.276 -0.89 . . . . 0.0 109.578 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -35.27 65.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.781 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' CD1' ' CE2' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -48.26 -32.3 7.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.816 -179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.68 -42.69 86.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.196 -0.94 . . . . 0.0 109.683 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -72.15 -4.28 28.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.515 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -80.8 -12.91 59.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 109.421 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 70.33 -155.15 52.96 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 1.6 mt 61.68 171.41 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -1.155 . . . . 0.0 109.408 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.19 108.12 16.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.862 . . . . 0.0 109.375 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -117.88 153.23 33.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.175 -0.953 . . . . 0.0 109.522 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.1 mmt180 -138.4 146.28 50.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.287 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 Cg_endo -78.67 146.69 21.43 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.553 2.169 . . . . 0.0 110.405 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.98 -151.92 0.49 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.159 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -126.11 169.13 12.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.44 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 35.7 Cg_endo -77.85 71.12 6.72 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.596 2.198 . . . . 0.0 110.278 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 36' ' ' PRO . 2.0 mt-10 -173.66 -35.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.243 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.42 27.99 3.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.406 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.77 110.12 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -51.64 -47.51 63.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 109.685 -179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 7' ' ' LEU . . . -119.77 149.83 41.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.804 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -130.79 109.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.651 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 96.6 mt -90.83 118.99 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.518 ' CG1' HG23 ' A' ' 56' ' ' ILE . 6.5 t -102.97 126.35 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.622 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 48' ' ' LEU . 3.5 mm? -92.04 131.82 37.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.81 5.14 51.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.37 -20.7 71.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 45' ' ' LEU . 0.4 OUTLIER -110.6 38.15 2.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -1.097 . . . . 0.0 109.2 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CE2' ' HG3' ' A' ' 82' ' ' PRO . 26.3 t-105 -80.96 -17.56 50.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.768 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.56 11.11 53.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 p -122.99 -59.47 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -1.181 . . . . 0.0 109.585 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' O ' HG12 ' A' ' 56' ' ' ILE . 1.3 mpt_? -116.69 53.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -47.85 82.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.294 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.04 -41.23 59.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.312 -0.867 . . . . 0.0 109.409 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -42.19 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.584 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 48' ' ' LEU . 25.2 mm -59.65 -62.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.937 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.65 -31.49 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.822 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.1 -61.92 4.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -46.49 -35.97 6.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -1.149 . . . . 0.0 109.768 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 61' ' ' ASP . 80.9 t -67.96 -63.67 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 60' ' ' VAL . 21.0 t70 -43.14 -30.8 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.157 -0.964 . . . . 0.0 109.824 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.7 tp -76.92 -42.72 38.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.237 -0.915 . . . . 0.0 109.595 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.02 -57.0 12.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -62.89 -13.58 35.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.127 -0.983 . . . . 0.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -46.82 -27.99 1.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -140.36 -71.1 0.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.88 33.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.509 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -71.24 147.02 92.97 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 40' ' ' ASP . 35.6 Cg_endo -78.1 125.01 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.657 2.238 . . . . 0.0 110.589 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.94 124.27 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 71' ' ' ILE . 2.8 mm -92.71 107.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.318 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -81.6 109.1 15.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.949 . . . . 0.0 109.704 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.2 106.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.193 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.478 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 18.6 ptt85 -48.86 161.98 0.39 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 109.496 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 35.0 Cg_endo -78.02 -162.1 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.626 2.218 . . . . 0.0 110.208 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 76' ' ' TYR . 9.0 t80 -108.14 15.33 24.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.44 17.86 47.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 78' ' ' LEU . 2.2 mm? -93.06 -67.24 0.87 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -1.196 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -109.48 14.16 23.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' GLU . 1.3 m120 46.41 -173.62 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.532 -0.73 . . . . 0.0 109.642 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 ' HD2' ' A' ' 82' ' ' PRO . 14.9 p -126.28 138.32 32.04 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.346 -0.847 . . . . 0.0 109.057 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HG3' ' CE2' ' A' ' 49' ' ' TRP . 35.9 Cg_endo -78.24 165.68 25.43 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.464 2.109 . . . . 0.0 110.437 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.19 4.72 5.97 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.57 2.18 . . . . 0.0 110.352 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.87 -10.45 59.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.49 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 -29.26 14.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -0.934 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -32.49 74.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.882 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.99 -16.61 62.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 109.322 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.0 m -144.75 52.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.37 130.26 52.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.537 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.0 t -103.13 -38.68 7.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -117.35 140.68 49.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.57 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 93' ' ' VAL . 97.2 t -123.1 130.38 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.238 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.493 HG21 HG22 ' A' ' 71' ' ' ILE . 12.8 m -153.34 138.57 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.068 -1.02 . . . . 0.0 109.801 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -92.41 -145.74 16.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -86.81 -4.69 59.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.239 -1.154 . . . . 0.0 109.588 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -57.64 151.15 42.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.12 -56.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.579 2.186 . . . . 0.0 110.551 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.478 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 11.3 m170 -56.2 -17.56 7.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.94 . . . . 0.0 109.668 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 -43.76 83.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 109.538 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.13 -24.13 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -74.32 -51.39 15.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.91 . . . . 0.0 109.28 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -60.14 -35.99 76.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 109.477 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.96 -61.99 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.96 HD21 HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -45.75 -32.28 2.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.724 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.03 -43.18 68.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.756 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.94 -44.37 96.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.248 -0.907 . . . . 0.0 109.734 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.12 83.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.9 tp -45.01 -39.73 5.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 109.617 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.31 167.3 10.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 109.726 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 110' ' ' VAL . 2.2 p 170.93 103.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.352 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.423 ' OXT' HG13 ' A' ' 111' ' ' ILE . 18.2 pt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.86 154.94 33.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.315 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 4' ' ' GLU . . . -162.98 -67.21 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 3' ' ' ALA . 56.9 mt-10 65.54 -176.38 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.423 HG21 ' CD2' ' A' ' 104' ' ' LEU . 14.9 mt -135.64 135.26 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' ASP . 7.7 mpt_? -99.2 115.98 30.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.248 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -141.21 171.08 14.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.683 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -138.29 124.57 20.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.524 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG22 ' HE1' ' A' ' 17' ' ' TYR . 24.8 mt -114.29 139.19 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 m -63.06 134.78 56.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.77 164.84 13.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.368 -0.832 . . . . 0.0 109.494 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.24 169.62 40.91 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -141.29 47.6 1.69 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.221 -1.164 . . . . 0.0 109.416 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.79 172.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.312 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 pt-20 -68.39 -24.32 64.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.536 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.93 -55.28 15.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' HE1' HG22 ' A' ' 9' ' ' ILE . 13.5 t80 -51.57 -39.17 57.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -63.17 -42.26 99.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.594 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 15' ' ' GLU . 87.0 t -61.47 -43.78 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 109.837 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -62.0 -47.72 83.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.09 -1.006 . . . . 0.0 109.558 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tp -65.68 -20.31 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.263 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' OE2' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -73.15 -55.6 6.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.292 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -58.04 -51.08 71.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.43 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -45.26 -44.04 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -62.92 -53.56 52.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.74 -19.2 5.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.362 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.0 m -65.6 -68.29 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.374 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.16 8.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.6 pp -59.7 151.53 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -1.117 . . . . 0.0 109.521 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -99.59 106.15 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.799 ' HB2' HD21 ' A' ' 7' ' ' LEU . 67.5 p-90 -105.42 167.47 9.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -147.45 145.4 21.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.356 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.21 105.69 2.03 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.613 2.209 . . . . 0.0 110.444 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.85 -154.66 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.654 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 19.2 p -100.63 158.12 32.48 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.964 . . . . 0.0 109.443 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 -3.3 13.45 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.588 2.192 . . . . 0.0 110.573 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.494 ' HG3' ' HB3' ' A' ' 62' ' ' LEU . 4.1 mt-10 -102.27 -17.59 15.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.917 . . . . 0.0 109.314 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -144.16 36.53 1.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.376 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -82.86 125.11 30.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.647 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 6' ' ' ARG . 2.7 t70 -50.87 -31.9 18.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.877 . . . . 0.0 109.417 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.41 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.865 . . . . 0.0 109.379 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.498 HG22 ' HB3' ' A' ' 39' ' ' ALA . 1.6 t -91.94 107.18 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.28 102.28 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.31 132.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.666 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD22 ' HB ' ' A' ' 73' ' ' VAL . 1.1 mm? -103.13 135.85 44.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.282 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.56 11.51 28.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 109.635 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.44 61.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 48' ' ' LEU . 1.2 mp -90.94 32.95 0.96 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -1.154 . . . . 0.0 109.54 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.472 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 32.0 t-105 -62.56 -16.97 58.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.305 -0.872 . . . . 0.0 109.594 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.38 35.45 3.33 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -144.31 -67.42 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.35 52.68 0.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 109.619 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.27 -47.74 81.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.246 -0.909 . . . . 0.0 109.309 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.61 -22.93 48.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -77.16 -50.61 12.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 60' ' ' VAL . 3.9 mt -62.41 -27.13 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.649 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.4 tp -71.89 -32.68 67.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.28 -41.12 26.99 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.72 80.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -1.137 . . . . 0.0 109.854 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 56' ' ' ILE . 39.9 t -74.09 -34.89 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.9 -46.31 82.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.934 . . . . 0.0 109.966 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 37' ' ' GLU . 62.2 mt -70.88 -41.88 70.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.003 . . . . 0.0 109.806 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -25.62 68.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 109.704 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER -77.25 -20.2 55.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.76 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -79.71 -9.55 59.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' SER . 0.3 OUTLIER -125.67 3.52 7.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.119 -0.988 . . . . 0.0 109.736 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 66' ' ' SER . 17.9 m 60.62 38.38 18.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.9 mmpt? -71.28 161.36 78.76 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 0.0 109.355 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 68' ' ' LYS . 34.2 Cg_endo -76.99 108.45 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.429 2.086 . . . . 0.0 110.176 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 70' ' ' ILE . 15.2 mt -108.78 109.09 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.307 -0.87 . . . . 0.0 109.715 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.6 HG12 ' HB1' ' A' ' 103' ' ' ALA . 3.2 mt -97.83 117.2 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.258 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 m -80.54 147.65 30.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.978 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 45' ' ' LEU . 74.4 t -122.16 113.17 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.89 . . . . 0.0 109.423 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 0.0 OUTLIER -52.89 159.35 1.86 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 36.2 Cg_endo -77.82 166.64 25.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.733 2.289 . . . . 0.0 110.246 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -74.49 -59.1 2.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -149.64 15.83 1.08 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.075 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 79' ' ' GLU . 32.3 tp -71.83 -78.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.112 -1.228 . . . . 0.0 109.354 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 75' ' ' PRO . 2.5 tt0 -147.51 -143.05 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 109.041 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.4 ' OD1' ' OE1' ' A' ' 79' ' ' GLU . 2.9 p30 -124.59 176.65 6.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.311 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 t -99.91 134.95 20.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.939 . . . . 0.0 109.45 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 35.4 Cg_endo -78.17 173.04 14.48 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.435 2.09 . . . . 0.0 110.519 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 34.8 Cg_endo -77.37 -1.53 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.576 2.184 . . . . 0.0 110.596 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -73.91 -70.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.306 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -16.22 54.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.922 . . . . 0.0 109.289 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -73.51 -42.96 61.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.359 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -33.16 68.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.6 m -102.94 38.62 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.3 t -128.7 105.63 8.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.164 -0.96 . . . . 0.0 109.539 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 91' ' ' GLU . 1.5 m -56.52 -39.68 73.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' OE2' ' OD2' ' A' ' 106' ' ' ASP . 13.1 mp0 -138.29 157.95 45.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.59 133.57 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.431 -0.793 . . . . 0.0 109.131 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 99' ' ' CYS . 15.0 m -139.99 169.42 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.101 -0.999 . . . . 0.0 109.873 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 74' ' ' ARG . . . -106.45 -144.37 11.94 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -93.06 47.63 1.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -1.143 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -100.73 146.47 32.14 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -38.73 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.551 2.168 . . . . 0.0 110.317 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.54 -23.26 56.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 0.8 OUTLIER -73.58 -15.44 61.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.63 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 24.9 mm -73.37 -40.23 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.544 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -76.81 -34.66 57.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.67 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.81 -31.87 70.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.674 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HG12 ' A' ' 71' ' ' ILE . . . -77.19 -44.96 28.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.179 -0.951 . . . . 0.0 109.84 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -66.02 -28.7 69.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 109.874 -179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 2.4 tp10 -66.06 -21.31 66.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.884 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' OD2' ' OE2' ' A' ' 91' ' ' GLU . 1.1 t70 -63.17 -30.31 71.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.107 -0.996 . . . . 0.0 109.58 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.59 41.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.573 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 109' ' ' ASP . 1.9 tp -58.17 -52.37 65.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.347 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 108' ' ' LEU . 4.0 m-20 60.94 -95.74 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 110' ' ' VAL . 2.8 m -77.54 162.37 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.146 -0.971 . . . . 0.0 109.379 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 pt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.582 -179.847 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' THR . 2.1 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.244 0.545 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 46.96 92.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.9 . . . . 0.0 109.547 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.56 -56.55 1.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -0.9 . . . . 0.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 mp0 56.1 175.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 30' ' ' GLU . 7.5 tt -146.7 141.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.496 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.725 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.6 mtt-85 -97.64 104.38 16.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.682 HD23 ' HB3' ' A' ' 41' ' ' ALA . 37.6 mt -113.35 157.73 21.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.301 -0.874 . . . . 0.0 109.424 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -134.88 92.12 2.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.742 HG21 ' CE1' ' A' ' 17' ' ' TYR . 2.7 mp -89.28 162.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.429 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.494 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -88.2 159.01 18.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 109.426 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.14 128.89 56.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.983 . . . . 0.0 109.61 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.21 -162.98 11.66 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -125.42 -4.67 7.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -1.147 . . . . 0.0 109.578 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 16' ' ' ASP . 18.1 m -83.74 -178.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.386 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 19' ' ' VAL . 13.3 pt-20 -92.2 -2.46 56.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.946 . . . . 0.0 109.655 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -65.95 -69.54 0.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.509 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.742 ' CE1' HG21 ' A' ' 9' ' ' ILE . 5.0 t80 -48.64 -29.15 4.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.664 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -51.5 65.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.096 -1.002 . . . . 0.0 109.427 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 15' ' ' GLU . 20.0 t -62.67 -33.08 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 109.743 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -63.22 -57.95 8.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.5 tt -55.65 -34.23 64.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.57 -40.03 95.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.894 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -40.52 74.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.929 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.83 71.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -34.69 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.672 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -68.96 -22.22 64.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.134 -0.979 . . . . 0.0 109.381 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -45.41 -45.99 13.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.475 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.04 -32.54 6.27 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.01 150.24 31.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -1.174 . . . . 0.0 109.533 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -87.91 151.5 22.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.9 . . . . 0.0 109.453 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.435 ' C ' ' HG3' ' A' ' 32' ' ' ARG . 46.8 p-90 -153.43 160.84 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 24.2 mtt-85 -141.86 158.6 61.97 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 32' ' ' ARG . 35.2 Cg_endo -78.18 95.47 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.677 2.251 . . . . 0.0 110.129 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 6' ' ' ARG . . . -73.78 -176.77 2.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 109.681 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -87.2 173.55 6.45 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.257 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HB2' HD13 ' A' ' 62' ' ' LEU . 35.7 Cg_endo -78.23 -9.81 16.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.557 2.171 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -114.51 -6.48 12.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.848 . . . . 0.0 109.415 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -139.38 48.13 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.255 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 35' ' ' THR . . . -101.83 127.61 48.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.922 . . . . 0.0 109.658 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -67.41 -40.71 85.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' HD23 ' A' ' 7' ' ' LEU . . . -142.07 134.8 28.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.43 126.24 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.98 . . . . 0.0 109.669 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 43' ' ' ILE . 2.5 mt -109.48 93.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 109.202 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.77 115.07 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.575 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 43' ' ' ILE . 13.6 mt -85.59 127.15 34.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.94 -0.47 35.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.211 -0.93 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.35 -15.52 70.35 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -105.87 29.41 6.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.331 -1.1 . . . . 0.0 109.21 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -72.5 -26.94 61.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.68 40.45 2.44 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.402 HG23 ' H ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -159.66 -55.08 0.06 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -1.182 . . . . 0.0 109.529 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.688 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.2 mpt_? -116.29 56.97 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -47.98 26.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.431 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.1 -36.77 75.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.833 . . . . 0.0 109.56 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -69.61 -62.04 1.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 60' ' ' VAL . 16.1 mt -43.14 -36.08 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.866 . . . . 0.0 109.688 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.9 tp -56.04 -56.05 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.42 -47.67 62.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.24 -38.45 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -1.185 . . . . 0.0 109.585 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 56' ' ' ILE . 2.7 t -71.89 -29.19 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -66.86 -38.7 86.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.787 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.663 HD13 ' HB2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -75.83 -43.14 47.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.944 . . . . 0.0 109.968 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.621 ' CB ' HD11 ' A' ' 70' ' ' ILE . . . -67.29 -27.64 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.952 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -77.24 -30.75 54.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.042 -1.036 . . . . 0.0 109.82 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 6.5 16.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 7.05 4.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.091 -1.006 . . . . 0.0 109.694 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.2 m 51.26 38.64 21.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 159.49 53.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.68 108.75 2.62 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.528 2.152 . . . . 0.0 110.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 63' ' ' ALA . 17.2 mt -108.66 114.71 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.8 mt -107.0 141.38 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.329 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 m -109.78 135.03 51.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.528 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.6 t -101.09 133.49 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 109.57 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -58.13 155.09 26.94 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.356 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.9 159.21 31.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.676 2.251 . . . . 0.0 110.403 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -81.57 -53.59 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -150.37 83.3 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.14 -35.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -1.155 . . . . 0.0 109.535 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 66.45 128.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.37 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' C ' ' HD3' ' A' ' 82' ' ' PRO . 1.8 m-20 171.96 39.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.15 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 81' ' ' VAL . 80.5 t -118.04 79.06 13.7 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 109.434 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 36.1 Cg_endo -78.29 174.67 12.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.595 2.197 . . . . 0.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 82' ' ' PRO . 36.2 Cg_endo -79.05 9.43 3.34 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.77 2.313 . . . . 0.0 110.613 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -56.47 3.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -0.997 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -11.23 60.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -0.971 . . . . 0.0 109.678 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -71.51 -28.82 64.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.556 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.87 -9.92 42.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.63 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.0 t -110.06 -59.25 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.197 -0.94 . . . . 0.0 109.43 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.97 150.47 2.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.3 m -106.38 -21.04 13.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -0.916 . . . . 0.0 109.372 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -151.39 163.92 37.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.92 . . . . 0.0 109.408 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.73 159.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 103' ' ' ALA . 54.1 t -128.3 160.25 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.11 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 93' ' ' VAL . . . -112.42 -152.71 11.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -107.14 50.24 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -1.134 . . . . 0.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.5 OUTLIER -125.49 162.19 45.98 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 96' ' ' ASN . 35.9 Cg_endo -78.07 -43.31 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.751 2.301 . . . . 0.0 110.572 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -26.34 58.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -0.941 . . . . 0.0 109.827 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.6 m -62.23 -64.57 0.89 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.743 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.453 HG12 HG11 ' A' ' 93' ' ' VAL . 67.9 mt -44.68 -25.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -0.899 . . . . 0.0 109.839 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.13 -46.93 39.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.108 -0.995 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.86 -17.5 64.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.626 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 93' ' ' VAL . . . -71.13 -59.14 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.12 -0.988 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.63 -37.56 86.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.562 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -51.4 -48.21 62.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -31.32 72.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.8 -62.22 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 35.06 2.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -46.51 131.79 10.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.531 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 14.6 p -107.87 -10.22 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.375 -0.828 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.441 ' OXT' HG22 ' A' ' 111' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 1' ' ' VAL . 9.3 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 p -110.9 114.0 27.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.467 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.31 106.07 6.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.519 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.65 141.94 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.15 -0.968 . . . . 0.0 109.332 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.8 160.68 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.187 -0.945 . . . . 0.0 109.69 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 6.5 mpt_? -106.98 128.83 54.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.999 ' HG ' ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -137.61 166.98 22.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.695 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -151.13 115.42 5.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.56 141.26 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.58 125.67 10.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.78 126.64 28.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.99 30.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -129.0 53.12 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -1.151 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.731 HG23 ' H ' ' A' ' 17' ' ' TYR . 15.4 m -112.62 143.23 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.306 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 19' ' ' VAL . 29.0 tt0 -54.31 -25.12 22.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -70.58 -65.37 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.512 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 14' ' ' VAL . 5.5 t80 -50.08 -28.36 7.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.383 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -48.4 55.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 15' ' ' GLU . 71.7 t -61.37 -29.51 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.852 . . . . 0.0 109.657 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -71.19 -45.93 62.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.917 . . . . 0.0 109.358 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD23 ' CE1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -56.98 -46.17 82.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -36.79 84.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.51 71.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.566 ' CD2' ' NE1' ' A' ' 31' ' ' TRP . 0.4 OUTLIER -75.69 -49.06 19.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.63 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -68.22 -17.97 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.903 . . . . 0.0 109.571 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -70.67 -52.5 20.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.493 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.4 t -47.76 -35.85 10.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.537 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 29' ' ' LEU . . . 125.58 -154.79 18.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.432 ' CB ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 71.04 165.92 0.29 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 109.454 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -137.69 100.86 4.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.659 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' CD2' ' A' ' 24' ' ' LEU . 60.8 p-90 -115.36 157.93 23.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 109.28 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -125.17 152.46 70.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 0.0 109.514 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.46 125.64 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.699 2.266 . . . . 0.0 110.512 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.96 153.43 35.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.486 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -53.92 173.21 0.21 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.331 -0.856 . . . . 0.0 109.392 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 35' ' ' THR . 34.8 Cg_endo -76.9 -0.34 10.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.541 2.161 . . . . 0.0 110.372 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -104.25 -6.09 21.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.345 -0.847 . . . . 0.0 109.303 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.34 30.07 1.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.82 98.96 12.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 6' ' ' ARG . 12.4 m-20 -50.76 -45.32 58.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.196 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.999 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . . . -116.02 121.92 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.363 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.01 110.56 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 7' ' ' LEU . 6.6 mt -103.23 123.25 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.83 HG11 HG23 ' A' ' 56' ' ' ILE . 2.4 t -113.77 120.89 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD11 ' CD1' ' A' ' 17' ' ' TYR . 53.0 mt -80.21 148.25 30.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.906 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.38 17.06 24.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.499 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -87.74 -29.85 19.93 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 24.14 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -1.152 . . . . 0.0 109.424 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 49' ' ' TRP . 41.8 t-105 -60.71 -14.21 19.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.55 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.91 37.96 2.28 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.0 p -150.31 -58.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.266 -1.137 . . . . 0.0 109.549 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -116.24 46.21 1.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.0 109.725 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HA ' HD12 ' A' ' 56' ' ' ILE . 2.1 ttt180 -57.84 -34.26 69.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -39.74 94.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.605 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . 3.7 tt0 -65.59 -41.69 92.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.643 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.83 HG23 HG11 ' A' ' 44' ' ' VAL . 5.2 mt -70.82 -23.91 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -73.11 -52.65 13.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.71 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.98 73.97 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.91 -62.15 1.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -1.157 . . . . 0.0 109.599 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 70' ' ' ILE . 80.8 t -55.62 -31.02 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -63.0 -55.3 26.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -60.47 -25.08 65.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 0.0 109.281 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.61 -50.53 62.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -7.56 38.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.841 . . . . 0.0 109.644 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -49.21 -32.61 10.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -135.58 -69.55 0.49 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.493 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.43 43.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.686 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.25 151.15 75.11 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.139 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.08 116.53 4.21 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.807 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 60' ' ' VAL . 4.4 mt -107.43 98.53 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 108.881 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.549 ' CG2' ' CG2' ' A' ' 93' ' ' VAL . 10.4 mt -90.22 112.75 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 85' ' ' LEU . 15.0 p -89.41 141.51 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.13 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 93' ' ' VAL . 84.6 t -115.68 132.36 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.124 -0.985 . . . . 0.0 109.688 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HG2' ' HA2' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -51.7 158.47 1.58 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . 36.2 Cg_endo -78.96 169.7 19.0 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 0.0 110.507 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 76' ' ' TYR . 74.8 t80 -82.9 8.85 11.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' O ' HD12 ' A' ' 78' ' ' LEU . . . 122.12 71.49 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -151.98 81.9 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.562 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 78' ' ' LEU . 3.1 mt-10 70.91 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.476 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -59.8 137.06 58.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.613 HG13 ' HD2' ' A' ' 82' ' ' PRO . 86.9 t -68.44 141.04 92.92 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD2' HG13 ' A' ' 81' ' ' VAL . 35.5 Cg_endo -78.45 155.81 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.563 2.176 . . . . 0.0 110.412 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -78.16 -10.09 16.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.555 2.17 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -67.87 -15.93 63.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.295 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 72' ' ' THR . 42.2 tp -93.84 -18.79 21.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -24.47 43.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.191 -0.943 . . . . 0.0 109.589 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.13 61.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.93 . . . . 0.0 109.389 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.7 -0.18 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.51 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 21.3 t -96.23 135.84 37.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.58 -33.01 54.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.82 168.99 24.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 72' ' ' THR . 5.2 m -130.71 156.65 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.897 . . . . 0.0 109.464 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 73' ' ' VAL . 2.1 t -135.97 155.56 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' ' HG2' ' A' ' 74' ' ' ARG . . . -116.98 -155.69 10.33 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -88.89 37.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -1.199 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.1 149.05 39.53 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 -66.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.609 2.206 . . . . 0.0 110.517 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.24 -32.28 1.86 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.229 -0.919 . . . . 0.0 109.687 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.54 -53.11 59.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.836 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 45.6 mt -55.05 -23.56 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.988 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -69.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -28.08 50.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.161 -0.962 . . . . 0.0 109.993 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.33 -51.73 48.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 109.452 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 7' ' ' LEU . 5.6 tt -72.46 -15.06 61.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.257 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.3 -28.97 63.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.296 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -68.2 -12.53 61.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.429 -0.794 . . . . 0.0 109.537 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.53 -58.8 4.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.583 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.4 2.35 16.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.73 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.41 152.96 28.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.528 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.16 -4.46 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.077 -1.014 . . . . 0.0 109.433 179.935 . . . . . . . . 0 0 . 1 stop_ save_